
<html lang="en"     class="pb-page"  data-request-id="cb36f36e-4457-4e10-8cf2-e6f7ec95337e"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2017.60.issue-10;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.7b00441;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="4-Anilino-2-pyridylquinazolines and -pyrimidines as Highly Potent and Nontoxic Inhibitors of Breast Cancer Resistance Protein (ABCG2)" /></meta><meta name="dc.Creator" content="Michael K.  Krapf" /></meta><meta name="dc.Creator" content="Jennifer  Gallus" /></meta><meta name="dc.Creator" content="Michael  Wiese" /></meta><meta name="dc.Description" content="Multidrug resistance (MDR) mediated by ATP-binding cassette (ABC) transport proteins remains a major problem in the chemotherapeutic treatment of cancer and might be overcome by inhibition of the t..." /></meta><meta name="Description" content="Multidrug resistance (MDR) mediated by ATP-binding cassette (ABC) transport proteins remains a major problem in the chemotherapeutic treatment of cancer and might be overcome by inhibition of the t..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 12, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00441" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00441" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00441" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00441" /></link>
        
    
    

<title>4-Anilino-2-pyridylquinazolines and -pyrimidines as Highly Potent and Nontoxic Inhibitors of Breast Cancer Resistance Protein (ABCG2) | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00441" /></meta><meta property="og:title" content="4-Anilino-2-pyridylquinazolines and -pyrimidines as Highly Potent and Nontoxic Inhibitors of Breast Cancer Resistance Protein (ABCG2)" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0014.jpeg" /></meta><meta property="og:description" content="Multidrug resistance (MDR) mediated by ATP-binding cassette (ABC) transport proteins remains a major problem in the chemotherapeutic treatment of cancer and might be overcome by inhibition of the transporter. Because of the lack of understanding, the complex mechanisms involved in the transport process, in particular for breast cancer resistance protein (BCRP/ABCG2), there is a persistent need for studies of inhibitors of ABCG2. In this study, we investigated a systematic series of 4-substituted-2-pyridylquinazolines in terms of their inhibitory potency as well as selectivity toward ABCG2. For comparison, the quinazoline scaffold was reduced to the significantly smaller 4-methylpyrimidine basic structure. Furthermore, the cytotoxicity and the ability to reverse MDR was tested with the chemotherapeutic agents SN-38 and mitoxantrone (MX). Interaction of the compounds with ABCG2 was investigated by a colorimetric ATPase assay. Enzyme kinetic studies were carried out with Hoechst 33342 as fluorescent dye and substrate of ABCG2 to elucidate the compounds binding modes." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00441"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00441">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00441&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00441&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00441&amp;href=/doi/10.1021/acs.jmedchem.7b00441" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 10</span><span class="cit-fg-pageRange">, 4474-4495</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/10" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00418" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b01472" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">4-Anilino-2-pyridylquinazolines and -pyrimidines as Highly Potent and Nontoxic Inhibitors of Breast Cancer Resistance Protein (ABCG2)</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+K.++Krapf">Michael K. Krapf</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jennifer++Gallus">Jennifer Gallus</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Wiese">Michael Wiese</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-5851-5336" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Pharmaceutical Institute, University of Bonn, An der Immenburg 4, 53121 Bonn, Germany</span></div><div class="corresp-info"><strong>*</strong>Phone: +49-228-735213. Fax: 0049-228-737929. E-mail: <a href="/cdn-cgi/l/email-protection#8ee3f9e7ebfdebcefbe0e7a3ece1e0e0a0eaeb"><span class="__cf_email__" data-cfemail="0d607a64687e684d786364206f626363236968">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00441&amp;href=/doi/10.1021%2Facs.jmedchem.7b00441" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 10</span><span class="cit-pageRange">, 4474–4495</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 4, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>22 March 2017</li><li><span class="item_label"><b>Published</b> online</span>12 May 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 May 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00441" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00441</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4474%26pageCount%3D22%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMichael%2BK.%2BKrapf%252C%2BJennifer%2BGallus%252C%2BMichael%2BWiese%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D10%26contentID%3Dacs.jmedchem.7b00441%26title%3D4-Anilino-2-pyridylquinazolines%2Band%2B-pyrimidines%2Bas%2BHighly%2BPotent%2Band%2BNontoxic%2BInhibitors%2Bof%2BBreast%2BCancer%2BResistance%2BProtein%2B%2528ABCG2%2529%26numPages%3D22%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4495%26publicationDate%3DMay%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00441"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1197</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">27</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00441" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;4-Anilino-2-pyridylquinazolines and -pyrimidines as Highly Potent and Nontoxic Inhibitors of Breast Cancer Resistance Protein (ABCG2)&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;K. Krapf&quot;},{&quot;first_name&quot;:&quot;Jennifer&quot;,&quot;last_name&quot;:&quot;Gallus&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Wiese&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;12&quot;,&quot;issue&quot;:&quot;10&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;4474-4495&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00441&quot;},&quot;abstract&quot;:&quot;Multidrug resistance (MDR) mediated by ATP-binding cassette (ABC) transport proteins remains a major problem in the chemotherapeutic treatment of cancer and might be overcome by inhibition of the transporter. Because of the lack of understanding, the complex mechanisms involved in the transport process, in particular for breast cancer resistance protein (BCRP/ABCG2), there is a persistent need for studies of inhibitors of ABCG2. In this study, we investigated a systematic series of 4-substituted-2-pyridylquinazolines in terms of their inhibitory potency as well as selectivity toward ABCG2. For comparison, the quinazoline scaffold was reduced to the significantly smaller 4-methylpyrimidine basic structure. Furthermore, the cytotoxicity and the ability to reverse MDR was tested with the chemotherapeutic agents SN-38 and mitoxantrone (MX). Interaction of the compounds with ABCG2 was investigated by a colorimetric ATPase assay. Enzyme kinetic studies were carried out with Hoechst 33342 as fluorescent dye and subs&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00441&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00441" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00441&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00441" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00441&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00441" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00441&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00441&amp;href=/doi/10.1021/acs.jmedchem.7b00441" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00441" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00441" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00441%26sid%3Dliteratum%253Aachs%26pmid%3D28471656%26genre%3Darticle%26aulast%3DKrapf%26date%3D2017%26atitle%3D4-Anilino-2-pyridylquinazolines%2Band%2B-pyrimidines%2Bas%2BHighly%2BPotent%2Band%2BNontoxic%2BInhibitors%2Bof%2BBreast%2BCancer%2BResistance%2BProtein%2B%2528ABCG2%2529%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D10%26spage%3D4474%26epage%3D4495%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292201" title="Scaffolds">Scaffolds</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=290832" title="Pyridyl">Pyridyl</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/10" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/jmcmar.2017.60.issue-10/20170525/jmcmar.2017.60.issue-10.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/medium/jm-2017-00441x_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00441&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Multidrug resistance (MDR) mediated by ATP-binding cassette (ABC) transport proteins remains a major problem in the chemotherapeutic treatment of cancer and might be overcome by inhibition of the transporter. Because of the lack of understanding, the complex mechanisms involved in the transport process, in particular for breast cancer resistance protein (BCRP/ABCG2), there is a persistent need for studies of inhibitors of ABCG2. In this study, we investigated a systematic series of 4-substituted-2-pyridylquinazolines in terms of their inhibitory potency as well as selectivity toward ABCG2. For comparison, the quinazoline scaffold was reduced to the significantly smaller 4-methylpyrimidine basic structure. Furthermore, the cytotoxicity and the ability to reverse MDR was tested with the chemotherapeutic agents SN-38 and mitoxantrone (MX). Interaction of the compounds with ABCG2 was investigated by a colorimetric ATPase assay. Enzyme kinetic studies were carried out with Hoechst 33342 as fluorescent dye and substrate of ABCG2 to elucidate the compounds binding modes.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01372" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01372" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">ATP-binding cassette (ABC) transporter form a large superfamily of which members are found in all organisms from bacteria over plants to men. In humans, 49 ABC transporters were identified and classified according to their phylogenetic similarities in seven subfamilies, ABC A to ABC G.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1-3)</a> While most ABC transporters have well-defined substrates, some are multispecific playing an important role in the protection of the human body against xenobiotics to enhance survival.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Naturally, these are expressed in organs with barrier function, as intestine or the blood–brain barrier. Unfortunately, they are frequently overexpressed in some tumor tissues which may lead to resistance against anticancer drugs and failure of a chemotherapeutic treatment due to insufficient drug concentration in the cancer cell.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Regarding dissemination of tumors, chemotherapy remains the most promising therapy although its prognosis of curing is rather limited due to acquired or intrinsic drug resistance which accounts for roughly 90% of treatment failures.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> This so-called multidrug resistance (MDR) is often associated with the three major MDR related ABC transport proteins, P-glycoprotein (P-gp, ABCB1), multidrug resistance-associated protein 1 (MRP1, ABCC1), and breast cancer resistance protein (BCRP, ABCG2).<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> Among these, ABCG2 was most recently discovered and found to be mainly overexpressed in drug-resistant solid tumors as well as hematopoietic tumors.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a></div><div class="NLM_p">Unlike ABCB1 and ABCC1, the breast cancer resistance protein ABCG2 is a half-transporter consisting of 655 amino acids with only one cytosolic nucleotide-binding domain (NBD) and one transmembrane domain (TMD).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> For its function, it is assumed to form dimers or tetramers as several studies suggest.<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11-13)</a> Also, the details of the transport process of the drugs remain unclear and there is need for further investigations.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a></div><div class="NLM_p">Recently, a crystal structure of the human sterol transporter ABCG5/ABCG8 was published that could be used for homology modeling of ABCG2.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Although the X-ray crystal structure of the protein possessed a relative low resolution of 3.9 Å only, it is the first structure with an inverse organization of the NBD and TMD domains. Shortly afterward, a homology model of ABCG2 was created and employed to investigate substrate binding and effects of point mutations in the transporter comparing the in silico results to experimental data.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><div class="NLM_p">Since its discovery in 1998 by Doyle et al., in MCF-7/AdrVp human breast cell carcinoma cells, many chemotherapeutics like mitoxantrone (MX), flavopiridol, methotrexate, irinotecan, and its active metabolite SN-38 were identified as substrates of ABCG2.<a onclick="showRef(event, 'ref1 ref18'); return false;" href="javascript:void(0);" class="ref ref1 ref18">(1, 18)</a> Therefore, inhibition of the target with potent, selective, and nontoxic inhibitors in coadministration could be a possible approach to overcome ABCG2 caused MDR.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a> Recent studies suggest that the expression of ABCG2 in colorectal cancer is associated with shortened patient survival and less response to chemotherapeutic treatment with oxaliplatin and 5-fluorouracil (FOLFOX).<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a> Although ABCG2 expression and clinical outcomes sometimes found to be contradictory, inhibition of ABCG2 remains a promising tool to increase the oral bioavailability of chemotherapeutics or to overcome MDR.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><div class="NLM_p">Relating to inhibitors of ABCG2, only a few potent compounds active at a submicromolar concentration range have been reported, revealing high selectivity and low cytotoxicity.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> As one of the first potent inhibitors, fumitremorgin C (FTC) was isolated from <i>Aspergillus fumigates</i> and found to restore sensitivity toward MX in the resistant S1-M1-3.2 cell line.<a onclick="showRef(event, 'ref21 ref24'); return false;" href="javascript:void(0);" class="ref ref21 ref24">(21, 24)</a> Because of neurotoxic effects of FTC, an analogue named Ko143 (<b>55</b>) was developed.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> This second-generation inhibitor exhibited moderate toxicity and a high inhibitory potency as well as good selectivity toward ABCG2. However, recent studies suggest that selectivity at concentrations ≥1 μM is restricted because effects on the transport activity of ABCB1 and ABCC1 were observed.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Recently the synthesis of highly potent and nontoxic inhibitors with a phenolic indeno[1,2-<i>b</i>]indole core has been reported,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and more recently highly potent and nontoxic inhibitors containing the chromone scaffold with potency comparable to compound <b>55</b> have been developed by the same working group.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Also tyrosine kinase inhibitors like gefitinib that found clinical application in the treatment of cancer have been shown to be potent inhibitors of ABCG2.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div><div class="NLM_p">On the basis of the quinazoline scaffold of gefitinib, we designed a focused library of different 4-substituted-2-phenylquinazolines. The studies revealed distinct trends regarding different substitutions and yielded new compounds, some with higher inhibitory potencies than compound <b>55</b> as well as high selectivity toward ABCG2 and considerably low toxicities.<a onclick="showRef(event, 'ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32">(30-32)</a> In the present study, a pyridyl substituent was introduced in position 2 with the nitrogen in <i>ortho</i>, <i>meta</i>, and <i>para</i> position. Additionally, a systematic variation at the anilino linker in position 4 was carried out in <i>meta</i> and <i>para</i> position to elucidate the structure–activity relationship (SAR), providing a comparison to the 2-phenyl analogues from our previous study.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Moreover, compounds based on a 4-methylpyrimidine scaffold were synthesized to investigate the importance of the condensed aromatic ring of the quinazoline scaffold with regard to its inhibitory potency toward ABCG2.</div><div class="NLM_p last">On the basis of the new findings, insights in the development of new potent inhibitors based on both a quinazoline and a 4-methylpyrimidine scaffold is provided, yielding new inhibitors of ABCG2 with promising characteristics for further in vitro and in vivo applications.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83438" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83438" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">A brief description of the synthetic route for all compounds is provided in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Precursors of the quinazoline derivatives were prepared by a cyclic condensation reaction of anthranilamide with the corresponding pyridine carboxaldehyde to yield the 2-substituted quinazolinone derivatives <b>1</b>–<b>3</b>. Chlorination of position 4 of the quinazolinone derivative was achieved by refluxing with POCl<sub>3</sub> to obtain the 4-chloro derivatives <b>4</b>–<b>6</b>. Final compounds <b>11</b>–<b>41</b> were synthesized by aromatic nucleophilic substitution of <b>4</b>–<b>6</b> with a <i>meta</i> and/or <i>para</i> substituted aniline derivative using microwave irradiation.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/medium/jm-2017-00441x_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthesis Route for the Compounds <b>1</b>–<b>48</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00441&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) DMF, I<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 70–90 °C, 4–8 h; (ii) MeOH, NaOMe, 60 W microwave irradiation, 70 °C, 4 h; (iii) POCl<sub>3</sub>, reflux, 4–12 h; (iv) Substituted aniline, 100 W microwave irradiation, 110 °C, 15–30 min.</p></p></figure><div class="NLM_p">The 2-substituted 6-methyl-pyrimidine derivatives <b>42</b>–<b>48</b> were synthesized starting from a cyclic condensation reaction of methyl 3-oxobutanoate with isonicotinimidamide or benzimidamide to obtain <b>7</b> and <b>8</b>, respectively. Refluxing with POCl<sub>3</sub> yielded the 4-chloro derivatives <b>9</b> and <b>10</b>. In the last step, the chloro-substituted compounds were reacted with a <i>meta</i> and/or <i>para</i> substituted aniline derivatives using microwave irradiation to yield <b>42</b>–<b>48</b> by a nucleophilic aromatic substitution reaction.</div><div class="NLM_p">Because <i>ortho</i>-substitution of the 4-anilino linker resulted in poor inhibitory activities in previous studies, only <i>meta</i> and <i>para</i> substitutions were considered in this work.</div><div class="NLM_p last">The identity of all compounds was confirmed by <sup>1</sup>H and <sup>13</sup>C NMR spectra and the purity by elemental analysis. Moreover, the melting points of all test compounds were determined.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Biological Evaluation</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83587" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83587" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Hoechst 33342 Accumulation Assay</h3><div class="NLM_p">The Hoechst 33342 accumulation assay was used to determine the inhibitory activity of each test compound against ABCG2 using the MDCK II BCRP cell line. The fluorescent dye Hoechst 33342 is a substrate of ABCG2 and significantly increases its fluorescence when bound to DNA or embedded in lipophilic environment like the cell membrane.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> This is utilized to determine the intracellular accumulation of the substrate that correlates with the degree of inhibition of the transport protein by a compound.</div><div class="NLM_p">An overview of the inhibitory activities obtained in the Hoechst 33342 accumulation assay along with the structural features of the compounds is depicted in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>. A summary of the SAR is given in the end of this section, providing a quick overview of the most important results (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibitory Activities Determined in the Hoechst 33342 Accumulation Assay Using ABCG2 Overexpressing MDCK II Cells: Structural Formulas of Scaffolds A and B Are Depicted Below</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/medium/jm-2017-00441x_0013.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">scaffold</th><th class="colsep0 rowsep0" align="center" char="±">Hoechst 33342 IC<sub>50</sub>  ± SD [nM]<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">2-Pyr</td><td class="colsep0 rowsep0" align="left">3-NO<sub>2</sub></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">376 ± 91</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">3-Pyr</td><td class="colsep0 rowsep0" align="left">3-NO<sub>2</sub></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">105 ± 35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">4-Pyr</td><td class="colsep0 rowsep0" align="left">3-NO<sub>2</sub></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">117 ± 29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">3-Pyr</td><td class="colsep0 rowsep0" align="left">4-NO<sub>2</sub></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">64.1 ± 8.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">2-Pyr</td><td class="colsep0 rowsep0" align="left">3-CN</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">507 ± 61</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">3-Pyr</td><td class="colsep0 rowsep0" align="left">3-CN</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">108 ± 21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">4-Pyr</td><td class="colsep0 rowsep0" align="left">3-CN</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">134 ± 10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">3-Pyr</td><td class="colsep0 rowsep0" align="left">4-CN</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">166 ± 29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">2-Pyr</td><td class="colsep0 rowsep0" align="left">3-OMe</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">1630 ± 320</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">3-Pyr</td><td class="colsep0 rowsep0" align="left">3-OMe</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">1020 ± 180</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">4-Pyr</td><td class="colsep0 rowsep0" align="left">3-OMe</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">558 ± 111</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">4-Pyr</td><td class="colsep0 rowsep0" align="left">4-OMe</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">742 ± 21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">2-Pyr</td><td class="colsep0 rowsep0" align="left">3,4-OMe</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">1060 ± 80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">3-Pyr</td><td class="colsep0 rowsep0" align="left">3,4-OMe</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">753 ± 151</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">4-Pyr</td><td class="colsep0 rowsep0" align="left">3,4-OMe</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">545 ± 113</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">4-Pyr</td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">216 ± 40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">4-Pyr</td><td class="colsep0 rowsep0" align="left">4-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">488 ± 38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">4-Pyr</td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>,4-OMe</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">146 ± 23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">3-Pyr</td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">156 ± 37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">4-Pyr</td><td class="colsep0 rowsep0" align="left">3-SO<sub>2</sub>F</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">1380 ± 184</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">3-Pyr</td><td class="colsep0 rowsep0" align="left">3-N(Me)<sub>2</sub></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">1200 ± 210</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">4-Pyr</td><td class="colsep0 rowsep0" align="left">3-OH</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">1070 ± 190</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">4-Pyr</td><td class="colsep0 rowsep0" align="left">4-OH</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">4260 ± 1220</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">3-Pyr</td><td class="colsep0 rowsep0" align="left">3-CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">810 ± 0.239</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">4-Pyr</td><td class="colsep0 rowsep0" align="left">3-CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">921 ± 216</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">3-Pyr</td><td class="colsep0 rowsep0" align="left">3-NO<sub>2</sub>,4-OH</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">245 ± 21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">3-Pyr</td><td class="colsep0 rowsep0" align="left">3-CO<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">362 ± 74</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">4-Pyr</td><td class="colsep0 rowsep0" align="left">3-CO<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">405 ± 98</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">4-Pyr</td><td class="colsep0 rowsep0" align="left">3-CO<sub>2</sub><i>t</i>Bu</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">299 ± 97</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">4-Pyr</td><td class="colsep0 rowsep0" align="left">3-CO<sub>2</sub>H</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">60000 ± 14800</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">4-Pyr</td><td class="colsep0 rowsep0" align="left">4-CO<sub>2</sub>H</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">9640 ± 2068</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">4-Pyr</td><td class="colsep0 rowsep0" align="left">3-CN</td><td class="colsep0 rowsep0" align="center">B</td><td class="colsep0 rowsep0" align="char" char="±">132 ± 24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">4-Pyr</td><td class="colsep0 rowsep0" align="left">3-OMe</td><td class="colsep0 rowsep0" align="center">B</td><td class="colsep0 rowsep0" align="char" char="±">271 ± 28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">4-Pyr</td><td class="colsep0 rowsep0" align="left">4-OMe</td><td class="colsep0 rowsep0" align="center">B</td><td class="colsep0 rowsep0" align="char" char="±">874 ± 181</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">3-CN</td><td class="colsep0 rowsep0" align="center">B</td><td class="colsep0 rowsep0" align="char" char="±">122 ± 24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">4-CN</td><td class="colsep0 rowsep0" align="center">B</td><td class="colsep0 rowsep0" align="char" char="±">128 ± 32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">3-NO<sub>2</sub>, 4-OH</td><td class="colsep0 rowsep0" align="center">B</td><td class="colsep0 rowsep0" align="char" char="±">98.8 ± 17.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">B</td><td class="colsep0 rowsep0" align="char" char="±">648 ± 149</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">3-CN</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">140 ± 40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">4-CN</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">71.4 ± 10.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">3-NO<sub>2</sub>, 4-OH</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">81.1. ± 9.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">4-OH</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">211 ± 38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">363 ± 54</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">882 ± 157</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>55</b><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="±">227 ± 14</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">IC<sub>50</sub> value taken from literature.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Compounds synthesized in earlier study.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">Used as reference in the assay.</p></div><div class="footnote" id="t1fn4"><sup>d</sup><p class="last">IC<sub>50</sub> values are means of at least three independent experiments. Maximum inhibition compared to the standard compound <b>55</b> ranged between 80 and 110%.</p></div></div></div><div class="NLM_p">At first, the interrelation of the <i>ortho</i>, <i>meta</i>, and <i>para</i> substituted pyridyl residues at position 2 (R<sup>1</sup>) with differently substituted 4-anilino residues (R<sup>2</sup>) was investigated for the quinazoline scaffold A: compounds <b>11</b>, <b>12</b>, and <b>13</b> all contain a 3-nitro substitution at R<sup>2</sup>, whereas R<sup>1</sup> is equipped with an <i>ortho</i>, <i>meta</i>, or <i>para</i> substituted pyridyl residue, respectively. Inhibitory activities against ABCG2 expressed by the IC<sub>50</sub> values of 376, 105, and 117 nM were obtained in the given order of the compounds. Interestingly, the <i>ortho</i> pyridyl substitution on R<sup>1</sup> yields approximately a 3-fold decreased inhibitory activity in comparison to the <i>meta</i> and <i>para</i> analogues. Similar observations were made for the next series with a 3-cyano residue at R<sup>2</sup>: again, the <i>ortho</i> pyridyl species <b>15</b> showed a significantly lower activity (IC<sub>50</sub> = 507 nM) than its <i>meta</i> and <i>para</i> analogues <b>16</b> (108 nM) and <b>17</b> (134 nM), respectively. For derivatives with a 3-methoxy group at R<sup>2</sup>, the same trend was observed with regard to the pyridyl group at R<sup>1</sup>: compound <b>19</b> with the 2-pyridyl substitution was the least potent (1630 nM), while <i>meta</i> and <i>para</i> pyridyl derivatives yielded lower IC<sub>50</sub> values of 1020 nM (<b>20</b>) and 558 nM (<b>21</b>), respectively. This clearly illustrates that an <i>ortho</i> pyridyl residue at R<sup>1</sup> decreased the inhibitory activity against ABCG2 in every derivative tested so far. Therefore, we concentrated our efforts on compounds with <i>meta</i> and <i>para</i> pyridyl groups.</div><div class="NLM_p">Compound <b>14</b> with a 3-pyridyl residue at R<sup>1</sup> and a 4-nitro substituent at R<sup>2</sup> yielded the lowest IC<sub>50</sub> value in the test set (64.1 nM) and confirmed the results of previous studies that <i>meta</i> and <i>para</i> substitutions at the anilino moiety (R<sup>2</sup>) with nitro, cyano, trifluoromethyl, and other residues is beneficial for high inhibitory activities.<a onclick="showRef(event, 'ref32 ref34'); return false;" href="javascript:void(0);" class="ref ref32 ref34">(32, 34)</a> In comparison to the standard inhibitor <b>55</b> (IC<sub>50</sub> = 227 nM in the Hoechst 33342 accumulation assay), currently one of the most potent inhibitors of ABCG2, compound <b>14</b>, is roughly 4-fold more potent.</div><div class="NLM_p">In most cases, a <i>meta</i> substitution at R<sup>2</sup> resulted in higher inhibitory potency than the corresponding <i>para</i> substituted derivative. The differences varied from slight, exemplified in 3-methoxy (<b>21</b>, IC<sub>50</sub> = 558 nM) and 4-methoxy (<b>22</b>, IC<sub>50</sub> = 742 nM), to more than 2-fold (compounds <b>26</b>, IC<sub>50</sub> = 216 nM; <b>27</b>, IC<sub>50</sub> = 488 nM). But there were significant exceptions where the para substituted derivative was more potent. Compare compounds <b>12</b> and <b>14</b> or <b>49</b> and <b>50</b>. Due to the fact that further enhancement of the inhibitory activity was often achieved by disubstitution of the anilino moiety R<sup>2</sup> at positions 3 and 4 of a 2-phenylquinazoline scaffold,<a onclick="showRef(event, 'ref32 ref34'); return false;" href="javascript:void(0);" class="ref ref32 ref34">(32, 34)</a> several combinations were investigated.</div><div class="NLM_p">The 3,4-dimethoxy substituted compound was investigated with different pyridyl residues at R<sup>1</sup>. Again the <i>ortho</i> pyridyl derivative <b>23</b> was least potent with an IC<sub>50</sub> of 1060 nM, while the <i>meta</i> and <i>para</i> derivatives yielded lower IC<sub>50</sub> values of 753 and 545 nM, respectively. Disubstitution led to a slight potency increase compared to the monomethoxy derivatives.</div><div class="NLM_p">The combination of a 3-trifluoromethyl and 4-methoxy group at R<sup>2</sup> along with a 4-pyridyl residue at R<sup>1</sup> as present in compound <b>28</b> resulted in an IC<sub>50</sub> of 146 nM, which exceeded the inhibitory potency of both single substitutions found in compounds <b>22</b> and <b>26</b>. In the following, the effect of substituents with strong influence on the electron density of the aromatic residue R<sup>2</sup> was investigated using a strong electron withdrawing group and a strong electron donating group. Hence, compound <b>30</b> with a 3-fluorosulfonyl residue at R<sup>2</sup> and 4-pyridyl at R<sup>1</sup> was compared with <b>31</b>, comprising a 3-dimethylamino group at R<sup>2</sup> and 3-pyridyl at R<sup>1</sup>. Both compounds yielded increased IC<sub>50</sub> values of 1380 and 1200 nM, respectively. This is in agreement with earlier results, confirming that the electron density at the anilino moiety does not play a major role for the inhibitory activity of a compound. Furthermore, a more bulky ester was synthesized to elucidate some more structure–activity relations. Hence, a <i>tert</i>-butyl 3-aminobenzoate residue at position 4 was combined with a 4-pyridyl residue at R<sup>1</sup> (<b>39</b>). The obtained IC<sub>50</sub> of 299 nM is negligibly lower than the value found for the methyl ester analogue <b>38</b>. Compounds containing an ionized carboxy group possessed the lowest inhibitory activities in the test set with IC<sub>50</sub> values in the micromolar range.</div><div class="NLM_p">Although the IC<sub>50</sub> values of the <i>meta</i> and <i>para</i> substituted 2-pyridylquinazoline derivatives were so far in good agreement with the IC<sub>50</sub> values in the 2-phenylquinazoline series, a 3-fluoro residue at R<sup>2</sup> with a 3-pyridyl moiety at R<sup>1</sup> (<b>29</b>) resulted in a much lower IC<sub>50</sub> of 156 nM than its phenyl analogue <b>53</b> (363 nM). With regard to substitution of phenyl or <i>para</i> pyridyl at R<sup>1</sup>, the largest differences were observed for a hydroxy substitutent at R<sup>2</sup>. Compound <b>32</b> with a 3-hydroxy group at R<sup>2</sup> and 4-pyridyl at R<sup>1</sup> yielded an IC<sub>50</sub> of 1070 nM, and the corresponding 4-hydroxy derivative <b>33</b> yielded an IC<sub>50</sub> of only 4260 nM. While for the 2-phenylquinazoline analogue <b>52</b> with 4-hydroxy at R<sup>2</sup> an excellent IC<sub>50</sub> of 211 nM had been found. Furthermore, a 3-hydroxymethyl group at R<sup>2</sup> was either combined with 3-pyridyl (<b>34</b>, 810 nM) or 4-pyridyl (<b>35</b>, 921 nM) at R<sup>1</sup>. The alteration from 3-hydroxy to 3-hydroxymethyl had only slight effects on the inhibitory activity. Again, no significant distinction between <i>meta</i> and <i>para</i> pyridyl was observed regarding the inhibitory activity. Following, a disubstitution of 3-hydroxy and 4-nitro at R<sup>2</sup> was investigated with a 3-pyridyl moiety on R<sup>1</sup>. The resulting IC<sub>50</sub> value of 245 nM for compound <b>36</b> was about 3-fold higher than for the 2-phenylquinazoline analogue <b>51</b> (IC<sub>50</sub> = 81.1 nM). This is probably due to unfavorable effects of the 3-pyridyl group at R<sup>1</sup>, which results in lower inhibitory activities when combined with <i>meta</i> or <i>para</i> hydroxy residues at R<sup>2</sup> as observed in case of compounds <b>32</b> and <b>33</b>.</div><div class="NLM_p">In the next series, the condensed aromatic ring next to the heterocycle of the quinazoline scaffold was replaced by a methyl group (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, scaffold B) to evaluate the impact of the aromatic moiety on the inhibitory activity. For better comparison, a 4-pyridyl as well as a phenyl residue was investigated at R<sup>1</sup> to give insights in the SAR of these small molecules. First, a 4-pyridyl residue at R<sup>1</sup> and a 3-cyano group at R<sup>2</sup> were introduced in compound <b>42</b>. The resulting IC<sub>50</sub> of 132 nM is in excellent agreement with its quinazoline analogue <b>17</b> (IC<sub>50</sub> = 134 nM). Furthermore, compounds <b>43</b> and <b>44</b> with a 4-pyridyl residue at R<sup>1</sup> together with a 3-methoxy or 4-methoxy group at R<sup>2</sup> yielded IC<sub>50</sub> values of 271 and 874 nM. In accordance to the <i>meta</i> and <i>para</i> methoxy substituted quinazoline analogues <b>21</b> (IC<sub>50</sub> = 558 nM) and <b>22</b> (IC<sub>50</sub> = 742 nM) the <i>meta</i> substitution resulted in higher inhibitory potency. Moreover, some 4-methylpyrimidines bearing a 2-phenyl group were investigated. Two derivatives with <i>meta</i> or <i>para</i> cyano substituents at R<sup>2</sup> yielded IC<sub>50</sub> values of 122 nM (<b>45</b>) and 128 nM (<b>46</b>), respectively. Both values are in good agreement with their 2-phenylquinazoline analogues with a 3-cyano (<b>49</b>, 140 nM) or a 4-cyano (<b>50</b>, 71.4 nM) residue at R<sup>2</sup>. Also, the disubstitution with 3-nitro and 4-hydroxy at R<sup>2</sup> exhibited only negligible differences between the 2-phenyl derivatives of scaffold B (<b>47</b>, 98.8 nM) and scaffold A (<b>51</b>, 81.1 nM). For the basic structures of scaffold A and scaffold B with R<sup>1</sup> = phenyl and R<sup>2</sup> = H, very similar IC<sub>50</sub> values of 648 nM (<b>48</b>) and 882 nM (<b>54</b>) were found. Concentration–response curves of the two most potent compounds <b>14</b> and <b>47</b> in comparison to the standard inhibitor <b>55</b> are depicted in <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>.</div><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/medium/jm-2017-00441x_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Concentration–response curve of compound <b>14</b> (■, IC<sub>50</sub> = 64.1 nM) and <b>47</b> (▲, IC<sub>50</sub> = 98.8 nM) in a Hoechst 33342 accumulation assay with compound <b>55</b> (○, IC<sub>50</sub> = 227 nM) as reference, using the ABCG2 overexpressing MDCK II cell line.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00441&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/medium/jm-2017-00441x_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. SAR of some substitution patterns used in derivatives with scaffold A. IC<sub>50</sub> range corresponds to given residue containing <i>p</i>-pyridyl or <i>m</i>-pyridyl that were found to be about equally active. Regarding compounds containing scaffold B, the same ranking and similar IC<sub>50</sub> values were obtained in comparison to scaffold A.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00441&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">From this study it was found that the substitution pattern of the pyridyl residue at R<sup>1</sup> of scaffold A has a major impact on the inhibitory activity: substitution with <i>ortho</i> pyridyl yielded less potent compounds while <i>meta</i> and <i>para</i> substitutions both resulted in increased activities. Regarding the substituents at R<sup>2</sup>, nitro, cyano, trifluoromethyl, or fluoro substituents in <i>meta</i> and <i>para</i> yielded very potent inhibitors. No clear preference was noticeable for <i>meta</i> and <i>para</i> substitution of compounds containing a pyridyl or phenyl moiety at R<sup>1</sup>. In contrast to earlier studies, hydroxyl residues turned out to decrease the inhibitory activity when combined with pyridyl at R<sup>1</sup> instead of phenyl.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Apart from that, very similar potencies were obtained with both moieties. Again, the electron density of the aromatic ring influenced by substituents at R<sup>2</sup> exhibits no clear correlation with the IC<sub>50</sub> values. Introducing esters in <i>meta</i> position also resulted in high activities independent of the bulkiness of the alkyl residue. According to calculation, the pyridyl residue decreases the log <i>P</i> in comparison to a phenyl substitution by about 1.18 units to an average of 3.00. No correlation of the calculated log <i>P</i> values with the pIC<sub>50</sub> values was observed.</div><div class="NLM_p last">Interestingly, the potency of the 4-methylpyrimidine analogues, lacking the condensed aromatic ring of the quinazoline scaffold, was similar to the quinazoline-based derivatives. Earlier studies have emphasized the need of aromatic substitution at R<sup>1</sup> as well as the importance of the nitrogen in position 3 of the heterocycle for potent compounds.<a onclick="showRef(event, 'ref32 ref34'); return false;" href="javascript:void(0);" class="ref ref32 ref34">(32, 34)</a> Simplification of the quinazoline scaffold to a 4-methylpyrimidine heterocycle leads to an extraordinary high ligand efficacy, reducing relevant components for a potent inhibitor to three aromatic rings substituted with few small residues.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Screening for ABCB1 and ABCC1 Inhibition</h3><div class="NLM_p">The selectivity of selected compounds toward ABCG2 was investigated by the calcein AM assay. For this purpose, the ABCC1 overexpressing cell line H69AR and the ABCB1 overexpressing cell line A2780adr were used as described in the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>. A screening of the inhibitory effect of the substances toward the polyspecific transporters ABCB1 and ABCC1 was carried out at a concentration of 10 μM. Cyclosporine A (CsA) was used as positive control, leading to total inhibition of both transporters. Compounds which exhibit an inhibitory potency of more than 25% relative to the standard were additionally tested with more dilutions to generate a concentration–response curve to calculate an IC<sub>50</sub> value. The screening results for the inhibitory activity toward ABCB1 and ABCC1 are depicted in the bar charts in parts a and b of <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>, respectively. A summary of the IC<sub>50</sub> values of the compounds showing more than 25% of inhibition in the screening is given in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/medium/jm-2017-00441x_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Inhibitory effect of screened compounds toward ABCB1 overexpressing cell line A2780adr (a) and ABCC1 overexpressing cell line H69AR (b) in a calcein AM assay at a concentration of 10 μM. Cyclosporine A (CsA) was used as positive control, indicating complete inhibition. The length of the bars represents the inhibition compared to the positive control in percent. For each compound, three independent experiments were performed and the standard deviation expressed as error bars.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00441&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Inhibitory Activity of Compounds Exhibiting an Inhibition of More than 25% in Comparison to the Reference CsA in a Calcein AM Assay at 10 μM</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">scaffold</th><th class="colsep0 rowsep0" align="center" char="±">calcein AM (ABCB1) IC<sub>50</sub>  ± SD [μM]<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="±">calcein AM (ABCC1) IC<sub>50</sub>  ± SD [μM]<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">2-Pyr</td><td class="colsep0 rowsep0" align="left">3-OMe</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">12.7 ± 1.8</td><td class="colsep0 rowsep0" align="char" char="±"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">3-Pyr</td><td class="colsep0 rowsep0" align="left">3-OMe</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">4.78 ± 0.57</td><td class="colsep0 rowsep0" align="char" char="±"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">4-Pyr</td><td class="colsep0 rowsep0" align="left">3-OMe</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">5.43 ± 0.83</td><td class="colsep0 rowsep0" align="char" char="±"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">4-Pyr</td><td class="colsep0 rowsep0" align="left">4-OMe</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="char" char="±">17.9 ± 2.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">2-Pyr</td><td class="colsep0 rowsep0" align="left">3,4-OMe</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">6.30 ± 0.36</td><td class="colsep0 rowsep0" align="char" char="±"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">3-Pyr</td><td class="colsep0 rowsep0" align="left">3,4-OMe</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">3.11 ± 0.21</td><td class="colsep0 rowsep0" align="char" char="±"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">4-Pyr</td><td class="colsep0 rowsep0" align="left">3,4-OMe</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">2.08 ± 0.36</td><td class="colsep0 rowsep0" align="char" char="±"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">4-Pyr</td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>, 4-OMe</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">2.78 ± 0.50</td><td class="colsep0 rowsep0" align="char" char="±"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">4-Pyr</td><td class="colsep0 rowsep0" align="left">3-CO<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">6.37 ± 0.12</td><td class="colsep0 rowsep0" align="char" char="±"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">4-Pyr</td><td class="colsep0 rowsep0" align="left">3-CO<sub>2</sub><i>t</i>Bu</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">0.334 ± 0.056</td><td class="colsep0 rowsep0" align="char" char="±"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">4-Pyr</td><td class="colsep0 rowsep0" align="left">4-CO<sub>2</sub>H</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">3.67 ± 0.10</td><td class="colsep0 rowsep0" align="char" char="±"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">3-NO<sub>2</sub>, 4-OH</td><td class="colsep0 rowsep0" align="center">B</td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="char" char="±">15.9 ± 2.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CsA<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="±">1.21 ± 0.16</td><td class="colsep0 rowsep0" align="char" char="±">2.97 ± 0.38</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">The ABCB1 overexpressing cell line A2780adr was used.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">The ABCC1 overexpressing cell line H69AR was used.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">Cyclosporine A is used as reference for both assays.</p></div></div></div><div class="NLM_p">In the calcein AM assay with ABCB1 overexpressing cells, the following compounds showed a relative inhibitory activity of more than 25% in relation to the positive control CsA. Bearing a 3-methoxy residue at R<sup>2</sup>, compounds <b>19</b>, <b>20</b>, and <b>21</b> show relatively high inhibitory activity toward ABCB1. They were synthesized in the given order with a <i>ortho</i>, <i>meta</i>, and <i>para</i> pyridyl moiety at R<sup>1</sup> and have IC<sub>50</sub> values of 12.7, 4.78, and 5.43 μM, respectively. As expected, the inhibitory activity toward ABCB1 is increased for the 3,4-dimethoxy derivatives because methoxy groups are favorable for ABCB1 inhibition.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> The <i>ortho</i>, <i>meta</i>, and <i>para</i> pyridyl (R<sup>1</sup>) substituted compounds <b>23</b>, <b>24</b>, and <b>25</b> show inhibitory activities of 6.30, 3.11, and 2.08 μM, respectively. As observed for inhibition of ABCG2, the substitution pattern of the pyridyl residue is also crucial for the inhibitory potency against ABCB1. Substitution with <i>ortho</i> pyridyl decreases the activity in comparison to the <i>meta</i> and <i>para</i> derivatives. In comparison to the monosubstituted compound <b>22</b>, <b>28</b> revealed a good IC<sub>50</sub> value of 2.78 μM with 4-pyridyl at R<sup>1</sup> and a disubstitution with 3-trifluoromethyl and 4-methoxy at R<sup>2</sup>. Furthermore, a 4-pyridyl residue at R<sup>1</sup> combined with a methyl 3-aminobenzoate moiety (<b>38</b>, IC<sub>50</sub> = 6.37 μM) or a <i>tert</i>-butyl 3-aminobenzoate residue (<b>39</b>, IC<sub>50</sub> = 0.334 μM) at position 4, led to noticeable inhibition of ABCB1. In particular, the <i>tert</i>-butyl ester obtained a considerable potency superior to the standard CsA (IC<sub>50</sub> = 1.21 μM). A concentration response curve of <b>39</b> and CsA is provided in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>. Then, a substitution of 4-pyridyl at R<sup>1</sup> each with a 3-aminobenzoic acid (<b>40</b>) and a 4-aminobenzoic acid moiety (<b>41</b>, IC<sub>50</sub> = 3.67 μM) was carried out. The <i>meta</i> substituted compound exhibited no activity, whereas the <i>para</i> substituted one possessed a considerable potency.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/medium/jm-2017-00441x_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Concentration–response curve of compound <b>39</b> (●, IC<sub>50</sub> = 0.334 μM) in a calcein AM assay with cyclosporine A (○, IC<sub>50</sub> = 1.21 μM) as reference, using the ABCB1 overexpressing cell line A2780adr. Results were obtained in at least three independent experiments, and the standard deviation is expressed by error bars.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00441&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">All of the investigated nitro and cyano substituted compounds <b>11</b>–<b>18</b> showed high activities toward ABCG2 and low activities toward ABCB1. Compounds bearing at least one methoxy group generally showed an increased inhibitory activity toward ABCB1. Adding more methoxy groups to the molecule resulted in a further increased activity. Additionally, a correlation of the substitution pattern of the pyridyl residue at R<sup>1</sup> was observed, showing increased activities from <i>ortho</i> to <i>meta</i> to <i>para</i>. Some ester moieties also exhibit significant potencies in the screening: compound <b>39</b> with a <i>tert</i>-butyl ester had the lowest IC<sub>50</sub> value of 0.334 μM.</div><div class="NLM_p">To investigate the inhibitory effect of the compounds toward ABCC1, they were screened in a calcein AM assay with the ABCC1 overexpressing cell line H69 AR. The results of the screening are depicted in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>b as a bar chart. Only compounds <b>22</b> and <b>47</b> slightly exceeded the 25% range of inhibitory activity relative to the positive control CsA (IC<sub>50</sub> = 2.97 μM) at a concentration of 10 μM. It was found in earlier studies that compounds with a quinazoline scaffold, like the substituted 4-anilino-2-phenylquinazolines, exhibit no inhibitory activity toward ABCC1 unless they form charged species under physiological conditions.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Compound <b>22</b> (IC<sub>50</sub> = 15.9 μM) was the only one from the quinazoline series that slightly exceeded the 25% mark.</div><div class="NLM_p last">For the substances with a 4-methyl pyrimidine structure (scaffold B), only a negligible activity was found. Mere compound <b>47</b> (IC<sub>50</sub> = 17.8 μM) with a disubstitution of 3-nitro and 4-hydroxy at the aniline moiety showed barely more than 25% of inhibition compared to the positive control CsA. Regarding quinazoline derivatives as inhibitors of ABCC1, this study is consistent with earlier findings that the inhibitory activity toward ABCC1 plays only a negligible role.<a onclick="showRef(event, 'ref32 ref34'); return false;" href="javascript:void(0);" class="ref ref32 ref34">(32, 34)</a></div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Determination of the Intrinsic Cytotoxicity via MTT Assay</h3><div class="NLM_p">The intrinsic cytotoxicity of selected compounds was determined in the MTT assay. The results for selected compounds are depicted in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a> and given as cell growth inhibition leading to a cell survival of 50% of the control (GI<sub>50</sub>). Small amounts of methanol (1.8%) and DMSO (1%) from the stock solutions of the compounds were present at the highest concentration of 100 μM, leading to apparent slight toxicity of otherwise nontoxic compounds. Therefore, additionally, the toxic effect of the used dilution without modulator was determined at GI<sub>50</sub> = 96.1 μM (MDCK II ABCG2 overexpressing cells). For comparison, the GI<sub>50</sub> of the established inhibitor of ABCG2 compound <b>55</b> (12.6 μM) was obtained in analogy to the other test substances.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Intrinsic Toxicity of Selected Compounds toward MDCK II ABCG2 Overexpressing and Parental Cells</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">scaffold</th><th class="colsep0 rowsep0" align="center" char="±">GI<sub>50</sub> ABCG2 ± SD [μM]<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="±">GI<sub>50</sub> parental ± SD [μM]<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">therapeutic ratio<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">3-Pyr</td><td class="colsep0 rowsep0" align="left">3- NO<sub>2</sub></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">70.8 ± 23.2</td><td class="colsep0 rowsep0" align="char" char="±">64.6 ± 20.4</td><td class="colsep0 rowsep0" align="char" char=".">615</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">3-Pyr</td><td class="colsep0 rowsep0" align="left">4- NO<sub>2</sub></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">73.3 ± 17.1</td><td class="colsep0 rowsep0" align="char" char="±">74.1 ± 28.0</td><td class="colsep0 rowsep0" align="char" char=".">1140</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">3-Pyr</td><td class="colsep0 rowsep0" align="left">3-CN</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">75.3 ± 18.8</td><td class="colsep0 rowsep0" align="char" char="±">90.7 ± 20.2</td><td class="colsep0 rowsep0" align="char" char=".">697</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">4-Pyr</td><td class="colsep0 rowsep0" align="left">3-CN</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">88.1 ± 8.6</td><td class="colsep0 rowsep0" align="char" char="±">112 ± 20</td><td class="colsep0 rowsep0" align="char" char=".">657</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">3-Pyr</td><td class="colsep0 rowsep0" align="left">4-CN</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">79.4 ± 4.6</td><td class="colsep0 rowsep0" align="char" char="±">104 ± 8</td><td class="colsep0 rowsep0" align="char" char=".">241</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">4-Pyr</td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">12.6 ± 2.8</td><td class="colsep0 rowsep0" align="char" char="±">12.3 ± 3.3</td><td class="colsep0 rowsep0" align="char" char=".">58.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">4-Pyr</td><td class="colsep0 rowsep0" align="left">4-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">117 ± 41</td><td class="colsep0 rowsep0" align="char" char="±">166 ± 38</td><td class="colsep0 rowsep0" align="char" char=".">240</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">4-Pyr</td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>, 4-OMe</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">2.88 ± 0.10</td><td class="colsep0 rowsep0" align="char" char="±">2.46 ± 0.08</td><td class="colsep0 rowsep0" align="char" char=".">19.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">3-Pyr</td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">46.8 ± 4.7</td><td class="colsep0 rowsep0" align="char" char="±">100 ± 16</td><td class="colsep0 rowsep0" align="char" char=".">300</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">3-Pyr</td><td class="colsep0 rowsep0" align="left">3-N(Me)<sub>2</sub></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">10.0 ± 0.7</td><td class="colsep0 rowsep0" align="char" char="±">14.1 ± 0.6</td><td class="colsep0 rowsep0" align="char" char=".">8.33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">4-Pyr</td><td class="colsep0 rowsep0" align="left">3-OH</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">9.22 ± 0.32</td><td class="colsep0 rowsep0" align="char" char="±">12.4 ± 0.2</td><td class="colsep0 rowsep0" align="char" char=".">8.62</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">4-Pyr</td><td class="colsep0 rowsep0" align="left">4-OH</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">55.0 ± 12.7</td><td class="colsep0 rowsep0" align="char" char="±">120.2 ± 7.0</td><td class="colsep0 rowsep0" align="char" char=".">12.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">4-Pyr</td><td class="colsep0 rowsep0" align="left">3-CN</td><td class="colsep0 rowsep0" align="center">B</td><td class="colsep0 rowsep0" align="char" char="±">6.92 ± 2.04</td><td class="colsep0 rowsep0" align="char" char="±">9.33 ± 0.60</td><td class="colsep0 rowsep0" align="char" char=".">52.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">4-CN</td><td class="colsep0 rowsep0" align="center">B</td><td class="colsep0 rowsep0" align="char" char="±">17.8 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">28.4 ± 2.3</td><td class="colsep0 rowsep0" align="char" char=".">139</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">3-NO<sub>2</sub>, 4-OH</td><td class="colsep0 rowsep0" align="center">B</td><td class="colsep0 rowsep0" align="char" char="±">49.0 ± 3.2</td><td class="colsep0 rowsep0" align="char" char="±">57.5 ± 1.2</td><td class="colsep0 rowsep0" align="char" char=".">496</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">B</td><td class="colsep0 rowsep0" align="char" char="±">107 ± 4</td><td class="colsep0 rowsep0" align="char" char="±">136 ± 35</td><td class="colsep0 rowsep0" align="char" char=".">165</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">4-CN</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">10.4 ± 2.0</td><td class="colsep0 rowsep0" align="char" char="±">14.2 ± 2.0</td><td class="colsep0 rowsep0" align="char" char=".">146</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">3-NO<sub>2</sub>, 4-OH</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">52.4 ± 1.7</td><td class="colsep0 rowsep0" align="char" char="±">152 ± 43</td><td class="colsep0 rowsep0" align="char" char=".">647</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">4-OH</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">14.6 ± 1.7</td><td class="colsep0 rowsep0" align="char" char="±">22.6 ± 3.7</td><td class="colsep0 rowsep0" align="char" char=".">69.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">18.0 ± 1.9</td><td class="colsep0 rowsep0" align="char" char="±">27.5 ± 0.7</td><td class="colsep0 rowsep0" align="char" char=".">49.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char="±">26.6 ± 1.2</td><td class="colsep0 rowsep0" align="char" char="±">26.0 ± 2.1</td><td class="colsep0 rowsep0" align="char" char=".">30.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>55</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="±">12.6 ± 0.6</td><td class="colsep0 rowsep0" align="char" char="±">12.5 ± 0.8</td><td class="colsep0 rowsep0" align="char" char=".">48.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MeOH/DMSO</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="±">96.1<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a> ± 13</td><td class="colsep0 rowsep0" align="char" char="±">125<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a> ± 16</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Concentration accomplishing 50% of the maximal inhibition of cell proliferation with MDCK II BCRP and parental cells, respectively. The data was obtained from at least two independent experiments as mean values.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Compound was synthesized before.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">Positive control of the cytotoxicity from dilution with DMSO/MeOH without compound.</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">The therapeutic ratio (TR) was calculated as the ratio of GI<sub>50</sub> and IC<sub>50</sub> values for the MDCK II BCRP cells.</p></div></div></div><div class="NLM_p">Four potent compounds (<b>14</b>, <b>16</b>, <b>17</b>, and <b>47</b>) with low intrinsic cytotoxicity were additionally investigated in a modified MTT viability assay without DMSO and with a constant amount of 1% methanol (data not shown). This modification was possible due to the good water solubility of the compounds. Either no effect or stimulation of the cell proliferation was observed at low concentrations, which is probably explained by a defensive cellular mechanism. Further increase of the concentration eventually reversed this effect leading to a decreasing cell viability.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/medium/jm-2017-00441x_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Representative examples of MTT viability assays of compounds <b>14</b> and <b>42</b> with low and higher cytotoxicity using the MDCK II ABCG2 overexpressing (●) and parental MDCK II cell line (○). There is no significant difference in the intrinsic toxicities comparing the parental and ABCG2 expressing cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00441&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/medium/jm-2017-00441x_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Therapeutic ratios of selected compounds, calculated from the ratio of GI<sub>50</sub> to IC<sub>50</sub> derived from MTT viability assay and Hoechst 33342 accumulation assay, respectively. The highest score was obtained for compound <b>14</b> (GI<sub>50</sub>/IC<sub>50</sub> = 1140), while the reference compound <b>55</b> yielded GI<sub>50</sub>/IC<sub>50</sub> = 55.5.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00441&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">All tested compounds showed no significant cytotoxic effects up to 100 μM. Because of restricted solubility, higher concentrations could not be used in order to create sigmoidal dose–viability curves obtaining a GI<sub>50</sub> value. Thus, the GI<sub>50</sub> of the nontoxic compounds is very likely higher than 96 μM, resulting from the cytotoxic effects of the solvents only.</div><div class="NLM_p">The following section discusses GI<sub>50</sub> values determined with the MTT assay using MDCK II ABCG2 overexpressing cells.</div><div class="NLM_p">For the 3-nitro (<b>12</b>) and 4-nitro (<b>14</b>) substituted compounds (R<sup>2</sup>), both with a 3-pyridyl moiety at R<sup>1</sup>, GI<sub>50</sub> values of 70.8 and 73.3 μM were calculated, respectively, revealing almost no cytotoxic effect caused by the compounds. Moreover, a compound containing 3-cyano residue at R<sup>2</sup> was investigated with a <i>meta</i> pyridyl (<b>16</b>) and <i>para</i> pyridyl (<b>17</b>) residue at R<sup>1</sup>. Here, both compounds show very low cytotoxicity of 75.3 and 88.1 μM, respectively. Furthermore, the 3-pyridyl (R<sup>1</sup>), 4-cyano (R<sup>2</sup>) derivative <b>18</b> was investigated. Again, only negligible cytotoxicity was found, giving a GI<sub>50</sub> of 79.4 μM. By the first results, some trends among the nitro and cyano substituents at R<sup>2</sup> combined with <i>meta</i> and <i>para</i> pyridyl moieties at R<sup>1</sup> can be perceived: substitution with cyano resulted in slightly decreased toxic effects in comparison to nitro, although both yielded considerably high GI<sub>50</sub> values. Moreover, substitution with <i>meta</i> pyridyl seems to be beneficial for low cytotoxicity over a <i>para</i> substitution based on compounds <b>16</b> and <b>17</b>. Although the differences among the pyridyl derivatives are rather small, the advantage of the pyridyl over a phenyl moiety becomes clearly evident by comparison of compounds <b>18</b> and <b>49</b>. Both contain a 4-cyano substitution at R<sup>2</sup> along with 3-pyridyl or a phenyl residue at R<sup>1</sup>, respectively. The phenyl derivative <b>49</b> has approximately an 8-fold lower GI<sub>50</sub> (10.4 μM) than the 3-pyridyl derivative <b>18</b> (GI<sub>50</sub> = 79.4 μM). This observation was also made for several more compounds presented below. Another effect was noticed regarding the substitution in <i>meta</i> and <i>para</i> position: the 4-pyridyl (R<sup>1</sup>) derivatives substituted with trifluoromethyl groups in <i>meta</i> (<b>26</b>) or <i>para</i> (<b>27</b>) position resulted in GI<sub>50</sub> values of 12.6 and 117 μM that reflects the great impact of this modification (<i>meta</i> vs <i>para</i>), which is also noticeable by the significant difference of the compounds IC<sub>50</sub> values. Similar results were also found in earlier studies with the 2-phenyl analogues regarding the IC<sub>50</sub> values and particularly the GI<sub>50</sub> values.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> A possible explanation for this observation was suggested by studies of the enzyme kinetics and ATPase assays described in the corresponding chapters. The lowest GI<sub>50</sub> value (2.88 μM) in the test set was obtained for compound <b>28</b> with a 4-pyridyl residue at R<sup>1</sup> and a disubstitution of 3-fluoromethyl and 4-methoxy at the aniline moiety in position 4. In comparison to compound <b>26</b>, the additional methoxy group lowers the GI<sub>50</sub> about 4-fold. Compound <b>29</b> with a 3-pyridyl moiety at R<sup>1</sup> and 3-fluoro at R<sup>2</sup> has a GI<sub>50</sub> of 46.8 μM. The comparison to its 2-phenyl analogue <b>53</b> (GI<sub>50</sub> = 18.0 μM) once more demonstrates the beneficial effect of the pyridyl moieties for cytotoxicity. Compound <b>31</b> with a 3-pyridyl moiety (R<sup>1</sup>) and a 3-dimethylamino group (R<sup>2</sup>) shows an increased cytotoxicity (GI<sub>50</sub> = 10.0 μM). Furthermore, a 4-pyridyl substitution at R<sup>1</sup> was combined with 3-hydroxy (<b>32</b>) and 4-hydroxy residue (<b>33</b>) at R<sup>2</sup>, respectively. The <i>meta</i> substitution was found to be considerably more cytotoxic (GI<sub>50</sub> = 9.22 μM) than the <i>para</i> derivative (GI<sub>50</sub> = 55.0 μM). Similar tendencies regarding IC<sub>50</sub> and GI<sub>50</sub> values as found for compounds <b>26</b> and <b>27</b> apply for the <i>meta</i> and <i>para</i> hydroxy derivatives. As expected, the 2-phenyl analogue <b>52</b> exhibits a significantly higher cytotoxicity than compound <b>33</b> with a pyridyl moiety.</div><div class="NLM_p">Additionally, some derivatives with the pyrimidine scaffold B were investigated. First, compound <b>42</b> containing a 4-pyridyl substituent at R<sup>1</sup> and a 3-cyano group at R<sup>2</sup>. The determined GI<sub>50</sub> of 6.92 μM discloses a considerably higher cytotoxicity than its quinazoline analogue <b>17</b> (GI<sub>50</sub> = 88.1 μM). Concentration-response curves of compounds <b>14</b> and <b>42</b> with low and higher cytotoxicity are shown in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>. Moreover, compound <b>46</b> with a phenyl substitution at R<sup>1</sup> along with a 4-cyano group at R<sup>2</sup> was investigated, yielding a GI<sub>50</sub> value of 17.8 μM which is slightly less toxic than the corresponding quinazoline analogue <b>49</b> (GI<sub>50</sub> = 10.4 μM). Further, compound <b>47</b> with a phenyl residue at R<sup>1</sup> and a disubstitution of 3-nitro and 4-hydroxy at R<sup>2</sup> had a GI<sub>50</sub> of 49.0 μM, which is identical to the quinazoline analogue <b>51</b> (GI<sub>50</sub> = 52.4). Because of the low cytotoxicity along with the observed high inhibitory activity, high therapeutic ratios were obtained for such combinations (see <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a> and <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>). Finally, the basic scaffold B bearing phenyl at R<sup>1</sup> and hydrogen at R<sup>2</sup> was investigated: the calculated GI<sub>50</sub> of 107 μM for compound <b>48</b> was significantly higher than for its analogue derivative <b>54</b> based on scaffold A (GI<sub>50</sub> = 26.6 μM).</div><div class="NLM_p last">From the data it can be concluded, that <i>meta</i> and <i>para</i> pyridyl residues (R<sup>1</sup>) on a quinazoline scaffold A reduce the cytotoxicity in comparison to a phenyl moiety considerably. For the <i>meta</i> and <i>para</i> substitutions at R<sup>2</sup> distinct differences were observed concerning the GI<sub>50</sub> as well as IC<sub>50</sub> values. In general, the 2-phenyl derivatives based on a 4-methylpyrimidine scaffold B exhibit a lower cytotoxicity in comparison with their quinazoline analogues based on scaffold A. However, scaffold B was less beneficial in comparison to scaffold A with a 4-pyridyl residue at R<sup>1</sup> and 3-cyano at R<sup>2</sup> (see <b>17</b> and <b>42</b>). Because of the limited amount of investigated compounds containing scaffold B in the MTT toxicity assay, further compounds have to be synthesized and investigated to confirm these findings.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Determination of the Ability to Reverse MDR via MTT Assay</h3><div class="NLM_p">A MDR reversal assay was performed for some of the most active compounds (<b>14</b>, <b>16</b>, and <b>47</b>). The assay was carried out with MDCK II ABCG2 overexpressing cells. As a cytostatic drug, SN-38, which is a well-known substrate of ABCG2, was used. Different dilutions of the cytostatic were combined with different modulator concentrations. Intracellular accumulation of the cytostatic is induced by the inhibitory effect of the modulator toward ABCG2, which restrains the efflux of SN-38 out of the cell and leads to a decreased cell viability. As a positive control the MDCK II parental cells were used to represent total inhibition due to the lack of ABCG2 transport proteins. The evaluation of the assay was carried out analogously to the MTT viability assay described above.</div><div class="NLM_p">For this investigation, the most potent 2-pyridylquinazoline derivatives containing a nitro (<b>14</b>) and a cyano (<b>16</b>) group were selected. Additionally, compound <b>47</b> was chosen from the derivatives based on the 4-methylpyrimidine scaffold B due to its highest inhibitory activity among them. All compounds displayed the ability to fully reverse the MDR of the ABCG2 overexpressing cells, as shown in <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>a,c,e. Reversal of the resistance is illustrated by the shift of the IC<sub>50</sub> values of the ABCG2 overexpressing cells toward the parental cells with increasing modulator concentration (gray arrow). At a modulator concentration of ≥1 μM, full sensitization of the ABCG2 overexpressing cells was achieved, indicated by a similar IC<sub>50</sub> value as the parental cells. Additionally, the MTT assay was repeated using parental MDCK II cells to elucidate possible interactions of the modulator and SN-38 which could affect the IC<sub>50</sub> values obtained from the concentration–response curves. The obtained concentration–response curves are shown in <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>b,d,f. Clearly, there is no effect of the compounds on the wild-type cells. Furthermore, a quantification of a compounds efficacy in reversing MDR was calculated by plotting each GI<sub>50</sub> value from the reversal assay against the logarithm of the compound concentration and calculating an IC<sub>50</sub> value: the state “no inhibition” is defined with ABCG2 overexpressing cells without modulator, which show maximal resistance toward SN-38, and “total inhibition” of ABCG2 is defined by the pIC<sub>50</sub> value of the parental cells. Corresponding concentration–response curves were fitted with the logistic equation yielding pEC<sub>50</sub> values that can be compared with the inhibitory activities from the Hoechst 33342 accumulation assay (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>).</div><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/medium/jm-2017-00441x_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. MTT assay to determine the ability of compounds <b>14</b> (a,b), <b>16</b> (c,d), and <b>47</b> (e,f) to reverse the resistance against the cytostatic SN-38, using the ABCG2 overexpressing cell line (a,c,e) and parental MDCK II cells (b,d,f). The gray arrow indicates the increasing sensitization of the ABCG2 overexpressing cells with higher compound concentrations. The following concentrations were used: control (●), 0.01 μM (■), 0.03 μM (▲), 0.1 μM (▼), 1 μM (△), 5 μM (□), parental cell line (○). At a compound concentration of 1 μM, full reversal is achieved, indicated by a similar pGI<sub>50</sub> as the parental cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00441&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/medium/jm-2017-00441x_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Nonlinear regression of the pGI<sub>50</sub> values determined in the MDR reversal assay (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>a,c,e) against the corresponding concentrations of compounds <b>14</b>, <b>16</b>, and <b>47</b>. pEC<sub>50</sub> is the concentration that reduces resistance of the ABCG2 overexpressing cells to 50%. The following EC<sub>50</sub> values were calculated: 21.2 nM (<b>14</b>), 85.0 nM (<b>16</b>), and 62.3 nM (<b>47</b>). The pGI<sub>50</sub> values of the parental cells determined in an analogous assay (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>b,d,f) are depicted by open circles. The point in parentheses at 0.1 μM in (c) was excluded.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00441&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>14</b> with a 3-pyridyl residue at R<sup>1</sup> and a 4-nitro group at R<sup>2</sup> (scaffold A) yielded an EC<sub>50</sub> of 21.2 nM determined in the MDR reversal assay. This suggests an about 3-fold higher inhibitory potency for inhibiting the transport of SN-38 than that found in the Hoechst 33342 accumulation assay (64.1 nM). As expected, the compound obtained a sigmoidal curve with the ABCG2 overexpressing cells (solid circles) and reaches its top on a similar level to the parental cells (open circles) with increasing modulator concentration (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>a). Moreover, the IC<sub>50</sub> values of the parental cells stay the same throughout the different modulator concentrations. Following, for compound <b>16</b> with a 3-pyridyl moiety at R<sup>1</sup> and 3-cyano at R<sup>2</sup> (scaffold A) an IC<sub>50</sub> value of 85 nM was calculated with this method (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>b). This is again slightly less than the IC<sub>50</sub> value of 108 nM found in the Hoechst 33342 accumulation assay. Also compound <b>47</b> with a phenyl moiety at R<sup>1</sup> and a disubstitution of 3-nitro and 4-hydroxy at R<sup>2</sup> (scaffold B) exhibits a good correlation of the IC<sub>50</sub> value derived from the MDR reversal assay (62.3 nM) and the Hoechst 33342 accumulation assay (98.8 nM). The differences in the IC<sub>50</sub> values can be explained by different affinities of Hoechst 33342 and SN-38 for ABCG2, suggesting a higher affinity of Hoechst 33342. The concentration–response curves are depicted in <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>c.</div><div class="NLM_p">Additionally, the antineoplastic drug mitoxantrone (MX) was used to demonstrate the reversal of resistance of the ABCG2 overexpressing MDCK II cells with compounds <b>14</b> and <b>47</b>. For this purpose, the cell viability was measured as described above after 72 h incubation with different modulator concentrations in the presence of 0.5 μM cytostatic drug. Decrease of cell viability caused by the cytotoxicity of the compound was taken into account by performing a dilution of the substance without MX. Wells with only cells and medium in presence and absence of MX were used as negative control. For both compounds, the reversal of resistance was demonstrated as shown in <a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>. The half-maximal growth inhibition was achieved for compound <b>14</b> at 12.6 nM and for <b>47</b> at 22.0 nM, respectively. The same tendencies in reversing MDR as observed for SN-38 could be reproduced using MX as cytostatic as well as confirming the ability of the compounds to effectively reverse ABCG2 mediated MDR.</div><figure id="fig9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/medium/jm-2017-00441x_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. MDR reversal assay of compound <b>14</b> (a, EC<sub>50</sub> 12.6 nM) and <b>47</b> (b, EC<sub>50</sub> 22.0 nM), demonstrating the ability to reverse the MDR toward the cytostatic MX, using ABCG2 overexpressing cell line MDCK II. The bars represent the cell viability at a given modulator concentration in the presence (light gray) and absence (dark gray) of 5 μM MX. The control shows cell viability of cells without modulator in the presence and absence of 5 μM MX. Standard deviation is expressed by error bars.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00441&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Investigation of ATPase Activity</h3><div class="NLM_p">ATPase measurements were carried out using High Five insect cell membranes, which were infected with baculovirus containing ABCG2 cDNA. Therefore, selected compounds based on scaffold A (4-substituted-2-phenylquinazolines) with high inhibitory potencies were investigated, together with compounds comprising scaffold B (4-methylpyrimidine). The determined EC<sub>50</sub> values and the maximal stimulation caused by the compounds including quercetin as the standard activator are summarized in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>. Three compounds (<b>13</b>, <b>14</b>, <b>17</b>) exhibited about the same activating effect as the standard quercetin. While most substances produced only low activation of less than 40%, having only a low effect on the ATPase activity. One compound (<b>48</b>) was inactive producing a stimulation of less than 10%. To confirm this unexpected result, the measurement was repeated six times. Compound <b>39</b> was the only compound in the data set exhibiting an inhibitory ATPase activity down to 40% of control. Interestingly there are two compounds, namely compound <b>26</b> and <b>27</b>, which demonstrate an increase of activation at lower concentrations on the one hand and a decrease of activation at higher concentrations on the other hand. About one-third of all investigated compounds showed an activation of 40 to 60%.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. EC<sub>50</sub> Values of Selected Compounds in the ATPase Activity Assay: All Values are Relative Vanadate-Sensitive ATPase Activities in Relation to the Basal Activity, Which is Set to 100%</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> [nM]</th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>max</sub> [% of control]</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="center">676</td><td class="colsep0 rowsep0" align="center">119</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="center">21</td><td class="colsep0 rowsep0" align="center">154</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="center">4</td><td class="colsep0 rowsep0" align="center">185</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="center">9</td><td class="colsep0 rowsep0" align="center">164</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="center">1530</td><td class="colsep0 rowsep0" align="center">115</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="center">350</td><td class="colsep0 rowsep0" align="center">151</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="center">16</td><td class="colsep0 rowsep0" align="center">178</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="center">4</td><td class="colsep0 rowsep0" align="center">137</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="center">50</td><td class="colsep0 rowsep0" align="center">137</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="center">42</td><td class="colsep0 rowsep0" align="center">132</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="center">70</td><td class="colsep0 rowsep0" align="center">137</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="center">79</td><td class="colsep0 rowsep0" align="center">152</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="center">10</td><td class="colsep0 rowsep0" align="center">150</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="center">58</td><td class="colsep0 rowsep0" align="center">140</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="center">7</td><td class="colsep0 rowsep0" align="center">151</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="center">1540</td><td class="colsep0 rowsep0" align="center">40<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="center">22</td><td class="colsep0 rowsep0" align="center">133</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="center">82</td><td class="colsep0 rowsep0" align="center">144</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="center">85</td><td class="colsep0 rowsep0" align="center">146</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="center">2080</td><td class="colsep0 rowsep0" align="center">134</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="center">2460</td><td class="colsep0 rowsep0" align="center">140</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="center">1800</td><td class="colsep0 rowsep0" align="center">154</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="center">no effect</td><td class="colsep0 rowsep0" align="center">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="center">15</td><td class="colsep0 rowsep0" align="center">145</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="center">20</td><td class="colsep0 rowsep0" align="center">135</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="center">131</td><td class="colsep0 rowsep0" align="center">142</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">quercetin</td><td class="colsep0 rowsep0" align="center">278</td><td class="colsep0 rowsep0" align="center">177</td></tr></tbody></table><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">biphasic</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>M</sub> [nM]</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> [nM]</th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>max</sub> [% of control]</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="center">9</td><td class="colsep0 rowsep0" align="center">28000</td><td class="colsep0 rowsep0" align="center">155</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="center">2</td><td class="colsep0 rowsep0" align="center">27000</td><td class="colsep0 rowsep0" align="center">152</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Inhibiting compound.</p></div></div></div><div class="NLM_p">Inspection of the EC<sub>50</sub> values shows that in case of the methylpyrimidines with scaffold B a large difference in magnitude exists depending on the substituent at position two. Derivatives containing a pyridyl group (<b>42</b>, <b>43</b>, <b>44</b>) have EC<sub>50</sub> values in the low nanomolar range, like the corresponding quinazolines with scaffold A (<b>17</b>, <b>21</b>, <b>22</b>). However, all investigated compounds with scaffold B and a 2-phenyl substituent (<b>45</b>, <b>46</b>, <b>47</b>) were much less potent with EC<sub>50</sub> values in the micromolar range. The ATPase activation is only noticeable at concentrations far higher than the IC<sub>50</sub> for ABCG2 inhibition. Therefore, we investigated additionally some quinazolines from our previous publication containing a 2-phenyl substituent for their effect on ATPase activity (<b>49</b>, <b>51</b>, <b>53</b>). Interestingly for the quinazolines this difference between a 2-phenyl substituent and a pyridyl group in position 2 in activating efficacy is not apparent. Both groups of compounds are potent activators of ATPase activity with comparable EC<sub>50</sub> values. But like most of the quinazolines (scaffold A) with a pyridyl substituent, the investigated 2-phenyl derivatives were found to exert only low stimulating effect of less than 50%.</div><div class="NLM_p">While comparing the substitution pattern of scaffold A in relation to the position of the nitrogen atom in the pyridyl group, it becomes obvious that compounds comprising a 2-pyridyl moiety are less potent in the ABCG2 inhibition assay as well as less effective in ATPase activation than their corresponding 3-pyridyl and 4-pyridyl analogues (<b>11</b>, <b>12</b>, and <b>13</b> and <b>15</b>, <b>16</b>, and <b>17</b>).</div><div class="NLM_p">Representative concentration–response curves of compounds <b>14</b>, <b>26</b>, <b>39</b>, and quercetin are illustrated in <a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>. Compound <b>14</b>, being the most active with the lowest IC<sub>50</sub> value in the Hoechst 33342 accumulation assay (64 nM), exhibited solely activation of ATPase activity over the whole range of concentrations similar to quercetin. Compound <b>26</b> is one of the two derivatives showing a bell-shaped curve, which is typical for substrates having different affinities for two distinct binding sites.<a onclick="showRef(event, 'ref34 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref34 ref35 ref36">(34-36)</a> It is assumed that the transporter has two distinct binding sites for substrates, where the high affinity site is activating/transporting and the other one is inhibiting and has a low affinity for substrates. If both affinities are sufficiently different, a bell-shaped curve results. However, if the affinity to the activating binding site is several orders of magnitude higher than for the inhibitory site, a Michaelis–Menten type curve will be observed as only the activating site is targeted. The maximum of ATPase activity is reached at a concentration of about 0.5 μM with an activation of 55%. Further increase of concentration results in a decrease of ATPase activity going down to 25% at 35 μM. Fitting the data with a combination of an increasing and a decreasing logistic equation with a Hill coefficient fixed to one, an activating <i>K</i><sub>M</sub> of 9 nM and an inactivating <i>K</i><sub>i</sub> of 28000 nM was calculated. Although stimulation of ATPase activity is often considered as being typical for substrates, several direct and indirect evidence exists that challenges this simple view. In the case of high ATPase activity stimulation, recently a fluorescent heterodimeric ABCG2 inhibitor comprised of a quinazoline and chalcone moiety was shown to accumulate in transfected MDCK II BCRP cells to the same extent as in parental cells not expressing ABCG2 using confocal fluorescence microscopy.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Further indirect evidence that the compounds are no substrates comes from the MTT data of their intrinsic cytotoxicity. Here, no differences between the GI<sub>50</sub> values of the ABCG2 expressing and the parental cell line were observed, pointing to no or insufficient transport of the compounds. The same identical toxicity was observed in case of the quinazoline–chalcones. For further investigations of the binding mode of these compounds, enzyme kinetic studies with the substrate Hoechst 33342 were undertaken.</div><figure id="fig10" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/medium/jm-2017-00441x_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Concentration–response curves for compounds <b>14</b>, <b>26</b>, <b>39</b>, and quercetin in the ATPase assay. All values are relative vanadate-sensitive ATPase activities in relation to the basal activity, which is set to 100%.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00441&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Investigation of Inhibitory Enzyme Kinetics</h3><div class="NLM_p">Investigation of the mode of interaction was undertaken for compounds <b>14</b>, <b>21</b>, and <b>26</b>, which were selected based on their different ATPase activity profiles. Studies were carried out with ABCG2 overexpressing MDCK II cells and Hoechst 33342. The Lineweaver–Burk linearization of the data for compound <b>14</b> proposes a noncompetitive interaction with Hoechst 33342, as indicated by the intersection of the lines at the <i>X</i>-axis (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>a). Although linearization according to Lineweaver–Burk gives direct information on the type of interaction, this method has been criticized as being notoriously susceptible to experimental errors due to the double reciprocal plot. Therefore, we additionally analyzed the data using the method according to Hanes–Woolf. The half-reciprocal method according to Hanes–Woolf is claimed to be more robust to experimental errors. Compound <b>14</b> yielded an intersection of all lines at the <i>X</i>-axis, meaning that <i>K</i><sub>M</sub> remained constant but <i>V</i><sub>max</sub> decreased with increasing substrate concentrations that is characteristic for noncompetitive inhibitors (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>d). Thus, both methods indicate a noncompetitive interaction with Hoechst 33342, suggesting a different binding mode and/or binding pocket for compound <b>14</b>.</div><figure id="fig11" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/medium/jm-2017-00441x_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Lineweaver–Burk plots for compounds <b>14</b> (a), <b>21</b> (b), and <b>26</b> (c) at various concentrations together with the ABCG2 substrate Hoechst 33342. Hanes–Woolf plots at various concentrations of Hoechst 33342 for compounds <b>14</b> (d), <b>21</b> (e), and <b>26</b> (f). Plot of the Michaelis–Menten constant <i>K</i><sub>M</sub> (●) and the maximum velocity <i>V</i><sub>max</sub> (■) derived from the analysis according to Cornish–Bowden against the corresponding compound concentration (g,h,i). Here excluded values are depicted by the corresponding open symbols.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00441&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">For compound <b>21</b>, on the other hand, a competitive interaction with Hoechst 33342 was derived from the Lineweaver–Burk linearization visualized by the intersection of the lines at the <i>Y</i>-axis (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>b). This result is substantiated by the results of the analysis according to Hanes–Woolf (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>e). Here an increase of <i>K</i><sub>M</sub> with higher inhibition concentrations is noticeable while <i>V</i><sub>max</sub> remains constant. According to both methods, a competitive interaction is proposed for compound <b>21</b>, suggesting the same binding mode and/or pocket as Hoechst 33342. Furthermore, the data of compound <b>26</b> were analyzed with the Lineweaver–Burk linearization, obtaining straight lines with an intersection in the second quadrant of the coordinate system (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>c). This phenomenon is observed for “mixed-type” inhibitors with both competitive and noncompetitive characteristics. For instance, conformational change of the protein epitope upon binding of the “mixed-type” inhibitor can still affect the active site. Such inhibitors bind differently from the substrate but still influence substrate binding and turnover rate.</div><div class="NLM_p">Applying the Hanes–Woolf method equivalent results were obtained, as indicated by decreasing <i>V</i><sub>max</sub> values and increasing <i>K</i><sub>M</sub> values with higher substrate concentrations in agreement with a noncompetitive interaction of the “mixed type” (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>f).</div><div class="NLM_p last">As a third method the direct linear plot according to Cornish–Bowden was used to analyze the data. This method has been claimed to be insensitive to outliers. For compound <b>14</b>, analysis of the data according to Cornish–Bowden reveals a decline of the maximal velocity <i>V</i><sub>max</sub> with increasing compound concentration while the Michaelis–Menten constant <i>K</i><sub>M</sub> remains the same, indicative of a noncompetitive interaction with Hoechst 33342 (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>g). In compound <b>21</b> the plot of <i>K</i><sub>M</sub> (increasing) and <i>V</i><sub>max</sub> (constant) calculated from the analysis according to Cornish–Bowden (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>h) nicely confirms previous results, exhibiting a competitive character. In <a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>i, a decreasing <i>K</i><sub>M</sub> and a slightly increasing <i>V</i><sub>max</sub> with increasing compound concentration is seen for compound <b>26</b> indicative of a mixed type of inhibition.</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88710" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88710" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The purpose of this study was to extend the database of inhibitors based on a quinazoline scaffold. Notably, the comparison between 4-substituted 2-phenylquinazolines of our previous study and 4-substituted 2-pyridylquinazolines and 4-methylpyrimidine analogues with lower molecular weight was targeted.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> The investigation of the inhibitory activities against ABCG2 showed a distinct correlation between the position of the nitrogen atom in the pyridyl residue and the inhibitory potency: a nitrogen atom in <i>ortho</i> position resulted in less potent compounds, while <i>meta</i> and <i>para</i> pyridyl substituents were found to be beneficial. Regarding the substitution at the aniline linker in position 4, nitro, cyano, trifluoromethyl, and fluoro substituents yielded considerably high inhibitory activities toward ABCG2. The most potent compound in the test set contained a 3-pyridyl substitution at R<sup>1</sup> and a <i>para</i> nitro-group at R<sup>2</sup> (<b>14</b>) with an IC<sub>50</sub> value of 64.1 nM, which is 3.5-fold lower than for compound <b>55</b>. Among the 4-methylpyrimidine derivatives based on scaffold B, several compounds yielded IC<sub>50</sub> values between 100 and 150 nM. This demonstrates the extraordinary high ligand efficacy of this scaffold. For both scaffolds A and B, significant conformity regarding the IC<sub>50</sub> value was observed between derivatives bearing pyridyl and phenyl, respectively. However, substitution with hydroxy on R<sup>2</sup> in <i>meta</i> and <i>para</i> was found to be significantly more favorable using a phenyl substitution at R<sup>1</sup>. In general, the determined differences between the potencies of a <i>meta</i> or <i>para</i> substitution with the same residue is mentionable. Another advantage of the pyridyl derivatives compared to their phenyl analogues is the considerably lower calculated log <i>P</i> value that could be beneficial for bioavailability. For the whole test set, however, no correlation between log <i>P</i> and pIC<sub>50</sub> was found. Although sufficient lipophilicity is needed for membrane permeability, several compounds exhibit similar log <i>P</i> values but different inhibitory potencies. Hence, other determinants are probably influencing the potency of a compound to a higher degree. Furthermore, substitution with pyridyl yielded considerably lower cytotoxicities than with phenyl, resulting in several compounds with extraordinary high therapeutic ratios. Like for the IC<sub>50</sub>, the GI<sub>50</sub> of the compounds was often significantly influenced by the choice of substitution at R<sup>2</sup>, as well as by the position in <i>meta</i> or <i>para</i>. Regarding selectivity toward ABCG2, only compounds with one or more methoxy groups showed activity toward ABCB1, while none of the selected compounds obtained a significant activity toward ABCC1. The ability to reverse MDR was confirmed for the most potent compounds carrying out MDR reversal assays with the anticancer drugs SN-38 and MX. The IC<sub>50</sub> values derived from the MTT assay often exceeded the inhibitory potency found in the Hoechst 33342 accumulation assays, suggesting a higher affinity for Hoechst 33342 toward ABCG2.</div><div class="NLM_p last">Investigation of the effect on ATPase activity for selected compounds revealed four different types of ATPase activity curves. A small group of compounds showed solely an activating curve with high stimulating effect up to 85% in comparison to the basal activity. This group of compounds is comparable to quercetin, which is a well-known substrate of ABCG2 and shows high ATPase stimulating effects. Only one compound exhibited an inhibiting ATPase activity curve with 60% under the basal activity in the highest concentration. The third larger group of compounds comprises a half maximal ATPase activation of less than 50%. The last group illustrates a bell-shaped curve with a stimulation of ATPase activity by around 55% at the top of the curve and an inhibiting character at higher concentrations as also suggested in former studies.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31, 32)</a> Interestingly, in the enzyme kinetic studies, the same observations become obvious. Enzyme kinetic interaction studies with Hoechst 33342 as substrate with selected compounds exhibited three different modes of interaction: competitive, noncompetitive, and “mixed-type” inhibitors were identified using the double-reciprocal Lineweaver–Burk linearization, the half-reciprocal method according to Hanes–Woolf, and the direct linear plot according to Cornish–Bowden. The results of all three methods were in accordance. The current study of 4-substituted 2-pyridylquinazolines showed to be a worthwhile continuation of the earlier studies of 4-substituted 2-phenylquinazolines: extended insights into the SAR of this new class of inhibitors regarding the inhibitory activity and selectivity toward ABCG2 together with the predominantly low cytotoxic effects observed in the MTT assay are some of the findings. Potential applicability for in vivo studies was confirmed by the high efficacy in reversing MDR when coadministered with the cytostatic agents SN-38 and MX. ATPase results reflect the diversity of the compound interactions with the ABCG2 transport protein. This was also illustrated by the results of enzyme kinetic studies yielding different modes of interaction with the substrate Hoechst 33342.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72012" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72012" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Chemistry: Materials</h3><div class="NLM_p last">Chemicals were purchased from Acros Organics (Geel, Belgium), Alfa Aesar (Karlsruhe, Germany), Sigma-Aldrich (Steinheim, Germany), or Merck (Darmstadt, Germany) and used without further purification. Microwave reactions were carried out in 50 mL vials with a CEM Discover SP (CEM GmbH, Kamp-Lintfort, Germany). Progress of the reaction was monitored by thin layer chromatography (TLC) using an aluminum plate coated with silica gel 60 F<sub>254</sub> (Merck Millipore, Billerica, MA, USA). A mixture of dichloromethane and methanol (9:1) was used as eluent and the TLCs analyzed in a UV cabinet with an excitation wavelength of 254 nm. Identity of the compounds was confirmed by NMR. <sup>1</sup>H and <sup>13</sup>C spectra were either obtained on a Bruker Advance 500 MHz (500/126 MHz) or Bruker Advance 600 MHz (600/151 MHz). DMSO-<i>d</i><sub>6</sub> was used as solvent for the compounds as well as internal standard to give chemical shifts (δ) expressed in ppm. Assignment of the <sup>13</sup>C signals was carried out by distortionless enhancement by polarization transfer (DEPT) and attached proton test (APT). The signals multiplicity is indicated as singulet (s), doublet (d), doublet of doublets (dd), triplet of doublets (td), triplet (t), doublet of triplets (dt), quartet (q), and multiplet (m). Coupling constants <i>J</i> are given in Hz. The purity of all biologically evaluated compounds was determined to be >95% by elemental analysis recorded on a Vario EL V24 CHN elemental analyzer (Elementar Analysensysteme GmbH, Hanau, Germany). Found values were in the range of ±0.4% of the theoretical values unless indicated. Calculation of the log <i>P</i> values was performed with ACD/ChemSketch, file version C10E41, Advanced Chemistry Development, Inc., Toronto, ON, Canada, <a href="http://www.acdlabs.com" class="extLink">www.acdlabs.com</a>, 2015.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> General Procedure for the Preparation of the 2-Pyridylquinazolin-4(3<i>H</i>)-one Derivatives <b>1</b>–<b>3</b></h3><div class="NLM_p">A mixture of anthranilamide (2.72 g, 20 mmol), the corresponding pyridinecarboxaldehyde (20 mmol), iodine (3.17 g, 25 mmol), anhydrous potassium carbonate (2.76 g, 20 mmol), and 20 mL of DMF was stirred at 70–90 °C for 4–8 h. The end of the reaction was monitored by TLC and the mixture poured on crushed ice to form a precipitate. Incomplete precipitation was prevented by adjusting the pH with concentrated HCl solution to about 7. After filtering off the precipitate, it was thoroughly washed with 100 mL of a 20% sodium thiosulfate solution followed by 100 mL of hot distilled water. Purification was performed by recrystallization from ethanol.</div><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 2-(Pyridin-2-yl)quinazolin-4(3<i>H</i>)-one (<b>1</b>)</h4><div class="NLM_p last">The compound was synthesized from picolinaldehyde (2.14 g, 20 mmol) as described in the general procedure for <b>1</b>–<b>3</b> to yield <b>1</b> as a white solid (3.84 g, 86%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.77 (s, 1H), 8.76 (ddd, <i>J</i> = 4.7, 1.7, 0.9 Hz, 1H), 8.46 (dt, <i>J</i> = 7.9, 1.1 Hz, 1H), 8.18 (dd, <i>J</i> = 7.9, 1.5 Hz, 1H), 8.07 (td, <i>J</i> = 7.7, 1.7 Hz, 1H), 7.87 (ddd, <i>J</i> = 8.5, 7.0, 1.6 Hz, 1H), 7.80 (d, <i>J</i> = 8.0 Hz, 1H), 7.66 (ddd, <i>J</i> = 7.6, 4.8, 1.2 Hz, 1H), 7.57 (ddd, <i>J</i> = 8.1, 7.0, 1.2 Hz, 1H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 149.1, 148.8, 138.1, 134.8, 127.8, 127.4, 126.7, 126.2, 122.3, 122.1.</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 2-(Pyridin-3-yl)quinazolin-4(3<i>H</i>)-one (<b>2</b>)</h4><div class="NLM_p last">The compound was synthesized from nicotinaldehyde (2.14 g, 20 mmol) as described in the general procedure for <b>1</b>–<b>3</b> to yield <b>2</b> as a white solid (3.34 g, 75%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.70 (s, 1H), 9.30 (d, <i>J</i> = 2.3 Hz, 1H), 8.76 (dd, <i>J</i> = 4.8, 1.6 Hz, 1H), 8.51 (dt, <i>J</i> = 8.1, 1.9 Hz, 1H), 8.17 (dd, <i>J</i> = 7.9, 1.5 Hz, 1H), 7.85 (ddd, <i>J</i> = 8.5, 7.0, 1.6 Hz, 1H), 7.76 (dd, <i>J</i> = 8.2, 1.1 Hz, 1H), 7.60 (ddd, <i>J</i> = 8.0, 4.9, 0.8 Hz, 1H), 7.55 (ddd, <i>J</i> = 8.1, 7.1, 1.2 Hz, 1H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 162.2, 151.7, 150.8, 148.7, 148.6, 135.8, 134.8, 129.0, 127.6, 127.1, 126.0, 123.7, 121.3.</div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 2-(Pyridin-4-yl)quinazolin-4(3<i>H</i>)-one (<b>3</b>)</h4><div class="NLM_p last">The compound was synthesized from isonicotinaldehyde (2.14 g, 20 mmol) as described in the general procedure for <b>1</b>–<b>3</b> to yield <b>3</b> as a white solid (3,04 g, 68%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.73 (s, 1H), 8.83–8.74 (m, 2H), 8.18 (dd, <i>J</i> = 7.9, 1.5 Hz, 1H), 8.14–8.08 (m, 2H), 7.87 (ddd, <i>J</i> = 8.5, 7.1, 1.6 Hz, 1H), 7.79 (dd, <i>J</i> = 8.2, 1.1 Hz, 1H), 7.58 (ddd, <i>J</i> = 8.1, 7.1, 1.2 Hz, 1H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 162.1, 150.7, 150.3, 148.4, 140.1, 134.9, 127.9, 127.5, 126.1, 121.7, 121.6.</div></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> General Procedure for the Preparation of the 4-Chloro-2-pyridylquinazoline Derivatives <b>4</b>–<b>6</b></h3><div class="NLM_p">The corresponding 2-pyridylquinazolin-4(3<i>H</i>)-one derivative (10 mmol) was added to phosphorus oxychloride (30 mL, 0.32 mol) and stirred for 10 min at room temperature. The mixture was then refluxed for 4–8 h and the reaction monitored by TLC. After completion of the reaction, excess POCl<sub>3</sub> was removed under reduced pressure and the residue poured in 50 mL of ice–water. Subsequently, 50 mL of DCM was added while stirring and the pH of the mixture slowly adjusted to 7 with 25% ammonium solution. With a separatory funnel, the organic phase was collected, washed with 50 mL of brine, and dried over MgSO<sub>4</sub>. The solvent was removed under reduced pressure and the obtained solid recrystallized from 2-propanol.</div><div id="sec5_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 4-Chloro-2-(pyridin-2-yl)quinazoline (<b>4</b>)</h4><div class="NLM_p last">The compound was synthesized from <b>1</b> (2.23 g, 10 mmol) as described in the general procedure for <b>4</b>–<b>6</b> to yield <b>4</b> as a white solid (2.15 g, 89%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.77 (ddd, <i>J</i> = 4.8, 1.8, 1.0 Hz, 1H), 8.47 (dt, <i>J</i> = 7.9, 1.1 Hz, 1H), 8.21–8.14 (m, 1H), 8.09 (td, <i>J</i> = 7.8, 1.7 Hz, 1H), 7.87 (ddd, <i>J</i> = 8.5, 7.0, 1.6 Hz, 1H), 7.82 (dd, <i>J</i> = 7.9, 1.5 Hz, 1H), 7.67 (ddd, <i>J</i> = 7.6, 4.8, 1.2 Hz, 1H), 7.57 (ddd, <i>J</i> = 8.2, 7.0, 1.3 Hz, 1H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 160.9, 150.1, 149.0, 148.4, 147.8, 138.1, 134.7, 127.3, 127.2, 126.7, 126.1, 122.3, 121.9.</div></div><div id="sec5_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 4-Chloro-2-(pyridin-3-yl)quinazoline (<b>5</b>)</h4><div class="NLM_p last">The compound was synthesized from <b>2</b> (2.23 g, 10 mmol) as described in the general procedure for <b>4</b>–<b>6</b> to yield <b>5</b> as a white solid (2.27 g, 94%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.29 (d, <i>J</i> = 2.2 Hz, 1H), 8.74 (dd, <i>J</i> = 4.8, 1.6 Hz, 1H), 8.49 (dt, <i>J</i> = 8.0, 2.0 Hz, 1H), 8.16 (dd, <i>J</i> = 7.9, 1.5 Hz, 1H), 7.84 (ddd, <i>J</i> = 8.5, 7.0, 1.6 Hz, 1H), 7.78–7.72 (m, 1H), 7.61–7.49 (m, 2H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 162.2, 151.9, 150.9, 148.9, 148.6, 135.5, 134.8, 128.9, 127.7, 127.1, 126.0, 123.6, 121.3.</div></div><div id="sec5_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 4-Chloro-2-(pyridin-4-yl)quinazoline (<b>6</b>)</h4><div class="NLM_p last">The compound was synthesized from <b>3</b> (2.23 g, 10 mmol) as described in the general procedure for <b>4</b>–<b>6</b> to yield <b>6</b> as a white solid (2.18 g, 90%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.05–8.96 (m, 2H), 8.54–8.46 (m, 2H), 8.20 (dd, <i>J</i> = 8.0, 1.4 Hz, 1H), 7.90 (ddd, <i>J</i> = 8.5, 7.1, 1.6 Hz, 1H), 7.83 (dd, <i>J</i> = 8.3, 1.2 Hz, 1H), 7.62 (ddd, <i>J</i> = 8.1, 7.1, 1.2 Hz, 1H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 162.0, 149.4, 148.0, 145.5, 145.0, 135.1, 128.2, 128.1, 126.1, 124.0, 121.8.</div></div><div id="sec5_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 6-Methyl-2-(pyridin-4-yl)pyrimidin-4(3<i>H</i>)-one (<b>7</b>)</h4><div class="NLM_p last">To a solution of isonicotinimidamide hydrochloride (158 mg, 1 mmol) in methanol (5 mL) was added sodium methoxide (54.0 mg, 1 mmol) and stirred for 10 min at room temperature. After adding methyl acetoacetate (116 mg, 1 mmol), the mixture was transferred into a microwave tube, sealed, and heated to 70 °C at 60 W microwave irradiation for 4 h. After cooling to room temperature, the pH of the mixture was adjusted with 1 M hydrochloric acid to 7 and the formed precipitate filtered with suction. The solid was washed with water and dried in vacuo to give <b>7</b> as a white solid (76.8 mg, 41%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.59 (s, 1H), 8.80–8.66 (m, 2H), 8.09–7.99 (m, 2H), 6.37 (s, 1H), 2.39–2.24 (m, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 150.4, 121.6, 23.5.</div></div><div id="sec5_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 6-Methyl-2-phenylpyrimidin-4(3<i>H</i>)-one (<b>8</b>)</h4><div class="NLM_p last">This compound was sythesized according to the procedure described for <b>7</b>. Instead of isonicotinimidamide hydrochloride, benzimidamide hydrochloride (157 mg, 1 mmol) was used in the first step to yield <b>8</b> as a white solid (89.4 mg, 48%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.47 (s, 1H), 8.22–7.99 (m, 2H), 7.60–7.42 (m, 3H), 6.19 (s, 1H), 2.26 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 164.7, 163.9, 157.2, 132.9, 131.6, 128.7, 127.9, 110.0, 23.6.</div></div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> General Procedure for the Preparation of the 2-Substituted 4-Chloro-6-methylpyrimidine Derivatives <b>9</b> and <b>10</b></h3><div class="NLM_p">The compounds were synthesized according to the method described in the general methods for compounds <b>4</b>–<b>6</b> from the corresponding 2-substituted 6-methyl-pyrimidin-4(3<i>H</i>)-ones <b>7</b> and <b>8</b>. Complete chlorination was achieved within 4 h.</div><div id="sec5_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 4-Chloro-6-methyl-2-(pyridin-4-yl)pyrimidine (<b>9</b>)</h4><div class="NLM_p last">The compound was synthesized from <b>7</b> (1.87 g, 10 mmol) as described in the general procedure for <b>9</b>–<b>10</b> to yield <b>9</b> as a white solid (1.79 g, 87%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.81–8.74 (m, 2H), 8.21–8.16 (m, 2H), 7.69 (d, <i>J</i> = 0.7 Hz, 1H), 2.58 (s, 3H). <sup>13</sup>C NMR (151 MHz, DMSO) δ 170.6, 162.1, 160.9, 150.8, 143.0, 121.8, 120.8, 23.7.</div></div><div id="sec5_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 4-Chloro-6-methyl-2-phenylpyrimidine (<b>10</b>)</h4><div class="NLM_p last">The compound was synthesized from <b>8</b> (1.86 g, 10 mmol) as described in the general procedure for <b>9</b> and <b>10</b> to yield <b>10</b> as a white solid (1.90 g, 93%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.39–8.27 (m, 2H), 7.60–7.45 (m, 4H), 2.55 (d, <i>J</i> = 0.6 Hz, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 170.1, 163.8, 160.6, 135.9, 131.6, 128.9, 128.1, 119.0, 23.8.</div></div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> General Procedure for the Preparation of the Substituted 4-Anilinoquinazolines <b>11</b>–<b>41</b></h3><div class="NLM_p">The corresponding 4-chloroquinazoline derivative <b>4</b>–<b>6</b> (1 mmol) was added to 2-propanol (5 mL) with the corresponding substituted aniline derivative (1 mmol) and sealed in a microwave tube. The mixture was heated by 100 W microwave irradiation to 110 °C for a period of 15–30 min until completion of the reaction as indicated by TLC. The formed precipitate was filtered off, washed with 10 mL of 2-propanol, and dried in vacuo. If no precipitate is formed, the solvent was removed under reduced pressure and the remaining solid recrystallized from ethanol.</div><div id="sec5_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> <i>N</i>-(3-Nitrophenyl)-2-(pyridin-2-yl)quinazolin-4-amine (<b>11</b>)</h4><div class="NLM_p last">The compound was synthesized from <b>4</b> (242 mg, 1 mmol) and 3-nitroaniline (138 mg, 1 mmol) as described in the general procedure for compounds <b>11</b>–<b>41</b> to yield <b>11</b> as a yellow solid (292 mg, 85%), mp 274–275 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.09 (s, 1H), 9.09 (dd, <i>J</i> = 8.4, 1.3 Hz, 1H), 9.02 (t, <i>J</i> = 2.2 Hz, 1H), 8.93 (ddd, <i>J</i> = 4.8, 1.7, 0.9 Hz, 1H), 8.43 (dt, <i>J</i> = 7.9, 1.1 Hz, 1H), 8.39 (ddd, <i>J</i> = 8.1, 2.1, 0.9 Hz, 1H), 8.33 (dd, <i>J</i> = 8.5, 1.1 Hz, 1H), 8.24–8.17 (m, 2H), 8.14 (ddd, <i>J</i> = 8.5, 7.1, 1.2 Hz, 1H), 7.89 (ddd, <i>J</i> = 8.3, 7.1, 1.2 Hz, 1H), 7.86–7.78 (m, 2H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 159.8, 154.9, 149.4, 148.3, 148.0, 141.4, 139.4, 138.5, 136.4, 130.2, 128.8, 128.2, 125.0, 124.7, 122.1, 120.6, 118.8, 113.8. Anal. Calcd for C<sub>19</sub>H<sub>13</sub>N<sub>5</sub>O<sub>2</sub>: C, 66.47; H, 3.82; N, 20.40. Found: C, 66.38 ; H, 4.19; N, 20.16.</div></div><div id="sec5_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> <i>N</i>-(3-Nitrophenyl)-2-(pyridin-3-yl)quinazolin-4-amine (<b>12</b>)</h4><div class="NLM_p last">The compound was synthesized from <b>5</b> (242 mg, 1 mmol) and 3-nitroaniline (138 mg, 1 mmol) as described in the general procedure for compounds <b>11</b>–<b>41</b> to yield <b>12</b> as a yellow–beige solid (278 mg, 81%), mp >300 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.51 (s, 1H), 9.61 (s, 1H), 9.17 (t, <i>J</i> = 2.2 Hz, 1H), 8.99 (dt, <i>J</i> = 8.1, 1.9 Hz, 1H), 8.84 (d, <i>J</i> = 4.9 Hz, 1H), 8.68 (dt, <i>J</i> = 8.4, 1.0 Hz, 1H), 8.36 (ddd, <i>J</i> = 8.2, 2.2, 0.9 Hz, 1H), 8.04 (ddd, <i>J</i> = 8.2, 2.3, 0.9 Hz, 1H), 8.01–7.95 (m, 2H), 7.81 (dd, <i>J</i> = 8.0, 5.0 Hz, 1H), 7.79–7.72 (m, 2H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 158.2, 156.4, 149.9, 148.0, 140.4, 134.9, 134.3, 130.1, 128.2, 128.1, 127.3, 125.1, 123.5, 118.4, 116.5, 114.3. Anal. Calcd for C<sub>19</sub>H<sub>13</sub>N<sub>5</sub>O<sub>2</sub>: C, 66.47; H, 3.82; N, 0.40. Found: C, 66.73; H, 4.10; N, 20.14.</div></div><div id="sec5_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> <i>N</i>-(3-Nitrophenyl)-2-(pyridin-4-yl)quinazolin-4-amine (<b>13</b>)</h4><div class="NLM_p last">The compound was synthesized from <b>6</b> (242 mg, 1 mmol) and 3-nitroaniline (138 mg, 1 mmol) as described in the general procedure for compounds <b>11</b>–<b>41</b> to yield <b>13</b> as a yellow solid (264 mg, 77%), mp >300 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.59 (s, 1H), 9.16 (t, <i>J</i> = 2.2 Hz, 1H), 8.97 (d, <i>J</i> = 5.6 Hz, 2H), 8.73 (dt, <i>J</i> = 8.3, 1.0 Hz, 1H), 8.71–8.64 (m, 2H), 8.37 (ddd, <i>J</i> = 8.2, 2.2, 0.9 Hz, 1H), 8.07–7.97 (m, 3H), 7.83–7.73 (m, 2H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 158.4, 155.5, 150.5, 150.0, 148.0, 145.5, 140.3, 134.4, 128.7, 128.2, 123.8, 123.6, 118.4, 116.6, 114.7. Anal. Calcd for C<sub>19</sub>H<sub>13</sub>N<sub>5</sub>O<sub>2</sub>: C, 66.47; H, 3.82; N, 20.40. Found: C, 66.33; H, 4.20; N, 20.20.</div></div><div id="sec5_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> <i>N</i>-(4-Nitrophenyl)-2-(pyridin-4-yl)quinazolin-4-amine (<b>14</b>)</h4><div class="NLM_p last">The compound was synthesized from <b>5</b> (242 mg, 1 mmol) and 4-nitroaniline (138 mg, 1 mmol) as described in the general procedure for compounds <b>11</b>–<b>41</b> to yield <b>14</b> as a yellow solid (247 mg, 72%), mp >300 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.72 (s, 1H), 9.64–9.55 (m, 1H), 9.13 (dt, <i>J</i> = 8.1, 1.8 Hz, 1H), 8.98–8.87 (m, 1H), 8.76 (dd, <i>J</i> = 8.3, 1.0 Hz, 1H), 8.39–8.33 (m, 2H), 8.33–8.27 (m, 2H), 8.04–7.94 (m, 3H), 7.76 (ddd, <i>J</i> = 8.3, 5.5, 2.7 Hz, 1H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 158.2, 155.6, 149.8, 146.4, 145.6, 144.7, 142.6, 140.8, 135.2, 134.6, 128.0, 127.7, 126.2, 124.7, 123.8, 121.9, 114.6. Anal. Calcd for C<sub>19</sub>H<sub>13</sub>N<sub>5</sub>O<sub>2</sub>: C, 66.47; H, 3.82; N, 20.40. Found: C, 66.52; H, 3.66; N, 20.15.</div></div><div id="sec5_5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 3-((2-(Pyridin-2-yl)quinazolin-4-yl)amino)benzonitrile (<b>15</b>)</h4><div class="NLM_p last">The compound was synthesized from <b>4</b> (242 mg, 1 mmol) and 3-aminobenzonitrile (118 mg, 1 mmol) as described in the general procedure for compounds <b>11</b>–<b>41</b> to yield <b>15</b> as a light-yellow solid (242 mg, 75%), mp 261–263 °C (decomp). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.27 (s, 1H), 9.15 (dd, <i>J</i> = 8.3, 1.3 Hz, 1H), 8.92 (ddd, <i>J</i> = 4.8, 1.8, 0.9 Hz, 1H), 8.39 (t, <i>J</i> = 1.9 Hz, 1H), 8.33 (dd, <i>J</i> = 8.5, 1.1 Hz, 1H), 8.31–8.24 (m, 2H), 8.20 (td, <i>J</i> = 7.7, 1.7 Hz, 1H), 8.13 (ddd, <i>J</i> = 8.3, 7.0, 1.2 Hz, 1H), 7.87 (ddd, <i>J</i> = 8.3, 7.1, 1.2 Hz, 1H), 7.84–7.79 (m, 2H), 7.77 (t, <i>J</i> = 7.9 Hz, 1H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 160.0, 154.9, 149.5, 148.2, 140.9, 139.3, 138.1, 136.5, 130.3, 129.9, 129.4, 128.8, 128.2, 127.9, 125.2, 124.5, 121.6, 118.5, 113.7, 111.7. Anal. Calcd for C<sub>20</sub>H<sub>13</sub>N<sub>5</sub>: C, 74.29; H, 4.05; N, 21.66. Found: C, 74.05; H, 4.34; N, 21.50.</div></div><div id="sec5_5_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 3-((2-(Pyridin-3-yl)quinazolin-4-yl)amino)benzonitrile (<b>16</b>)</h4><div class="NLM_p last">The compound was synthesized from <b>5</b> (242 mg, 1 mmol) and 3-aminobenzonitrile (118 mg, 1 mmol) as described in the general procedure for compounds <b>11</b>–<b>41</b> to yield <b>16</b> as a yellow solid (252 mg, 78%), mp >300 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.17 (s, 1H), 9.52 (s, 1H), 8.68 (ddd, <i>J</i> = 9.9, 4.9, 3.0 Hz, 2H), 8.57 (dt, <i>J</i> = 8.4, 1.1 Hz, 1H), 8.45 (t, <i>J</i> = 1.8 Hz, 1H), 8.27 (ddd, <i>J</i> = 8.3, 2.2, 1.1 Hz, 1H), 7.96–7.90 (m, 2H), 7.73–7.65 (m, 2H), 7.62 (dt, <i>J</i> = 7.7, 1.3 Hz, 1H), 7.55 (ddd, <i>J</i> = 7.9, 4.7, 0.9 Hz, 1H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 158.1, 157.5, 151.2, 150.5, 149.3, 140.2, 135.2, 133.9, 133.6, 130.1, 128.4, 127.3, 127.0, 126.8, 125.3, 123.8, 123.2, 118.9, 114.2, 111.5. Anal. Calcd for C<sub>20</sub>H<sub>13</sub>N<sub>5</sub>: C, 74.29; H, 4.05; N, 21.66. Found: C, 74.27; H, 4.22; N, 21.46.</div></div><div id="sec5_5_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 3-((2-(Pyridin-4-yl)quinazolin-4-yl)amino)benzonitrile (<b>17</b>)</h4><div class="NLM_p last">The compound was synthesized from <b>6</b> (242 mg, 1 mmol) and 3-aminobenzonitrile (118 mg, 1 mmol) as described in the general procedure for compounds <b>11</b>–<b>41</b> to yield <b>17</b> as a yellow solid (252 mg, 78%), mp >300 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.62 (s, 1H), 9.04–8.94 (m, 2H), 8.81–8.72 (m, 1H), 8.68–8.60 (m, 2H), 8.36 (t, <i>J</i> = 1.8 Hz, 1H), 8.31 (dt, <i>J</i> = 7.8, 1.9 Hz, 1H), 8.03–7.95 (m, 2H), 7.77 (ddd, <i>J</i> = 8.3, 5.7, 2.5 Hz, 1H), 7.71–7.63 (m, 2H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 158.5, 155.1, 151.5, 149.8, 144.3, 139.8, 134.4, 130.1, 128.5, 128.2, 127.7, 127.5, 125.8, 124.2, 123.8, 118.8, 114.7, 111.6. Anal. Calcd for C<sub>20</sub>H<sub>13</sub>N<sub>5</sub>: C, 74.29; H, 4.05; N, 21.66. Found: C, 74.66; H, 4.32; N, 21.40.</div></div><div id="sec5_5_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 4-((2-(Pyridin-3-yl)quinazolin-4-yl)amino)benzonitrile (<b>18</b>)</h4><div class="NLM_p last">The compound was synthesized from <b>5</b> (242 mg, 1 mmol) and 4-aminobenzonitrile (118 mg, 1 mmol) as described in the general procedure for compounds <b>11</b>–<b>41</b> to yield <b>18</b> as a light-yellow solid (278 mg, 86%), mp 285–287 °C (decomp). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.75 (s, 1H), 9.54 (d, <i>J</i> = 2.0 Hz, 1H), 9.12 (dt, <i>J</i> = 8.1, 1.8 Hz, 1H), 8.95 (dd, <i>J</i> = 5.4, 1.5 Hz, 1H), 8.83–8.74 (m, 1H), 8.24–8.16 (m, 2H), 8.05–7.94 (m, 3H), 7.93–7.85 (m, 2H), 7.73 (ddd, <i>J</i> = 8.3, 6.6, 1.6 Hz, 1H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 158.3, 155.2, 149.1, 145.8, 144.0, 143.3, 141.4, 135.1, 134.6, 133.0, 127.7, 127.5, 126.4, 124.0, 122.7, 119.2, 114.5, 105.79. Anal. Calcd for C<sub>20</sub>H<sub>13</sub>N<sub>5</sub>: C, 74.29; H, 4.05; N, 21.66. Found: C, 74.42; H, 4.33; N, 21.33.</div></div><div id="sec5_5_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> <i>N</i>-(3-Methoxyphenyl)-2-(pyridin-2-yl)quinazolin-4-amine (<b>19</b>)</h4><div class="NLM_p last">The compound was synthesized from <b>4</b> (242 mg, 1 mmol) and 3-methoxyaniline (123 mg, 1 mmol) as described in the general procedure for compounds <b>11</b>–<b>41</b> to yield <b>19</b> as a yellow solid (207 mg, 63%), mp 115–117 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.83 (s, 1H), 8.78–8.68 (m, 1H), 8.64 (d, <i>J</i> = 8.2 Hz, 1H), 8.44 (dt, <i>J</i> = 8.0, 1.1 Hz, 1H), 8.27 (t, <i>J</i> = 2.2 Hz, 1H), 8.00–7.86 (m, 3H), 7.66 (ddd, <i>J</i> = 8.3, 6.6, 1.5 Hz, 1H), 7.56 (ddd, <i>J</i> = 8.2, 2.0, 0.9 Hz, 1H), 7.50 (ddd, <i>J</i> = 7.6, 4.7, 1.2 Hz, 1H), 7.30 (t, <i>J</i> = 8.1 Hz, 1H), 6.69 (ddd, <i>J</i> = 8.2, 2.5, 0.9 Hz, 1H), 3.88 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 159.6, 159.0, 158.1, 155.8, 150.6, 149.6, 141.1, 136.9, 133.4, 129.2, 128.6, 126.7, 124.8, 123.5, 123.1, 114.5, 113.7, 109.9, 107.0, 55.3. Anal. Calcd for C<sub>20</sub>H<sub>16</sub>N<sub>4</sub>O: C, 73.15; H, 4.91; N, 17.06. Found: C, 73.43; H, 5.27; N, 16.99.</div></div><div id="sec5_5_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> <i>N</i>-(3-Methoxyphenyl)-2-(pyridin-3-yl)quinazolin-4-amine (<b>20</b>)</h4><div class="NLM_p last">The compound was synthesized from <b>5</b> (242 mg, 1 mmol) and 3-methoxyaniline (123 mg, 1 mmol) as described in the general procedure for compounds <b>11</b>–<b>41</b> to yield <b>20</b> as a light-yellow solid (213 mg, 65%), mp 182–184 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.88 (s, 1H), 9.56 (d, <i>J</i> = 2.0 Hz, 1H), 8.72–8.65 (m, 2H), 8.60 (dt, <i>J</i> = 8.4, 1.1 Hz, 1H), 7.92–7.85 (m, 2H), 7.70 (t, <i>J</i> = 2.3 Hz, 1H), 7.67–7.61 (m, 1H), 7.58–7.50 (m, 2H), 7.36 (t, <i>J</i> = 8.1 Hz, 1H), 6.76 (ddd, <i>J</i> = 8.2, 2.6, 0.8 Hz, 1H), 3.82 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 159.6, 158.1, 157.6, 151.1, 150.4, 149.3, 140.5, 135.2, 133.8, 133.6, 129.4, 128.3, 126.5, 123.7, 123.2, 114.6, 114.3, 109.8, 107.9, 55.3. Anal. Calcd for C<sub>20</sub>H<sub>16</sub>N<sub>4</sub>O; C, 73.15; H, 4.91; N, 17.06. Found: C, 73.20; H, 4.82; N, 17.11.</div></div><div id="sec5_5_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> <i>N</i>-(3-Methoxyphenyl)-2-(pyridin-4-yl)quinazolin-4-amine (<b>21</b>)</h4><div class="NLM_p last">The compound was synthesized from <b>6</b> (242 mg, 1 mmol) and 3-methoxyaniline (123 mg, 1 mmol) as described in the general procedure for compounds <b>11</b>–<b>41</b> to yield <b>21</b> as a light-beige solid (230 mg, 70%), mp 202–203 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.92 (s, 1H), 8.79–8.69 (m, 2H), 8.61 (dt, <i>J</i> = 8.4, 1.0 Hz, 1H), 8.32–8.24 (m, 2H), 7.97–7.86 (m, 2H), 7.72–7.64 (m, 2H), 7.56 (ddd, <i>J</i> = 8.0, 2.0, 0.9 Hz, 1H), 7.37 (t, <i>J</i> = 8.1 Hz, 1H), 6.76 (ddd, <i>J</i> = 8.2, 2.5, 0.9 Hz, 1H), 3.83 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 159.6, 158.3, 157.4, 150.4, 150.3, 145.7, 140.4, 133.6, 129.4, 128.5, 127.0, 123.3, 121.9, 114.6, 109.9, 107.8, 55.3. Anal. Calcd for C<sub>20</sub>H<sub>16</sub>N<sub>4</sub>O: C, 73.15; H, 4.91; N, 17.06. Found: C, 73.42; H, 4.69; N,17.00.</div></div><div id="sec5_5_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> <i>N</i>-(4-Methoxyphenyl)-2-(pyridin-4-yl)quinazolin-4-amine (<b>22</b>)</h4><div class="NLM_p last">The compound was synthesized from <b>6</b> (242 mg, 1 mmol) and 4-methoxyaniline (123 mg, 1 mmol) as described in the general procedure for compounds <b>11</b>–<b>41</b> to yield <b>22</b> as a light-yellow solid (233 mg, 71%), mp 233–235 °C (decomp). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.89 (s, 1H), 8.76–8.68 (m, 2H), 8.56 (dt, <i>J</i> = 8.2, 1.0 Hz, 1H), 8.28–8.20 (m, 2H), 7.93–7.85 (m, 2H), 7.85–7.76 (m, 2H), 7.65 (ddd, <i>J</i> = 8.3, 4.7, 3.4 Hz, 1H), 7.09–7.00 (m, 2H), 3.81 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 158.4, 157.5, 156.1, 150.3, 150.2, 145.8, 133.4, 132.0, 128.4, 126.8, 124.4, 123.2, 121.9, 114.5, 113.9, 55.4. Anal. Calcd for C<sub>20</sub>H<sub>16</sub>N<sub>4</sub>O: C, 73.15; H, 4.91; N, 17.06. Found: C, 73.43; H, 5.01; N, 16.75.</div></div><div id="sec5_5_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> <i>N</i>-(3,4-Dimethoxyphenyl)-2-(pyridin-2-yl)quinazolin-4-amine (<b>23</b>)</h4><div class="NLM_p last">The compound was synthesized from <b>4</b> (242 mg, 1 mmol) and 3,4-dimethoxyaniline (153 mg, 1 mmol) as described in the general procedure for compounds <b>11</b>–<b>41</b> to yield <b>23</b> as a yellow solid (204 mg, 57%), mp 191–193 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.82 (s, 1H), 8.72 (ddd, <i>J</i> = 4.7, 1.9, 0.9 Hz, 1H), 8.65–8.57 (m, 1H), 8.45 (dt, <i>J</i> = 7.9, 1.1 Hz, 1H), 8.37 (d, <i>J</i> = 2.5 Hz, 1H), 7.96 (td, <i>J</i> = 7.7, 1.8 Hz, 1H), 7.94–7.85 (m, 2H), 7.65 (ddd, <i>J</i> = 8.3, 6.6, 1.6 Hz, 1H), 7.50 (ddd, <i>J</i> = 7.5, 4.7, 1.2 Hz, 1H), 7.43 (dd, <i>J</i> = 8.7, 2.5 Hz, 1H), 7.00 (d, <i>J</i> = 8.7 Hz, 1H), 3.91 (s, 3H), 3.78 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 159.0, 157.9, 155.7, 149.5, 148.5, 145.1, 136.9, 133.3, 128.3, 126.6, 124.8, 123.5, 123.0, 114.3, 113.3, 112.0, 107.2, 55.9, 55.6. Anal. Calcd for C<sub>21</sub>H<sub>18</sub>N<sub>4</sub>O<sub>2</sub>: C, 70.38; H, 5.06; N, 15.63. Found: C, 70.01; H, 5.31; N, 15.95.</div></div><div id="sec5_5_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> <i>N</i>-(3,4-Dimethoxyphenyl)-2-(pyridin-3-yl)quinazolin-4-amine (<b>24</b>)</h4><div class="NLM_p last">The compound was synthesized from <b>5</b> (242 mg, 1 mmol) and 3,4-dimethoxyaniline (153 mg, 1 mmol) as described in the general procedure for compounds <b>11</b>–<b>41</b> to yield <b>24</b> as a yellow solid (240 mg, 67%), mp 201–202 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.76 (s, 1H), 9.51 (d, <i>J</i> = 2.2 Hz, 1H), 8.97 (dt, <i>J</i> = 8.1, 1.8 Hz, 1H), 8.89 (dd, <i>J</i> = 5.1, 1.6 Hz, 1H), 8.77 (d, <i>J</i> = 8.2 Hz, 1H), 8.11 (d, <i>J</i> = 8.3 Hz, 1H), 7.99 (ddd, <i>J</i> = 8.4, 7.0, 1.3 Hz, 1H), 7.87 (dd, <i>J</i> = 8.1, 5.1 Hz, 1H), 7.75 (ddd, <i>J</i> = 8.3, 7.0, 1.2 Hz, 1H), 7.59 (d, <i>J</i> = 2.4 Hz, 1H), 7.40 (dd, <i>J</i> = 8.6, 2.5 Hz, 1H), 7.07 (d, <i>J</i> = 8.7 Hz, 1H), 3.81 (s, 3H), 3.81 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 158.5, 155.7, 148.6, 146.7, 134.8, 131.1, 127.7, 125.2, 124.0, 115.8, 113.8, 111.8, 108.6, 55.9, 55.8. Anal. Calcd for C<sub>21</sub>H<sub>18</sub>N<sub>4</sub>O<sub>2</sub>: C, 70.38; H, 5.06; N, 15.63. Found: C, 70.41; H, 4.93; N, 15.34.</div></div><div id="sec5_5_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> <i>N</i>-(3,4-Dimethoxyphenyl)-2-(pyridin-4-yl)quinazolin-4-amine (<b>25</b>)</h4><div class="NLM_p last">The compound was synthesized from <b>6</b> (242 mg, 1 mmol) and 3,4-dimethoxyaniline (153 mg, 1 mmol) as described in the general procedure for compounds <b>11</b>–<b>41</b> to yield <b>25</b> as a yellow solid (219 mg, 61%), mp 134–135 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.86 (s, 1H), 8.78–8.69 (m, 2H), 8.58 (dt, <i>J</i> = 8.5, 1.0 Hz, 1H), 8.31–8.24 (m, 2H), 7.93–7.86 (m, 2H), 7.72–7.61 (m, 2H), 7.46 (dd, <i>J</i> = 8.6, 2.5 Hz, 1H), 7.06 (d, <i>J</i> = 8.7 Hz, 1H), 3.83 (s, 3H), 3.80 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 158.2, 157.5, 150.3, 148.5, 145.8, 133.5, 132.5, 128.4, 126.9, 123.1, 121.9, 114.6, 112.0, 107.8, 55.9, 55.7. Anal. Calcd for C<sub>21</sub>H<sub>18</sub>N<sub>4</sub>O<sub>2</sub>: C, 70.38; H, 5.06; N, 15.63. Found: C, 70.70; H, 5.05; N, 15.28.</div></div><div id="sec5_5_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 2-(Pyridin-4-yl)-<i>N</i>-(3-(trifluoromethyl)phenyl)quinazolin-4-amine (<b>26</b>)</h4><div class="NLM_p last">The compound was synthesized from <b>6</b> (242 mg, 1 mmol) and 3-(trifluoromethyl)aniline (161 mg, 1 mmol) as described in the general procedure for compounds <b>11</b>–<b>41</b> to yield <b>26</b> as a white solid (322 mg, 88%), mp 249–250 °C (decomp). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.21 (s, 1H), 8.74 (d, <i>J</i> = 5.0 Hz, 2H), 8.62 (dt, <i>J</i> = 8.3, 1.0 Hz, 1H), 8.57 (d, <i>J</i> = 2.0 Hz, 1H), 8.32–8.24 (m, 2H), 8.21 (dd, <i>J</i> = 8.3, 2.0 Hz, 1H), 7.99–7.88 (m, 2H), 7.76–7.65 (m, 2H), 7.52 (ddd, <i>J</i> = 7.8, 1.9, 0.9 Hz, 1H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 158.2, 157.2, 150.4, 150.3, 145.5, 140.1, 133.9, 129.9, 129.4 (d, <i>J</i> = 31.6 Hz), 128.6, 127.3, 125.7, 123.2, 121.8, 120.0 (d, <i>J</i> = 3.9 Hz), 118.5 (d, <i>J</i> = 4.1 Hz), 114.5. Anal. Calcd for C<sub>20</sub>H<sub>13</sub>F<sub>3</sub>N<sub>4</sub>: C, 65.57; H, 3.58; N, 15.29. Found: C, 65.53; H, 3.93; N, 14.90.</div></div><div id="sec5_5_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 2-(Pyridin-4-yl)-<i>N</i>-(4-(trifluoromethyl)phenyl)quinazolin-4-amine (<b>27</b>)</h4><div class="NLM_p last">The compound was synthesized from <b>6</b> (242 mg, 1 mmol) and 4-(trifluoromethyl)aniline (161 mg, 1 mmol) as described in the general procedure for compounds <b>11</b>–<b>41</b> to yield <b>27</b> as a white solid (308 mg, 84%), mp 264–265 °C (decomp). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.22 (s, 1H), 8.83–8.68 (m, 2H), 8.64 (dt, <i>J</i> = 8.4, 1.1 Hz, 1H), 8.34–8.27 (m, 2H), 8.28–8.19 (m, 2H), 7.98–7.91 (m, 2H), 7.87–7.80 (m, 2H), 7.72 (ddd, <i>J</i> = 8.3, 5.4, 2.8 Hz, 1H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 158.2, 157.2, 150.4, 150.4, 145.5, 143.0, 134.0, 128.6, 127.29, 125.9 (d, <i>J</i> = 3.6 Hz), 123.6 (d, <i>J</i> = 32.1 Hz), 123.4, 122.0, 121.9, 114.6. Anal. Calcd for C<sub>20</sub>H<sub>13</sub>F<sub>3</sub>N<sub>4</sub>: C, 65.57; H, 3.58; N, 15.29. Found: C, 65.29; H, 3.86; N, 15.20.</div></div><div id="sec5_5_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> <i>N</i>-(4-Methoxy-3-(trifluoromethyl)phenyl)-2-(pyridin-4-yl)quinazolin-4-amine (<b>28</b>)</h4><div class="NLM_p last">The compound was synthesized from <b>6</b> (242 mg, 1 mmol) and 4-methoxy-3-(trifluoromethyl)aniline (191 mg, 1 mmol) as described in the general procedure for compounds <b>11</b>–<b>41</b> to yield <b>28</b> as a light-beige solid (226 mg, 57%), mp 256–257 °C (decomp). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.06 (s, 1H), 8.76–8.68 (m, 2H), 8.57 (dt, <i>J</i> = 8.4, 1.1 Hz, 1H), 8.39 (d, <i>J</i> = 2.7 Hz, 1H), 8.28–8.22 (m, 2H), 8.17 (dd, <i>J</i> = 9.0, 2.7 Hz, 1H), 7.95–7.88 (m, 2H), 7.69 (ddd, <i>J</i> = 8.3, 5.0, 3.2 Hz, 1H), 7.40 (d, <i>J</i> = 9.1 Hz, 1H), 3.94 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 158.2, 157.3, 153.3, 150.3, 150.2, 145.6, 133.7, 132.0, 128.5, 127.7, 127.1, 125.0, 123.1, 122.8, 121.8, 120.9 (d, <i>J</i> = 5.8 Hz), 116.6 (d, <i>J</i> = 30.2 Hz), 114.5, 113.4, 56.5. Anal. Calcd for C<sub>21</sub>H<sub>15</sub>F<sub>3</sub>N<sub>4</sub>O: C, 63.63; H, 3.81; N, 14.14. Found: C, 63.87; H, 3.87; N, 13.76.</div></div><div id="sec5_5_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> <i>N</i>-(3-Fluorophenyl)-2-(pyridin-3-yl)quinazolin-4-amine (<b>29</b>)</h4><div class="NLM_p last">The compound was synthesized from <b>5</b> (242 mg, 1 mmol) and 3-fluoroaniline (111 mg, 1 mmol) as described in the general procedure for compounds <b>11</b>–<b>41</b> to yield <b>29</b> as a yellow solid (253 mg, 80%), mp 272–274 °C (decomp). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.60 (s, 1H), 9.52 (d, <i>J</i> = 2.0 Hz, 1H), 9.04 (dt, <i>J</i> = 8.1, 1.9 Hz, 1H), 8.91 (dd, <i>J</i> = 5.3, 1.5 Hz, 1H), 8.76 (d, <i>J</i> = 8.2 Hz, 1H), 8.10–8.01 (m, 1H), 8.01–7.98 (m, 1H), 7.98–7.92 (m, 1H), 7.89 (dt, <i>J</i> = 11.6, 2.4 Hz, 1H), 7.82–7.76 (m, 1H), 7.74 (ddd, <i>J</i> = 8.1, 6.6, 1.3 Hz, 1H), 7.51 (td, <i>J</i> = 8.2, 6.8 Hz, 1H), 7.06 (td, <i>J</i> = 8.5, 2.6 Hz, 1H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 163.1, 161.2, 158.5, 155.7, 145.2, 140.4 (d, <i>J</i> = 10.9 Hz), 134.5, 130.3 (d, <i>J</i> = 9.4 Hz), 127.6, 126.8, 125.8, 123.8, 118.8, 111.2 (d, <i>J</i> = 21.2 Hz), 109.8 (d, <i>J</i> = 25.7 Hz). Anal. Calcd for C<sub>19</sub>H<sub>13</sub>FN<sub>4</sub>: C, 72.14; H, 4.14; N, 17.71. Found: C, 72.13; H, 4.38; N, 17.69.</div></div><div id="sec5_5_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 3-((2-(Pyridin-4-yl)quinazolin-4-yl)amino)benzenesulfonyl Fluoride (<b>30</b>)</h4><div class="NLM_p last">The compound was synthesized from <b>6</b> (242 mg, 1 mmol) and 3-aminobenzenesulfonyl fluoride (175 mg, 1 mmol) as described in the general procedure for compounds <b>11</b>–<b>41</b> to yield <b>30</b> as a yellow solid (293 mg, 77%), mp 291–292 °C (decomp). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.40 (s, 1H), 9.14 (t, <i>J</i> = 1.9 Hz, 1H), 8.73 (d, <i>J</i> = 5.1 Hz, 2H), 8.62 (d, <i>J</i> = 8.4 Hz, 1H), 8.42 (dt, <i>J</i> = 7.2, 2.1 Hz, 1H), 8.35–8.26 (m, 2H), 8.01–7.92 (m, 2H), 7.92–7.83 (m, 2H), 7.74 (ddd, <i>J</i> = 8.2, 5.5, 2.7 Hz, 1H). <sup>13</sup>C NMR (151 MHz, DMSO) δ 158.1, 157.1, 150.4, 150.4, 145.2, 141.0, 134.1, 131.9 (d, <i>J</i> = 23.1 Hz), 131.0, 129.0, 128.7, 127.5, 123.3, 122.8, 121.9, 120.6, 114.5. Anal. Calcd for C<sub>19</sub>H<sub>13</sub>FN<sub>4</sub>O<sub>2</sub>S: C, 59.99; H, 3.44; N, 14.73. Found: C, 60.36; H, 3.68; N, 14.48.</div></div><div id="sec5_5_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> <i>N</i>1,<i>N</i>1-Dimethyl-<i>N</i>3-(2-(pyridin-3-yl)quinazolin-4-yl)benzene-1,3-diamine (<b>31</b>)</h4><div class="NLM_p last">The compound was synthesized from <b>5</b> (242 mg, 1 mmol) and <i>N</i>1,<i>N</i>1-dimethylbenzene-1,3-diamine (136 mg, 1 mmol) as described in the general procedure for compounds <b>11</b>–<b>41</b> to yield <b>31</b> as a light-brown solid (201 mg, 59%), mp 202–203 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.87 (s, 1H), 9.62–9.48 (m, 1H), 9.18 (d, <i>J</i> = 8.1 Hz, 1H), 9.02–8.90 (m, 1H), 8.83 (dd, <i>J</i> = 8.5, 1.4 Hz, 1H), 8.11 (d, <i>J</i> = 8.3 Hz, 1H), 8.01 (ddd, <i>J</i> = 8.4, 5.9, 1.3 Hz, 3H), 7.76 (ddd, <i>J</i> = 8.3, 7.0, 1.2 Hz, 1H), 7.62 (s, 1H), 7.51 (t, <i>J</i> = 8.1 Hz, 1H), 7.25 (s, 1H), 3.09 (s, 6H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 158.6, 155.2, 141.3, 139.3, 134.8, 129.9, 127.9, 126.1, 124.1, 114.1, 43.5. Anal. Calcd for C<sub>21</sub>H<sub>19</sub>N<sub>5</sub>: C, 73.88; H, 5.61; N, 20.51. Found: C, 73.97; H, 5.37; N, 20.25.</div></div><div id="sec5_5_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 3-((2-(Pyridin-4-yl)quinazolin-4-yl)amino)phenol (<b>32</b>)</h4><div class="NLM_p last">The compound was synthesized from <b>6</b> (242 mg, 1 mmol) and 3-aminophenol (109 mg, 1 mmol) as described in the general procedure for compounds <b>11</b>–<b>41</b> to yield <b>32</b> as a yellow solid (148 mg, 47%), mp >300 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.13 (s, 1H), 9.60 (s, 1H), 8.97–8.91 (m, 2H), 8.70 (dt, <i>J</i> = 8.4, 0.9 Hz, 1H), 8.65–8.58 (m, 2H), 8.01–7.90 (m, 2H), 7.73 (ddd, <i>J</i> = 8.3, 6.5, 1.7 Hz, 1H), 7.44 (t, <i>J</i> = 2.2 Hz, 1H), 7.36 (ddd, <i>J</i> = 8.0, 2.0, 1.0 Hz, 1H), 7.25 (t, <i>J</i> = 8.0 Hz, 1H), 6.64 (ddd, <i>J</i> = 8.1, 2.4, 1.0 Hz, 1H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 158.5, 157.7, 155.8, 149.3, 145.7, 139.7, 134.1, 129.3, 128.1, 127.8, 123.8, 123.6, 114.7, 113.6, 111.8, 110.0. Anal. Calcd for C<sub>19</sub>H<sub>14</sub>N<sub>4</sub>O: C, 72.60; H, 4.49; N, 17.82. Found: C, 72.86; H, 4.63; N, 17.44.</div></div><div id="sec5_5_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 4-((2-(Pyridin-4-yl)quinazolin-4-yl)amino)phenol (<b>33</b>)</h4><div class="NLM_p last">The compound was synthesized from <b>6</b> (242 mg, 1 mmol) and 4-aminophenol (109 mg, 1 mmol) as described in the general procedure for compounds <b>11</b>–<b>41</b> to yield <b>33</b> as a yellow solid (182 mg, 58%), mp 293–295 °C (decomp). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.34 (s, 1H), 9.52 (s, 1H), 8.96 (d, <i>J</i> = 5.7 Hz, 2H), 8.73–8.63 (m, 1H), 8.63–8.50 (m, 2H), 8.00 (dd, <i>J</i> = 8.4, 1.3 Hz, 1H), 7.95 (ddd, <i>J</i> = 8.2, 6.8, 1.2 Hz, 1H), 7.72 (ddd, <i>J</i> = 8.2, 6.9, 1.4 Hz, 1H), 7.67–7.56 (m, 2H), 6.94–6.84 (m, 2H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 158.7, 155.4, 155.0, 134.2, 129.6, 127.9, 125.2, 123.9, 123.6, 115.3, 114.4. Anal. Calcd for C<sub>19</sub>H<sub>14</sub>N<sub>4</sub>O: C, 72.60; H, 4.49; N, 17.82. Found: C, 72.69; H, 4.67; N, 17.54.</div></div><div id="sec5_5_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> (4-((2-(Pyridin-3-yl)quinazolin-4-yl)amino)phenyl)methanol (<b>34</b>)</h4><div class="NLM_p last">The compound was synthesized from <b>5</b> (242 mg, 1 mmol) and (3-aminophenyl)methanol (123 mg, 1 mmol) as described in the general procedure for compounds <b>11</b>–<b>41</b> to yield <b>34</b> as a yellow solid (210 mg, 64%), mp >300 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.65 (s, 1H), 9.56 (d, <i>J</i> = 2.1 Hz, 1H), 9.07 (dt, <i>J</i> = 8.1, 1.9 Hz, 1H), 8.92 (dd, <i>J</i> = 5.2, 1.6 Hz, 1H), 8.83–8.73 (m, 1H), 8.08 (d, <i>J</i> = 8.3 Hz, 1H), 8.05–7.97 (m, 2H), 7.91 (dd, <i>J</i> = 8.1, 5.2 Hz, 1H), 7.82–7.73 (m, 2H), 7.45 (t, <i>J</i> = 7.8 Hz, 1H), 7.20 (d, <i>J</i> = 7.5 Hz, 1H), 4.63 (s, 2H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 158.6, 155.7, 143.3, 138.2, 134.6, 128.4, 127.6, 125.5, 123.9, 123.0, 121.6, 121.4, 114.1, 62.9. Anal. Calcd for C<sub>20</sub>H<sub>16</sub>N<sub>4</sub>O: C, 73.15; H, 4.91; N, 17.06. Found: C, 73.17; H, 5.07; N, 16.83.</div></div><div id="sec5_5_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> (4-((2-(Pyridin-4-yl)quinazolin-4-yl)amino)phenyl)methanol (<b>35</b>)</h4><div class="NLM_p last">The compound was synthesized from <b>6</b> (242 mg, 1 mmol) and (3-aminophenyl)methanol (123 mg, 1 mmol) as described in the general procedure for compounds <b>11</b>–<b>41</b> to yield <b>35</b> as a yellow solid (200 mg, 61%), mp >300 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.36 (s, 1H), 8.97 (d, <i>J</i> = 5.7 Hz, 2H), 8.80–8.60 (m, 3H), 8.06 (t, <i>J</i> = 1.9 Hz, 1H), 8.03–7.90 (m, 2H), 7.81–7.68 (m, 2H), 7.42 (t, <i>J</i> = 7.8 Hz, 1H), 7.19–7.12 (m, 1H), 4.62 (s, 2H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 158.5, 155.3, 149.2, 144.5, 143.3, 138.6, 134.2, 128.3, 128.0, 124.2, 123.7, 122.5, 121.1, 121.0, 114.6, 62.9. Anal. Calcd for C<sub>20</sub>H<sub>16</sub>N<sub>4</sub>O: C, 73.15; H, 4.91; N, 17.06. Found: C, 73.06; H, 5.27; N, 16.69.</div></div><div id="sec5_5_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 2-Nitro-4-((2-(pyridin-3-yl)quinazolin-4-yl)amino)phenol (<b>36</b>)</h4><div class="NLM_p last">The compound was synthesized from <b>5</b> (242 mg, 1 mmol) and 4-amino-2-nitrophenol (154 mg, 1 mmol) as described in the general procedure for compounds <b>11</b>–<b>41</b> to yield <b>36</b> as a yellow–orange solid (223 mg, 62%), mp 284–286 °C (decomp). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.83 (s, 1H), 10.06 (s, 1H), 9.56 (dd, <i>J</i> = 2.2, 0.9 Hz, 1H), 8.78 (d, <i>J</i> = 2.7 Hz, 1H), 8.74–8.70 (m, 1H), 8.68 (dd, <i>J</i> = 4.7, 1.7 Hz, 1H), 8.54 (dt, <i>J</i> = 8.4, 1.1 Hz, 1H), 8.04 (dd, <i>J</i> = 9.0, 2.7 Hz, 1H), 7.92–7.86 (m, 2H), 7.68–7.61 (m, 1H), 7.56–7.50 (m, 1H), 7.24 (d, <i>J</i> = 9.0 Hz, 1H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 158.0, 157.5, 151.1, 150.3, 149.4, 149.0, 135.7, 135.3, 133.7, 133.6, 131.0, 130.3, 128.4, 126.6, 123.7, 123.1, 119.4, 118.4, 114.2. Anal. Calcd for C<sub>19</sub>H<sub>13</sub>N<sub>5</sub>O<sub>3</sub>: C, 63.51; H, 3.65; N, 19.49. Found: C, 63.90; H, 3.81; N, 19.21.</div></div><div id="sec5_5_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> Methyl 3-((2-(Pyridin-3-yl)quinazolin-4-yl)amino)benzoate (<b>37</b>)</h4><div class="NLM_p last">The compound was synthesized from <b>5</b> (242 mg, 1 mmol) and methyl 3-aminobenzoate (151 mg, 1 mmol) as described in the general procedure for compounds <b>11</b>–<b>41</b> to yield <b>37</b> as a light-yellow solid (282 mg, 79%), mp 233–234 °C. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.73 (s, 1H), 9.55 (d, <i>J</i> = 2.1 Hz, 1H), 9.09 (dt, <i>J</i> = 8.2, 1.8 Hz, 1H), 8.92 (dd, <i>J</i> = 5.4, 1.5 Hz, 1H), 8.84–8.70 (m, 2H), 8.20 (ddd, <i>J</i> = 8.1, 2.3, 1.1 Hz, 1H), 8.08–8.01 (m, 1H), 8.01–7.90 (m, 2H), 7.80 (dt, <i>J</i> = 7.8, 1.3 Hz, 1H), 7.74 (ddd, <i>J</i> = 8.3, 6.9, 1.3 Hz, 1H), 7.62 (t, <i>J</i> = 7.9 Hz, 1H), 3.92 (s, 3H). <sup>13</sup>C NMR (151 MHz, DMSO) δ 166.3, 158.5, 155.5, 145.1, 140.3, 139.0, 134.6, 130.2, 129.2, 127.7, 127.3, 126.5, 125.9, 125.2, 123.9, 123.4, 114.2, 52.6. Anal. Calcd for C<sub>21</sub>H<sub>16</sub>N<sub>4</sub>O<sub>2</sub>: C, 70.77; H, 4.53; N, 15.72. Found: C, 71.08; H, 4.62; N, 15.49.</div></div><div id="sec5_5_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> Methyl 3-((2-(Pyridin-4-yl)quinazolin-4-yl)amino)benzoate (<b>38</b>)</h4><div class="NLM_p last">The compound was synthesized from <b>6</b> (242 mg, 1 mmol) and methyl 3-aminobenzoate (151 mg, 1 mmol) as described in the general procedure for compounds <b>11</b>–<b>41</b> to yield <b>38</b> as a yellow solid (256 mg, 76%), mp 251–252 °C (decomp). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.46 (s, 1H), 9.01–8.94 (m, 2H), 8.81 (t, <i>J</i> = 2.0 Hz, 1H), 8.75 (d, <i>J</i> = 8.3 Hz, 1H), 8.71–8.65 (m, 2H), 8.22 (ddd, <i>J</i> = 8.1, 2.3, 1.1 Hz, 1H), 8.04–7.95 (m, 2H), 7.83–7.74 (m, 2H), 7.63 (t, <i>J</i> = 7.9 Hz, 1H), 3.93 (s, 3H). <sup>13</sup>C NMR (151 MHz, DMSO) δ 166.3, 158.4, 155.3, 151.1, 149.7, 144.9, 139.4, 134.3, 130.1, 129.2, 128.5, 128.2, 126.9, 124.8, 124.0, 123.7, 123.0, 114.7, 52.5. Anal. Calcd for C<sub>21</sub>H<sub>16</sub>N<sub>4</sub>O<sub>2</sub>: C, 70.77; H, 4.53; N, 15.72. Found: C, 70.92; H, 4.63; N, 15.72.</div></div><div id="sec5_5_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> <i>tert</i>-Butyl 3-((2-(Pyridin-4-yl)quinazolin-4-yl)amino)benzoate (<b>39</b>)</h4><div class="NLM_p last">The compound was synthesized from <b>6</b> (242 mg, 1 mmol) and methyl <i>tert</i>-butyl 3-aminobenzoate (193 mg, 1 mmol) as described in the general procedure for compounds <b>11</b>–<b>41</b> to yield <b>39</b> as a yellow solid (255 mg, 64%), mp >300 °C. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.20 (s, 1H), 8.81–8.74 (m, 2H), 8.68–8.61 (m, 1H), 8.34–8.26 (m, 2H), 8.18–8.09 (m, 2H), 8.05–7.99 (m, 2H), 7.99–7.91 (m, 2H), 7.72 (ddd, <i>J</i> = 8.2, 5.8, 2.4 Hz, 1H), 1.57 (s, 9H). <sup>13</sup>C NMR (151 MHz, DMSO) δ 164.8, 158.1, 157.3, 150.5, 150.4, 145.4, 143.5, 133.9, 130.0, 128.6, 127.3, 126.1, 123.4, 121.9, 121.3, 114.7, 80.5, 28.1. Anal. Calcd for C<sub>24</sub>H<sub>22</sub>N<sub>4</sub>O<sub>2</sub>: C, 72.34; H, 5.57; N, 14.06. Found: C, 72.50; H, 5.88; N, 13.99.</div></div><div id="sec5_5_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 3-((2-(Pyridin-3-yl)quinazolin-4-yl)amino)benzoic Acid (<b>40</b>)</h4><div class="NLM_p last">The compound was synthesized from <b>6</b> (242 mg, 1 mmol) and methyl 3-aminobenzoic acid (137 mg, 1 mmol) as described in the general procedure for compounds <b>11</b>–<b>41</b> to yield <b>40</b> as a yellow–beige solid (147 mg, 43%), mp >300 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.07 (s, 1H), 10.48 (s, 1H), 9.11–8.88 (m, 2H), 8.84 (t, <i>J</i> = 1.9 Hz, 1H), 8.81–8.61 (m, 3H), 8.20 (ddd, <i>J</i> = 8.2, 2.3, 1.1 Hz, 1H), 8.11–7.90 (m, 2H), 7.90–7.68 (m, 2H), 7.62 (t, <i>J</i> = 7.9 Hz, 1H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 167.3, 158.5, 155.4, 150.8, 149.6, 145.1, 139.2, 134.2, 131.3, 129.0, 128.4, 128.1, 126.5, 124.9, 124.0, 123.6, 123.4, 114.7. Anal. Calcd for C<sub>20</sub>H<sub>14</sub>N<sub>4</sub>O<sub>2</sub>: C, 70.17; H, 4.12; N, 16.37. Found: C, 70.27; H, 4.44; N, 16.45.</div></div><div id="sec5_5_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 4-((2-(Pyridin-3-yl)quinazolin-4-yl)amino)benzoic Acid (<b>41</b>)</h4><div class="NLM_p last">The compound was synthesized from <b>6</b> (242 mg, 1 mmol) and methyl 4-aminobenzoic acid (137 mg, 1 mmol) as described in the general procedure for compounds <b>11</b>–<b>41</b> to yield <b>41</b> as a brown–beige solid (188 mg, 55%), mp >300 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.51 (s, 1H), 10.52 (s, 1H), 9.03–8.95 (m, 2H), 8.78 (dd, <i>J</i> = 8.3, 1.1 Hz, 1H), 8.74–8.68 (m, 2H), 8.16–8.09 (m, 2H), 8.08–8.03 (m, 2H), 8.03–7.95 (m, 2H), 7.77 (ddd, <i>J</i> = 8.2, 6.1, 2.1 Hz, 1H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 167.1, 158.4, 155.2, 151.5, 149.8, 144.3, 143.1, 134.3, 130.2, 128.5, 128.2, 125.9, 124.3, 123.8, 121.8, 114.8. Anal. Calcd for C<sub>20</sub>H<sub>14</sub>N<sub>4</sub>O<sub>2</sub>: C, 70.17; H, 4.12; N, 16.37. Found: C, 70.49; H, 4.38; N, 16.25.</div></div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> General Procedure for the Preparation of the 2-Substituted 6-Methyl-4-anilinopyrimidines <b>42</b>–<b>48</b></h3><div class="NLM_p">To the corresponding 2-substituted 6-methyl-4-chloropyrimidine derivatives <b>9</b> and <b>10</b> (1 mmol), 2-propanol (5 mL) was added together with the corresponding substituted aniline (1 mmol) and sealed in a microwave tube. The mixture was heated by 100 W microwave irradiation to 110 °C for a period of 15–30 min until completion of the reaction as indicated by TLC. The formed precipitate was filtered off, washed with 10 mL of 2-propanol, and dried in vacuo. If no precipitate was formed, the solvent was removed under reduced pressure and the remaining solid recrystallized from acetone.</div><div id="sec5_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 3-((6-Methyl-2-(pyridin-4-yl)pyrimidin-4-yl)amino)benzonitrile (<b>42</b>)</h4><div class="NLM_p last">The compound was synthesized from <b>9</b> (206 mg, 1 mmol) and methyl 3-aminobenzonitrile (118 mg, 1 mmol) as described in the general procedure for compounds <b>42</b>–<b>48</b> to yield <b>42</b> as a white solid (135 mg, 47%), mp >300 °C. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.97 (s, 1H), 8.73 (d, <i>J</i> = 4.8 Hz, 2H), 8.21 (t, <i>J</i> = 1.9 Hz, 1H), 8.18–8.10 (m, 2H), 8.07–7.95 (m, 1H), 7.58 (t, <i>J</i> = 8.0 Hz, 1H), 7.47 (dt, <i>J</i> = 7.7, 1.2 Hz, 1H), 6.69 (s, 1H), 2.43 (s, 3H). <sup>13</sup>C NMR (151 MHz, DMSO) δ 165.9, 160.8, 160.6, 150.4, 145.1, 140.8, 130.4, 125.7, 124.3, 122.5, 121.7, 119.0, 111.8, 105.5, 23.9. Anal. Calcd for C<sub>17</sub>H<sub>13</sub>N<sub>5</sub>: C, 71.06; H, 4.56; N, 24.37. Found: C, 71.17; H, 4.37; N, 24.07.</div></div><div id="sec5_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> <i>N</i>-(3-Methoxyphenyl)-6-methyl-2-(pyridin-4-yl)pyrimidin-4-amine (<b>43</b>)</h4><div class="NLM_p last">The compound was synthesized from <b>9</b> (206 mg, 1 mmol) and methyl 3-methoxyaniline (123 mg, 1 mmol) as described in the general procedure for compounds <b>42</b>–<b>48</b> to yield <b>43</b> as a light-beige solid (140 mg, 48%), mp 227–229 (decomp). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.23 (s, 1H), 9.04–8.95 (m, 2H), 8.63–8.53 (m, 2H), 7.43 (t, <i>J</i> = 2.2 Hz, 1H), 7.34–7.23 (m, 2H), 6.85 (s, 1H), 6.66 (ddd, <i>J</i> = 7.6, 2.4, 1.3 Hz, 1H), 3.78 (s, 3H), 2.45 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 164.6, 161.0, 159.8, 158.5, 144.4, 140.6, 129.8, 124.0, 112.6, 108.9, 106.1, 105.9, 55.2, 23.3. Anal. Calcd for C<sub>17</sub>H<sub>16</sub>N<sub>4</sub>O: C, 69.85; H, 5.52; N, 19.17. Found: C, 69.53; H, 5.71; N, 19.52.</div></div><div id="sec5_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> <i>N</i>-(4-Methoxyphenyl)-6-methyl-2-(pyridin-4-yl)pyrimidin-4-amine (<b>44</b>)</h4><div class="NLM_p last">The compound was synthesized from <b>9</b> (206 mg, 1 mmol) and methyl 4-methoxyaniline (123 mg, 1 mmol) as described in the general procedure for compounds <b>42</b>–<b>48</b> to yield <b>44</b> as a light-beige solid (114 mg, 39%), mp >300 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.59 (s, 1H), 8.81–8.76 (m, 2H), 8.29–8.24 (m, 2H), 7.58 (d, <i>J</i> = 8.4 Hz, 2H), 7.00–6.94 (m, 2H), 6.59 (d, <i>J</i> = 0.8 Hz, 1H), 3.76 (s, 3H), 2.39 (d, <i>J</i> = 0.7 Hz, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 148.8, 122.3, 114.3, 55.4, 23.6. Anal. Calcd for C<sub>17</sub>H<sub>16</sub>N<sub>4</sub>O: C, 69.85; H, 5.52; N, 19.17. Found: C, 69.53; H, 5.71; N, 19.52.</div></div><div id="sec5_6_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 3-((6-Methyl-2-phenylpyrimidin-4-yl)amino)benzonitrile (<b>45</b>)</h4><div class="NLM_p last">The compound was synthesized from <b>10</b> (205 mg, 1 mmol) and methyl 3-aminobenzonitrile (118 mg, 1 mmol) as described in the general procedure for compounds <b>42</b>–<b>48</b> to yield <b>45</b> as a white solid (157 mg, 55%), mp 290–291 °C (decomp). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.87 (s, 1H), 8.33–8.17 (m, 3H), 8.02 (d, <i>J</i> = 8.1 Hz, 1H), 7.69–7.47 (m, 5H), 6.83 (s, 1H), 2.52 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 160.9, 132.2, 130.5, 128.9, 128.4, 118.8, 111.9, 104.4. Anal. Calcd for C<sub>18</sub>H<sub>14</sub>N<sub>4</sub>: C, 75.50.85; H, 4.93; N, 19.57. Found: C, 75.82; H, 5.24; N, 19.38.</div></div><div id="sec5_6_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 4-((6-Methyl-2-phenylpyrimidin-4-yl)amino)benzonitrile (<b>46</b>)</h4><div class="NLM_p last">The compound was synthesized from <b>10</b> (205 mg, 1 mmol) and methyl 4-aminobenzonitrile (118 mg, 1 mmol) as described in the general procedure for compounds <b>42</b>–<b>48</b> to yield <b>46</b> as a white solid (180 mg, 63%), mp 262–264 °C (decomp). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.41 (s, 1H), 8.36–8.22 (m, 2H), 8.02 (d, <i>J</i> = 8.4 Hz, 2H), 7.94–7.82 (m, 2H), 6.98 (s, 1H), 2.55 (s, 3H). <sup>13</sup>C NMR (151 MHz, DMSO) δ 161.2, 160.9, 133.8, 132.8, 129.4, 129.1, 121.3, 119.5, 26.0. Anal. Calcd for C<sub>18</sub>H<sub>14</sub>N<sub>4</sub>: C, 75.50.85; H, 4.93; N, 19.57. Found: C, 75.74; H, 5.22; N, 19.22.</div></div><div id="sec5_6_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 4-((6-Methyl-2-phenylpyrimidin-4-yl)amino)-2-nitrophenol (<b>47</b>)</h4><div class="NLM_p last">The compound was synthesized from <b>10</b> (205 mg, 1 mmol) and methyl 4-amino-2-nitrophenol (154 mg, 1 mmol) as described in the general procedure for compounds <b>42</b>–<b>48</b> to yield <b>47</b> as a yellow solid (168 mg, 52%), mp 276–278 °C (decomp). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.07 (s, 1H), 8.61 (s, 1H), 8.35–8.25 (m, 2H), 7.76 (d, <i>J</i> = 8.9 Hz, 1H), 7.68 (t, <i>J</i> = 7.3 Hz, 1H), 7.61 (t, <i>J</i> = 7.6 Hz, 2H), 7.26 (d, <i>J</i> = 9.0 Hz, 1H), 6.82 (s, 1H), 2.53 (s, 3H). <sup>13</sup>C NMR (151 MHz, DMSO) δ 129.0, 128.8, 119.9. Anal. Calcd for C<sub>17</sub>H<sub>14</sub>N<sub>4</sub>O<sub>3</sub>: C, 63.35; H, 4.38; N, 17.38. Found: C, 63.63; H, 4.73; N, 17.26.</div></div><div id="sec5_6_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> 6-Methyl-<i>N</i>,2-diphenylpyrimidin-4-amine (<b>48</b>)</h4><div class="NLM_p last">The compound was synthesized from <b>10</b> (205 mg, 1 mmol) and methyl aniline (93 mg, 1 mmol) as described in the general procedure for compounds <b>42</b>–<b>48</b> to yield <b>48</b> as a white solid (165 mg, 63%), mp 250–251 °C (decomp). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.09 (s, 1H), 8.32–8.19 (m, 2H), 7.86–7.64 (m, 3H), 7.62 (dd, <i>J</i> = 8.3, 6.6 Hz, 2H), 7.50–7.39 (m, 2H), 7.21 (t, <i>J</i> = 7.4 Hz, 1H), 6.86 (s, 1H), 2.54 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 161.0, 159.8, 137.9, 132.8, 129.2, 129.0, 128.7, 125.0, 121.9, 104.0, 20.1. Anal. Calcd for C<sub>17</sub>H<sub>15</sub>N<sub>3</sub>: C, 78.13; H, 5.79; N, 16.08. Found: C, 78.05; H, 5.63; N, 16.00.</div></div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> Biological Investigations</h3><div id="sec5_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> Materials for Biological Investigation</h4><div class="NLM_p">Compound <b>55</b> ((3<i>S</i>,6<i>S</i>,12a<i>S</i>)-1,2,3,4,6,7,12,12a-octahydro-9-methoxy-6-(2-methylpropyl)-1,4-dioxopyrazino[1′,2′:1,6]pyrido[3,4-<i>b</i>]indole-3-propanoic acid 1,1-dimethylethyl ester) was purchased from Tocris Bioscience (Bristol, United Kingdom). All other chemicals were purchased from Sigma-Aldrich (Taufkirchen, Germany).</div><div class="NLM_p last">Cell-based assays were carried out with 10 mM stock solutions of the test compound in DMSO. Krebs–HEPES buffer (KHB) was prepared from a solution of 118.6 mM NaCl, 4.7 mM KCl, 1.2 mM MgSO<sub>4</sub>, 2.5 mM CaCl, 11.7 mM <span class="smallcaps smallerCapital">d</span>-glucose monohydrate, and 10.0 mM HEPES in doubly distilled water. The pH of the solution was adjusted with 4 N NaOH (aq) at 37 °C, and it was sterilized using a 0.2 μM membrane filter.</div></div><div id="sec5_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> Cell Culture</h4><div class="NLM_p last">MDCK II BCRP cells were generated by transfection of the canine kidney epithelial cell line MDCK II with human wild-type cDNA C-terminally linked to the cDNA of the green fluorescent protein (GFP) and were a kind gift of Dr. A. Schinkel (The Netherlands Cancer Institute, Amsterdam, The Netherlands).<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Cell culture was performed with Dulbecco’s Modified Eagle’s Medium (DMEM) containing 10% fetal calf serum (FCS), 50 μg/mL streptomycin, 50 U/mL penicillin G, and 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine. Human ovarian carcinoma cell line A2780adr was purchased from European Collection of Animal Cell Culture (ECACC, no. 93112520). The cell line shows an overexpression of ABCB1 and resistance against doxorubicin. Culture of these cells was carried out with RPMI-1640 medium supplemented with 20% FCS, 50 μg/mL streptomycin, 50 U/mL penicillin G, and 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine. To ensure the overexpression of ABCB1, treatment with doxorubicin was carried out every 10 passages for less than 40 passages. The small cell lung cancer cell line H69 AR with overexpression of ABCC1 was purchased from American Type Culture Collection (ATCC, CRL-11351). Culture of the cells was carried out in RPMI-1640 medium with 20% FCS, 50 mg/mL streptomycin, 50 U/mL penicillin G, and 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine and kept under a 5% CO<sub>2</sub> humidified atmosphere at 37 °C. Subculturing of cells was performed with 0.05% trypsin and 0.02% EDTA after reaching a confluence of 80–90%. Excess medium was removed from the cells by washing with PBS before trypsination. After detachment of the cells, they were centrifuged in a 50 mL falcon (266<i>g</i>, 4 °C, 4 min). The supernatant was removed by suction and the remaining cell pellet resuspended in fresh medium. The cell count for all cells was determined with a CASY1 model TT cell counter equipped with a 150 μm capillary (Schaerfe System GmbH, Reutlingen, Germany). To remove remaining liquids, all cells were washed with KHB three times before using them in cell-based assays.</div></div><div id="sec5_7_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> Hoechst 33342 Accumulation Assay</h4><div class="NLM_p">The Hoechst 33342 accumulation assay was performed to investigate the inhibitory effect on ABCG2, as described earlier with small modifications.<a onclick="showRef(event, 'ref39 ref40 ref41 ref42 ref43 ref44 ref45 ref46 ref47 ref48 ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref39 ref40 ref41 ref42 ref43 ref44 ref45 ref46 ref47 ref48 ref49 ref50">(39-50)</a> Stock-solutions were prepared by dissolving the test compound in DMSO at a final concentration of 10 mM. Sterile filtered KHB, a small amount of methanol together with the stock solution were used to prepare various dilutions of the corresponding compound. The amount of methanol and DMSO in the final concentration was chosen not to exceed 5% and 0.1%, respectively.</div><div class="NLM_p">Cells were harvested after reaching a confluence of 80–90% by gentle trypsination (0.05% trypsin/0.02% EDTA) and were centrifuged (266<i>g</i>, 4 °C, 4 min) to obtain a cell pellet. The cell pellet was resuspended in fresh medium and the cell density determined with a CASY1 model TT cell counter device. Residual medium was removed by centrifugation of the cell suspension three times in KHB.</div><div class="NLM_p last">The assay was carried out with 90 μL of the washed cell suspension together with 10 μL of different compound dilutions to obtain a cell density of approximately 30000 cells in each well (96-well plate, Greiner, Frickenhausen, Germany). Following a preincubation period of 30 min at 37 °C and 5% CO<sub>2</sub>, 20 μL of a 6 μM Hoechst 33342 solution (protected from light) was quickly added to each well, giving a final concentration of 1 μM Hoechst 33342. Measurement of the fluorescence was performed immediately in constant time intervals (60 s) up to 120 min with an excitation wavelength of 355 nm and an emission wavelength of 460 nm using a BMG POLARstar microplate reader (BMG Labtech, Offenburg, Germany). For the analysis of the data, fluorescence of the wells containing only compound in KHB was subtracted from the fluorescence reading obtained from the MDCK II cells to correct for potential fluorescence of the compound. Average of the fluorescence measured between 100 and 109 min (steady state) was calculated for each concentration and plotted against the logarithm of the compound concentration. Concentration–response curves were fitted by nonlinear regression using the four-parameter logistic equation with variable Hill slope or the three-parameter logistic equation with a fixed Hill slope of one, whatever equation was statistically preferred (GraphPad Prism, version 5.0, San Diego, CA, USA). From the pIC<sub>50</sub> values and their standard deviation, IC<sub>50</sub> values and standard deviations were calculated according to the equation for log-normal distributed values.<a onclick="showRef(event, 'ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref51 ref52">(51, 52)</a></div></div><div id="sec5_7_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> Calcein AM Assay</h4><div class="NLM_p last">Selectivity of the test compounds toward ABCG2 was determined by checking the inhibitory activity against ABCB1 and ABCC1 in the calcein AM assay described earlier.<a onclick="showRef(event, 'ref42 ref43 ref44 ref45 ref46 ref47 ref48 ref49 ref50 ref52 ref53 ref54 ref55 ref58'); return false;" href="javascript:void(0);" class="ref ref42 ref43 ref44 ref45 ref46 ref47 ref48 ref49 ref50 ref52 ref53 ref54 ref55 ref58">(42-50, 52-55, 58)</a> For the assay, the ABCB1 overexpressing cell line A2780adr and the ABCC1 overexpressing cell line H69AR were used. Cells were harvested at a confluence of 80–90% and prepared as described above for the MDCK II cells. After washing the cells three times with KHB, a 90 μL suspension containing approximately 30000 cells was seeded in each well of a colorless flat bottom 96-well plate (Greiner), along with 10 μL of different compound dilutions. Subsequently, the prepared plates were kept at 5% CO<sub>2</sub> and 37 °C for a period of 30 min. After this preincubation, 33 μL of a 1.25 μM calcein AM solution (protected from light) was quickly added to each well and fluorescence measured immediately in a 37 °C tempered BMG POLARstar microplate reader. Fluorescence was then measured over a period of 60 min in constant time intervals (60 s) using an excitation wavelength of 485 nm and an emission wavelength of 520 nm. From the initial linear part of the obtained fluorescence time curve, the slope for each concentration was calculated, thereby a slope concentration–response curve was obtained that was fitted by nonlinear regression using the four-parameter logistic equation with variable Hill slope or the three-parameter logistic equation with a Hill slope of one, whatever equation was statistically preferred. From the pIC<sub>50</sub> values and their standard deviation, IC<sub>50</sub> values and standard deviations were calculated according to the equation for log-normal distributed values.<a onclick="showRef(event, 'ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref53 ref54">(53, 54)</a></div></div><div id="sec5_7_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> MTT Viability Assay</h4><div class="NLM_p">Intrinsic cytotoxicity of selected compounds was investigated using the MTT viability assay as described earlier with slight modifications.<a onclick="showRef(event, 'ref32 ref43 ref46 ref47 ref48 ref49 ref52 ref56'); return false;" href="javascript:void(0);" class="ref ref32 ref43 ref46 ref47 ref48 ref49 ref52 ref56">(32, 43, 46-49, 52, 56)</a></div><div class="NLM_p last">MDCK II BCRP and parental cells were seeded in 96-well tissue culture plates (Sarsted, Newton, USA) at a density of approximately 2000 cells per well in a volume of 180 μL of culture medium and kept under 5% CO<sub>2</sub> and 37 °C for 12 h. The old medium was removed from the plate with the completely attached cells and quickly replaced with 180 μL of fresh medium. Then, 20 μL of different compound dilutions in culture medium was added to each well to a final volume of 200 μL, and plates were stored at 5% CO<sub>2</sub> and 37 °C for 72 h. The content of methanol and DMSO was chosen not to exceed 1.8% and 1% in the highest concentration, respectively. Toxic effects caused by the DMSO and methanol content, used for the compound dilutions, was determined by an additional dilution without compound. Moreover, a positive control with medium and 10% (v/v) DMSO and a negative control of only medium were carried out. After a 72 h period of incubation, 40 μL of MTT reagent (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) was added to each well and the plate incubated for 1 h. After removing the supernatants, 100 μL of DMSO to each well resulting in lysis of the cells and solubilization of the formed formazan. Absorbance was determined spectrophotometrically at 544 nm and background correction at 710 nm using a BMG POLARstar microplate reader. Concentration–response curves were fitted by nonlinear regression using the four-parameter logistic equation with variable Hill slope or the three-parameter logistic equation with a fixed Hill slope of one, whatever equation was statistically preferred (GraphPad Prism, version 5.0; San Diego, CA, USA). From the pIC<sub>50</sub> values and their standard deviation, IC<sub>50</sub> values and standard deviations were calculated according to the equation for log-normal distributed values.<a onclick="showRef(event, 'ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref53 ref54">(53, 54)</a></div></div><div id="sec5_7_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> MDR Reversal Assay</h4><div class="NLM_p">The ability to reverse resistance of ABCG2 expressing MDCK II cells toward cytotoxic substrates like SN-38 was tested for compounds <b>14</b>, <b>16</b>, and <b>47</b>. For this purpose, 160 μL of a cell suspension of MDCK II BCRP and parental cells in culture medium was added to each well of a clear 96-well tissue culture plate (Sarsted, Newton, USA), resulting in a cell density of approximately 2000 cells per well. The plate was stored under 5% CO<sub>2</sub> at 37 °C for 12 h. After incubation, the culture medium was replaced as described above. Then 20 μL of different compound dilutions in culture medium were added to each row. Columnwise, 20 μL of different dilutions of SN-38 were added to a final volume of 200 μL. A positive control was established using parental MDCK II cells without adding a modulator as well as a negative control by adding 10% (v/v) of DMSO to a well. After 72 h of incubation the plates were prepared and measured as described above.</div><div class="NLM_p last">Regarding the MTT assay with MX, plates were prepared with cells as described above. After replacement of the medium with fresh culture medium, 20 μL of different compound dilutions were added to the rows. Additionally, 20 μL of 5 μM MX and culture medium were added in alternating order to the rows, respectively, to a final volume of 200 μL. For comparison, complete cell death was induced by adding 10% (v/v) of DMSO to some wells. The preparation of the plate with subsequent measurement and data analysis was carried out as described above.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> Protein Expression in Insect Cells and ATPase Measurements of ABCG2Membranes</h4><div class="NLM_p last">High Five  insect cells were seeded in culture flasks with Express Five medium and were incubated at 27 °C. After a few passages when cells were healthy and homogeneous, cells were counted and about 20 million cells per flask were seeded for baculovirus infection with <i>Autographa californica</i> multicapsid nuclear polyhedrosis virus (AcMNPV). Cells were harvested 72 h after infection and centrifuged, and afterward membrane preparation was performed.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Two mL of membrane preparation homogenization buffer (50 mM Tris pH 7.5, 2 mM EGTA pH 7.0, 50 mM mannitol, 2 mM DTT, 1 mM PMSF, 2 μM pepstatin, 1 μM leupeptin, 1 mM benzamidine) was used for 20 million cells. Cells were disrupted by a dounce homogenizer. Cellular debris was pelleted by centrifugation at 500<i>g</i> for 10 min at 4 °C and was discarded. The supernatant was centrifuged at 300000<i>g</i> for 30 min at 4 °C to obtain a pellet of enriched plasma membranes. Finally, membranes were resuspended in 100 μL of resuspension buffer (50 mM Tris pH 7.5, 1 mM EGTA at pH 7.0, 10% (v/v) glycerol, 0.3 M mannitol, 1 mM DTT, 1 mM PMSF, 2 μM pepstatin, 1 μM leupeptin, 1 mM benzamidine) per flask and were frozen and stored at −80 °C. ATPase activity measurements of selected compounds was performed by a colorimetric ascorbic acid ammonia molybdate reaction.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> Vanadate-sensitive basal ATPase activity was compared to vanadate-sensitive drug-stimulated or inhibited activity. Compound <b>55</b> was used as standard for ATPase inhibition, and quercetin was used as positive control with high stimulation of ABCG2 transport activity. Investigated compounds were dissolved in DMSO, final concentration of DMSO was 1%, which showed no observable effect on basal ATPase activity. All measurements were repeated at least three times. Concentration–response curves were fitted by nonlinear regression using the three-parameter logistic equation with a fixed Hill slope of one (GraphPad Prism, version 5.0; San Diego, CA, USA). In the case of biphasic curves, a two-site binding model was used to determine <i>K</i><sub>m</sub> and <i>K</i><sub>i</sub>.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></div></div><div id="sec5_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> Inhibition Kinetics</h4><div class="NLM_p last">For more detailed information about the type of interaction with the substrate Hoechst 33342, we performed extended enzyme kinetic experiments with selected compounds. The experiments were carried out with various concentrations of selected compounds as well as of Hoechst 33342. For determination of the interaction type, we utilized the Lineweaver–Burk linearization technique, the half-reciprocal plot according to Hanes–Woolf and the direct linear plot according to Cornish–Bowden to confirm our results. The Hoechst 33342 assay was performed as described above, except that the concentration of Hoechst 33342 varied in the range of 0.4–2.4 μM, whereas the concentration of compounds was adjusted to the corresponding IC<sub>50</sub> value. Response in absence of investigated compounds was used as control.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i81"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00441">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52385" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52385" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00441" class="ext-link">10.1021/acs.jmedchem.7b00441</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">SMILES and log <i>P</i> values with the corresponding biological data (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00441/suppl_file/jm7b00441_si_001.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00441/suppl_file/jm7b00441_si_001.csv">jm7b00441_si_001.csv (3.89 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b00441" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26275" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26275" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Wiese</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical Institute, University of Bonn, An der Immenburg 4, 53121 Bonn, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5851-5336" title="Orcid link">http://orcid.org/0000-0002-5851-5336</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#68051f010d1b0d281d0601450a070606460c0d"><span class="__cf_email__" data-cfemail="aec3d9c7cbddcbeedbc0c783ccc1c0c080cacb">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael K. Krapf</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical Institute, University of Bonn, An der Immenburg 4, 53121 Bonn, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jennifer Gallus</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical Institute, University of Bonn, An der Immenburg 4, 53121 Bonn, Germany</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d183e7399-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i82">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81071" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81071" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Dr. A. Schinkel (The Netherlands Cancer Institute, Amsterdam, The Netherlands) for kindly providing the MDCK II ABCG2 expressing cell line. We also thank O. Laufkötter for providing the image used for the TOC graphic.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i83" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i83"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i84" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i84"> Abbreviations Used</h2><tr><td class="NLM_term">ABC</td><td class="NLM_def"><p class="first last">ATP-binding cassette</p></td></tr><tr><td class="NLM_term">BCRP</td><td class="NLM_def"><p class="first last">breast cancer resistance protein (ABCG2)</p></td></tr><tr><td class="NLM_term">CsA</td><td class="NLM_def"><p class="first last">cyclosporine A</p></td></tr><tr><td class="NLM_term">DMEM</td><td class="NLM_def"><p class="first last">Dulbecco’s Modified Eagle’s Medium</p></td></tr><tr><td class="NLM_term">FCS</td><td class="NLM_def"><p class="first last">fetal calf serum</p></td></tr><tr><td class="NLM_term">FTC</td><td class="NLM_def"><p class="first last">fumitremorgin C</p></td></tr><tr><td class="NLM_term">GI<sub>50</sub></td><td class="NLM_def"><p class="first last">half-maximal growth inhibition</p></td></tr><tr><td class="NLM_term">GFP</td><td class="NLM_def"><p class="first last">green fluorescent protein</p></td></tr><tr><td class="NLM_term">HEPES</td><td class="NLM_def"><p class="first last">4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">half-maximal inhibitory concentration</p></td></tr><tr><td class="NLM_term">KHB</td><td class="NLM_def"><p class="first last">Krebs–HEPES buffer</p></td></tr><tr><td class="NLM_term">MDCK</td><td class="NLM_def"><p class="first last">Madin–Darby canine kidney</p></td></tr><tr><td class="NLM_term">MDR</td><td class="NLM_def"><p class="first last">multidrug resistance</p></td></tr><tr><td class="NLM_term">MRP1</td><td class="NLM_def"><p class="first last">multidrug resistance-associated protein 1 (ABCC1)</p></td></tr><tr><td class="NLM_term">MTT</td><td class="NLM_def"><p class="first last">3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide</p></td></tr><tr><td class="NLM_term">MX</td><td class="NLM_def"><p class="first last">mitoxantrone</p></td></tr><tr><td class="NLM_term">NBD</td><td class="NLM_def"><p class="first last">nucleotid binding domain</p></td></tr><tr><td class="NLM_term">P-gp</td><td class="NLM_def"><p class="first last">P-glycoprotein (ABCB1)</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i85">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48573" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48573" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 58 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Robey, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">To, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polgar, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dohse, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fetsch, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S. E.</span><span> </span><span class="NLM_article-title">ABCG2: A Perspective</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span><span class="refDoi"> DOI: 10.1016/j.addr.2008.11.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2Fj.addr.2008.11.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=19135109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1alu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2009&pages=3-13&author=R.+W.+Robeyauthor=K.+K.+Toauthor=O.+Polgarauthor=M.+Dohseauthor=P.+Fetschauthor=M.+Deanauthor=S.+E.+Bates&title=ABCG2%3A+A+Perspective&doi=10.1016%2Fj.addr.2008.11.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">ABCG2: A perspective</span></div><div class="casAuthors">Robey, Robert W.; To, Kenneth K. K.; Polgar, Orsolya; Dohse, Marius; Fetsch, Patricia; Dean, Michael; Bates, Susan E.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-13</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  ABCG2, or breast cancer resistance protein (BCRP), is an ABC transporter that has been the subject of intense study since its discovery a decade ago.  With high normal tissue expression in the brain endothelium, gastrointestinal tract, and placenta, ABCG2 is believed to be important in the protection from xenobiotics, regulating oral bioavailability, forming part of the blood-brain barrier, the blood-testis barrier, and the maternal-fetal barrier.  Notably, ABCG2 is often expressed in stem cell populations, where it likely plays a role in xenobiotic protection.  However, clues to its epigenetic regulation in various cell populations are only beginning to emerge.  While ABCG2 overexpression has been demonstrated in cancer cells after in vitro drug treatment, endogenous ABCG2 expression in certain cancers is likely a reflection of the differentiated phenotype of the cell of origin and likely contributes to intrinsic drug resistance.  Notably, research into the transporter's role in cancer drug resistance and its development as a therapeutic target in cancer has lagged.  Substrates and inhibitors of the transporter have been described, among them chemotherapy drugs, tyrosine kinase inhibitors, antivirals, HMG-CoA reductase inhibitors, carcinogens, and flavonoids.  This broad range of substrates complements the efficiency of ABCG2 as a transporter in lab. studies and suggests that, while there are redundant mechanisms of xenobiotic protection, the protein is important in normal physiol.  Indeed, emerging studies in pharmacol. and toxicol. assessing polymorphic variants in man, in combination with murine knockout models have confirmed its dynamic role.  Work in pharmacol. may eventually lead us to a greater understanding of the physiol. role of ABCG2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXHdrQffcZprVg90H21EOLACvtfcHk0ljVvbLZJMS7bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1alu70%253D&md5=dc00a9793b185b7a23290a21ed3ea8ba</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2008.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2008.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DRobey%26aufirst%3DR.%2BW.%26aulast%3DTo%26aufirst%3DK.%2BK.%26aulast%3DPolgar%26aufirst%3DO.%26aulast%3DDohse%26aufirst%3DM.%26aulast%3DFetsch%26aufirst%3DP.%26aulast%3DDean%26aufirst%3DM.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DABCG2%253A%2520A%2520Perspective%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2009%26volume%3D61%26spage%3D3%26epage%3D13%26doi%3D10.1016%2Fj.addr.2008.11.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Mo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.-T.</span><span> </span><span class="NLM_article-title">Human ABCG2: Structure, Function, and its Role in Multidrug Resistance</span> <span class="citation_source-journal">Int. J. Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2012&pages=1-27&author=W.+Moauthor=J.-T.+Zhang&title=Human+ABCG2%3A+Structure%2C+Function%2C+and+its+Role+in+Multidrug+Resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMo%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DJ.-T.%26atitle%3DHuman%2520ABCG2%253A%2520Structure%252C%2520Function%252C%2520and%2520its%2520Role%2520in%2520Multidrug%2520Resistance%26jtitle%3DInt.%2520J.%2520Biochem.%2520Mol.%2520Biol.%26date%3D2012%26volume%3D1%26spage%3D1%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Zhang, J. T.</span><span> </span><span class="NLM_article-title">Use of Arrays to Investigate the Contribution of ATP-Binding Cassette Transporters to Drug Resistance in Cancer Chemotherapy and Prediction of Chemosensitivity</span> <span class="citation_source-journal">Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">323</span><span class="refDoi"> DOI: 10.1038/cr.2007.15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1038%2Fcr.2007.15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=17404598" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkt1Chtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=311-323&author=J.+T.+Zhang&title=Use+of+Arrays+to+Investigate+the+Contribution+of+ATP-Binding+Cassette+Transporters+to+Drug+Resistance+in+Cancer+Chemotherapy+and+Prediction+of+Chemosensitivity&doi=10.1038%2Fcr.2007.15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Use of arrays to investigate the contribution of ATP-binding cassette transporters to drug resistance in cancer chemotherapy and prediction of chemosensitivity</span></div><div class="casAuthors">Zhang, Jian-Ting</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">311-323</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Multidrug resistance (MDR) is a major problem in cancer chemotherapy.  One of the best known mechanisms of MDR is the elevated expression of ATP-binding cassette (ABC) transporters.  While some members of human ABC transporters have been shown to cause drug resistance with elevated expression, it is not yet known whether the over-expression of other members could also contribute to drug resistance in many model cancer cell lines and clinics.  The recent development of microarrays and quant. PCR arrays for expression profiling anal. of ABC transporters has helped address these issues.  In this article, various arrays with limited or full list of ABC transporter genes and their use in identifying ABC transporter genes in drug resistance and chemo-sensitivity prediction will be reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFJxltRNjjorVg90H21EOLACvtfcHk0lg8SyxTvkHdsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkt1Chtb0%253D&md5=28d341004d5cfc22a14048234ba704d3</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fcr.2007.15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcr.2007.15%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%2BT.%26atitle%3DUse%2520of%2520Arrays%2520to%2520Investigate%2520the%2520Contribution%2520of%2520ATP-Binding%2520Cassette%2520Transporters%2520to%2520Drug%2520Resistance%2520in%2520Cancer%2520Chemotherapy%2520and%2520Prediction%2520of%2520Chemosensitivity%26jtitle%3DCell%2520Res.%26date%3D2007%26volume%3D17%26spage%3D311%26epage%3D323%26doi%3D10.1038%2Fcr.2007.15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Gottesman, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fojo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S. E.</span><span> </span><span class="NLM_article-title">Multidrug Resistance in Cancer: Role of ATP-dependent Transporters</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">48</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span><span class="refDoi"> DOI: 10.1038/nrc706</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1038%2Fnrc706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=11902585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BD38XhvF2jtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=48-58&author=M.+M.+Gottesmanauthor=T.+Fojoauthor=S.+E.+Bates&title=Multidrug+Resistance+in+Cancer%3A+Role+of+ATP-dependent+Transporters&doi=10.1038%2Fnrc706"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug resistance in cancer: role of ATP-dependent transporters</span></div><div class="casAuthors">Gottesman, Michael M.; Fojo, Tito; Bates, Susan E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-58</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Chemotherapeutics are the most effective treatment for metastatic tumors.  However, the ability of cancer cells to become simultaneously resistant to different drugs, a trait known as multidrug resistance, remains a significant impediment to successful chemotherapy.  Three decades of multidrug-resistance research have identified a myriad of ways in which cancer cells can elude chemotherapy, and it has become apparent that resistance exists against every effective drug, even our newest agents.  Therefore, the ability to predict and circumvent drug resistance is likely to improve chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRJtnCZv-ZtrVg90H21EOLACvtfcHk0lg8SyxTvkHdsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhvF2jtL8%253D&md5=ec5284e1fe4a878c5ffc30ee83bccc9d</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrc706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc706%26sid%3Dliteratum%253Aachs%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26aulast%3DFojo%26aufirst%3DT.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DMultidrug%2520Resistance%2520in%2520Cancer%253A%2520Role%2520of%2520ATP-dependent%2520Transporters%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D48%26epage%3D58%26doi%3D10.1038%2Fnrc706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Miyake, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mickley, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristensen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brangi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenberger, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fojo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S. E.</span><span> </span><span class="NLM_article-title">Molecular Cloning of cDNAs Which are Highly Overexpressed in Mitoxantrone Resistant Cells: Demonstration of Homology to ABC Transport Genes</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">8</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=8-13&author=K.+Miyakeauthor=L.+Mickleyauthor=T.+Litmanauthor=Z.+Zhanauthor=R.+Robeyauthor=B.+Cristensenauthor=M.+Brangiauthor=L.+Greenbergerauthor=M.+Deanauthor=T.+Fojoauthor=S.+E.+Bates&title=Molecular+Cloning+of+cDNAs+Which+are+Highly+Overexpressed+in+Mitoxantrone+Resistant+Cells%3A+Demonstration+of+Homology+to+ABC+Transport+Genes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiyake%26aufirst%3DK.%26aulast%3DMickley%26aufirst%3DL.%26aulast%3DLitman%26aufirst%3DT.%26aulast%3DZhan%26aufirst%3DZ.%26aulast%3DRobey%26aufirst%3DR.%26aulast%3DCristensen%26aufirst%3DB.%26aulast%3DBrangi%26aufirst%3DM.%26aulast%3DGreenberger%26aufirst%3DL.%26aulast%3DDean%26aufirst%3DM.%26aulast%3DFojo%26aufirst%3DT.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DMolecular%2520Cloning%2520of%2520cDNAs%2520Which%2520are%2520Highly%2520Overexpressed%2520in%2520Mitoxantrone%2520Resistant%2520Cells%253A%2520Demonstration%2520of%2520Homology%2520to%2520ABC%2520Transport%2520Genes%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D8%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Pluchino, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldsborough, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callaghan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottesman, M. M.</span><span> </span><span class="NLM_article-title">Collateral Sensitivity as a Strategy Against Cancer Multidrug Resistance</span> <span class="citation_source-journal">Drug Resist. Updates</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">98</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span><span class="refDoi"> DOI: 10.1016/j.drup.2012.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2Fj.drup.2012.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=22483810" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC38XmslynsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2012&pages=98-105&author=K.+M.+Pluchinoauthor=M.+D.+Hallauthor=A.+S.+Goldsboroughauthor=R.+Callaghanauthor=M.+M.+Gottesman&title=Collateral+Sensitivity+as+a+Strategy+Against+Cancer+Multidrug+Resistance&doi=10.1016%2Fj.drup.2012.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Collateral sensitivity as a strategy against cancer multidrug resistance</span></div><div class="casAuthors">Pluchino, Kristen M.; Hall, Matthew D.; Goldsborough, Andrew S.; Callaghan, Richard; Gottesman, Michael M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Resistance Updates</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">98-105</span>CODEN:
                <span class="NLM_cas:coden">DRUPFW</span>;
        ISSN:<span class="NLM_cas:issn">1368-7646</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  While chemotherapy remains the most effective treatment for disseminated tumors, acquired or intrinsic drug resistance accounts for approx. 90% of treatment failure.  Multidrug resistance (MDR), the simultaneous resistance to drugs that differ both structurally and mechanistically, often results from drug efflux pumps in the cell membrane that reduce intracellular drug levels to less than therapeutic concns.  Expression of the MDR transporter P-glycoprotein (P-gp, MDR1, ABCB1) has been shown to correlate with overall poor chemotherapy response and prognosis.  This review will focus on collateral sensitivity (CS), the ability of compds. to kill MDR cells selectively over the parental cells from which they were derived.  Insights into CS may offer an alternative strategy for the clin. resoln. of MDR, as highly selective and potent CS agents may lead to drugs that are effective at MDR cell killing and tumor resensitization.  Four main mechanistic hypotheses for CS will be reviewed, followed by a discussion on quant. and exptl. evaluation of CS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox5FqYWa-hS7Vg90H21EOLACvtfcHk0li_jeBHEP832g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmslynsLg%253D&md5=237f7f798703a7f9c45e75796e0b5d2d</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.drup.2012.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drup.2012.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DPluchino%26aufirst%3DK.%2BM.%26aulast%3DHall%26aufirst%3DM.%2BD.%26aulast%3DGoldsborough%26aufirst%3DA.%2BS.%26aulast%3DCallaghan%26aufirst%3DR.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26atitle%3DCollateral%2520Sensitivity%2520as%2520a%2520Strategy%2520Against%2520Cancer%2520Multidrug%2520Resistance%26jtitle%3DDrug%2520Resist.%2520Updates%26date%3D2012%26volume%3D15%26spage%3D98%26epage%3D105%26doi%3D10.1016%2Fj.drup.2012.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Fojo, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slamon, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poplack, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottesman, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastan, I.</span><span> </span><span class="NLM_article-title">Expression of a Multidrug-resistance Gene in Human Tumors and Tissues</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span><span class="refDoi"> DOI: 10.1073/pnas.84.1.265</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1073%2Fpnas.84.1.265" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=2432605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADyaL2sXhtFCmsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=1987&pages=265-269&author=A.+T.+Fojoauthor=K.+Uedaauthor=D.+J.+Slamonauthor=D.+G.+Poplackauthor=M.+M.+Gottesmanauthor=I.+Pastan&title=Expression+of+a+Multidrug-resistance+Gene+in+Human+Tumors+and+Tissues&doi=10.1073%2Fpnas.84.1.265"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of a multidrug-resistance gene in human tumors and tissues</span></div><div class="casAuthors">Fojo, A. T.; Ueda, K.; Slamon, D. J.; Poplack, D. G.; Gottesman, M. M.; Pastan, I.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">265-9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The identification and cloning of a segment of a human multidrug resistance gene (mdr1) has been reported.  To examine the mol. basis of one type of multidrug resistance, RNA was prepd. from human tumors and normal tissues and their content of mdr1 RNA was measured.  The mdr1 gene is expressed at a very high level in the adrenal gland; at a high level in the kidney; at intermediate levels in the lung, liver, lower jejunum, colon, and rectum; and at low levels in many other tissues.  The mdr1 gene is also expressed in several human tumors, including many but not all tumors derived from the adrenal gland and the colon.  In addn., increased expression was detected in a few tumors at the time of relapse following initial chemotherapy.  Although controlled clin. studies will be required, the results suggest that measurement of mdr1 RNA may prove to be a valuable tool in the design of chemotherapy protocols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1ZJTrls19i7Vg90H21EOLACvtfcHk0li_jeBHEP832g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXhtFCmsr4%253D&md5=b75baa0e65eb1e16ac2e192ac0f05965</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1073%2Fpnas.84.1.265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.84.1.265%26sid%3Dliteratum%253Aachs%26aulast%3DFojo%26aufirst%3DA.%2BT.%26aulast%3DUeda%26aufirst%3DK.%26aulast%3DSlamon%26aufirst%3DD.%2BJ.%26aulast%3DPoplack%26aufirst%3DD.%2BG.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26aulast%3DPastan%26aufirst%3DI.%26atitle%3DExpression%2520of%2520a%2520Multidrug-resistance%2520Gene%2520in%2520Human%2520Tumors%2520and%2520Tissues%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1987%26volume%3D84%26spage%3D265%26epage%3D269%26doi%3D10.1073%2Fpnas.84.1.265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">McDevitt, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerr, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callaghan, R.</span><span> </span><span class="NLM_article-title">Purification and Structural Analyses of ABCG2</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">65</span><span class="refDoi"> DOI: 10.1016/j.addr.2008.07.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2Fj.addr.2008.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=19124053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1alu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2009&pages=57-65&author=C.+A.+McDevittauthor=R.+Collinsauthor=I.+D.+Kerrauthor=R.+Callaghan&title=Purification+and+Structural+Analyses+of+ABCG2&doi=10.1016%2Fj.addr.2008.07.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Purification and structural analyses of ABCG2</span></div><div class="casAuthors">McDevitt, Christopher A.; Collins, Richard; Kerr, Ian D.; Callaghan, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-65</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The ABCG2/BRCP protein is best known as a multidrug transporter capable of conferring resistance to cancer cells.  However, the protein is also inherently expressed in numerous barrier tissues and intriguingly within hematopoietic stem cells.  Unlike its partners, ABCB1 and ABCC1, there is considerably less information available on the mol. mechanism of ABCG2/BRCP.  The transporter has a distinct topol. and is presumed to function as a homodimer.  However, a no. of biochem. studies have presented data to suggest that the protein adopts higher order oligomers.  This review focuses on this controversial issue with particular ref. to findings from low resoln. structural data.  In addn., a no. of mol. models of ABCG2/BRCP based on high-resoln. structures of bacterial ABC transporters have recently become available and are critically assessed.  ABCG2/BRCP is a structurally distinct member of the triumvirate of human multidrug transporters and continues to evade description of a unifying mol. mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-26N0eXV32LVg90H21EOLACvtfcHk0li_jeBHEP832g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1alu7g%253D&md5=8afc7467f79e661e505d5bccbc17cfbf</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2008.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2008.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DMcDevitt%26aufirst%3DC.%2BA.%26aulast%3DCollins%26aufirst%3DR.%26aulast%3DKerr%26aufirst%3DI.%2BD.%26aulast%3DCallaghan%26aufirst%3DR.%26atitle%3DPurification%2520and%2520Structural%2520Analyses%2520of%2520ABCG2%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2009%26volume%3D61%26spage%3D57%26epage%3D65%26doi%3D10.1016%2Fj.addr.2008.07.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Ricci, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovato, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larson, R. S.</span><span> </span><span class="NLM_article-title">ABCG2 Inhibitors: Will They Find Clinical Relevance?</span> <span class="citation_source-journal">J. Dev. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">138</span><span class="refDoi"> DOI: 10.4172/2329-6631.1000138</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.4172%2F2329-6631.1000138" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2015&pages=138&author=J.+W.+Ricciauthor=D.+Lovatoauthor=R.+S.+Larson&title=ABCG2+Inhibitors%3A+Will+They+Find+Clinical+Relevance%3F&doi=10.4172%2F2329-6631.1000138"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.4172%2F2329-6631.1000138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4172%252F2329-6631.1000138%26sid%3Dliteratum%253Aachs%26aulast%3DRicci%26aufirst%3DJ.%2BW.%26aulast%3DLovato%26aufirst%3DD.%26aulast%3DLarson%26aufirst%3DR.%2BS.%26atitle%3DABCG2%2520Inhibitors%253A%2520Will%2520They%2520Find%2520Clinical%2520Relevance%253F%26jtitle%3DJ.%2520Dev.%2520Drugs%26date%3D2015%26volume%3D4%26spage%3D138%26doi%3D10.4172%2F2329-6631.1000138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Diestra, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheffer, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Català, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maliepaard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schellens, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheper, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germà-Lluch, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izquierdo, M.</span><span> </span><span class="NLM_article-title">A. Frequent Expression of the Multi-drug Resistance-associated Protein BCRP/MXR/ABCP/ABCG2 in Human Tumours Detected by the BXP-21 Monoclonal Antibody in Paraffin-Embedded Material</span> <span class="citation_source-journal">J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">198</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">219</span><span class="refDoi"> DOI: 10.1002/path.1203</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1002%2Fpath.1203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=12237881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivV2jsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=198&publication_year=2002&pages=213-219&author=J.+E.+Diestraauthor=G.+L.+Schefferauthor=I.+Catal%C3%A0author=M.+Maliepaardauthor=J.+H.+Schellensauthor=R.+J.+Scheperauthor=J.+R.+Germ%C3%A0-Lluchauthor=M.+Izquierdo&title=A.+Frequent+Expression+of+the+Multi-drug+Resistance-associated+Protein+BCRP%2FMXR%2FABCP%2FABCG2+in+Human+Tumours+Detected+by+the+BXP-21+Monoclonal+Antibody+in+Paraffin-Embedded+Material&doi=10.1002%2Fpath.1203"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Frequent expression of the multi-drug resistance-associated protein BCRP/MXR/ABCP/ABCG2 in human tumours detected by the BXP-21 monoclonal antibody in paraffin-embedded material</span></div><div class="casAuthors">Diestra, Julio E.; Scheffer, George L.; Catala, Isabel; Maliepaard, Marc; Schellens, Jan H. M.; Scheper, Rik J.; Germa-Lluch, Jose R.; Izquierdo, Miguel A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pathology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">198</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-219</span>CODEN:
                <span class="NLM_cas:coden">JPTLAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-3417</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Breast cancer resistance protein (BCRP/MXR/ABCP/ABCG2; hereafter ABCG2) is a member of the ATP-binding-cassette family of transporters that causes multi-drug resistance to various anticancer drugs.  The expression of ABCG2 in human tumors and its potential involvement in clin. drug resistance are unknown.  Recently, two monoclonal antibodies against human ABCG2 were produced, BXP-34 and BXP-21.  This study describes an immunohistochem. method using BXP-21 to study ABCG2 expression in formalin-fixed, paraffin-embedded tissues.  No staining was seen using BXP-34 with the same protocols.  The expression of ABCG2 was then investigated in a panel of 150 untreated human solid tumors comprising 21 tumor types.  Overall, ABCG2 expression was frequent.  Specificity of immunohistochem. was confirmed by the detection of a 72 kDa band in western blotting.  ABCG2 expression was seen in all tumor types, but it seemed more frequent in adenocarcinomas of the digestive tract, endometrium, and lung, and melanoma.  Pos. tumors showed membranous and cytoplasmic staining.  In certain adenocarcinomas, prominent membranous staining was seen.  Endothelial cells frequently displayed moderate to strong staining.  ABCG2 is widely present in untreated human solid tumors and may represent a clin. relevant mechanism of drug resistance.  Future studies in specific tumor types are needed to ascertain its clin. relevance.  BXP-21 and the immunohistochem. protocol described here will be of value in these investigations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-8qhpeoHKKbVg90H21EOLACvtfcHk0ljcDBySdAtaWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivV2jsrY%253D&md5=546dc08a9f0a65804245ffcb5a6dfe04</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1002%2Fpath.1203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpath.1203%26sid%3Dliteratum%253Aachs%26aulast%3DDiestra%26aufirst%3DJ.%2BE.%26aulast%3DScheffer%26aufirst%3DG.%2BL.%26aulast%3DCatal%25C3%25A0%26aufirst%3DI.%26aulast%3DMaliepaard%26aufirst%3DM.%26aulast%3DSchellens%26aufirst%3DJ.%2BH.%26aulast%3DScheper%26aufirst%3DR.%2BJ.%26aulast%3DGerm%25C3%25A0-Lluch%26aufirst%3DJ.%2BR.%26aulast%3DIzquierdo%26aufirst%3DM.%26atitle%3DA.%2520Frequent%2520Expression%2520of%2520the%2520Multi-drug%2520Resistance-associated%2520Protein%2520BCRP%252FMXR%252FABCP%252FABCG2%2520in%2520Human%2520Tumours%2520Detected%2520by%2520the%2520BXP-21%2520Monoclonal%2520Antibody%2520in%2520Paraffin-Embedded%2520Material%26jtitle%3DJ.%2520Pathol.%26date%3D2002%26volume%3D198%26spage%3D213%26epage%3D219%26doi%3D10.1002%2Fpath.1203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Rosenberg, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bikadi, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, Q.</span><span> </span><span class="NLM_article-title">The Human Breast Cancer Resistance Protein (BCRP/ABCG2) Shows Conformational Changes with Mitoxantrone</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">482</span><span class="NLM_x">–</span> <span class="NLM_lpage">493</span><span class="refDoi"> DOI: 10.1016/j.str.2010.01.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2Fj.str.2010.01.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=20399185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvFKnu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=482-493&author=M.+F.+Rosenbergauthor=Z.+Bikadiauthor=J.+Chanauthor=X.+Liuauthor=Z.+Niauthor=X.+Caiauthor=R.+C.+Fordauthor=Q.+Mao&title=The+Human+Breast+Cancer+Resistance+Protein+%28BCRP%2FABCG2%29+Shows+Conformational+Changes+with+Mitoxantrone&doi=10.1016%2Fj.str.2010.01.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The Human Breast Cancer Resistance Protein (BCRP/ABCG2) Shows Conformational Changes with Mitoxantrone</span></div><div class="casAuthors">Rosenberg, Mark F.; Bikadi, Zsolt; Chan, Janice; Liu, Xiaoping; Ni, Zhanglin; Cai, Xiaokun; Ford, Robert C.; Mao, Qingcheng</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">482-493</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">BCRP/ABCG2 mediates efflux of drugs and xenobiotics.  BCRP was expressed in Pichia pastoris, purified to > 90% homogeneity, and subjected to two-dimensional (2D) crystn.  The 2D crystals showed a p121 symmetry and projection maps were detd. at 5 Å resoln. by cryo-electron microscopy.  Two crystal forms with and without mitoxantrone were obsd. with unit cell dimensions of a = 55.4 Å, b = 81.4 Å, γ = 89.8°, and a = 57.3 Å, b = 88.0 Å, γ = 89.7°, resp.  The projection map without mitoxantrone revealed an asym. structure with ring-shaped d. features probably corresponding to a bundle of transmembrane α helixes, and appeared more open and less sym. than the map with mitroxantrone.  The open and closed inward-facing forms of BCRP were generated by homol. modeling, representing the substrate-free and substrate-bound conformations in the absence of nucleotide, resp.  These models are consistent with the exptl. obsd. conformational change upon substrate binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy41Lg_ARysLVg90H21EOLACvtfcHk0ljtW85hdhv14w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvFKnu7s%253D&md5=259f90447cbb30589018f12c155cf19e</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2010.01.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2010.01.017%26sid%3Dliteratum%253Aachs%26aulast%3DRosenberg%26aufirst%3DM.%2BF.%26aulast%3DBikadi%26aufirst%3DZ.%26aulast%3DChan%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DNi%26aufirst%3DZ.%26aulast%3DCai%26aufirst%3DX.%26aulast%3DFord%26aufirst%3DR.%2BC.%26aulast%3DMao%26aufirst%3DQ.%26atitle%3DThe%2520Human%2520Breast%2520Cancer%2520Resistance%2520Protein%2520%2528BCRP%252FABCG2%2529%2520Shows%2520Conformational%2520Changes%2520with%2520Mitoxantrone%26jtitle%3DStructure%26date%3D2010%26volume%3D18%26spage%3D482%26epage%3D493%26doi%3D10.1016%2Fj.str.2010.01.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Wong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briddon, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holliday, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerr, I. D.</span><span> </span><span class="NLM_article-title">Plasma Membrane Dynamics and Tetrameric Organisation of ABCG2 Transporters in Mammalian Cells Revealed by Single Particle Imaging Techniques</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">1863</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span><span class="refDoi"> DOI: 10.1016/j.bbamcr.2015.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2Fj.bbamcr.2015.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=26453803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Chtb%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1863&publication_year=2016&pages=19-29&author=K.+Wongauthor=S.+J.+Briddonauthor=N.+D.+Hollidayauthor=I.+D.+Kerr&title=Plasma+Membrane+Dynamics+and+Tetrameric+Organisation+of+ABCG2+Transporters+in+Mammalian+Cells+Revealed+by+Single+Particle+Imaging+Techniques&doi=10.1016%2Fj.bbamcr.2015.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma membrane dynamics and tetrameric organisation of ABCG2 transporters in mammalian cells revealed by single particle imaging techniques</span></div><div class="casAuthors">Wong, Kelvin; Briddon, Stephen J.; Holliday, Nicholas D.; Kerr, Ian D.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">1863</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-29</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">ABCG2 is one of three human ATP binding cassette (ABC) transporters involved in the export from cells of a chem. and structurally diverse range of compds.  This multidrug efflux capability, together with a broad tissue distribution in the body, means that ABCG2 exerts a range of effects on normal physiol. such as kidney urate transport, as well as contributing towards the pharmacokinetic profiles of many exogenous drugs.  The primary sequence of ABCG2 contains only half the no. of domains required for a functioning ABC transporter and so it must oligomerise in order to function, yet its oligomeric state in intact cell membranes remains uncharacterized.  We have analyzed ABCG2 in living cell membranes using a combination of fluorescence correlation spectroscopy, photon counting histogram anal., and stepwise photobleaching to demonstrate a predominantly tetrameric structure for ABCG2 in the presence or absence of transport substrates.  These results provide the essential basis for exploring pharmacol. manipulation of oligomeric state as a strategy to modulate ABCG2 activity in future selective therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCBGt4Y70W5LVg90H21EOLACvtfcHk0ljtW85hdhv14w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Chtb%252FN&md5=89fe45505b932fa860e4c9151fc610e0</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2015.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2015.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DK.%26aulast%3DBriddon%26aufirst%3DS.%2BJ.%26aulast%3DHolliday%26aufirst%3DN.%2BD.%26aulast%3DKerr%26aufirst%3DI.%2BD.%26atitle%3DPlasma%2520Membrane%2520Dynamics%2520and%2520Tetrameric%2520Organisation%2520of%2520ABCG2%2520Transporters%2520in%2520Mammalian%2520Cells%2520Revealed%2520by%2520Single%2520Particle%2520Imaging%2520Techniques%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2016%26volume%3D1863%26spage%3D19%26epage%3D29%26doi%3D10.1016%2Fj.bbamcr.2015.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Dezi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fribourg, P.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Cicco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnaud, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Pietro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lévy, D.</span><span> </span><span class="NLM_article-title">The Multidrug Resistance Half-transporter ABCG2 is Purified as a Tetramer Upon Selective Extraction from Membranes</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Biomembr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1798</span><span class="NLM_x">, </span> <span class="NLM_fpage">2094</span><span class="NLM_x">–</span> <span class="NLM_lpage">2101</span><span class="refDoi"> DOI: 10.1016/j.bbamem.2010.07.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2Fj.bbamem.2010.07.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=20691149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFGhurvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1798&publication_year=2010&pages=2094-2101&author=M.+Deziauthor=P.-F.+Fribourgauthor=A.+Di+Ciccoauthor=O.+Arnaudauthor=S.+Marcoauthor=P.+Falsonauthor=A.+Di+Pietroauthor=D.+L%C3%A9vy&title=The+Multidrug+Resistance+Half-transporter+ABCG2+is+Purified+as+a+Tetramer+Upon+Selective+Extraction+from+Membranes&doi=10.1016%2Fj.bbamem.2010.07.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The multidrug resistance half-transporter ABCG2 is purified as a tetramer upon selective extraction from membranes</span></div><div class="casAuthors">Dezi, Manuela; Fribourg, Pierre-Frederic; Di Cicco, Aurelie; Arnaud, Ophelie; Marco, Sergio; Falson, Pierre; Di Pietro, Attilio; Levy, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1798</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2094-2101</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">ABCG2 is a human membrane ATP-binding cassette half-transporter that hydrolyzes ATP to efflux a large no. of chemotherapeutic agents.  Several oligomeric states of ABCG2 from homodimers to dodecamers have been reported depending on the overexpression systems and/or the protocols used for purifn.  Here, we compared the oligomeric state of His6-ABCG2 expressed in Sf9 insect cells and in human Flp-In-293/ABCG2 cells after solubilization in mild detergents.  His6-ABCG2 was purified through a new approach involving its specific recognition onto a functionalized lipid layer contg. a Ni-NTA lipid.  This approach allowed the purifn. of His-ABCG2 in presence of all solubilized membrane components that might be involved in the stabilization of native oligomers and without requiring any addnl. washing or concn. passages.  ABCG2 purified onto the NiNTA lipid surfaces were directly analyzed by electron microscopy and by biochem. assays.  Altogether, our data are consistent with a tetrameric organization of ABCG2 when expressed in either heterologous Sf9 insect cells or in human homologous cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp83AnAMdQg6bVg90H21EOLACvtfcHk0ljtW85hdhv14w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFGhurvL&md5=9e1f93b37b94937cb10dd19ec9a8c985</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamem.2010.07.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamem.2010.07.034%26sid%3Dliteratum%253Aachs%26aulast%3DDezi%26aufirst%3DM.%26aulast%3DFribourg%26aufirst%3DP.-F.%26aulast%3DDi%2BCicco%26aufirst%3DA.%26aulast%3DArnaud%26aufirst%3DO.%26aulast%3DMarco%26aufirst%3DS.%26aulast%3DFalson%26aufirst%3DP.%26aulast%3DDi%2BPietro%26aufirst%3DA.%26aulast%3DL%25C3%25A9vy%26aufirst%3DD.%26atitle%3DThe%2520Multidrug%2520Resistance%2520Half-transporter%2520ABCG2%2520is%2520Purified%2520as%2520a%2520Tetramer%2520Upon%2520Selective%2520Extraction%2520from%2520Membranes%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D2010%26volume%3D1798%26spage%3D2094%26epage%3D2101%26doi%3D10.1016%2Fj.bbamem.2010.07.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">McDevitt, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modok, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storm, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerr, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callaghan, R.</span><span> </span><span class="NLM_article-title">Purification and 3D Structural Analysis of Oligomeric Human Multidrug Transporter ABCG2</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1623</span><span class="NLM_x">–</span> <span class="NLM_lpage">1632</span><span class="refDoi"> DOI: 10.1016/j.str.2006.08.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2Fj.str.2006.08.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=17098188" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1SmtrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=1623-1632&author=C.+A.+McDevittauthor=R.+F.+Collinsauthor=M.+Conwayauthor=S.+Modokauthor=J.+Stormauthor=I.+D.+Kerrauthor=R.+C.+Fordauthor=R.+Callaghan&title=Purification+and+3D+Structural+Analysis+of+Oligomeric+Human+Multidrug+Transporter+ABCG2&doi=10.1016%2Fj.str.2006.08.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Purification and 3D Structural Analysis of Oligomeric Human Multidrug Transporter ABCG2</span></div><div class="casAuthors">McDevitt, Christopher A.; Collins, Richard F.; Conway, Michael; Modok, Szabolcs; Storm, Janet; Kerr, Ian D.; Ford, Robert C.; Callaghan, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1623-1632</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">ABCG2 is a multidrug efflux pump assocd. with resistance of cancer cells to a plethora of unrelated drugs.  ABCG2 is a "half-transporter," and previous studies have indicated that it forms homodimers and higher oligomeric species.  In this manuscript, electron microscopic structural anal. directly addressed this issue.  An N-terminal hexahistidine-tagged ABCG2R482G isoform was expressed to high levels in insect cells.  An extensive detergent screen was employed to effect extn. of ABCG2R482G from membranes and identified only the fos-choline detergents as efficient.  Sol. protein was purified to >95% homogeneity by a three-step procedure while retaining the ability to bind substrates.  Cryoneg. stain electron microscopy of purified ABCG2R482G provided 3D structural data at a resoln. of ∼18 Å.  Single-particle anal. revealed that the complex forms a tetrameric complex (∼180 Å in diam. × ∼140 Å high) with an aq. central region.  We interpret the tetrameric structure as comprising four homodimeric ABCG2R482G complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwtScpCugTgbVg90H21EOLACvtfcHk0ljtW85hdhv14w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1SmtrzN&md5=f56278a6fc2b6b53312b604f018d89d8</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2006.08.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2006.08.014%26sid%3Dliteratum%253Aachs%26aulast%3DMcDevitt%26aufirst%3DC.%2BA.%26aulast%3DCollins%26aufirst%3DR.%2BF.%26aulast%3DConway%26aufirst%3DM.%26aulast%3DModok%26aufirst%3DS.%26aulast%3DStorm%26aufirst%3DJ.%26aulast%3DKerr%26aufirst%3DI.%2BD.%26aulast%3DFord%26aufirst%3DR.%2BC.%26aulast%3DCallaghan%26aufirst%3DR.%26atitle%3DPurification%2520and%25203D%2520Structural%2520Analysis%2520of%2520Oligomeric%2520Human%2520Multidrug%2520Transporter%2520ABCG2%26jtitle%3DStructure%26date%3D2006%26volume%3D14%26spage%3D1623%26epage%3D1632%26doi%3D10.1016%2Fj.str.2006.08.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.-T.</span><span> </span><span class="NLM_article-title">Characterization of Oligomeric Human Half-ABC Transporter ATP-binding Cassette G2</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">19781</span><span class="NLM_x">–</span> <span class="NLM_lpage">19789</span><span class="refDoi"> DOI: 10.1074/jbc.M310785200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1074%2Fjbc.M310785200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=15001581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1Wit7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=19781-19789&author=J.+Xuauthor=Y.+Liuauthor=Y.+Yangauthor=S.+Batesauthor=J.-T.+Zhang&title=Characterization+of+Oligomeric+Human+Half-ABC+Transporter+ATP-binding+Cassette+G2&doi=10.1074%2Fjbc.M310785200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of Oligomeric Human Half-ABC Transporter ATP-binding Cassette G2</span></div><div class="casAuthors">Xu, Junkang; Liu, Yang; Yang, Youyun; Bates, Susan; Zhang, Jian-Ting</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">19781-19789</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Human ATP-binding cassette G2 (ABCG2, also known as mitoxantrone resistance protein, breast cancer-resistance protein, ABC placenta) is a member of the superfamily of ATP-binding cassette (ABC) transporters that have a wide variety of substrates.  Overexpression of human ABCG2 in model cancer cell lines causes multidrug resistance by actively effluxing anticancer drugs.  Unlike most of the other ABC transporters which usually have two nucleotide-binding domains and two transmembrane domains, ABCG2 consists of only one nucleotide-binding domain followed by one transmembrane domain.  Thus, ABCG2 has been thought to be a half-transporter that may function as a homodimer.  In this study, we characterized the oligomeric feature of human ABCG2 using non-denaturing detergent perfluoro-octanoic acid and Triton X-100 in combination with gel filtration, sucrose d. gradient sedimentation, and gel electrophoresis.  Unexpectedly, we found that human ABCG2 exists mainly as a tetramer, with a possibility of a higher form of oligomerization.  Monomeric and dimeric ABCG2 did not appear to be the major form of the protein.  Further immunopptn. anal. showed that the oligomeric ABCG2 did not contain any other proteins.  Taken together, we conclude that human ABCG2 likely exists and functions as a homotetramer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogS9hRAh_FSbVg90H21EOLACvtfcHk0lhFaQB_ZFq8aQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1Wit7g%253D&md5=c45adb759c2de874ef4c299eb3d0c99e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M310785200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M310785200%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DBates%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DJ.-T.%26atitle%3DCharacterization%2520of%2520Oligomeric%2520Human%2520Half-ABC%2520Transporter%2520ATP-binding%2520Cassette%2520G2%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D19781%26epage%3D19789%26doi%3D10.1074%2Fjbc.M310785200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Lee, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinch, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borek, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urbatsch, I. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, X. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grishin, N. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otwinowski, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobbs, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbaum, D. M.</span><span> </span><span class="NLM_article-title">Crystal structure of the human sterol transporter ABCG5/ABCG8</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">533</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">564</span><span class="refDoi"> DOI: 10.1038/nature17666</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1038%2Fnature17666" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=27144356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC28Xnt1OgsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=533&publication_year=2016&pages=561-564&author=J.+Y.+Leeauthor=L.+N.+Kinchauthor=D.+M.+Borekauthor=J.+Wangauthor=J.+Wangauthor=I.+L.+Urbatschauthor=X.+S.+Xieauthor=N.+V.+Grishinauthor=J.+C.+Cohenauthor=Z.+Otwinowskiauthor=H.+H.+Hobbsauthor=D.+M.+Rosenbaum&title=Crystal+structure+of+the+human+sterol+transporter+ABCG5%2FABCG8&doi=10.1038%2Fnature17666"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the human sterol transporter ABCG5/ABCG8</span></div><div class="casAuthors">Lee, Jyh-Yeuan; Kinch, Lisa N.; Borek, Dominika M.; Wang, Jin; Wang, Junmei; Urbatsch, Ina L.; Xie, Xiao-Song; Grishin, Nikolai V.; Cohen, Jonathan C.; Otwinowski, Zbyszek; Hobbs, Helen H.; Rosenbaum, Daniel M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">533</span>
        (<span class="NLM_cas:issue">7604</span>),
    <span class="NLM_cas:pages">561-564</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">ATP binding cassette (ABC) transporters play crit. roles in maintaining sterol balance in higher eukaryotes.  The ABCG5/ABCG8 heterodimer (G5G8) mediates excretion of neutral sterols in liver and intestines.  Mutations disrupting G5G8 cause sitosterolemia, a disorder characterized by sterol accumulation and premature atherosclerosis.  Here we use crystn. in lipid bilayers to det. the X-ray structure of human G5G8 in a nucleotide-free state at 3.9 Å resoln., generating the first at. model of an ABC sterol transporter.  The structure reveals a new transmembrane fold that is present in a large and functionally diverse superfamily of ABC transporters.  The transmembrane domains are coupled to the nucleotide-binding sites by networks of interactions that differ between the active and inactive ATPases, reflecting the catalytic asymmetry of the transporter.  The G5G8 structure provides a mechanistic framework for understanding sterol transport and the disruptive effects of mutations causing sitosterolemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3PVxVbqX6yLVg90H21EOLACvtfcHk0lhFaQB_ZFq8aQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xnt1OgsrY%253D&md5=fde81e0a40d432c14d192687d0b6f2a3</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnature17666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature17666%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BY.%26aulast%3DKinch%26aufirst%3DL.%2BN.%26aulast%3DBorek%26aufirst%3DD.%2BM.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DUrbatsch%26aufirst%3DI.%2BL.%26aulast%3DXie%26aufirst%3DX.%2BS.%26aulast%3DGrishin%26aufirst%3DN.%2BV.%26aulast%3DCohen%26aufirst%3DJ.%2BC.%26aulast%3DOtwinowski%26aufirst%3DZ.%26aulast%3DHobbs%26aufirst%3DH.%2BH.%26aulast%3DRosenbaum%26aufirst%3DD.%2BM.%26atitle%3DCrystal%2520structure%2520of%2520the%2520human%2520sterol%2520transporter%2520ABCG5%252FABCG8%26jtitle%3DNature%26date%3D2016%26volume%3D533%26spage%3D561%26epage%3D564%26doi%3D10.1038%2Fnature17666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">László, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarkadi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegedűs, T.</span><span> </span><span class="NLM_article-title">Jump into a New Fold-A Homology Based Model for the ABCG2/BCRP Multidrug Transporter</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0164426</span><span class="refDoi"> DOI: 10.1371/journal.pone.0164426</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1371%2Fjournal.pone.0164426" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=27741279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVamt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=e0164426&author=L.+L%C3%A1szl%C3%B3author=B.+Sarkadiauthor=T.+Heged%C5%B1s&title=Jump+into+a+New+Fold-A+Homology+Based+Model+for+the+ABCG2%2FBCRP+Multidrug+Transporter&doi=10.1371%2Fjournal.pone.0164426"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Jump into a new fold - a homology based model for the ABCG2/BCRP multidrug transporter</span></div><div class="casAuthors">Laszlo, Laura; Sarkadi, Balazs; Hegedus, Tamas</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e0164426/1-e0164426/22</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">ABCG2/BCRP is a membrane protein, involved in xenobiotic and endobiotic transport in key pharmacol. barriers and drug metabolizing organs, in the protection of stem cells, and in multidrug resistance of cancer.  Pharmacogenetic studies implicated the role of ABCG2 in response to widely used medicines and anticancer agents, as well as in gout.  Its Q141K variant exhibits decreased functional expression thus increased drug accumulation and decreased urate secretion.  Still, there has been no reliable mol. model available for this protein, as the published structures of other ABC transporters could not be properly fitted to the ABCG2 topol. and exptl. data.  The recently published high resoln. structure of a close homolog, the ABCG5-ABCG8 heterodimer, revealed a new ABC transporter fold, unique for ABCG proteins.  Here we present a structural model of the ABCG2 homodimer based on this fold and detail the exptl. results supporting this model.  In order to describe the effect of mutations on structure and dynamics, and characterize substrate recognition and cholesterol regulation we performed mol. dynamics simulations using full length ABCG2 protein embedded in a membrane bilayer and in silico docking simulations.  Our results show that in the Q141K variant the introduced pos. charge diminishes the interaction between the nucleotide binding and transmembrane domains and the R482G variation alters the orientation of transmembrane helixes.  Moreover, the R482 position, which plays a role the substrate specificity of the transporter, is located in one of the substrate binding pockets identified by the in silico docking calcns.  In summary, the ABCG2 model and in silico simulations presented here may have significant impact on understanding drug distribution and toxicity, as well as drug development against cancer chemotherapy resistance or gout.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEixXLOPXPv7Vg90H21EOLACvtfcHk0lhFaQB_ZFq8aQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVamt74%253D&md5=c30656bb73b52cec8482f00110f573c9</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0164426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0164426%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25A1szl%25C3%25B3%26aufirst%3DL.%26aulast%3DSarkadi%26aufirst%3DB.%26aulast%3DHeged%25C5%25B1s%26aufirst%3DT.%26atitle%3DJump%2520into%2520a%2520New%2520Fold-A%2520Homology%2520Based%2520Model%2520for%2520the%2520ABCG2%252FBCRP%2520Multidrug%2520Transporter%26jtitle%3DPLoS%2520One%26date%3D2016%26volume%3D11%26spage%3De0164426%26doi%3D10.1371%2Fjournal.pone.0164426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Doyle, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, D. D.</span><span> </span><span class="NLM_article-title">Multidrug Resistance Mediated by the Breast Cancer Resistance Protein BCRP (ABCG2)</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">7340</span><span class="NLM_x">–</span> <span class="NLM_lpage">7358</span><span class="refDoi"> DOI: 10.1038/sj.onc.1206938</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1038%2Fsj.onc.1206938" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=14576842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A280%3ADC%252BD3svpvFCjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=7340-7358&author=J.+A.+Doyleauthor=D.+D.+Ross&title=Multidrug+Resistance+Mediated+by+the+Breast+Cancer+Resistance+Protein+BCRP+%28ABCG2%29&doi=10.1038%2Fsj.onc.1206938"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)</span></div><div class="casAuthors">Doyle L Austin; Ross Douglas D</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">7340-58</span>
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    </div><div class="casAbstract">Observations of functional adenosine triphosphate (ATP)-dependent drug efflux in certain multidrug-resistant cancer cell lines without overexpression of P-glycoprotein or multidrug resistance protein (MRP) family members suggested the existence of another ATP-binding cassette (ABC) transporter capable of causing cancer drug resistance.  In one such cell line (MCF-7/AdrVp), the overexpression of a novel member of the G subfamily of ABC transporters was found.  The new transporter was termed the breast cancer resistance protein (BCRP), because of its identification in MCF-7 human breast carcinoma cells.  BCRP is a 655 amino-acid polypeptide, formally designated as ABCG2.  Like all members of the ABC G (white) subfamily, BCRP is a half transporter.  Transfection and enforced overexpression of BCRP in drug-sensitive MCF-7 or MDA-MB-231 cells recapitulates the drug-resistance phenotype of MCF-7/AdrVp cells, consistent with current evidence suggesting that functional BCRP is a homodimer.  BCRP maps to chromosome 4q22, downstream from a TATA-less promoter.  The spectrum of anticancer drugs effluxed by BCRP includes mitoxantrone, camptothecin-derived and indolocarbazole topoisomerase I inhibitors, methotrexate, flavopiridol, and quinazoline ErbB1 inhibitors.  Transport of anthracyclines is variable and appears to depend on the presence of a BCRP mutation at codon 482.  Potent and specific inhibitors of BCRP are now being developed, opening the door to clinical applications of BCRP inhibition.  Owing to tissue localization in the placenta, bile canaliculi, colon, small bowel, and brain microvessel endothelium, BCRP may play a role in protecting the organism from potentially harmful xenobiotics.  BCRP expression has also been demonstrated in pluripotential "side population" stem cells, responsible for the characteristic ability of these cells to exclude Hoechst 33342 dye, and possibly for the maintenance of the stem cell phenotype.  Studies are emerging on the role of BCRP expression in drug resistance in clinical cancers.  More prospective studies are needed, preferably combining BCRP protein or mRNA quantification with functional assays, in order to determine the contribution of BCRP to drug resistance in human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSVhfZWKJa6Ui6Ufuk_1xoTfW6udTcc2eYjZT5dVYQRD7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3svpvFCjug%253D%253D&md5=e47830ac42603a5253b8148ca0e86fe2</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1206938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1206938%26sid%3Dliteratum%253Aachs%26aulast%3DDoyle%26aufirst%3DJ.%2BA.%26aulast%3DRoss%26aufirst%3DD.%2BD.%26atitle%3DMultidrug%2520Resistance%2520Mediated%2520by%2520the%2520Breast%2520Cancer%2520Resistance%2520Protein%2520BCRP%2520%2528ABCG2%2529%26jtitle%3DOncogene%26date%3D2003%26volume%3D22%26spage%3D7340%26epage%3D7358%26doi%3D10.1038%2Fsj.onc.1206938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Stacy, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansson, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, D. R.</span><span> </span><span class="NLM_article-title">Molecular Pharmacology of ABCG2 and its Role in Chemoresistance</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">655</span><span class="NLM_x">–</span> <span class="NLM_lpage">669</span><span class="refDoi"> DOI: 10.1124/mol.113.088609</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1124%2Fmol.113.088609" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=24021215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1KjtLjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2013&pages=655-669&author=A.+E.+Stacyauthor=P.+J.+Janssonauthor=D.+R.+Richardson&title=Molecular+Pharmacology+of+ABCG2+and+its+Role+in+Chemoresistance&doi=10.1124%2Fmol.113.088609"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular pharmacology of ABCG2 and its role in chemoresistance</span></div><div class="casAuthors">Stacy, Alexandra E.; Jansson, Patric J.; Richardson, Des R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">655-669</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The ATP-binding cassette, subfamily G, isoform 2 protein (ABCG2) is an important member of the ABC transporter superfamily, which has been suggested to be involved in multidrug resistance (MDR) in cancer.  Its diverse range of substrates includes many common chemotherapeutics such as imatinib, doxorubicin, and mitoxantrone.  Physiol., ABCG2 is highly expressed in areas such as the blood-brain barrier and gastrointestinal tract, where it is thought to play a role in protection against xenobiotic exposure.  High ABCG2 expression has also been found in a variety of solid tumors and in hematol. malignancies and has been correlated with poorer clin. outcomes.  Furthermore, ABCG2 expression is a characteristic feature of cancer stem cells, which are able to self-renew and differentiate.  These cancer stem cells have been postulated to play an important role in MDR, where their inherent ABCG2 expression may allow them to survive chemotherapy and repopulate the tumor after exposure to chemotherapeutics.  This observation raises the exciting possibility that by inhibiting ABCG2, cancer stem cells and other cancers may be targeted and eradicated, at which point conventional chemotherapeutics would be sufficient to eliminate the remaining tumor cells.  Inhibitors of ABCG2, such as tyrosine kinase inhibitors, phosphodiesterase-5 inhibitors, and the fumitremorgin-type indolyl diketopiperazine, Ko143 [(3S,6S,12aS)-1,2,3,4,6,7,12,12a-octahydro-9-methoxy-6-(2-methylpropyl)-1,4-dioxopyrazino[1',2':1,6]pyrido[3,4-b]indole-3-propanoic acid 1,1-dimethylethyl ester], could potentially be used for this purpose.  However, these agents are still awaiting comprehensive clin. assessment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplO8F0Ak6Zp7Vg90H21EOLACvtfcHk0lgWRGKg-RUJ1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1KjtLjP&md5=d619971aca497b3b66e70c3c5bcca0bb</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1124%2Fmol.113.088609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.113.088609%26sid%3Dliteratum%253Aachs%26aulast%3DStacy%26aufirst%3DA.%2BE.%26aulast%3DJansson%26aufirst%3DP.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BR.%26atitle%3DMolecular%2520Pharmacology%2520of%2520ABCG2%2520and%2520its%2520Role%2520in%2520Chemoresistance%26jtitle%3DMol.%2520Pharmacol.%26date%3D2013%26volume%3D84%26spage%3D655%26epage%3D669%26doi%3D10.1124%2Fmol.113.088609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Juvale, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span> </span><span class="NLM_article-title">Design of Inhibitors of BCRP/ABCG2</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1521</span><span class="NLM_x">–</span> <span class="NLM_lpage">1527</span><span class="refDoi"> DOI: 10.4155/fmc.15.83</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.4155%2Ffmc.15.83" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=26293476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVegsLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=1521-1527&author=K.+Juvaleauthor=M.+Wiese&title=Design+of+Inhibitors+of+BCRP%2FABCG2&doi=10.4155%2Ffmc.15.83"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Design of inhibitors of BCRP/ABCG2</span></div><div class="casAuthors">Juvale, Kapil; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1521-1527</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">BCRP/ABCG2, a second member of ABC transporter subclass G, has been shown to be overexpressed in several solid tumors, acute myelogenous leukemia and chronic myeloid leukemia.  A variety of chem. unrelated anticancer drugs have been found to be transported by ABCG2 leading to their lower intracellular accumulation and hence causing chemoresistance.  Until now several efforts have been taken to identify potent and selective inhibitors of ABCG2.  Recent studies carried out to deign BCRP inhibitors have been able to point out the effect of the substitution pattern in compd. scaffolds on the potency, selectivity and cytotoxicity of ABCG2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH22yJaa4iMLVg90H21EOLACvtfcHk0lgWRGKg-RUJ1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVegsLfI&md5=3fe4045f02e562a52ee0a674d09d3ffb</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.4155%2Ffmc.15.83&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.15.83%26sid%3Dliteratum%253Aachs%26aulast%3DJuvale%26aufirst%3DK.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DDesign%2520of%2520Inhibitors%2520of%2520BCRP%252FABCG2%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2015%26volume%3D7%26spage%3D1521%26epage%3D1527%26doi%3D10.4155%2Ffmc.15.83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, B.</span><span> </span><span class="NLM_article-title">Membranous ABCG2 Expression in Colorectal Cancer Independently Correlates with Shortened Patient Survival</span> <span class="citation_source-journal">Cancer Biomarkers</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span><span class="refDoi"> DOI: 10.3233/CBM-130344</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.3233%2FCBM-130344" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=23838136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtV2msb3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=81-88&author=X.+Wangauthor=B.+Xiaauthor=Y.+Liangauthor=L.+Pengauthor=Z.+Wangauthor=J.+Zhuoauthor=W.+Wangauthor=B.+Jiang&title=Membranous+ABCG2+Expression+in+Colorectal+Cancer+Independently+Correlates+with+Shortened+Patient+Survival&doi=10.3233%2FCBM-130344"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Membranous ABCG2 expression in colorectal cancer independently correlates with shortened patient survival</span></div><div class="casAuthors">Wang, Xinying; Xia, Bingqing; Liang, Yan; Peng, Liang; Wang, Zhongqiu; Zhuo, Jingwei; Wang, Weifei; Jiang, Bo</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biomarkers</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">81-88</span>CODEN:
                <span class="NLM_cas:coden">CBAIBM</span>;
        ISSN:<span class="NLM_cas:issn">1574-0153</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">BACKGROUND: ABCG2 is a member of the ATP binding cassette (ABC) transporter superfamily and identified to play an important role in multidrug resistance in many studies.  But the expression of ABCG2 is controversial in many kinds of tumors including colorectal cancer (CRC).  OBJECTIVE: To clarify the expression patterns of ABCG2 and elucidate the prognostic value of ABCG2 in CRC.  METHODS: ABCG2 expression was analyzed in 225 primary CRC tissues using immunohistochem. assessment.  Cytoplasmic and membranous immunoreactivity were semiquant. scored and correlated with clinicopathol. variables. 69 cases were used for survival anal. χ2 test for trends, Kaplan-Meier anal. and Cox's regression were used for statistical anal.  RESULTS: 83.1% cases showed pos. cytoplasmic expression including 13.3% strongly pos. 66.2% showed pos. membranous expression including 15.6% strongly pos. 50% normal mucosa exhibited a strong membranous staining on the apical membrane.  The strongly membranous staining significantly correlated to lymph node and distant metastasis.  While the cytoplasmic expression levels of ABCG2 protein were only correlated with tumor stage.  Survival anal. showed strongly membranous ABCG2 staining correlated to shortened patient survival than neg. one (HR=2.439, 95%CI 1.053-5.650, P=0.038), but not cytoplasmic ABCG2 staining.  DISCUSSION: Our results showed that membranous ABCG2 expression was significantly assocd. with Dukes' stage, lymph node metastasis and distant metastasis.  However, cytoplasmic ABCG2 expression was only significantly assocd. with Dukes' stage.  CONCLUSIONS: Strong membranous ABCG2 staining is a potential new independent prognostic factor of CRC.  Further studies are needed to clarify the role of ABCG2 in colon carcinogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYMptqQbtln7Vg90H21EOLACvtfcHk0liK7eZiT63wjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtV2msb3M&md5=5e61d07cf9ff492ce3ec51cd09a29408</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.3233%2FCBM-130344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FCBM-130344%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DXia%26aufirst%3DB.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DPeng%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DZhuo%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DJiang%26aufirst%3DB.%26atitle%3DMembranous%2520ABCG2%2520Expression%2520in%2520Colorectal%2520Cancer%2520Independently%2520Correlates%2520with%2520Shortened%2520Patient%2520Survival%26jtitle%3DCancer%2520Biomarkers%26date%3D2013%26volume%3D13%26spage%3D81%26epage%3D88%26doi%3D10.3233%2FCBM-130344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Lin, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, S. C.</span><span> </span><span class="NLM_article-title">Expression of ABCG2 Associated with Tumor Response in Metastatic Colorectal Cancer Patients Receiving First-Line FOLFOX Therapy - Preliminary Evidence</span> <span class="citation_source-journal">Int. J. Biol. Markers</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">182</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span><span class="refDoi"> DOI: 10.5301/jbm.5000004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.5301%2Fjbm.5000004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=23558935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVOgsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2013&pages=182-186&author=P.+C.+Linauthor=H.+H.+Linauthor=J.+K.+Linauthor=C.+C.+Linauthor=S.+H.+Yangauthor=A.+F.+Liauthor=W.+S.+Chenauthor=S.+C.+Chang&title=Expression+of+ABCG2+Associated+with+Tumor+Response+in+Metastatic+Colorectal+Cancer+Patients+Receiving+First-Line+FOLFOX+Therapy+-+Preliminary+Evidence&doi=10.5301%2Fjbm.5000004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of ABCG2 associated with tumor response in metastatic colorectal cancer patients receiving first-line FOLFOX therapy - preliminary evidence</span></div><div class="casAuthors">Lin, Pei-Ching; Lin, Hung-Hsin; Lin, Jen-Kou; Lin, Chun-Chi; Yang, Shung-Haur; Li, Anna Fen-Yau; Chen, Wei-Shone; Chang, Shih-Ching</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biological Markers</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">182-186</span>CODEN:
                <span class="NLM_cas:coden">IBMAEP</span>;
        ISSN:<span class="NLM_cas:issn">1724-6008</span>.
    
            (<span class="NLM_cas:orgname">Wichtig Editore</span>)
        </div><div class="casAbstract">Purpose: We retrospectively analyzed ABCG2 expression levels in patients with metastatic colorectal cancer (CRC) to investigate the interaction between ABCG2 expression and the tumor response to oxaliplatin and 5-fluorouracil (FOLFOX).  Methods: Forty-three patients with CRC with liver metastasis who received first-line FOLFOX treatment at our institution between 2008 and 2010 were enrolled.  ABCG2 expression was assessed by immunohistochem.  Tumor response was detd. using the modified Response Evaluation Criteria in Solid Tumors criteria.  Results: At least 50% tumor shrinkage was obsd. in 16/43 patients (37.2%), including a complete response in 1 patient.  According to the intensity of ABCG2 expression and the percentage of tumor cells expressing ABCG2, 21 tumors displayed high ABCG2 expression.  Among these tumors, only 2 (9.5%) exhibited partial responses to FOLFOX; conversely, 63.6% of tumors with low ABCG2 expression (14/22) responded to FOLFOX.  Primary and corresponding metastatic samples were available for 15 patients, and 13 of the metastatic tumors had higher ABCG2 expression than the corresponding primary tumors, but only 1 of these tumors responded to FOLFOX (7.7%).  Conclusions: ABCG2 expression is assocd. with the tumor response to FOLFOX in patients with metastatic CRC.  ABCC2 may be a selective marker for the efficacy of FOLFOX in treating CRC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxTcS23Oi30bVg90H21EOLACvtfcHk0liK7eZiT63wjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVOgsLk%253D&md5=2ddddb221d1c545c5908224d801e2b3f</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.5301%2Fjbm.5000004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5301%252Fjbm.5000004%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DP.%2BC.%26aulast%3DLin%26aufirst%3DH.%2BH.%26aulast%3DLin%26aufirst%3DJ.%2BK.%26aulast%3DLin%26aufirst%3DC.%2BC.%26aulast%3DYang%26aufirst%3DS.%2BH.%26aulast%3DLi%26aufirst%3DA.%2BF.%26aulast%3DChen%26aufirst%3DW.%2BS.%26aulast%3DChang%26aufirst%3DS.%2BC.%26atitle%3DExpression%2520of%2520ABCG2%2520Associated%2520with%2520Tumor%2520Response%2520in%2520Metastatic%2520Colorectal%2520Cancer%2520Patients%2520Receiving%2520First-Line%2520FOLFOX%2520Therapy%2520-%2520Preliminary%2520Evidence%26jtitle%3DInt.%2520J.%2520Biol.%2520Markers%26date%3D2013%26volume%3D28%26spage%3D182%26epage%3D186%26doi%3D10.5301%2Fjbm.5000004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Szakács, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottesman, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boumendjel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kachadourian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baubichon-Cortay, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Pietro, A.</span><span> </span><span class="NLM_article-title">Targeting the Achilles Heel of Multidrug-resistant Cancer by Exploiting the Fitness Cost of Resistance</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">5753</span><span class="NLM_x">–</span> <span class="NLM_lpage">5774</span><span class="refDoi"> DOI: 10.1021/cr4006236</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr4006236" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmslSqs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=5753-5774&author=G.+Szak%C3%A1csauthor=M.+D.+Hallauthor=M.+M.+Gottesmanauthor=A.+Boumendjelauthor=R.+Kachadourianauthor=B.+J.+Dayauthor=H.+Baubichon-Cortayauthor=A.+Di+Pietro&title=Targeting+the+Achilles+Heel+of+Multidrug-resistant+Cancer+by+Exploiting+the+Fitness+Cost+of+Resistance&doi=10.1021%2Fcr4006236"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the Achilles Heel of Multidrug-Resistant Cancer by Exploiting the Fitness Cost of Resistance</span></div><div class="casAuthors">Szakacs, Gergely; Hall, Matthew D.; Gottesman, Michael M.; Boumendjel, Ahcene; Kachadourian, Remy; Day, Brian J.; Baubichon-Cortay, Helene; Di Pietro, Attilio</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5753-5774</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The development of multidrug resistance (MDR) in patients suffering cancer remains a significant clin. challenge, with drug efflux by ABC (ATP-binding cassette) transporters contributing significantly.  Strategies to circumvent the reduced drug accumulation conferred by these polyspecific efflux transporters have relied on attempts to develop drugs that bypass extrusion or the exploration of clin. inhibitors that, although showing promise in vitro, have not translated to the clinic.  Alterations that confer selective advantage during the evolution of cancer cells might also create vulnerabilities that can be exploited therapeutically.  As defined by Szybalski and Bryson, collateral sensitivity is a "phenomenon in drug-resistant cells (prokaryotic or eukaryotic) identified during most in vitro studies... [whereby] the development of resistance in cells to one agent can confer higher sensitivity to an alternate agent than seen in the original (parental) line" .  In other words, the resistant cell line is more sensitive to a cytotoxin than the parental line from which it is derived.  From this perspective, resistance can be interpreted as a trait that could be targeted by new drugs.  In this review, we discuss general mechanisms underlying collateral sensitivity and focus on small mols. reported to elicit increased toxicity in cells overexpressing one of the 3 major multidrug transporters.  Such mols. (termed MDR-selective compds.) target multidrug-resistant cycling cells, suggesting that MDR Abc transporters could be considered as the ultimate "Achilles' heel" - the exquisite spot to fatally wound a multidrug-resistant cancer cell.  Herein, we discuss the potential of this emerging technol., cataloging MDR-selective compds. reported in the literature and highlighting chem. features that are assocd. with MDR-selective toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMLnJNMfm0QLVg90H21EOLACvtfcHk0liK7eZiT63wjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmslSqs7Y%253D&md5=7d834ffe642887c535fc295efc772d73</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fcr4006236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr4006236%26sid%3Dliteratum%253Aachs%26aulast%3DSzak%25C3%25A1cs%26aufirst%3DG.%26aulast%3DHall%26aufirst%3DM.%2BD.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26aulast%3DBoumendjel%26aufirst%3DA.%26aulast%3DKachadourian%26aufirst%3DR.%26aulast%3DDay%26aufirst%3DB.%2BJ.%26aulast%3DBaubichon-Cortay%26aufirst%3DH.%26aulast%3DDi%2BPietro%26aufirst%3DA.%26atitle%3DTargeting%2520the%2520Achilles%2520Heel%2520of%2520Multidrug-resistant%2520Cancer%2520by%2520Exploiting%2520the%2520Fitness%2520Cost%2520of%2520Resistance%26jtitle%3DChem.%2520Rev.%26date%3D2014%26volume%3D114%26spage%3D5753%26epage%3D5774%26doi%3D10.1021%2Fcr4006236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Rabindran, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annable, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenberger, L. M.</span><span> </span><span class="NLM_article-title">Reversal of a Novel Multidrug Resistance Mechanism in Human Colon Carcinoma Cells by Fumitremorgin C</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">5850</span><span class="NLM_x">–</span> <span class="NLM_lpage">5858</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=9865745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADyaK1MXivFah" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1998&pages=5850-5858&author=S.+K.+Rabindranauthor=H.+Heauthor=M.+Singhauthor=E.+Brownauthor=K.+I.+Collinsauthor=I.+Annableauthor=L.+M.+Greenberger&title=Reversal+of+a+Novel+Multidrug+Resistance+Mechanism+in+Human+Colon+Carcinoma+Cells+by+Fumitremorgin+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C</span></div><div class="casAuthors">Rabindran, Sridhar K.; He, Haiyin; Singh, Maya; Brown, Eileen; Collins, Karen I.; Annable, Tami; Greenberger, Lee M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">5850-5858</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">AACR Subscription Office</span>)
        </div><div class="casAbstract">We selected a human colon carcinoma cell line in increasing concns. of mitoxantrone to obtain a resistant subline, S1-M1-3.2, with the following characteristics: profound resistance to mitoxantrone; significant cross-resistance to doxorubicin, bisantrene, and topotecan; and very low levels of resistance to Taxol, vinblastine, colchicine, and camptothecin.  This multidrug resistance (MDR) phenotype, which was not reversed by verapamil or another potent P-glycoprotein (Pgp) inhibitor, CL 329,753, was dependent, in part, upon an energy-dependent drug efflux mechanism.  Pgp and the multidrug resistance protein (MRP) were not elevated in the resistant cells relative to the drug-sensitive parent, suggesting that resistance was mediated by a novel pathway of drug transport.  A cell-based screen with S1-M1-3.2 cells was used to identify agents capable of circumventing this non-Pgp, non-MRP MDR.  One of the active agents identified was a mycotoxin, fumitremorgin C.  This mol. was extremely effective in reversing resistance to mitoxantrone, doxorubicin, and topotecan in multidrug-selected cell lines showing this novel phenotype.  Reversal of resistance was assocd. with an increase in drug accumulation.  The compd. did not reverse drug resistance in cells with elevated expression of Pgp or MRP.  We suggest that fumitremorgin C is a highly selective chemosensitizing agent for the resistance pathway we have identified and can be used as a specific pharmacol. probe to distinguish between the diverse resistance mechanisms that occur in the MDR cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG-Y6qf2FmRbVg90H21EOLACvtfcHk0lhgffvodF_g0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXivFah&md5=cacafc261f829003219cdd9f518ac900</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRabindran%26aufirst%3DS.%2BK.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DSingh%26aufirst%3DM.%26aulast%3DBrown%26aufirst%3DE.%26aulast%3DCollins%26aufirst%3DK.%2BI.%26aulast%3DAnnable%26aufirst%3DI.%26aulast%3DGreenberger%26aufirst%3DL.%2BM.%26atitle%3DReversal%2520of%2520a%2520Novel%2520Multidrug%2520Resistance%2520Mechanism%2520in%2520Human%2520Colon%2520Carcinoma%2520Cells%2520by%2520Fumitremorgin%2520C%26jtitle%3DCancer%2520Res.%26date%3D1998%26volume%3D58%26spage%3D5850%26epage%3D5858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Allen, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Loevezijn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakhai, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Valk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Tellingen, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schellens, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koomen, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinkel, A. H.</span><span> </span><span class="NLM_article-title">Potent and Specific Inhibition of the Breast Cancer Resistance Protein Multidrug Transporter in Vitro and in Mouse Intestine by a Novel Analogue of Fumitremorgin C</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">425</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.4161%2Fcbt.1.4.22" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=12477054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BD38Xjt1yqs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=417-425&author=J.+D.+Allenauthor=A.+van+Loevezijnauthor=J.+M.+Lakhaiauthor=M.+van+der+Valkauthor=O.+van+Tellingenauthor=G.+Reidauthor=J.+H.+Schellensauthor=G.+J.+Koomenauthor=A.+H.+Schinkel&title=Potent+and+Specific+Inhibition+of+the+Breast+Cancer+Resistance+Protein+Multidrug+Transporter+in+Vitro+and+in+Mouse+Intestine+by+a+Novel+Analogue+of+Fumitremorgin+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C</span></div><div class="casAuthors">Allen, John D.; Van Loevezijn, Arnold; Lakhai, Jeany M.; Van der Valk, Martin; Van Tellingen, Olaf; Reid, Glen; Schellens, Jan H. M.; Koomen, Gerrit-Jan; Schinkel, Alfred H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">417-425</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Inhibitors of the breast cancer resistance protein (BCRP/ABCG2) multidrug transporter are of interest as chemosensitizers for clin. drug resistance, for improving the pharmacokinetics of substrate chemotherapeutic drugs, and in functional assays of BCRP activity for tailoring chemotherapy.  The fungal toxin fumitremorgin C (FTC) is a potent and specific inhibitor of BCRP, but its neurotoxic effects preclude use in vivo.  We have therefore evaluated a new tetracyclic analog of FTC, Ko143, as a practical inhibitor of BCRP, comparing it with two other analogs in the same class and with GF120918.  All three FTC analogs are effective inhibitors of both mouse Bcrp1 and human BCRP, proving highly active for increasing the intracellular drug accumulation and reversing Bcrp1/BCRP-mediated multidrug resistance.  Indeed, Ko143 appears to be the most potent BCRP inhibitor known thus far.  In contrast, the compds. have only low activity against P-glycoprotein, the multidrug resistance-assocd. protein (MRP1), or other known drug transporters.  They are nontoxic in vitro at useful concns. and evinced no signs of toxicity in mice at high oral or i.p. doses.  Administered p.o. to inhibit intestinal Bcrp1, Ko143 markedly increased the oral availability of topotecan in mice.  It is thus the first highly potent and specific BCRP inhibitor applicable in vivo.  As such, Ko143 and other FTC analogs of this type represent valuable reagents for anal. of drug resistance mechanisms and may be candidates for development as clin. BCRP inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpdmIQAa5j5rVg90H21EOLACvtfcHk0lhgffvodF_g0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xjt1yqs7g%253D&md5=8a54c6c38d9639ec70faa97a279d0a12</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.4161%2Fcbt.1.4.22&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.1.4.22%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DJ.%2BD.%26aulast%3Dvan%2BLoevezijn%26aufirst%3DA.%26aulast%3DLakhai%26aufirst%3DJ.%2BM.%26aulast%3Dvan%2Bder%2BValk%26aufirst%3DM.%26aulast%3Dvan%2BTellingen%26aufirst%3DO.%26aulast%3DReid%26aufirst%3DG.%26aulast%3DSchellens%26aufirst%3DJ.%2BH.%26aulast%3DKoomen%26aufirst%3DG.%2BJ.%26aulast%3DSchinkel%26aufirst%3DA.%2BH.%26atitle%3DPotent%2520and%2520Specific%2520Inhibition%2520of%2520the%2520Breast%2520Cancer%2520Resistance%2520Protein%2520Multidrug%2520Transporter%2520in%2520Vitro%2520and%2520in%2520Mouse%2520Intestine%2520by%2520a%2520Novel%2520Analogue%2520of%2520Fumitremorgin%2520C%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2002%26volume%3D1%26spage%3D417%26epage%3D425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Weidner, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoghbi, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shukla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambudkar, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, V. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulder, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottesman, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Innis, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, M. D.</span><span> </span><span class="NLM_article-title">The Inhibitor Ko143 Is Not Specific for ABCG2</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">354</span><span class="NLM_x">, </span> <span class="NLM_fpage">384</span><span class="NLM_x">–</span> <span class="NLM_lpage">393</span><span class="refDoi"> DOI: 10.1124/jpet.115.225482</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1124%2Fjpet.115.225482" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=26148857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlGrtb7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=354&publication_year=2015&pages=384-393&author=L.+D.+Weidnerauthor=S.+S.+Zoghbiauthor=S.+Luauthor=S.+Shuklaauthor=S.+V.+Ambudkarauthor=V.+W.+Pikeauthor=J.+Mulderauthor=M.+M.+Gottesmanauthor=R.+B.+Innisauthor=M.+D.+Hall&title=The+Inhibitor+Ko143+Is+Not+Specific+for+ABCG2&doi=10.1124%2Fjpet.115.225482"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The inhibitor Ko143 is not specific for ABCG2</span></div><div class="casAuthors">Weidner, Lora D.; Zoghbi, Sami S.; Lu, Shuiyu; Shukla, Suneet; Ambudkar, Suresh V.; Pike, Victor W.; Mulder, Jan; Gottesman, Michael M.; Innis, Robert B.; Hall, Matthew D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">354</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">384-393</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Imaging ATP-binding cassette (ABC) transporter activity in vivo with positron emission tomog. requires both a substrate and a transporter inhibitor.  However, for ABCG2, there is no inhibitor proven to be specific to that transporter alone at the blood-brain barrier.  Ko143 [(3S,6S,12aS)-1,2,3,4,6,7,12,12a-octahydro-9-methoxy-6-(2-methylpropyl)-1,4-dioxopyrazino[1',2':1,6]pyrido[3,4-b]indole-3-propanoic acid 1,1-dimethylethyl ester], a nontoxic analog of fungal toxin fumitremorgin C, is a potent inhibitor of ABCG2, although its specificity in mouse and human systems is unclear.  This study examd. the selectivity of Ko143 using human embryonic kidney cell lines transfected with ABCG2, ABCB1, or ABCC1 in several in vitro assays.  The stability of Ko143 in rat plasma was measured using high performance liq. chromatog.  Our results show that, in addn. to being a potent inhibitor of ABCG2, at higher concns. (≥1 μM) Ko143 also has an effect on the transport activity of both ABCB1 and ABCC1.  Furthermore, Ko143 was found to be unstable in rat plasma.  These findings indicate that Ko143 lacks specificity for ABCG2 and this should be taken into consideration when using Ko143 for both in vitro and in vivo expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqWjvTByDwbLVg90H21EOLACvtfcHk0lhgffvodF_g0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlGrtb7L&md5=4336228ff99f608f6452dca312e78a5a</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1124%2Fjpet.115.225482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.115.225482%26sid%3Dliteratum%253Aachs%26aulast%3DWeidner%26aufirst%3DL.%2BD.%26aulast%3DZoghbi%26aufirst%3DS.%2BS.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DShukla%26aufirst%3DS.%26aulast%3DAmbudkar%26aufirst%3DS.%2BV.%26aulast%3DPike%26aufirst%3DV.%2BW.%26aulast%3DMulder%26aufirst%3DJ.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26aulast%3DInnis%26aufirst%3DR.%2BB.%26aulast%3DHall%26aufirst%3DM.%2BD.%26atitle%3DThe%2520Inhibitor%2520Ko143%2520Is%2520Not%2520Specific%2520for%2520ABCG2%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2015%26volume%3D354%26spage%3D384%26epage%3D393%26doi%3D10.1124%2Fjpet.115.225482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Gozzi, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouaziz, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daflon-Yunes, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honorat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guragossian, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marminon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valdameri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bollacke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinaud, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchivie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cadena, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jose, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Borgne, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Pietro, A.</span><span> </span><span class="NLM_article-title">Phenolic Indeno[1,2-b]indoles as ABCG2-selective Potent and Non-toxic Inhibitors Stimulating Basal ATPase Activity</span> <span class="citation_source-journal">Drug Des., Dev. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">3481</span><span class="NLM_x">–</span> <span class="NLM_lpage">3495</span><span class="refDoi"> DOI: 10.2147/DDDT.S84982</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.2147%2FDDDT.S84982" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=26170632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A280%3ADC%252BC28%252FivFaisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2015&pages=3481-3495&author=G.+J.+Gozziauthor=Z.+Bouazizauthor=E.+Winterauthor=N.+Daflon-Yunesauthor=M.+Honoratauthor=N.+Guragossianauthor=C.+Marminonauthor=G.+Valdameriauthor=A.+Bollackeauthor=J.+Guillonauthor=N.+Pinaudauthor=M.+Marchivieauthor=S.+M.+Cadenaauthor=J.+Joseauthor=M.+Le+Borgneauthor=A.+Di+Pietro&title=Phenolic+Indeno%5B1%2C2-b%5Dindoles+as+ABCG2-selective+Potent+and+Non-toxic+Inhibitors+Stimulating+Basal+ATPase+Activity&doi=10.2147%2FDDDT.S84982"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Phenolic indeno[1,2-b]indoles as ABCG2-selective potent and non-toxic inhibitors stimulating basal ATPase activity</span></div><div class="casAuthors">Gozzi Gustavo Jabor; Valdameri Glaucio; Bouaziz Zouhair; Guragossian Nathalie; Marminon Christelle; Le Borgne Marc; Winter Evelyn; Daflon-Yunes Nathalia; Honorat Mylene; Di Pietro Attilio; Bollacke Andre; Jose Joachim; Guillon Jean; Pinaud Noel; Marchivie Mathieu; Cadena Silvia M</div><div class="citationInfo"><span class="NLM_cas:title">Drug design, development and therapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3481-95</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Ketonic indeno[1,2-b]indole-9,10-dione derivatives, initially designed as human casein kinase II (CK2) inhibitors, were recently shown to be converted into efficient inhibitors of drug efflux by the breast cancer resistance protein ABCG2 upon suited substitutions including a N (5)-phenethyl on C-ring and hydrophobic groups on D-ring.  A series of ten phenolic and seven p-quinonic derivatives were synthesized and screened for inhibition of both CK2 and ABCG2 activities.  The best phenolic inhibitors were about threefold more potent against ABCG2 than the corresponding ketonic derivatives, and showed low cytotoxicity.  They were selective for ABCG2 over both P-glycoprotein and MRP1 (multidrug resistance protein 1), whereas the ketonic derivatives also interacted with MRP1, and they additionally displayed a lower interaction with CK2.  Quite interestingly, they strongly stimulated ABCG2 ATPase activity, in contrast to ketonic derivatives, suggesting distinct binding sites.  In contrast, the p-quinonic indenoindoles were cytotoxic and poor ABCG2 inhibitors, whereas a partial inhibition recovery could be reached upon hydrophobic substitutions on D-ring, similarly to the ketonic derivatives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSs5R1_TNnRTV1C8OJBvdfbfW6udTcc2eYkoHBo3j-NOrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252FivFaisg%253D%253D&md5=2e5893234583c7d11b128c73fce246dd</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.2147%2FDDDT.S84982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FDDDT.S84982%26sid%3Dliteratum%253Aachs%26aulast%3DGozzi%26aufirst%3DG.%2BJ.%26aulast%3DBouaziz%26aufirst%3DZ.%26aulast%3DWinter%26aufirst%3DE.%26aulast%3DDaflon-Yunes%26aufirst%3DN.%26aulast%3DHonorat%26aufirst%3DM.%26aulast%3DGuragossian%26aufirst%3DN.%26aulast%3DMarminon%26aufirst%3DC.%26aulast%3DValdameri%26aufirst%3DG.%26aulast%3DBollacke%26aufirst%3DA.%26aulast%3DGuillon%26aufirst%3DJ.%26aulast%3DPinaud%26aufirst%3DN.%26aulast%3DMarchivie%26aufirst%3DM.%26aulast%3DCadena%26aufirst%3DS.%2BM.%26aulast%3DJose%26aufirst%3DJ.%26aulast%3DLe%2BBorgne%26aufirst%3DM.%26aulast%3DDi%2BPietro%26aufirst%3DA.%26atitle%3DPhenolic%2520Indeno%255B1%252C2-b%255Dindoles%2520as%2520ABCG2-selective%2520Potent%2520and%2520Non-toxic%2520Inhibitors%2520Stimulating%2520Basal%2520ATPase%2520Activity%26jtitle%3DDrug%2520Des.%252C%2520Dev.%2520Ther.%26date%3D2015%26volume%3D9%26spage%3D3481%26epage%3D3495%26doi%3D10.2147%2FDDDT.S84982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">do Rocio Andrade Pires, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lecerf-Schmidt, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guragossian, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pazinato, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gozzi, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valdameri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boumendjel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Pietro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérès, B.</span><span> </span><span class="NLM_article-title">New, Highly Potent and Non-toxic, Chromone Inhibitors of the Human Breast Cancer Resistance Protein ABCG2</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">301</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2016.05.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2Fj.ejmech.2016.05.053" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2016&pages=291-301&author=A.+do+Rocio+Andrade+Piresauthor=F.+Lecerf-Schmidtauthor=N.+Guragossianauthor=J.+Pazinatoauthor=G.+J.+Gozziauthor=E.+Winterauthor=G.+Valdameriauthor=A.+Vealeauthor=A.+Boumendjelauthor=A.+Di+Pietroauthor=B.+P%C3%A9r%C3%A8s&title=New%2C+Highly+Potent+and+Non-toxic%2C+Chromone+Inhibitors+of+the+Human+Breast+Cancer+Resistance+Protein+ABCG2&doi=10.1016%2Fj.ejmech.2016.05.053"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.05.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.05.053%26sid%3Dliteratum%253Aachs%26aulast%3Ddo%2BRocio%2BAndrade%2BPires%26aufirst%3DA.%26aulast%3DLecerf-Schmidt%26aufirst%3DF.%26aulast%3DGuragossian%26aufirst%3DN.%26aulast%3DPazinato%26aufirst%3DJ.%26aulast%3DGozzi%26aufirst%3DG.%2BJ.%26aulast%3DWinter%26aufirst%3DE.%26aulast%3DValdameri%26aufirst%3DG.%26aulast%3DVeale%26aufirst%3DA.%26aulast%3DBoumendjel%26aufirst%3DA.%26aulast%3DDi%2BPietro%26aufirst%3DA.%26aulast%3DP%25C3%25A9r%25C3%25A8s%26aufirst%3DB.%26atitle%3DNew%252C%2520Highly%2520Potent%2520and%2520Non-toxic%252C%2520Chromone%2520Inhibitors%2520of%2520the%2520Human%2520Breast%2520Cancer%2520Resistance%2520Protein%2520ABCG2%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D122%26spage%3D291%26epage%3D301%26doi%3D10.1016%2Fj.ejmech.2016.05.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Pick, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span> </span><span class="NLM_article-title">Tyrosine Kinase Inhibitors Influence ABCG2 Expression in EGFR-positive MDCK BCRP Cells Via the PI3K/Akt Signaling Pathway</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">650</span><span class="NLM_x">–</span> <span class="NLM_lpage">662</span><span class="refDoi"> DOI: 10.1002/cmdc.201100543</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1002%2Fcmdc.201100543" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=22354538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC38XisFyis78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=650-662&author=A.+Pickauthor=M.+Wiese&title=Tyrosine+Kinase+Inhibitors+Influence+ABCG2+Expression+in+EGFR-positive+MDCK+BCRP+Cells+Via+the+PI3K%2FAkt+Signaling+Pathway&doi=10.1002%2Fcmdc.201100543"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosine Kinase Inhibitors Influence ABCG2 Expression in EGFR-Positive MDCK BCRP Cells via the PI3K/Akt Signaling Pathway</span></div><div class="casAuthors">Pick, Anne; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">650-662</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Multidrug resistance obsd. in cancer chemotherapy is commonly attributed to overexpression of efflux transporter proteins.  These proteins act as ATP-dependent drug efflux pumps, actively extruding chemotherapeutic agents from cells and causing a decrease in intracellular drug accumulation.  Besides the well-recognized role of P-glycoprotein (P-gp, ABCB1), the breast cancer resistance protein (BCRP, ABCG2) is becoming increasingly accepted as playing an important role in multidrug resistance.  In contrast to P-glycoprotein, only a few inhibitors of ABCG2 are known.  According to the literature, tyrosine kinase inhibitors (TKIs) can be considered to be broad-spectrum inhibitors, interacting with ABCB1, ABCC1 and ABCG2.  Here, the authors investigated seven different TKIs, gefitinib, erlotinib, AG1478, PD158780, PD153035, nilotinib and imatinib, for their potential to restore ABCG2 sensitivity to cells.  Furthermore, the authors analyzed the alteration of ABCG2 expression caused by TKIs and demonstrated that EGFR inhibitors such as gefitinib and PD158780 reduced both total and surface expression of ABCG2 in EGRF-pos. MDCK BCRP cells by interaction with the PI3K/Akt signaling pathway.  The reduced ABCG2 content led to an increased effect of XR9577, a well-known ABCG2 modulator, lowering the concn. required for half maximal inhibition.  BCR-ABL inhibitors had no influence on ABCG2 expression and modulator activity.  Interestingly, a combination of an EGFR inhibitor with the PI3K/Akt inhibitor LY294002 led to a significant redn. of ABCG2 expression at low concns. of the drugs.  Based on the authors' results, the authors assume that EGFR exerts a post-transcriptional enhancing effect on ABCG2 expression via the PI3K/Akt signaling pathway, which can be attenuated by EGFR inhibitors.  Blocking the key signaling pathway regulating ABCG2 expression with EGFR inhibitors, combined with the inhibition of ABCG2 with potent modulators might be a promising approach to circumvent MDR in cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouvP7V8QMUi7Vg90H21EOLACvtfcHk0lhIsRT533BIwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisFyis78%253D&md5=c78fc69da2c5a134dd3f669c165364c2</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100543%26sid%3Dliteratum%253Aachs%26aulast%3DPick%26aufirst%3DA.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DTyrosine%2520Kinase%2520Inhibitors%2520Influence%2520ABCG2%2520Expression%2520in%2520EGFR-positive%2520MDCK%2520BCRP%2520Cells%2520Via%2520the%2520PI3K%252FAkt%2520Signaling%2520Pathway%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D650%26epage%3D662%26doi%3D10.1002%2Fcmdc.201100543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Juvale, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span> </span><span class="NLM_article-title">4-Substituted-2-phenylquinazolines as Inhibitors of BCRP</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">6766</span><span class="NLM_x">–</span> <span class="NLM_lpage">6769</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.08.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2Fj.bmcl.2012.08.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=23017888" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVSjsrbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=6766-6769&author=K.+Juvaleauthor=M.+Wiese&title=4-Substituted-2-phenylquinazolines+as+Inhibitors+of+BCRP&doi=10.1016%2Fj.bmcl.2012.08.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">4-Substituted-2-phenylquinazolines as inhibitors of BCRP</span></div><div class="casAuthors">Juvale, Kapil; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6766-6769</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We investigated several 2-phenylquinazolines with different substitutions at position 4 for their BCRP inhibition.  Compds. with Ph ring attached via an amine-contg. linker at position 4 were found to be potent inhibitors of BCRP.  In general compds. with meta substitution of Ph ring at position 4 were found to have higher inhibitory effect, compd. 12 being the most potent and selective towards BCRP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf-v9OH4Nxr7Vg90H21EOLACvtfcHk0ljtJJTBFfS05w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVSjsrbJ&md5=e96d4566ff6ae54c8e454bda7b50c873</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.08.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.08.024%26sid%3Dliteratum%253Aachs%26aulast%3DJuvale%26aufirst%3DK.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3D4-Substituted-2-phenylquinazolines%2520as%2520Inhibitors%2520of%2520BCRP%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D6766%26epage%3D6769%26doi%3D10.1016%2Fj.bmcl.2012.08.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Juvale, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallus, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span> </span><span class="NLM_article-title">Investigation of Quinazolines as Inhibitors of Breast Cancer Resistance Protein (ABCG2)</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">7858</span><span class="NLM_x">–</span> <span class="NLM_lpage">7873</span><span class="refDoi"> DOI: 10.1016/j.bmc.2013.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2Fj.bmc.2013.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=24184213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWmsb3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=7858-7873&author=K.+Juvaleauthor=J.+Gallusauthor=M.+Wiese&title=Investigation+of+Quinazolines+as+Inhibitors+of+Breast+Cancer+Resistance+Protein+%28ABCG2%29&doi=10.1016%2Fj.bmc.2013.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Investigation of quinazolines as inhibitors of breast cancer resistance protein (ABCG2)</span></div><div class="casAuthors">Juvale, Kapil; Gallus, Jennifer; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7858-7873</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Chemotherapy is one of the major forms of cancer treatment.  Unfortunately, tumors are prone to multidrug resistance leading to failure of treatment.  Breast cancer resistance protein (BCRP), the second member of ABC transporter subfamily G, has been found to play a major role in drug efflux and hence multidrug resistance.  Until now, very few potent and selective BCRP inhibitors like Ko143 have been identified.  In the search for more potent and selective BCRP inhibitors, we synthesized and investigated a series of differently substituted quinazoline compds.  Several variations at positions 2, 4, 6 and 7 of the quinazoline scaffold were carried out to develop a structure-activity-relationship anal. for these compds.  It was found that compds. bearing a Ph substituent at position 2 of the 4-anilinoquinazoline scaffold were most potent.  On the aniline ring at position 4 of the quinazoline moiety substituents like NO2, CN, CF3 led to very high BCRP inhibition potencies.  The most potent compds. were further investigated for their intrinsic cytotoxicity and their ability to reverse the multidrug resistance.  Compd. 20, an anilinoquinazoline bearing a Ph ring at position 2 and meta-nitro substitution on the 4-anilino ring, was found to have the highest therapeutic ratio.  The most active compds. from each variation were also investigated for their effect on BCRP expression.  It was found that compd. 20 has no significant effect on BCRP expression, while compd. 31 decreased the surface BCRP expression.  The only difference in the two compds. was the presence of a 3,4-dimethoxyphenyl ring in compd. 31 instead of Ph substitution at position 2 of the quinazoline moiety.  From the study of all target compds., compd. 20 was the most prominent compd. having inhibitory potency even higher than Ko143, the most potent BCRP inhibitor known.  Compd. 20 was also found to be selective towards BCRP with a very high therapeutic ratio.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwQG7UwDr2PrVg90H21EOLACvtfcHk0ljtJJTBFfS05w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWmsb3P&md5=45a1d684ff3849c478498ede66d0cda8</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DJuvale%26aufirst%3DK.%26aulast%3DGallus%26aufirst%3DJ.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DInvestigation%2520of%2520Quinazolines%2520as%2520Inhibitors%2520of%2520Breast%2520Cancer%2520Resistance%2520Protein%2520%2528ABCG2%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D7858%26epage%3D7873%26doi%3D10.1016%2Fj.bmc.2013.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Krapf, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of 4-Anilino-quinazolines and -quinolines as Inhibitors of Breast Cancer Resistance Protein (ABCG2)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">5449</span><span class="NLM_x">–</span> <span class="NLM_lpage">5461</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00330</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00330" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC28XntlCnurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=5449-5461&author=M.+K.+Krapfauthor=M.+Wiese&title=Synthesis+and+Biological+Evaluation+of+4-Anilino-quinazolines+and+-quinolines+as+Inhibitors+of+Breast+Cancer+Resistance+Protein+%28ABCG2%29&doi=10.1021%2Facs.jmedchem.6b00330"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of 4-Anilino-quinazolines and -quinolines as Inhibitors of Breast Cancer Resistance Protein (ABCG2)</span></div><div class="casAuthors">Krapf, Michael K.; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5449-5461</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Chemotherapeutic treatment of cancer often fails due to overexpression of the ATP-binding cassette (ABC) transport proteins, like ABCG2, triggering active efflux of various structurally unrelated drugs.  This so-called multidrug resistance (MDR) may be reversed by selective, potent, and nontoxic inhibitors of ABCG2.  As only a few potent inhibitors are known, new compds. based on a 4-substituted-2-phenylquinazoline scaffold were investigated.  Substitution with hydroxy, cyano, nitro, acetamido, and fluoro, e.g., I, led to high inhibitory activities toward ABCG2.  The ability to reverse MDR of the most active compds. was confirmed in a MTT efficacy assay.  Moreover, a negligibly low intrinsic cytotoxicity was found resulting in a high therapeutic ratio.  Investigations of the inhibitory activity toward ABCB1 and ABCC1 yielded a high selectivity toward ABCG2 for the quinazoline compds.  Quinoline-based analogs showed lower inhibitory activity and selectivity.  The study yielded a variety of promising compds., some with superior properties compared to those of the std. inhibitor Ko143.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdz9Uvqz3i6rVg90H21EOLACvtfcHk0ljtJJTBFfS05w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntlCnurY%253D&md5=a127c60fe7ecf9d5fc76a13903e794db</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00330%26sid%3Dliteratum%253Aachs%26aulast%3DKrapf%26aufirst%3DM.%2BK.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%25204-Anilino-quinazolines%2520and%2520-quinolines%2520as%2520Inhibitors%2520of%2520Breast%2520Cancer%2520Resistance%2520Protein%2520%2528ABCG2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D5449%26epage%3D5461%26doi%3D10.1021%2Facs.jmedchem.6b00330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Tawar, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dwarakanath, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhury, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khaitan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tandon, V.</span><span> </span><span class="NLM_article-title">Influence of Phenyl Ring Disubstitution on Bisbenzimidazole and Terbenzimidazole Cytotoxicity: Synthesis and Biological Evaluation as Radioprotectors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3785</span><span class="NLM_x">–</span> <span class="NLM_lpage">3792</span><span class="refDoi"> DOI: 10.1021/jm030114w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030114w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=3785-3792&author=U.+Tawarauthor=A.+K.+Jainauthor=B.+S.+Dwarakanathauthor=R.+Chandraauthor=Y.+Singhauthor=N.+K.+Chaudhuryauthor=D.+Khaitanauthor=V.+Tandon&title=Influence+of+Phenyl+Ring+Disubstitution+on+Bisbenzimidazole+and+Terbenzimidazole+Cytotoxicity%3A+Synthesis+and+Biological+Evaluation+as+Radioprotectors&doi=10.1021%2Fjm030114w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm030114w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030114w%26sid%3Dliteratum%253Aachs%26aulast%3DTawar%26aufirst%3DU.%26aulast%3DJain%26aufirst%3DA.%2BK.%26aulast%3DDwarakanath%26aufirst%3DB.%2BS.%26aulast%3DChandra%26aufirst%3DR.%26aulast%3DSingh%26aufirst%3DY.%26aulast%3DChaudhury%26aufirst%3DN.%2BK.%26aulast%3DKhaitan%26aufirst%3DD.%26aulast%3DTandon%26aufirst%3DV.%26atitle%3DInfluence%2520of%2520Phenyl%2520Ring%2520Disubstitution%2520on%2520Bisbenzimidazole%2520and%2520Terbenzimidazole%2520Cytotoxicity%253A%2520Synthesis%2520and%2520Biological%2520Evaluation%2520as%2520Radioprotectors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D3785%26epage%3D3792%26doi%3D10.1021%2Fjm030114w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Litman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skovsgaard, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeuthen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, W. D.</span><span> </span><span class="NLM_article-title">ATPase Activity of P-glycoprotein Related to Emergence of Drug Resistance in Ehrlich Ascites Tumor Cell-lines</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Basis Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">1361</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">158</span><span class="refDoi"> DOI: 10.1016/S0925-4439(97)00025-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2FS0925-4439%2897%2900025-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=9300796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADyaK2sXks12gur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1361&publication_year=1997&pages=147-158&author=T.+Litmanauthor=D.+Nielsenauthor=T.+Skovsgaardauthor=T.+Zeuthenauthor=W.+D.+Stein&title=ATPase+Activity+of+P-glycoprotein+Related+to+Emergence+of+Drug+Resistance+in+Ehrlich+Ascites+Tumor+Cell-lines&doi=10.1016%2FS0925-4439%2897%2900025-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">ATPase activity of P-glycoprotein related to emergence of drug resistance in Ehrlich ascites tumor cell lines</span></div><div class="casAuthors">Litman, Thomas; Nielsen, Dorte; Skovsgaard, Torben; Zeuthen, Thomas; Stein, Wilfred D.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">1361</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">147-158</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The ATPase activities of a sensitive and five progressively daunorubicin-resistant Ehrlich ascites tumor cell lines passaged in mice were characterized.  For the nine different modulators of drug resistance that the authors have studied, the ATPase activity first rose with the modulator concn. and then declined.  The authors analyzed the ATPase activity profiles in terms of an activation const. and an inhibition const. for each of the nine drugs and six cell lines.  In this series of cell lines, the drug-stimulatable ATPase activity was directly proportional to the amt. of P-glycoprotein.  Pumping of daunorubicin was also correlated with the amt. of P-glycoprotein, except that, for a highly passaged line more daunorubicin was pumped than could be accounted for by the content of P-glycoprotein.  Between the 12th and the 36th passage an addnl. source of resistance emerged, which was not correlated with P-glycoprotein.  Pumping of daunorubicin was neg. correlated with the cell vol. for the different lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4nNQbXUAWILVg90H21EOLACvtfcHk0lgFok1Py6cPBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXks12gur4%253D&md5=1a125c51d7d41d1451958f014693bd30</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2FS0925-4439%2897%2900025-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0925-4439%252897%252900025-2%26sid%3Dliteratum%253Aachs%26aulast%3DLitman%26aufirst%3DT.%26aulast%3DNielsen%26aufirst%3DD.%26aulast%3DSkovsgaard%26aufirst%3DT.%26aulast%3DZeuthen%26aufirst%3DT.%26aulast%3DStein%26aufirst%3DW.%2BD.%26atitle%3DATPase%2520Activity%2520of%2520P-glycoprotein%2520Related%2520to%2520Emergence%2520of%2520Drug%2520Resistance%2520in%2520Ehrlich%2520Ascites%2520Tumor%2520Cell-lines%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D1997%26volume%3D1361%26spage%3D147%26epage%3D158%26doi%3D10.1016%2FS0925-4439%2897%2900025-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Buxbaum, E.</span><span> </span><span class="NLM_article-title">Co-operating ATP Sites in the Multiple Drug Resistance Transporter Mdr1</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">265</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span><span class="refDoi"> DOI: 10.1046/j.1432-1327.1999.00643.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1046%2Fj.1432-1327.1999.00643.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10491157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADyaK1MXmsFKlu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=265&publication_year=1999&pages=54-63&author=E.+Buxbaum&title=Co-operating+ATP+Sites+in+the+Multiple+Drug+Resistance+Transporter+Mdr1&doi=10.1046%2Fj.1432-1327.1999.00643.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Co-operating ATP sites in the multiple drug resistance transporter Mdr1</span></div><div class="casAuthors">Buxbaum, Engelbert</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">265</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">54-63</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">The ATPase activity of the multiple drug resistance transporter Mdr1 (P-glycoprotein, gp170) depended on the concn. of ATP with both pos. and neg. co-operativity both in the absence and in the presence of verapamil.  Four co-operating binding sites for ATP were required to adequately model the exptl. findings.  The activation energy for the ATPase activity increased from ≈ 385 kJ·mol-1 at 10 μM ATP to 512 kJ·mol-1 at 1600 μM, while changes in verapamil concn. had little effect.  This indicates that the reaction mechanism of ATP hydrolysis depends on ATP concn. and is further evidence for co-operation of ATP binding sites.  Free ATP in higher concn. was inhibitory; however, this inhibition could be reduced by complexing the ATP with Mg2+.  Free Mg2+ had little effect on Mdrl apart from complexing ATP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY_Ls-awEH0bVg90H21EOLACvtfcHk0lgFok1Py6cPBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmsFKlu70%253D&md5=bdf80cb1013bf698360a5dadd8492c9d</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1327.1999.00643.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1327.1999.00643.x%26sid%3Dliteratum%253Aachs%26aulast%3DBuxbaum%26aufirst%3DE.%26atitle%3DCo-operating%2520ATP%2520Sites%2520in%2520the%2520Multiple%2520Drug%2520Resistance%2520Transporter%2520Mdr1%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1999%26volume%3D265%26spage%3D54%26epage%3D63%26doi%3D10.1046%2Fj.1432-1327.1999.00643.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Egido, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li-Blatter, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seelig, A.</span><span> </span><span class="NLM_article-title">Predicting Activators and Inhibitors of the Breast Cancer Resistance Protein (ABCG2) and P-Glycoprotein (ABCB1) Based on Mechanistic Considerations</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">4026</span><span class="NLM_x">–</span> <span class="NLM_lpage">4037</span><span class="refDoi"> DOI: 10.1021/acs.molpharmaceut.5b00463</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.molpharmaceut.5b00463" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsV2gt73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=4026-4037&author=E.+Egidoauthor=R.+M%C3%BCllerauthor=X.+Li-Blatterauthor=G.+Merinoauthor=A.+Seelig&title=Predicting+Activators+and+Inhibitors+of+the+Breast+Cancer+Resistance+Protein+%28ABCG2%29+and+P-Glycoprotein+%28ABCB1%29+Based+on+Mechanistic+Considerations&doi=10.1021%2Facs.molpharmaceut.5b00463"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Predicting Activators and Inhibitors of the Breast Cancer Resistance Protein (ABCG2) and P-Glycoprotein (ABCB1) Based on Mechanistic Considerations</span></div><div class="casAuthors">Egido, Estefania; Muller, Rita; Li-Blatter, Xiaochun; Merino, Gracia; Seelig, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4026-4037</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Colocalized in membrane barriers, the ABC transporters ABCB1 and ABCG2 strongly contribute to multidrug resistance (MDR).  Here we investigate the as yet unknown mechanisms of activation and inhibition of ABCG2.  For this purpose we measured the ATPase activity of ABCG2 and ABCB1 as a function of allocrite concn. using a calibration set of 30 diverse compds. and a validation set of 23 compds.  We demonstrate that ABCG2 is activated at low and inhibited at high allocrite concns., yielding bell-shaped activity curves.  With an ATP regeneration assay we prove that the inhibitory part is indeed due to a decrease in activity because of high allocrite load in the transporter.  However, inhibition is only obsd. if the membrane soly. of allocrites is sufficiently high.  The concns. of half-max. activation and inhibition are at least 10-fold lower for ABCG2 than for ABCB1.  Because ABCG2 binds its allocrites with higher affinity than ABCB1, it can ext. hydrophilic, nonamphiphilic, and highly charged compds. out of the lipid membrane, typically exhibiting low lipid-water partition coeffs., but is inhibited by hydrophobic, amphiphilic, and moderately charged compds., with high lipid-water partition coeffs.  In contrast, ABCB1 is barely interacting with hydrophilic compds., but is activated by hydrophobic compds.  We show that hydrophobicity, amphiphilicity, and charge have a dual role; they predict, on the one hand, allocrites' lipid-water partition coeff. and, on the other hand, the transporters' preference for the chem. nature of allocrites.  Parameters reflecting hydrophobicity, amphiphilicity, and charge are therefore sufficient for differentiating between allocrites, activators, and inhibitors of ABCB1 and ABCG2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJh4vqCxSM8bVg90H21EOLACvtfcHk0lgFok1Py6cPBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsV2gt73P&md5=259f05bf2b3c5cfcbdcdcc6f4fb453ea</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facs.molpharmaceut.5b00463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.molpharmaceut.5b00463%26sid%3Dliteratum%253Aachs%26aulast%3DEgido%26aufirst%3DE.%26aulast%3DM%25C3%25BCller%26aufirst%3DR.%26aulast%3DLi-Blatter%26aufirst%3DX.%26aulast%3DMerino%26aufirst%3DG.%26aulast%3DSeelig%26aufirst%3DA.%26atitle%3DPredicting%2520Activators%2520and%2520Inhibitors%2520of%2520the%2520Breast%2520Cancer%2520Resistance%2520Protein%2520%2528ABCG2%2529%2520and%2520P-Glycoprotein%2520%2528ABCB1%2529%2520Based%2520on%2520Mechanistic%2520Considerations%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2015%26volume%3D12%26spage%3D4026%26epage%3D4037%26doi%3D10.1021%2Facs.molpharmaceut.5b00463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Kraege, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juvale, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willmes, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span> </span><span class="NLM_article-title">The Combination of Quinazoline and Chalcone Moieties Leads to Novel Potent Heterodimeric Modulators of Breast Cancer Resistance Protein (BCRP/ABCG2)</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">212</span><span class="NLM_x">–</span> <span class="NLM_lpage">229</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2016.03.067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2Fj.ejmech.2016.03.067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=27100033" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC28XmsFyms7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2016&pages=212-229&author=S.+Kraegeauthor=K.+Stefanauthor=K.+Juvaleauthor=T.+Rossauthor=T.+Willmesauthor=M.+Wiese&title=The+Combination+of+Quinazoline+and+Chalcone+Moieties+Leads+to+Novel+Potent+Heterodimeric+Modulators+of+Breast+Cancer+Resistance+Protein+%28BCRP%2FABCG2%29&doi=10.1016%2Fj.ejmech.2016.03.067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The combination of quinazoline and chalcone moieties leads to novel potent heterodimeric modulators of breast cancer resistance protein (BCRP/ABCG2)</span></div><div class="casAuthors">Kraege, Stefanie; Stefan, Katja; Juvale, Kapil; Ross, Thomas; Willmes, Thomas; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">212-229</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">During the last decade it has been found that chalcones and quinazolines are promising inhibitors of ABCG2.  The combination of these two scaffolds offers a new class of heterocyclic compds. with potentially high inhibitory activity against ABCG2.  For this purpose we investigated 22 different heterodimeric derivs.  In this series only methoxy groups were used as substituents as these had been proven superior for inhibitory activity of chalcones.  All compds. were tested for their inhibitory activity, specificity and cytotoxicity.  The most potent ABCG2 inhibitor in this series showed an IC50 value of 0.19 μM.  It possesses low cytotoxicity (GI50 = 93 μM), the ability to reverse MDR and is nearly selective toward ABCG2.  Most compds. contg. dimethoxy groups showed slight activity against ABCB1 too.  Among these three compds. (17, 19 and 24) showed even higher activity toward ABCB1 than ABCG2.  All inhibitors were further screened for their effect on basal ATPase activity.  Although the basal ATPase activity was partially stimulated, the compds. were not transported by ABCG2.  Thus, quinazoline-chalcones are a new class of effective ABCG2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAiBrpQVZkPrVg90H21EOLACvtfcHk0liyZ-gI9NND7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmsFyms7Y%253D&md5=91877b15d0301ec2bbcd468f63ea1a2b</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.03.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.03.067%26sid%3Dliteratum%253Aachs%26aulast%3DKraege%26aufirst%3DS.%26aulast%3DStefan%26aufirst%3DK.%26aulast%3DJuvale%26aufirst%3DK.%26aulast%3DRoss%26aufirst%3DT.%26aulast%3DWillmes%26aufirst%3DT.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DThe%2520Combination%2520of%2520Quinazoline%2520and%2520Chalcone%2520Moieties%2520Leads%2520to%2520Novel%2520Potent%2520Heterodimeric%2520Modulators%2520of%2520Breast%2520Cancer%2520Resistance%2520Protein%2520%2528BCRP%252FABCG2%2529%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D117%26spage%3D212%26epage%3D229%26doi%3D10.1016%2Fj.ejmech.2016.03.067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Pavek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagenaar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolscher, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novotna, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonker, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinkel, A. H.</span><span> </span><span class="NLM_article-title">Human Breast Cancer Resistance Protein: Interactions with Steroid Drugs, Hormones, the Dietary Carcinogen 2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine, and Transport of Cimetidine</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">312</span><span class="NLM_x">, </span> <span class="NLM_fpage">144</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span><span class="refDoi"> DOI: 10.1124/jpet.104.073916</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1124%2Fjpet.104.073916" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=15365089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVWmt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=312&publication_year=2005&pages=144-152&author=P.+Pavekauthor=G.+Merinoauthor=E.+Wagenaarauthor=E.+Bolscherauthor=M.+Novotnaauthor=J.+W.+Jonkerauthor=A.+H.+Schinkel&title=Human+Breast+Cancer+Resistance+Protein%3A+Interactions+with+Steroid+Drugs%2C+Hormones%2C+the+Dietary+Carcinogen+2-Amino-1-methyl-6-phenylimidazo%284%2C5-b%29pyridine%2C+and+Transport+of+Cimetidine&doi=10.1124%2Fjpet.104.073916"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Human breast cancer resistance protein: Interactions with steroid drugs, hormones, the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine, and transport of cimetidine</span></div><div class="casAuthors">Pavek, Petr; Merino, Gracia; Wagenaar, Els; Bolscher, Ellen; Novotna, Martina; Jonker, Johan W.; Schinkel, Alfred H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">312</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">144-152</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The breast cancer resistance protein (BCRP/ABCG2) is an ATP-binding cassette drug efflux transporter that extrudes xenotoxins from cells, mediating drug resistance and affecting the pharmacol. behavior of many compds.  To study the interaction of human wild-type BCRP with steroid drugs, hormones, and the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhIP), we expressed human BCRP in the murine MEF3.8 fibroblast cell line, which lacks Mdr1a/1b P-glycoprotein and Mrp1, and in the polarized epithelial MDCKII cell line.  We show that PhIP was efficiently transported by human BCRP in MDCKII-BCRP cells, as was found previously for murine Bcrp1.  Furthermore, we show that six out of nine glucocorticoid drugs, corticosterone, and digoxin increased the accumulation of mitoxantrone in the MEF3.8-BCRP cell line, indicating inhibition of BCRP.  In contrast, aldosterone and ursodeoxycholic acid had no significant effect on BCRP.  The four most efficiently reversing glucocorticoid drugs (beclomethasone, 6α-methylprednisolone, dexamethasone, and triamcinolone) and 17β-estradiol showed a significantly reduced BCRP-mediated transepithelial transport of PhIP by MDCKII-BCRP cells, with the highest redn. of PhIP transport ratio for beclomethasone (from 25.0±1.1 to 2.7±0.0).  None of the tested endogenous steroids or synthetic glucocorticoids or digoxin, however, were transported substrates of BCRP.  We also identified the H2-receptor antagonist drug cimetidine as a novel efficiently transported substrate for human BCRP and mouse Bcrp1.  The generated BCRP-expressing cell lines thus provide valuable tools to study pharmacol. and toxicol. interactions mediated by BCRP and to identify new BCRP substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxbdxUda3-ErVg90H21EOLACvtfcHk0liyZ-gI9NND7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVWmt7c%253D&md5=0f1615781de79b8fa8eaa1e7bc12d617</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.073916&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.073916%26sid%3Dliteratum%253Aachs%26aulast%3DPavek%26aufirst%3DP.%26aulast%3DMerino%26aufirst%3DG.%26aulast%3DWagenaar%26aufirst%3DE.%26aulast%3DBolscher%26aufirst%3DE.%26aulast%3DNovotna%26aufirst%3DM.%26aulast%3DJonker%26aufirst%3DJ.%2BW.%26aulast%3DSchinkel%26aufirst%3DA.%2BH.%26atitle%3DHuman%2520Breast%2520Cancer%2520Resistance%2520Protein%253A%2520Interactions%2520with%2520Steroid%2520Drugs%252C%2520Hormones%252C%2520the%2520Dietary%2520Carcinogen%25202-Amino-1-methyl-6-phenylimidazo%25284%252C5-b%2529pyridine%252C%2520and%2520Transport%2520of%2520Cimetidine%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D312%26spage%3D144%26epage%3D152%26doi%3D10.1124%2Fjpet.104.073916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Pick, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span> </span><span class="NLM_article-title">Structure-activity Relationships of New Inhibitors of Breast Cancer Resistance Protein (ABCG2)</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">8224</span><span class="NLM_x">–</span> <span class="NLM_lpage">8236</span><span class="refDoi"> DOI: 10.1016/j.bmc.2008.07.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2Fj.bmc.2008.07.034" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=8224-8236&author=A.+Pickauthor=H.+M%C3%BCllerauthor=M.+Wiese&title=Structure-activity+Relationships+of+New+Inhibitors+of+Breast+Cancer+Resistance+Protein+%28ABCG2%29&doi=10.1016%2Fj.bmc.2008.07.034"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.07.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.07.034%26sid%3Dliteratum%253Aachs%26aulast%3DPick%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DH.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DStructure-activity%2520Relationships%2520of%2520New%2520Inhibitors%2520of%2520Breast%2520Cancer%2520Resistance%2520Protein%2520%2528ABCG2%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D8224%26epage%3D8236%26doi%3D10.1016%2Fj.bmc.2008.07.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Pick, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klinkhammer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span> </span><span class="NLM_article-title">Specific Inhibitors of the Breast Cancer Resistance Protein (BCRP)</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1498</span><span class="NLM_x">–</span> <span class="NLM_lpage">1505</span><span class="refDoi"> DOI: 10.1002/cmdc.201000216</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1002%2Fcmdc.201000216" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=20632361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFWgsbnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1498-1505&author=A.+Pickauthor=W.+Klinkhammerauthor=M.+Wiese&title=Specific+Inhibitors+of+the+Breast+Cancer+Resistance+Protein+%28BCRP%29&doi=10.1002%2Fcmdc.201000216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Specific Inhibitors of the Breast Cancer Resistance Protein (BCRP)</span></div><div class="casAuthors">Pick, Anne; Klinkhammer, Werner; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1498-1505</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A new class of specific breast cancer resistance protein (BCRP) inhibitors was identified, showing no inhibition of the ATP binding cassette (ABC) transporters P-gp and MRP1.  Some of these modulators inhibit BCRP with high potency; they are only slightly less potent than Ko143 and could serve as promising lead structures for the design of novel effective BCRP inhibitors.  These inhibitors are structurally related to tariquidar (XR9576) and belong to a library of multidrug-resistance modulators synthesized by our research group.  The absence of the tetrahydroisoquinoline substructure appears to play a crucial role for specificity; we found that the presence of this substructure is not essential for interaction with BCRP.  To det. the type of interaction between pheophorbide A and compds. with and without the tetrahydroisoquinoline substructure, various substrate pheophorbide A concns. were used in enzyme kinetics assays.  The resulting data show that these compds. share a noncompetitive-type interaction with pheophorbide A.  Expts. with imatinib and pheophorbide A revealed a mixed-type interaction.  The combination of imatinib and compds. with and without the tetrahydroisoquinoline substructure resulted in a pos. cooperative effect, indicating that imatinib engages a binding site distinct from that of the new compds. on one side and distinct from that of pheophorbide A on the other side as well.  The results of this study suggest that the category of BCRP-specific inhibitors, which includes only fumitremorgin C, Ko143 and analogs, and novobiocin needs to be extended by this new class of inhibitors, which possess three key characteristics: specificity, potency, and low toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdbFkR4oCa3bVg90H21EOLACvtfcHk0liyZ-gI9NND7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFWgsbnK&md5=751e5cb7fb4a5db8645196ff3b3ae28a</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000216%26sid%3Dliteratum%253Aachs%26aulast%3DPick%26aufirst%3DA.%26aulast%3DKlinkhammer%26aufirst%3DW.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DSpecific%2520Inhibitors%2520of%2520the%2520Breast%2520Cancer%2520Resistance%2520Protein%2520%2528BCRP%2529%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D1498%26epage%3D1505%26doi%3D10.1002%2Fcmdc.201000216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Marighetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steggemann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span> </span><span class="NLM_article-title">Synthesis and Quantitative Structure-activity Relationships of Selective BCRP Inhibitors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">135</span><span class="refDoi"> DOI: 10.1002/cmdc.201200377</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1002%2Fcmdc.201200377" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=125-135&author=F.+Marighettiauthor=K.+Steggemannauthor=M.+Hanlauthor=M.+Wiese&title=Synthesis+and+Quantitative+Structure-activity+Relationships+of+Selective+BCRP+Inhibitors&doi=10.1002%2Fcmdc.201200377"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200377%26sid%3Dliteratum%253Aachs%26aulast%3DMarighetti%26aufirst%3DF.%26aulast%3DSteggemann%26aufirst%3DK.%26aulast%3DHanl%26aufirst%3DM.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520Quantitative%2520Structure-activity%2520Relationships%2520of%2520Selective%2520BCRP%2520Inhibitors%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D125%26epage%3D135%26doi%3D10.1002%2Fcmdc.201200377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Pick, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haenisch, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pajeva, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonisch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span> </span><span class="NLM_article-title">Structure-activity Relationships of Flavonoids as Inhibitors of Breast Cancer Resistance Protein (BCRP)</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2090</span><span class="NLM_x">–</span> <span class="NLM_lpage">2102</span><span class="refDoi"> DOI: 10.1016/j.bmc.2010.12.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2Fj.bmc.2010.12.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=21354800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtFCnu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=2090-2102&author=A.+Pickauthor=H.+M%C3%BCllerauthor=R.+Mayerauthor=B.+Haenischauthor=I.+K.+Pajevaauthor=M.+Weigtauthor=H.+Bonischauthor=C.+E.+Mullerauthor=M.+Wiese&title=Structure-activity+Relationships+of+Flavonoids+as+Inhibitors+of+Breast+Cancer+Resistance+Protein+%28BCRP%29&doi=10.1016%2Fj.bmc.2010.12.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP)</span></div><div class="casAuthors">Pick, Anne; Mueller, Henrik; Mayer, Ralf; Haenisch, Britta; Pajeva, Ilza K.; Weigt, Mathias; Boenisch, Heinz; Mueller, Christa E.; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2090-2102</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Flavonoids are an interesting group of natural products ubiquitously present in human diet.  Their consumption has been assocd. with various and differing beneficial health effects.  However, several flavonoids have been reported to inhibit the breast cancer resistance protein (BCRP) encoded by the ABCG2 gene.  Thus, the consumption of flavonoids with high inhibitory activity could change pharmacokinetics and drug levels of drugs that are BCRP substrates.  In cancer patients receiving chemotherapy an increased intake of such flavonoids could lead to adverse effects.  We investigated a structurally diverse set of flavonoids, including derivs. with a rare C-methylated structure that were isolated from plants used in traditional medicine.  The flavones retusin and ayanin were found to be highly potent inhibitors of BCRP, showing only slightly less potency than Ko143, the most potent ABCG2 inhibitor known so far.  The activity data were analyzed by 2D and 3D QSAR analyses and the results revealed the impact of the different substituents at the various positions of the flavonoid core on activity.  Addnl., a lateral 2D QSAR anal. of data collected from the literature was performed aiming to derive more general information about the influence of distinct structural features on the inhibitory potency of flavonoids.  The comparative QSAR analyses led to a consistent picture of the effects of the different substituents at various positions of the flavone backbone.  The following structural features were found to contribute pos. to BCRP inhibition: a hydroxyl group in position 5, double bond between position 2 and 3, and a methoxy group in position 3.  The exchange of a 3-methoxy group by an OH-group acting also as a hydrogen bond donor, resulted in decrease in activity underlining the potential role of the hydrogen bond acceptor 3-OCH3 for the interaction with BCRP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre-4pma6sNmrVg90H21EOLACvtfcHk0lhsldNqAnHRUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtFCnu7g%253D&md5=2a9156b065c5df1a3e517cca93f59db8</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.12.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.12.043%26sid%3Dliteratum%253Aachs%26aulast%3DPick%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DH.%26aulast%3DMayer%26aufirst%3DR.%26aulast%3DHaenisch%26aufirst%3DB.%26aulast%3DPajeva%26aufirst%3DI.%2BK.%26aulast%3DWeigt%26aufirst%3DM.%26aulast%3DBonisch%26aufirst%3DH.%26aulast%3DMuller%26aufirst%3DC.%2BE.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DStructure-activity%2520Relationships%2520of%2520Flavonoids%2520as%2520Inhibitors%2520of%2520Breast%2520Cancer%2520Resistance%2520Protein%2520%2528BCRP%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D2090%26epage%3D2102%26doi%3D10.1016%2Fj.bmc.2010.12.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Müller, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klinkhammer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Globisch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassack, M. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pajeva, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span> </span><span class="NLM_article-title">New Functional Assay of P-glycoprotein Activity Using Hoechst 33342</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">7470</span><span class="NLM_x">–</span> <span class="NLM_lpage">7479</span><span class="refDoi"> DOI: 10.1016/j.bmc.2007.07.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2Fj.bmc.2007.07.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=17890094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFKitb3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=7470-7479&author=H.+M%C3%BCllerauthor=W.+Klinkhammerauthor=C.+Globischauthor=M.+U.+Kassackauthor=I.+K.+Pajevaauthor=M.+Wiese&title=New+Functional+Assay+of+P-glycoprotein+Activity+Using+Hoechst+33342&doi=10.1016%2Fj.bmc.2007.07.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">New functional assay of P-glycoprotein activity using Hoechst 33342</span></div><div class="casAuthors">Mueller, Henrik; Klinkhammer, Werner; Globisch, Christoph; Kassack, Matthias U.; Pajeva, Ilza K.; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7470-7479</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">In this study the authors describe a simplified, HTS-capable functional assay for the multidrug resistance (MDR) transporter P-glycoprotein (P-gp) based on its substrate Hoechst 33342.  The physicochem. properties of Hoechst 33342 and the enormous milieu dependency of its fluorescence intensity allowed performing the assay in a homogeneous manner.  This new assay served as an effective tool to est. the potency of 10 well recognized P-gp substrates and modulators.  Further, the potency of these compds. was also estd. in the calcein AM assay.  The Hoechst 33342 and calcein AM assays yielded significantly comparable results for all compds. tested.  Principal component anal. (PCA) applied to literature data on inhibition of P-gp activity and the authors' results obtained in the Hoechst 33342 and calcein AM assay indicated similarity of compared functional transport assays.  However, no correlation could be detected between these functional assays and the ATPase activity assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTSVlzt7xQp7Vg90H21EOLACvtfcHk0lhsldNqAnHRUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFKitb3E&md5=265484311a72ee68d952e31d700195b0</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2007.07.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2007.07.024%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DH.%26aulast%3DKlinkhammer%26aufirst%3DW.%26aulast%3DGlobisch%26aufirst%3DC.%26aulast%3DKassack%26aufirst%3DM.%2BU.%26aulast%3DPajeva%26aufirst%3DI.%2BK.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DNew%2520Functional%2520Assay%2520of%2520P-glycoprotein%2520Activity%2520Using%2520Hoechst%252033342%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D7470%26epage%3D7479%26doi%3D10.1016%2Fj.bmc.2007.07.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Juvale, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pape, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span> </span><span class="NLM_article-title">Investigation of Chalcones and Benzochalcones as Inhibitors of Breast Cancer Resistance Protein</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span><span class="NLM_x">–</span> <span class="NLM_lpage">355</span><span class="refDoi"> DOI: 10.1016/j.bmc.2011.10.074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2Fj.bmc.2011.10.074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=22112540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC38XitlGgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=346-355&author=K.+Juvaleauthor=V.+F.+Papeauthor=M.+Wiese&title=Investigation+of+Chalcones+and+Benzochalcones+as+Inhibitors+of+Breast+Cancer+Resistance+Protein&doi=10.1016%2Fj.bmc.2011.10.074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Investigation of chalcones and benzochalcones as inhibitors of breast cancer resistance protein</span></div><div class="casAuthors">Juvale, Kapil; Pape, Veronika F. S.; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">346-355</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Breast cancer resistance protein (BCRP/ABCG2) belongs to the ATP binding cassette family of transport proteins.  BCRP has been found to confer multidrug resistance in cancer cells.  A strategy to overcome resistance due to BCRP overexpression is the investigation of potent and specific BCRP inhibitors.  The aim of the current study was to investigate different multi-substituted chalcones for their BCRP inhibition.  We synthesized chalcones and benzochalcones with different substituents (viz. OH, OCH3, Cl) on ring A and B of the chalcone structure.  All synthesized compds. were tested by Hoechst 33342 accumulation assay to det. inhibitory activity in MCF-7 MX and MDCK cells expressing BCRP.  The compds. were also screened for their P-glycoprotein (P-gp) and Multidrug resistance-assocd. protein 1 (MRP1) inhibitory activity in the calcein AM accumulation assay and were found to be selective towards inhibition of BCRP.  Substituents at position 2' and 4' on chalcone ring A were found to be essential for activity; addnl. there was a great influence of substituents on ring B. Presence of 3,4-dimethoxy substitution on ring B was found to be optimal, while presence of 2- and 4-chloro substitution also showed a pos. effect on BCRP inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoTQiCUqdyrLVg90H21EOLACvtfcHk0lho5kbMTEaQmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitlGgtw%253D%253D&md5=0884fa3575f8e159c7500abbacb31c9b</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.10.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.10.074%26sid%3Dliteratum%253Aachs%26aulast%3DJuvale%26aufirst%3DK.%26aulast%3DPape%26aufirst%3DV.%2BF.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DInvestigation%2520of%2520Chalcones%2520and%2520Benzochalcones%2520as%2520Inhibitors%2520of%2520Breast%2520Cancer%2520Resistance%2520Protein%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D346%26epage%3D355%26doi%3D10.1016%2Fj.bmc.2011.10.074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Gallus, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juvale, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span> </span><span class="NLM_article-title">Characterization of 3-Methoxy Flavones for their Interaction with ABCG2 as Suggested by ATPase Activity</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Biomembr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">1838</span><span class="NLM_x">, </span> <span class="NLM_fpage">2929</span><span class="NLM_x">–</span> <span class="NLM_lpage">2938</span><span class="refDoi"> DOI: 10.1016/j.bbamem.2014.08.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2Fj.bbamem.2014.08.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=25128152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlKmt7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1838&publication_year=2014&pages=2929-2938&author=J.+Gallusauthor=K.+Juvaleauthor=M.+Wiese&title=Characterization+of+3-Methoxy+Flavones+for+their+Interaction+with+ABCG2+as+Suggested+by+ATPase+Activity&doi=10.1016%2Fj.bbamem.2014.08.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of 3-methoxy flavones for their interaction with ABCG2 as suggested by ATPase activity</span></div><div class="casAuthors">Gallus, Jennifer; Juvale, Kapil; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1838</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2929-2938</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Breast Cancer Resistance Protein (BCRP/ABCG2) belongs to the superfamily of ATP binding cassette (ABC) transporters.  Characteristic of some of these transporter proteins is the transport of a variety of structurally unrelated substances against a concn. gradient by using the energy of ATP hydrolysis.  ABCG2 has been found to confer multidrug resistance (MDR) in cancer cells.  Several anticancer drugs have been identified as ABCG2 substrates including mitoxantrone, etoposide and topotecan.  As inhibition of the transporter is one of the strategies to overcome MDR, we have synthesized and tested several 3-methoxy flavones and investigated them for their ABCG2 inhibition.  Among these, pentamethyl quercetin (compd. 4) and pentamethyl morin (compd. 5) were found to be fluorescent and hence screened for their possible transport by ABCG2 using confocal microscopy.  This study showed that pentamethyl quercetin was far less accumulated in ABCG2 overexpressing MDCK BCRP cells as compared to MDCK sensitive cells, suggesting possible efflux of this compd. by ABCG2.  Pentamethyl morin showed no visible difference in both cell lines.  Based on this observation, we studied several other fluorescent 3-methoxy flavones for their accumulation in ABCG2 overexpressing cells.  To confirm the substrate or inhibitor nature of the tested compds., these compds. were further investigated by ATPase assay.  If stimulation of the transporter ATPase activity is detected, one can conclude that the compd. is probably a transported substrate.  All compds. except pentamethyl morin (compd. 5) and tetra-Me quercetin (compd. 6) were found to stimulate ATPase activity pointing to possible substrates despite being potent inhibitors of ABCG2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTbvTdBi-Ut7Vg90H21EOLACvtfcHk0lho5kbMTEaQmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlKmt7vE&md5=a7418d37edaaec640ebadd9305d152b1</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamem.2014.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamem.2014.08.003%26sid%3Dliteratum%253Aachs%26aulast%3DGallus%26aufirst%3DJ.%26aulast%3DJuvale%26aufirst%3DK.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DCharacterization%2520of%25203-Methoxy%2520Flavones%2520for%2520their%2520Interaction%2520with%2520ABCG2%2520as%2520Suggested%2520by%2520ATPase%2520Activity%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D2014%26volume%3D1838%26spage%3D2929%26epage%3D2938%26doi%3D10.1016%2Fj.bbamem.2014.08.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Singh, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juvale, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamprecht, A.</span><span> </span><span class="NLM_article-title">Evaluation of Dual P-gp-BCRP Inhibitors as Nanoparticle Formulation</span> <span class="citation_source-journal">Eur. J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span><span class="refDoi"> DOI: 10.1016/j.ejps.2015.04.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2Fj.ejps.2015.04.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=25976226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC2MXotlGntrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2015&pages=1-8&author=M.+S.+Singhauthor=K.+Juvaleauthor=M.+Wieseauthor=A.+Lamprecht&title=Evaluation+of+Dual+P-gp-BCRP+Inhibitors+as+Nanoparticle+Formulation&doi=10.1016%2Fj.ejps.2015.04.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of dual P-gp-BCRP inhibitors as nanoparticle formulation</span></div><div class="casAuthors">Singh, Manu Smriti; Juvale, Kapil; Wiese, Michael; Lamprecht, Alf</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-8</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Overcoming multidrug resistance (MDR) in cancer is a major challenge and efforts are on-going to develop inhibitors against the most characterized and ubiquitous MDR transporters: P-glycoprotein (P-gp), multidrug resistance-assocd. protein (MRP1) and breast cancer resistance protein (BCRP).  Recently reported, two 4-anilinoquinazolines (compds. 1 and 2), demonstrate potential MDR reversal activity against BCRP and to a lesser extent, P-gp.  In this work, we formulated the compds. as polymeric nanoparticles (NPs) and assessed their MDR inhibitory activity in relevant BCRP and P-gp over-expressing cell line models.  Particles in the size range 300-365 nm with a loading efficiency of 69% (compd. 1 NP) and 77% (compd. 2 NP) resp. were obtained.  BCRP inhibition was obsd. in Hoechst 33342 and pheophorbide A assays while P-gp inhibition was evaluated in calcein AM and rhodamine-123 assays.  In cytotoxicity studies, while BCRP expressing cells showed complete reversal of drug resistance in nearly all treatment groups (both compds. and their resp. NP); a higher reversal in NP treated group was obtained as compared with inhibitory compd. treated group in P-gp expressing cells.  These results demonstrate promising inhibitory activity of both formulations, esp. against P-gp expressing cells; which is possibly due to a prolonged presence of encapsulated compds. in NPs and consequently a prolonged sensitization of transmembrane drug transporter.  These formulations can therefore be considered as dual-transporter inhibitors and it is imperative to investigate both inhibitors in animal models of MDR owing to the presence of multiple efflux transporters in several cancer models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrB94y74OV717Vg90H21EOLACvtfcHk0lho5kbMTEaQmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXotlGntrY%253D&md5=b0cb7e6ed2815efd7d7471776525bc31</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2015.04.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2015.04.027%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DM.%2BS.%26aulast%3DJuvale%26aufirst%3DK.%26aulast%3DWiese%26aufirst%3DM.%26aulast%3DLamprecht%26aufirst%3DA.%26atitle%3DEvaluation%2520of%2520Dual%2520P-gp-BCRP%2520Inhibitors%2520as%2520Nanoparticle%2520Formulation%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2015%26volume%3D77%26spage%3D1%26epage%3D8%26doi%3D10.1016%2Fj.ejps.2015.04.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Juvale, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of Flavones and Benzoflavones as Inhibitors of BCRP/ABCG2</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2013.06.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2Fj.ejmech.2013.06.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=23851114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVeis73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2013&pages=115-126&author=K.+Juvaleauthor=K.+Stefanauthor=M.+Wiese&title=Synthesis+and+Biological+Evaluation+of+Flavones+and+Benzoflavones+as+Inhibitors+of+BCRP%2FABCG2&doi=10.1016%2Fj.ejmech.2013.06.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of flavones and benzoflavones as inhibitors of BCRP/ABCG2</span></div><div class="casAuthors">Juvale, Kapil; Stefan, Katja; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">115-126</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Multidrug resistance (MDR) often leads to a failure of cancer chemotherapy.  Breast Cancer Resistance Protein (BCRP/ABCG2), a member of the superfamily of ATP binding cassette proteins has been found to confer MDR in cancer cells by transporting mols. with amphiphilic character out of the cells using energy from ATP hydrolysis.  Inhibiting BCRP can be a soln. to overcome MDR.  The authors synthesized a series of flavones, 7,8-benzoflavones and 5,6-benzoflavones with varying substituents at positions 3, 3' and 4' of the (benzo)flavone structure.  All synthesized compds. were tested for BCRP inhibition in Hoechst 33342 and pheophorbide A accumulation assays using MDCK cells expressing BCRP.  All the compds. were further screened for their P-glycoprotein (P-gp) and Multidrug resistance-assocd. protein 1 (MRP1) inhibitory activity by calcein AM accumulation assay to check the selectivity towards BCRP.  In addn. most active compds. were investigated for their cytotoxicity.  It was obsd. that in most cases 7,8-benzoflavones are more potent in comparison to the 5,6-benzoflavones.  In general it was found that presence of a 3-OCH3 substituent leads to increase in activity in comparison to presence of OH or no substitution at position 3.  Also, it was found that presence of 3',4'-OCH3 on Ph ring lead to increase in activity as compared to other substituents.  Compd. 24, a 7,8-benzoflavone deriv. was found to be most potent being 50 times selective for BCRP and showing very low cytotoxicity at higher concns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoep2o4_wG7XrVg90H21EOLACvtfcHk0lho5kbMTEaQmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVeis73E&md5=961e1899a816717d108c5c8e71944f70</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.06.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.06.035%26sid%3Dliteratum%253Aachs%26aulast%3DJuvale%26aufirst%3DK.%26aulast%3DStefan%26aufirst%3DK.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520Flavones%2520and%2520Benzoflavones%2520as%2520Inhibitors%2520of%2520BCRP%252FABCG2%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D67%26spage%3D115%26epage%3D126%26doi%3D10.1016%2Fj.ejmech.2013.06.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Müller, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pajeva, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Globisch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span> </span><span class="NLM_article-title">Functional Assay and Structure-activity Relationships of New Third-generation P-glycoprotein Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2448</span><span class="NLM_x">–</span> <span class="NLM_lpage">2462</span><span class="refDoi"> DOI: 10.1016/j.bmc.2007.11.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2Fj.bmc.2007.11.057" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=2448-2462&author=H.+M%C3%BCllerauthor=I.+K.+Pajevaauthor=C.+Globischauthor=M.+Wiese&title=Functional+Assay+and+Structure-activity+Relationships+of+New+Third-generation+P-glycoprotein+Inhibitors&doi=10.1016%2Fj.bmc.2007.11.057"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2007.11.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2007.11.057%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DH.%26aulast%3DPajeva%26aufirst%3DI.%2BK.%26aulast%3DGlobisch%26aufirst%3DC.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DFunctional%2520Assay%2520and%2520Structure-activity%2520Relationships%2520of%2520New%2520Third-generation%2520P-glycoprotein%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D2448%26epage%3D2462%26doi%3D10.1016%2Fj.bmc.2007.11.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Pick, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span> </span><span class="NLM_article-title">Structure-activity Relationship of New Inhibitors of Breast Cancer Resistance Protein (ABCG2)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">180</span><span class="NLM_x">–</span> <span class="NLM_lpage">183</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.11.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2Fj.bmcl.2009.11.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=180-183&author=A.+Pickauthor=H.+Mullerauthor=M.+Wiese&title=Structure-activity+Relationship+of+New+Inhibitors+of+Breast+Cancer+Resistance+Protein+%28ABCG2%29&doi=10.1016%2Fj.bmcl.2009.11.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.11.004%26sid%3Dliteratum%253Aachs%26aulast%3DPick%26aufirst%3DA.%26aulast%3DMuller%26aufirst%3DH.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DStructure-activity%2520Relationship%2520of%2520New%2520Inhibitors%2520of%2520Breast%2520Cancer%2520Resistance%2520Protein%2520%2528ABCG2%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D180%26epage%3D183%26doi%3D10.1016%2Fj.bmcl.2009.11.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Köhler, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span> </span><span class="NLM_article-title">HM30181 Derivatives as Novel Potent and Selective Inhibitors of the Breast Cancer Resistance Protein (BCRP/ABCG2)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">3910</span><span class="NLM_x">–</span> <span class="NLM_lpage">3921</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00188</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00188" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A280%3ADC%252BC2Mjitlelsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3910-3921&author=S.+K%C3%B6hlerauthor=M.+Wiese&title=HM30181+Derivatives+as+Novel+Potent+and+Selective+Inhibitors+of+the+Breast+Cancer+Resistance+Protein+%28BCRP%2FABCG2%29&doi=10.1021%2Facs.jmedchem.5b00188"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">HM30181 Derivatives as Novel Potent and Selective Inhibitors of the Breast Cancer Resistance Protein (BCRP/ABCG2)</span></div><div class="casAuthors">Kohler Sebastian C; Wiese Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3910-21</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The breast cancer resistance protein (BCRP, ABCG2) belongs to the superfamily of ATP binding-cassette (ABC) proteins.  In addition to other physiological functions, it transports potentially cell-damaging compounds out of the cell using the energy from ATP hydrolysis.  Certain tumors overexpressing BCRP were found to become resistant against various anticancer drugs.  In previous work, we found that tariquidar analogues lacking the tetrahydroisoquinoline moiety selectively inhibit BCRP.  In the present study, we synthesized 21 derivatives of the third-generation P-gp inhibitor HM30181, which is structurally related to tariquidar.  The compounds were tested for their inhibitory activities against BCRP and screened against P-glycoprotein (P-gp, ABCB1) and multidrug resistance protein 1 (MRP1, ABCC1) to confirm the selectivity toward BCRP.  The most potent compounds are selective toward BCRP and 2-fold more potent than the reference Ko143.  Qualitative structure-activity relationship (SAR) analysis revealed that the presence of a methoxy group in the ortho or para position of at least one phenyl ring is beneficial for inhibitory activity.  Furthermore, the cytotoxicity and multidrug resistance (MDR)-reversal ability of selected compounds were investigated.  It was shown that they have a low cytotoxicity and the ability to reverse the BCRP-mediated SN-38 resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ_-1BYW7HmO9-cVm4E2RlLfW6udTcc2eaYcAEhpx2BHbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mjitlelsg%253D%253D&md5=777b13f427105e8909ae751d11e8c7b4</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00188%26sid%3Dliteratum%253Aachs%26aulast%3DK%25C3%25B6hler%26aufirst%3DS.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DHM30181%2520Derivatives%2520as%2520Novel%2520Potent%2520and%2520Selective%2520Inhibitors%2520of%2520the%2520Breast%2520Cancer%2520Resistance%2520Protein%2520%2528BCRP%252FABCG2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3910%26epage%3D3921%26doi%3D10.1021%2Facs.jmedchem.5b00188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span>Log-Normal Distribution; <a href="https://en.wikipedia.org/wiki/Log-normal_distribution" class="extLink">https://en.wikipedia.org/wiki/Log-normal_distribution</a> (accessed on March 10, 2016).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Log-Normal+Distribution%3B+https%3A%2F%2Fen.wikipedia.org%2Fwiki%2FLog-normal_distribution+%28accessed+on+March+10%2C+2016%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DLog-Normal%2520Distribution" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span>lognstat; <a href="http://de.mathworks.com/help/stats/lognstat.html" class="extLink">http://de.mathworks.com/help/stats/lognstat.html</a> (accessed on March 10, 2016).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=lognstat%3B+http%3A%2F%2Fde.mathworks.com%2Fhelp%2Fstats%2Flognstat.html+%28accessed+on+March+10%2C+2016%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3Dlognstat" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Leyers, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Häcker, H.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiendlocha, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gütschow, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span> </span><span class="NLM_article-title">A 4-Aminobenzoic Acid Derivative as Novel Lead for Selective Inhibitors of Multidrug Resistance-associated Proteins</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4761</span><span class="NLM_x">–</span> <span class="NLM_lpage">4763</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2008.07.127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2Fj.bmcl.2008.07.127" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4761-4763&author=S.+Leyersauthor=H.-G.+H%C3%A4ckerauthor=J.+Wiendlochaauthor=M.+G%C3%BCtschowauthor=M.+Wiese&title=A+4-Aminobenzoic+Acid+Derivative+as+Novel+Lead+for+Selective+Inhibitors+of+Multidrug+Resistance-associated+Proteins&doi=10.1016%2Fj.bmcl.2008.07.127"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.07.127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.07.127%26sid%3Dliteratum%253Aachs%26aulast%3DLeyers%26aufirst%3DS.%26aulast%3DH%25C3%25A4cker%26aufirst%3DH.-G.%26aulast%3DWiendlocha%26aufirst%3DJ.%26aulast%3DG%25C3%25BCtschow%26aufirst%3DM.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DA%25204-Aminobenzoic%2520Acid%2520Derivative%2520as%2520Novel%2520Lead%2520for%2520Selective%2520Inhibitors%2520of%2520Multidrug%2520Resistance-associated%2520Proteins%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4761%26epage%3D4763%26doi%3D10.1016%2Fj.bmcl.2008.07.127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Klinkhammer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Globisch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pajeva, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of a Small Molecule Library of 3rd Generation Multidrug Resistance Modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2524</span><span class="NLM_x">–</span> <span class="NLM_lpage">2535</span><span class="refDoi"> DOI: 10.1016/j.bmc.2009.01.072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2Fj.bmc.2009.01.072" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=2524-2535&author=W.+Klinkhammerauthor=H.+M%C3%BCllerauthor=C.+Globischauthor=I.+K.+Pajevaauthor=M.+Wiese&title=Synthesis+and+Biological+Evaluation+of+a+Small+Molecule+Library+of+3rd+Generation+Multidrug+Resistance+Modulators&doi=10.1016%2Fj.bmc.2009.01.072"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.01.072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.01.072%26sid%3Dliteratum%253Aachs%26aulast%3DKlinkhammer%26aufirst%3DW.%26aulast%3DM%25C3%25BCller%26aufirst%3DH.%26aulast%3DGlobisch%26aufirst%3DC.%26aulast%3DPajeva%26aufirst%3DI.%2BK.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520a%2520Small%2520Molecule%2520Library%2520of%25203rd%2520Generation%2520Multidrug%2520Resistance%2520Modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D2524%26epage%3D2535%26doi%3D10.1016%2Fj.bmc.2009.01.072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Häcker, H.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leyers, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiendlocha, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gütschow, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span> </span><span class="NLM_article-title">Aromatic 2-(Thio)ureidocarboxylic Acids As a New Family of Modulators of Multidrug Resistance-Associated Protein 1: Synthesis, Biological Evaluation, and Structure-Activity Relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4586</span><span class="NLM_x">–</span> <span class="NLM_lpage">4595</span><span class="refDoi"> DOI: 10.1021/jm900688v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900688v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4586-4595&author=H.-G.+H%C3%A4ckerauthor=S.+Leyersauthor=J.+Wiendlochaauthor=M.+G%C3%BCtschowauthor=M.+Wiese&title=Aromatic+2-%28Thio%29ureidocarboxylic+Acids+As+a+New+Family+of+Modulators+of+Multidrug+Resistance-Associated+Protein+1%3A+Synthesis%2C+Biological+Evaluation%2C+and+Structure-Activity+Relationships&doi=10.1021%2Fjm900688v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjm900688v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900688v%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25A4cker%26aufirst%3DH.-G.%26aulast%3DLeyers%26aufirst%3DS.%26aulast%3DWiendlocha%26aufirst%3DJ.%26aulast%3DG%25C3%25BCtschow%26aufirst%3DM.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DAromatic%25202-%2528Thio%2529ureidocarboxylic%2520Acids%2520As%2520a%2520New%2520Family%2520of%2520Modulators%2520of%2520Multidrug%2520Resistance-Associated%2520Protein%25201%253A%2520Synthesis%252C%2520Biological%2520Evaluation%252C%2520and%2520Structure-Activity%2520Relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4586%26epage%3D4595%26doi%3D10.1021%2Fjm900688v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Marighetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steggemann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karbaum, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span> </span><span class="NLM_article-title">Scaffold Identification of a New Class of Potent and Selective BCRP-inhibitors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">742</span><span class="NLM_x">–</span> <span class="NLM_lpage">751</span><span class="refDoi"> DOI: 10.1002/cmdc.201402498</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1002%2Fcmdc.201402498" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=742-751&author=F.+Marighettiauthor=K.+Steggemannauthor=M.+Karbaumauthor=M.+Wiese&title=Scaffold+Identification+of+a+New+Class+of+Potent+and+Selective+BCRP-inhibitors&doi=10.1002%2Fcmdc.201402498"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201402498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201402498%26sid%3Dliteratum%253Aachs%26aulast%3DMarighetti%26aufirst%3DF.%26aulast%3DSteggemann%26aufirst%3DK.%26aulast%3DKarbaum%26aufirst%3DM.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DScaffold%2520Identification%2520of%2520a%2520New%2520Class%2520of%2520Potent%2520and%2520Selective%2520BCRP-inhibitors%26jtitle%3DChemMedChem%26date%3D2015%26volume%3D10%26spage%3D742%26epage%3D751%26doi%3D10.1002%2Fcmdc.201402498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Sarkadi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germann, U. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarborough, G. A.</span><span> </span><span class="NLM_article-title">Expression of the Human Multidrug Resistance cDNA in Insect Cells Generates a High Activity Drug-stimulated Membrane ATPase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">4854</span><span class="NLM_x">–</span> <span class="NLM_lpage">4858</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=4854-4858&author=B.+Sarkadiauthor=E.+M.+Priceauthor=R.+C.+Boucherauthor=U.+A.+Germannauthor=G.+A.+Scarborough&title=Expression+of+the+Human+Multidrug+Resistance+cDNA+in+Insect+Cells+Generates+a+High+Activity+Drug-stimulated+Membrane+ATPase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSarkadi%26aufirst%3DB.%26aulast%3DPrice%26aufirst%3DE.%2BM.%26aulast%3DBoucher%26aufirst%3DR.%2BC.%26aulast%3DGermann%26aufirst%3DU.%2BA.%26aulast%3DScarborough%26aufirst%3DG.%2BA.%26atitle%3DExpression%2520of%2520the%2520Human%2520Multidrug%2520Resistance%2520cDNA%2520in%2520Insect%2520Cells%2520Generates%2520a%2520High%2520Activity%2520Drug-stimulated%2520Membrane%2520ATPase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D4854%26epage%3D4858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Al-Shawi, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polar, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omote, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figler, R. A.</span><span> </span><span class="NLM_article-title">Transition State Analysis of the Coupling of Drug Transport to ATP Hydrolysis by P-glycoprotein</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">52629</span><span class="NLM_x">–</span> <span class="NLM_lpage">52640</span><span class="refDoi"> DOI: 10.1074/jbc.M308175200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1074%2Fjbc.M308175200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=52629-52640&author=M.+K.+Al-Shawiauthor=M.+K.+Polarauthor=H.+Omoteauthor=R.+A.+Figler&title=Transition+State+Analysis+of+the+Coupling+of+Drug+Transport+to+ATP+Hydrolysis+by+P-glycoprotein&doi=10.1074%2Fjbc.M308175200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M308175200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M308175200%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Shawi%26aufirst%3DM.%2BK.%26aulast%3DPolar%26aufirst%3DM.%2BK.%26aulast%3DOmote%26aufirst%3DH.%26aulast%3DFigler%26aufirst%3DR.%2BA.%26atitle%3DTransition%2520State%2520Analysis%2520of%2520the%2520Coupling%2520of%2520Drug%2520Transport%2520to%2520ATP%2520Hydrolysis%2520by%2520P-glycoprotein%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D52629%26epage%3D52640%26doi%3D10.1074%2Fjbc.M308175200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 27 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Katja Silbermann, Jiyang Li, Vigneshwaran Namasivayam, Fabian Baltes, Gerd Bendas, Sven Marcel Stefan, <span class="NLM_string-name hlFld-ContribAuthor">Michael Wiese</span>. </span><span class="cited-content_cbyCitation_article-title">Superior Pyrimidine Derivatives as Selective ABCG2 Inhibitors and Broad-Spectrum ABCB1, ABCC1, and ABCG2 Antagonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (18)
                                     , 10412-10432. <a href="https://doi.org/10.1021/acs.jmedchem.0c00961" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00961</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00961%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSuperior%252BPyrimidine%252BDerivatives%252Bas%252BSelective%252BABCG2%252BInhibitors%252Band%252BBroad-Spectrum%252BABCB1%25252C%252BABCC1%25252C%252Band%252BABCG2%252BAntagonists%26aulast%3DSilbermann%26aufirst%3DKatja%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D05062020%26date%3D11092020%26date%3D31072020%26volume%3D63%26issue%3D18%26spage%3D10412%26epage%3D10432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xuezhen Zhu, Iris L. K. Wong, Kin-Fai Chan, Jiahua Cui, Man Chun Law, Tsz Cheung Chong, Xuesen Hu, Larry M. C. Chow, <span class="NLM_string-name hlFld-ContribAuthor">Tak Hang Chan</span>. </span><span class="cited-content_cbyCitation_article-title">Triazole Bridged Flavonoid Dimers as Potent, Nontoxic, and Highly Selective Breast Cancer Resistance Protein (BCRP/ABCG2) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (18)
                                     , 8578-8608. <a href="https://doi.org/10.1021/acs.jmedchem.9b00963" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00963</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00963%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTriazole%252BBridged%252BFlavonoid%252BDimers%252Bas%252BPotent%25252C%252BNontoxic%25252C%252Band%252BHighly%252BSelective%252BBreast%252BCancer%252BResistance%252BProtein%252B%252528BCRP%25252FABCG2%252529%252BInhibitors%26aulast%3DZhu%26aufirst%3DXuezhen%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D17062019%26date%3D12092019%26date%3D29082019%26volume%3D62%26issue%3D18%26spage%3D8578%26epage%3D8608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Katja Silbermann, Sven Marcel Stefan, Randa Elshawadfy, Vigneshwaran Namasivayam, <span class="NLM_string-name hlFld-ContribAuthor">Michael Wiese</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Thienopyrimidine Scaffold as an Inhibitor of the ABC Transport Protein ABCC1 (MRP1) and Related Transporters Using a Combined Virtual Screening Approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (9)
                                     , 4383-4400. <a href="https://doi.org/10.1021/acs.jmedchem.8b01821" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01821</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01821%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BThienopyrimidine%252BScaffold%252Bas%252Ban%252BInhibitor%252Bof%252Bthe%252BABC%252BTransport%252BProtein%252BABCC1%252B%252528MRP1%252529%252Band%252BRelated%252BTransporters%252BUsing%252Ba%252BCombined%252BVirtual%252BScreening%252BApproach%26aulast%3DSilbermann%26aufirst%3DKatja%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D21112018%26date%3D30042019%26date%3D29032019%26volume%3D62%26issue%3D9%26spage%3D4383%26epage%3D4400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Michael
K. Krapf, Jennifer Gallus, Vigneshwaran Namasivayam, <span class="NLM_string-name hlFld-ContribAuthor">Michael Wiese</span>. </span><span class="cited-content_cbyCitation_article-title">2,4,6-Substituted Quinazolines with Extraordinary Inhibitory Potency toward ABCG2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (17)
                                     , 7952-7976. <a href="https://doi.org/10.1021/acs.jmedchem.8b01011" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01011%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D2%25252C4%25252C6-Substituted%252BQuinazolines%252Bwith%252BExtraordinary%252BInhibitory%252BPotency%252Btoward%252BABCG2%26aulast%3DKrapf%26aufirst%3DMichael%2BK.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D26062018%26date%3D20082018%26date%3D03082018%26volume%3D61%26issue%3D17%26spage%3D7952%26epage%3D7976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Michael
K. Krapf, Jennifer Gallus, Sahel Vahdati, <span class="NLM_string-name hlFld-ContribAuthor">Michael Wiese</span>. </span><span class="cited-content_cbyCitation_article-title">New Inhibitors of Breast Cancer Resistance Protein (ABCG2) Containing a 2,4-Disubstituted Pyridopyrimidine Scaffold. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (8)
                                     , 3389-3408. <a href="https://doi.org/10.1021/acs.jmedchem.7b01012" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01012%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNew%252BInhibitors%252Bof%252BBreast%252BCancer%252BResistance%252BProtein%252B%252528ABCG2%252529%252BContaining%252Ba%252B2%25252C4-Disubstituted%252BPyridopyrimidine%252BScaffold%26aulast%3DKrapf%26aufirst%3DMichael%2BK.%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D11072017%26date%3D18042018%26date%3D16032018%26volume%3D61%26issue%3D8%26spage%3D3389%26epage%3D3408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katja  Stefan</span>, <span class="hlFld-ContribAuthor ">Sven Marcel  Schmitt</span>, and <span class="hlFld-ContribAuthor ">Michael  Wiese</span>  . </span><span class="cited-content_cbyCitation_article-title">9-Deazapurines as Broad-Spectrum Inhibitors of the ABC Transport Proteins P-Glycoprotein, Multidrug Resistance-Associated Protein 1, and Breast Cancer Resistance Protein. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (21)
                                     , 8758-8780. <a href="https://doi.org/10.1021/acs.jmedchem.7b00788" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00788</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00788%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D9-Deazapurines%252Bas%252BBroad-Spectrum%252BInhibitors%252Bof%252Bthe%252BABC%252BTransport%252BProteins%252BP-Glycoprotein%25252C%252BMultidrug%252BResistance-Associated%252BProtein%252B1%25252C%252Band%252BBreast%252BCancer%252BResistance%252BProtein%26aulast%3DStefan%26aufirst%3DKatja%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D30052017%26date%3D26102017%26date%3D09112017%26date%3D10102017%26volume%3D60%26issue%3D21%26spage%3D8758%26epage%3D8780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Minh-Tri  Le</span>, <span class="hlFld-ContribAuthor ">Viet-Nham  Hoang</span>, <span class="hlFld-ContribAuthor ">Dac-Nhan  Nguyen</span>, <span class="hlFld-ContribAuthor ">Thi-Hoang-Linh  Bui</span>, <span class="hlFld-ContribAuthor ">Thien-Vy  Phan</span>, <span class="hlFld-ContribAuthor ">Phuong Nguyen-Hoai  Huynh</span>, <span class="hlFld-ContribAuthor ">Thanh-Dao  Tran</span>, <span class="hlFld-ContribAuthor ">Khac-Minh  Thai</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Discovery of ABCG2 Inhibitors: A Homology Protein-Based Pharmacophore Modeling and Molecular Docking Approach. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (11)
                                     , 3115. <a href="https://doi.org/10.3390/molecules26113115" title="DOI URL">https://doi.org/10.3390/molecules26113115</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26113115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26113115%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DStructure-Based%252BDiscovery%252Bof%252BABCG2%252BInhibitors%25253A%252BA%252BHomology%252BProtein-Based%252BPharmacophore%252BModeling%252Band%252BMolecular%252BDocking%252BApproach%26aulast%3DLe%26aufirst%3DMinh-Tri%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D11%26spage%3D3115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raed M.  Al‐Zoubi</span>, <span class="hlFld-ContribAuthor ">Walid K.  Al‐Jammal</span>, <span class="hlFld-ContribAuthor ">Mazhar S.  Al‐Zoubi</span>, <span class="hlFld-ContribAuthor ">Michael J.  Ferguson</span>, <span class="hlFld-ContribAuthor ">Ahmad  Zarour</span>, <span class="hlFld-ContribAuthor ">Aksam  Yassin</span>, <span class="hlFld-ContribAuthor ">Abdulla  Al‐Ansari</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium‐Catalyzed Regioselective Coupling of Amidines and 1,2,3‐Triiodobenzenes: Facile Synthesis of 2,3‐Diiodinated
              N
              ‐Arylbenzimidamides as Potential MDM
              2
              and MDM
              4
              Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2021,</strong> <em>6 </em>
                                    (14)
                                     , 3417-3423. <a href="https://doi.org/10.1002/slct.202100671" title="DOI URL">https://doi.org/10.1002/slct.202100671</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202100671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202100671%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DPalladium%2525E2%252580%252590Catalyzed%252BRegioselective%252BCoupling%252Bof%252BAmidines%252Band%252B1%25252C2%25252C3%2525E2%252580%252590Triiodobenzenes%25253A%252BFacile%252BSynthesis%252Bof%252B2%25252C3%2525E2%252580%252590Diiodinated%252BN%252B%2525E2%252580%252590Arylbenzimidamides%252Bas%252BPotential%252BMDM%252B2%252Band%252BMDM%252B4%252BInhibitors%26aulast%3DAl%25E2%2580%2590Zoubi%26aufirst%3DRaed%2BM.%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D14%26spage%3D3417%26epage%3D3423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Satyaveni  Malasala</span>, <span class="hlFld-ContribAuthor ">Md Naiyaz  Ahmad</span>, <span class="hlFld-ContribAuthor ">Ravikumar  Akunuri</span>, <span class="hlFld-ContribAuthor ">Manjulika  Shukla</span>, <span class="hlFld-ContribAuthor ">Grace  Kaul</span>, <span class="hlFld-ContribAuthor ">Arunava  Dasgupta</span>, <span class="hlFld-ContribAuthor ">Y.V.  Madhavi</span>, <span class="hlFld-ContribAuthor ">Sidharth  Chopra</span>, <span class="hlFld-ContribAuthor ">Srinivas  Nanduri</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of new quinazoline-benzimidazole hybrids as potent anti-microbial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>212 </em>, 112996. <a href="https://doi.org/10.1016/j.ejmech.2020.112996" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112996</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112996&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112996%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bnew%252Bquinazoline-benzimidazole%252Bhybrids%252Bas%252Bpotent%252Banti-microbial%252Bagents%252Bagainst%252Bmultidrug%252Bresistant%252BStaphylococcus%252Baureus%252Band%252BMycobacterium%252Btuberculosis%26aulast%3DMalasala%26aufirst%3DSatyaveni%26date%3D2021%26volume%3D212%26spage%3D112996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katja  Silbermann</span>, <span class="hlFld-ContribAuthor ">Jiyang  Li</span>, <span class="hlFld-ContribAuthor ">Vigneshwaran  Namasivayam</span>, <span class="hlFld-ContribAuthor ">Sven Marcel  Stefan</span>, <span class="hlFld-ContribAuthor ">Michael  Wiese</span>. </span><span class="cited-content_cbyCitation_article-title">Rational drug design of 6-substituted 4-anilino-2-phenylpyrimidines for exploration of novel ABCG2 binding site. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>212 </em>, 113045. <a href="https://doi.org/10.1016/j.ejmech.2020.113045" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113045%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRational%252Bdrug%252Bdesign%252Bof%252B6-substituted%252B4-anilino-2-phenylpyrimidines%252Bfor%252Bexploration%252Bof%252Bnovel%252BABCG2%252Bbinding%252Bsite%26aulast%3DSilbermann%26aufirst%3DKatja%26date%3D2021%26volume%3D212%26spage%3D113045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ranju  Bansal</span>, <span class="hlFld-ContribAuthor ">Anjleena  Malhotra</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic progression of quinazolines as targeted chemotherapeutic agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>211 </em>, 113016. <a href="https://doi.org/10.1016/j.ejmech.2020.113016" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113016%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTherapeutic%252Bprogression%252Bof%252Bquinazolines%252Bas%252Btargeted%252Bchemotherapeutic%252Bagents%26aulast%3DBansal%26aufirst%3DRanju%26date%3D2021%26volume%3D211%26spage%3D113016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jie  Ren</span>, <span class="hlFld-ContribAuthor ">Yanzhen  Huang</span>, <span class="hlFld-ContribAuthor ">Chao  Pi</span>, <span class="hlFld-ContribAuthor ">Xiuling  Cui</span>, <span class="hlFld-ContribAuthor ">Yangjie  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Rhodium(III)-catalyzed [4 + 2] annulation of N-arylbenzamidines with 1,4,2-dioxazol-5-ones: Easy access to 4-aminoquinazolines via highly selective C H bond activation. </span><span class="cited-content_cbyCitation_journal-name">Chinese Chemical Letters</span><span> <strong>2021,</strong> <em>25 </em><a href="https://doi.org/10.1016/j.cclet.2021.02.061" title="DOI URL">https://doi.org/10.1016/j.cclet.2021.02.061</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cclet.2021.02.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cclet.2021.02.061%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Chemical%2520Letters%26atitle%3DRhodium%252528III%252529-catalyzed%252B%25255B4%2525E2%252580%252589%25252B%2525E2%252580%2525892%25255D%252Bannulation%252Bof%252BN-arylbenzamidines%252Bwith%252B1%25252C4%25252C2-dioxazol-5-ones%25253A%252BEasy%252Baccess%252Bto%252B4-aminoquinazolines%252Bvia%252Bhighly%252Bselective%252BC%252BH%252Bbond%252Bactivation%26aulast%3DRen%26aufirst%3DJie%26date%3D2021%26volume%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Volodymyr A.  Tkachuk</span>, <span class="hlFld-ContribAuthor ">Vyacheslav O.  Shishkanu</span>, <span class="hlFld-ContribAuthor ">Tetiana M.  Tkachuk</span>, <span class="hlFld-ContribAuthor ">Svitlana V.  Shishkina</span>, <span class="hlFld-ContribAuthor ">Olga V.  Hordiyenko</span>. </span><span class="cited-content_cbyCitation_article-title">2-Carbamimidoylbenzoic Acid as a New Effective and Available Precursor for the Synthesis of Substituted 2-(Pyrimidin-2-yl)benzoic Acids. </span><span class="cited-content_cbyCitation_journal-name">Synthesis</span><span> <strong>2021,</strong> <em>53 </em>
                                    (02)
                                     , 371-382. <a href="https://doi.org/10.1055/s-0040-1705941" title="DOI URL">https://doi.org/10.1055/s-0040-1705941</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1055/s-0040-1705941&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1055%2Fs-0040-1705941%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthesis%26atitle%3D2-Carbamimidoylbenzoic%252BAcid%252Bas%252Ba%252BNew%252BEffective%252Band%252BAvailable%252BPrecursor%252Bfor%252Bthe%252BSynthesis%252Bof%252BSubstituted%252B2-%252528Pyrimidin-2-yl%252529benzoic%252BAcids%26aulast%3DTkachuk%26aufirst%3DVolodymyr%2BA.%26date%3D2021%26date%3D2020%26volume%3D53%26issue%3D02%26spage%3D371%26epage%3D382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Satyaveni  Malasala</span>, <span class="hlFld-ContribAuthor ">Jitendra  Gour</span>, <span class="hlFld-ContribAuthor ">Md. Naiyaz  Ahmad</span>, <span class="hlFld-ContribAuthor ">Srikanth  Gatadi</span>, <span class="hlFld-ContribAuthor ">Manjulika  Shukla</span>, <span class="hlFld-ContribAuthor ">Grace  Kaul</span>, <span class="hlFld-ContribAuthor ">Arunava  Dasgupta</span>, <span class="hlFld-ContribAuthor ">Y. V.  Madhavi</span>, <span class="hlFld-ContribAuthor ">Sidharth  Chopra</span>, <span class="hlFld-ContribAuthor ">Srinivas  Nanduri</span>. </span><span class="cited-content_cbyCitation_article-title">Copper mediated one-pot synthesis of quinazolinones and exploration of piperazine linked quinazoline derivatives as anti-mycobacterial agents. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2020,</strong> <em>10 </em>
                                    (71)
                                     , 43533-43538. <a href="https://doi.org/10.1039/D0RA08644D" title="DOI URL">https://doi.org/10.1039/D0RA08644D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA08644D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA08644D%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DCopper%252Bmediated%252Bone-pot%252Bsynthesis%252Bof%252Bquinazolinones%252Band%252Bexploration%252Bof%252Bpiperazine%252Blinked%252Bquinazoline%252Bderivatives%252Bas%252Banti-mycobacterial%252Bagents%26aulast%3DMalasala%26aufirst%3DSatyaveni%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D71%26spage%3D43533%26epage%3D43538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dejun  Jiang</span>, <span class="hlFld-ContribAuthor ">Tailong  Lei</span>, <span class="hlFld-ContribAuthor ">Zhe  Wang</span>, <span class="hlFld-ContribAuthor ">Chao  Shen</span>, <span class="hlFld-ContribAuthor ">Dongsheng  Cao</span>, <span class="hlFld-ContribAuthor ">Tingjun  Hou</span>. </span><span class="cited-content_cbyCitation_article-title">ADMET evaluation in drug discovery. 20. Prediction of breast cancer resistance protein inhibition through machine learning. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cheminformatics</span><span> <strong>2020,</strong> <em>12 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13321-020-00421-y" title="DOI URL">https://doi.org/10.1186/s13321-020-00421-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13321-020-00421-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13321-020-00421-y%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cheminformatics%26atitle%3DADMET%252Bevaluation%252Bin%252Bdrug%252Bdiscovery.%252B20.%252BPrediction%252Bof%252Bbreast%252Bcancer%252Bresistance%252Bprotein%252Binhibition%252Bthrough%252Bmachine%252Blearning%26aulast%3DJiang%26aufirst%3DDejun%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Satyaveni  Malasala</span>, <span class="hlFld-ContribAuthor ">Md Naiyaz  Ahmad</span>, <span class="hlFld-ContribAuthor ">Jitendra  Gour</span>, <span class="hlFld-ContribAuthor ">Manjulika  Shukla</span>, <span class="hlFld-ContribAuthor ">Grace  Kaul</span>, <span class="hlFld-ContribAuthor ">Abdul  Akhir</span>, <span class="hlFld-ContribAuthor ">Srikanth  Gatadi</span>, <span class="hlFld-ContribAuthor ">Y.V.  Madhavi</span>, <span class="hlFld-ContribAuthor ">Sidharth  Chopra</span>, <span class="hlFld-ContribAuthor ">Srinivas  Nanduri</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, biological evaluation and molecular modelling insights of 2-arylquinazoline benzamide derivatives as anti-tubercular agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2020,</strong> <em>1218 </em>, 128493. <a href="https://doi.org/10.1016/j.molstruc.2020.128493" title="DOI URL">https://doi.org/10.1016/j.molstruc.2020.128493</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2020.128493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2020.128493%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DSynthesis%25252C%252Bbiological%252Bevaluation%252Band%252Bmolecular%252Bmodelling%252Binsights%252Bof%252B2-arylquinazoline%252Bbenzamide%252Bderivatives%252Bas%252Banti-tubercular%252Bagents%26aulast%3DMalasala%26aufirst%3DSatyaveni%26date%3D2020%26volume%3D1218%26spage%3D128493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wen-Jing  Li</span>, <span class="hlFld-ContribAuthor ">Xin-Hui  Chen</span>, <span class="hlFld-ContribAuthor ">Jia-Cheng  Zeng</span>, <span class="hlFld-ContribAuthor ">Li-Li  Duan</span>, <span class="hlFld-ContribAuthor ">Zhao-Hua  Liu</span>, <span class="hlFld-ContribAuthor ">Xie-Huang  Sheng</span>. </span><span class="cited-content_cbyCitation_article-title">Theoretical insight into the multiple interactions of quinazoline inhibitors with breast cancer resistance protein (BCRP/ABCG2). </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2020,</strong> <em>38 </em>
                                    (14)
                                     , 4336-4343. <a href="https://doi.org/10.1080/07391102.2019.1677503" title="DOI URL">https://doi.org/10.1080/07391102.2019.1677503</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2019.1677503&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2019.1677503%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DTheoretical%252Binsight%252Binto%252Bthe%252Bmultiple%252Binteractions%252Bof%252Bquinazoline%252Binhibitors%252Bwith%252Bbreast%252Bcancer%252Bresistance%252Bprotein%252B%252528BCRP%25252FABCG2%252529%26aulast%3DLi%26aufirst%3DWen-Jing%26date%3D2020%26date%3D2019%26volume%3D38%26issue%3D14%26spage%3D4336%26epage%3D4343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhang-Xu  He</span>, <span class="hlFld-ContribAuthor ">Tao-Qian  Zhao</span>, <span class="hlFld-ContribAuthor ">Yun-Peng  Gong</span>, <span class="hlFld-ContribAuthor ">Xin  Zhang</span>, <span class="hlFld-ContribAuthor ">Li-Ying  Ma</span>, <span class="hlFld-ContribAuthor ">Hong-Min  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrimidine: A promising scaffold for optimization to develop the inhibitors of ABC transporters. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>200 </em>, 112458. <a href="https://doi.org/10.1016/j.ejmech.2020.112458" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112458</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112458%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPyrimidine%25253A%252BA%252Bpromising%252Bscaffold%252Bfor%252Boptimization%252Bto%252Bdevelop%252Bthe%252Binhibitors%252Bof%252BABC%252Btransporters%26aulast%3DHe%26aufirst%3DZhang-Xu%26date%3D2020%26volume%3D200%26spage%3D112458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K.  Ghosh</span>, <span class="hlFld-ContribAuthor ">B.  Bhardwaj</span>, <span class="hlFld-ContribAuthor ">S.A.  Amin</span>, <span class="hlFld-ContribAuthor ">T.  Jha</span>, <span class="hlFld-ContribAuthor ">S.  Gayen</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of structural fingerprints for ABCG2 inhibition by using Monte Carlo optimization, Bayesian classification, and structural and physicochemical interpretation (SPCI) analysis. </span><span class="cited-content_cbyCitation_journal-name">SAR and QSAR in Environmental Research</span><span> <strong>2020,</strong> <em>31 </em>
                                    (6)
                                     , 439-455. <a href="https://doi.org/10.1080/1062936X.2020.1771769" title="DOI URL">https://doi.org/10.1080/1062936X.2020.1771769</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/1062936X.2020.1771769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F1062936X.2020.1771769%26sid%3Dliteratum%253Aachs%26jtitle%3DSAR%2520and%2520QSAR%2520in%2520Environmental%2520Research%26atitle%3DIdentification%252Bof%252Bstructural%252Bfingerprints%252Bfor%252BABCG2%252Binhibition%252Bby%252Busing%252BMonte%252BCarlo%252Boptimization%25252C%252BBayesian%252Bclassification%25252C%252Band%252Bstructural%252Band%252Bphysicochemical%252Binterpretation%252B%252528SPCI%252529%252Banalysis%26aulast%3DGhosh%26aufirst%3DK.%26date%3D2020%26date%3D2020%26volume%3D31%26issue%3D6%26spage%3D439%26epage%3D455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jingqiu  Wang</span>, <span class="hlFld-ContribAuthor ">Jing-Quan  Wang</span>, <span class="hlFld-ContribAuthor ">Chao-Yun  Cai</span>, <span class="hlFld-ContribAuthor ">Qingbin  Cui</span>, <span class="hlFld-ContribAuthor ">Yuqi  Yang</span>, <span class="hlFld-ContribAuthor ">Zhuo-Xun  Wu</span>, <span class="hlFld-ContribAuthor ">Xingduo  Dong</span>, <span class="hlFld-ContribAuthor ">Leli  Zeng</span>, <span class="hlFld-ContribAuthor ">Linguo  Zhao</span>, <span class="hlFld-ContribAuthor ">Dong-Hua  Yang</span>, <span class="hlFld-ContribAuthor ">Zhe-Sheng  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Reversal Effect of ALK Inhibitor NVP-TAE684 on ABCG2-Overexpressing Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2020,</strong> <em>10 </em><a href="https://doi.org/10.3389/fonc.2020.00228" title="DOI URL">https://doi.org/10.3389/fonc.2020.00228</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2020.00228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2020.00228%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DReversal%252BEffect%252Bof%252BALK%252BInhibitor%252BNVP-TAE684%252Bon%252BABCG2-Overexpressing%252BCancer%252BCells%26aulast%3DWang%26aufirst%3DJingqiu%26date%3D2020%26date%3D2020%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Wiese</span>, <span class="hlFld-ContribAuthor ">Sven Marcel  Stefan</span>. </span><span class="cited-content_cbyCitation_article-title">The A‐B‐C of small‐molecule ABC transport protein modulators: From inhibition to activation—a case study of multidrug resistance‐associated protein 1 (ABCC1). </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2019,</strong> <em>39 </em>
                                    (6)
                                     , 2031-2081. <a href="https://doi.org/10.1002/med.21573" title="DOI URL">https://doi.org/10.1002/med.21573</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21573%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DThe%252BA%2525E2%252580%252590B%2525E2%252580%252590C%252Bof%252Bsmall%2525E2%252580%252590molecule%252BABC%252Btransport%252Bprotein%252Bmodulators%25253A%252BFrom%252Binhibition%252Bto%252Bactivation%2525E2%252580%252594a%252Bcase%252Bstudy%252Bof%252Bmultidrug%252Bresistance%2525E2%252580%252590associated%252Bprotein%252B1%252B%252528ABCC1%252529%26aulast%3DWiese%26aufirst%3DMichael%26date%3D2019%26date%3D2019%26volume%3D39%26issue%3D6%26spage%3D2031%26epage%3D2081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guillermo  Virkel</span>, <span class="hlFld-ContribAuthor ">Mariana  Ballent</span>, <span class="hlFld-ContribAuthor ">Carlos  Lanusse</span>, <span class="hlFld-ContribAuthor ">Adrián  Lifschitz</span>. </span><span class="cited-content_cbyCitation_article-title">Role of ABC Transporters in Veterinary Medicine: Pharmaco- Toxicological Implications. </span><span class="cited-content_cbyCitation_journal-name">Current Medicinal Chemistry</span><span> <strong>2019,</strong> <em>26 </em>
                                    (7)
                                     , 1251-1269. <a href="https://doi.org/10.2174/0929867325666180201094730" title="DOI URL">https://doi.org/10.2174/0929867325666180201094730</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/0929867325666180201094730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F0929867325666180201094730%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Medicinal%2520Chemistry%26atitle%3DRole%252Bof%252BABC%252BTransporters%252Bin%252BVeterinary%252BMedicine%25253A%252BPharmaco-%252BToxicological%252BImplications%26aulast%3DVirkel%26aufirst%3DGuillermo%26date%3D2019%26volume%3D26%26issue%3D7%26spage%3D1251%26epage%3D1269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katja  Silbermann</span>, <span class="hlFld-ContribAuthor ">Chetan P.  Shah</span>, <span class="hlFld-ContribAuthor ">Niteshkumar U.  Sahu</span>, <span class="hlFld-ContribAuthor ">Kapil  Juvale</span>, <span class="hlFld-ContribAuthor ">Sven Marcel  Stefan</span>, <span class="hlFld-ContribAuthor ">Prashant S.  Kharkar</span>, <span class="hlFld-ContribAuthor ">Michael  Wiese</span>. </span><span class="cited-content_cbyCitation_article-title">Novel chalcone and flavone derivatives as selective and dual inhibitors of the transport proteins ABCB1 and ABCG2. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>164 </em>, 193-213. <a href="https://doi.org/10.1016/j.ejmech.2018.12.019" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.12.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.12.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.12.019%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bchalcone%252Band%252Bflavone%252Bderivatives%252Bas%252Bselective%252Band%252Bdual%252Binhibitors%252Bof%252Bthe%252Btransport%252Bproteins%252BABCB1%252Band%252BABCG2%26aulast%3DSilbermann%26aufirst%3DKatja%26date%3D2019%26volume%3D164%26spage%3D193%26epage%3D213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sven Marcel  Stefan</span>, <span class="hlFld-ContribAuthor ">Michael  Wiese</span>. </span><span class="cited-content_cbyCitation_article-title">Small-molecule inhibitors of multidrug resistance-associated protein 1 and related processes: A historic approach and recent advances. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2019,</strong> <em>39 </em>
                                    (1)
                                     , 176-264. <a href="https://doi.org/10.1002/med.21510" title="DOI URL">https://doi.org/10.1002/med.21510</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21510%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DSmall-molecule%252Binhibitors%252Bof%252Bmultidrug%252Bresistance-associated%252Bprotein%252B1%252Band%252Brelated%252Bprocesses%25253A%252BA%252Bhistoric%252Bapproach%252Band%252Brecent%252Badvances%26aulast%3DStefan%26aufirst%3DSven%2BMarcel%26date%3D2019%26date%3D2018%26volume%3D39%26issue%3D1%26spage%3D176%26epage%3D264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tao  Jin</span>, <span class="hlFld-ContribAuthor ">Hongdong  Yuan</span>, <span class="hlFld-ContribAuthor ">Shikuan  Su</span>, <span class="hlFld-ContribAuthor ">Xueshun  Jia</span>, <span class="hlFld-ContribAuthor ">Chunju  Li</span>, <span class="hlFld-ContribAuthor ">Jian  Li</span>, <span class="hlFld-ContribAuthor ">Jianhui  Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Carbon–nitrogen bond cleavage of pyridine with two molecular substituted allenoates: access to 2-arylpyrimidin-4(3
              H
              )-one. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2018,</strong> <em>54 </em>
                                    (100)
                                     , 14128-14131. <a href="https://doi.org/10.1039/C8CC08946A" title="DOI URL">https://doi.org/10.1039/C8CC08946A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8CC08946A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8CC08946A%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DCarbon%2525E2%252580%252593nitrogen%252Bbond%252Bcleavage%252Bof%252Bpyridine%252Bwith%252Btwo%252Bmolecular%252Bsubstituted%252Ballenoates%25253A%252Baccess%252Bto%252B2-arylpyrimidin-4%2525283%252BH%252B%252529-one%26aulast%3DJin%26aufirst%3DTao%26date%3D2018%26date%3D2018%26volume%3D54%26issue%3D100%26spage%3D14128%26epage%3D14131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">V.  Alagarsamy</span>, <span class="hlFld-ContribAuthor ">K.  Chitra</span>, <span class="hlFld-ContribAuthor ">G.  Saravanan</span>, <span class="hlFld-ContribAuthor ">V. Raja  Solomon</span>, <span class="hlFld-ContribAuthor ">M.T.  Sulthana</span>, <span class="hlFld-ContribAuthor ">B.  Narendhar</span>. </span><span class="cited-content_cbyCitation_article-title">An overview of quinazolines: Pharmacological significance and recent developments. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>151 </em>, 628-685. <a href="https://doi.org/10.1016/j.ejmech.2018.03.076" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.03.076</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.03.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.03.076%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAn%252Boverview%252Bof%252Bquinazolines%25253A%252BPharmacological%252Bsignificance%252Band%252Brecent%252Bdevelopments%26aulast%3DAlagarsamy%26aufirst%3DV.%26date%3D2018%26volume%3D151%26spage%3D628%26epage%3D685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael K.  Krapf</span>, <span class="hlFld-ContribAuthor ">Jennifer  Gallus</span>, <span class="hlFld-ContribAuthor ">Michael  Wiese</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological investigation of 2,4-substituted quinazolines as highly potent inhibitors of breast cancer resistance protein (ABCG2). </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>139 </em>, 587-611. <a href="https://doi.org/10.1016/j.ejmech.2017.08.020" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.08.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.08.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.08.020%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Binvestigation%252Bof%252B2%25252C4-substituted%252Bquinazolines%252Bas%252Bhighly%252Bpotent%252Binhibitors%252Bof%252Bbreast%252Bcancer%252Bresistance%252Bprotein%252B%252528ABCG2%252529%26aulast%3DKrapf%26aufirst%3DMichael%2BK.%26date%3D2017%26volume%3D139%26spage%3D587%26epage%3D611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/medium/jm-2017-00441x_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00441&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/medium/jm-2017-00441x_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthesis Route for the Compounds <b>1</b>–<b>48</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00441&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) DMF, I<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 70–90 °C, 4–8 h; (ii) MeOH, NaOMe, 60 W microwave irradiation, 70 °C, 4 h; (iii) POCl<sub>3</sub>, reflux, 4–12 h; (iv) Substituted aniline, 100 W microwave irradiation, 110 °C, 15–30 min.</p></p></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/medium/jm-2017-00441x_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Concentration–response curve of compound <b>14</b> (■, IC<sub>50</sub> = 64.1 nM) and <b>47</b> (▲, IC<sub>50</sub> = 98.8 nM) in a Hoechst 33342 accumulation assay with compound <b>55</b> (○, IC<sub>50</sub> = 227 nM) as reference, using the ABCG2 overexpressing MDCK II cell line.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00441&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/medium/jm-2017-00441x_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. SAR of some substitution patterns used in derivatives with scaffold A. IC<sub>50</sub> range corresponds to given residue containing <i>p</i>-pyridyl or <i>m</i>-pyridyl that were found to be about equally active. Regarding compounds containing scaffold B, the same ranking and similar IC<sub>50</sub> values were obtained in comparison to scaffold A.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00441&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/medium/jm-2017-00441x_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Inhibitory effect of screened compounds toward ABCB1 overexpressing cell line A2780adr (a) and ABCC1 overexpressing cell line H69AR (b) in a calcein AM assay at a concentration of 10 μM. Cyclosporine A (CsA) was used as positive control, indicating complete inhibition. The length of the bars represents the inhibition compared to the positive control in percent. For each compound, three independent experiments were performed and the standard deviation expressed as error bars.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00441&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/medium/jm-2017-00441x_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Concentration–response curve of compound <b>39</b> (●, IC<sub>50</sub> = 0.334 μM) in a calcein AM assay with cyclosporine A (○, IC<sub>50</sub> = 1.21 μM) as reference, using the ABCB1 overexpressing cell line A2780adr. Results were obtained in at least three independent experiments, and the standard deviation is expressed by error bars.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00441&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/medium/jm-2017-00441x_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Representative examples of MTT viability assays of compounds <b>14</b> and <b>42</b> with low and higher cytotoxicity using the MDCK II ABCG2 overexpressing (●) and parental MDCK II cell line (○). There is no significant difference in the intrinsic toxicities comparing the parental and ABCG2 expressing cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00441&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/medium/jm-2017-00441x_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Therapeutic ratios of selected compounds, calculated from the ratio of GI<sub>50</sub> to IC<sub>50</sub> derived from MTT viability assay and Hoechst 33342 accumulation assay, respectively. The highest score was obtained for compound <b>14</b> (GI<sub>50</sub>/IC<sub>50</sub> = 1140), while the reference compound <b>55</b> yielded GI<sub>50</sub>/IC<sub>50</sub> = 55.5.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00441&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/medium/jm-2017-00441x_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. MTT assay to determine the ability of compounds <b>14</b> (a,b), <b>16</b> (c,d), and <b>47</b> (e,f) to reverse the resistance against the cytostatic SN-38, using the ABCG2 overexpressing cell line (a,c,e) and parental MDCK II cells (b,d,f). The gray arrow indicates the increasing sensitization of the ABCG2 overexpressing cells with higher compound concentrations. The following concentrations were used: control (●), 0.01 μM (■), 0.03 μM (▲), 0.1 μM (▼), 1 μM (△), 5 μM (□), parental cell line (○). At a compound concentration of 1 μM, full reversal is achieved, indicated by a similar pGI<sub>50</sub> as the parental cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00441&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/medium/jm-2017-00441x_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Nonlinear regression of the pGI<sub>50</sub> values determined in the MDR reversal assay (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>a,c,e) against the corresponding concentrations of compounds <b>14</b>, <b>16</b>, and <b>47</b>. pEC<sub>50</sub> is the concentration that reduces resistance of the ABCG2 overexpressing cells to 50%. The following EC<sub>50</sub> values were calculated: 21.2 nM (<b>14</b>), 85.0 nM (<b>16</b>), and 62.3 nM (<b>47</b>). The pGI<sub>50</sub> values of the parental cells determined in an analogous assay (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>b,d,f) are depicted by open circles. The point in parentheses at 0.1 μM in (c) was excluded.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00441&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/medium/jm-2017-00441x_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. MDR reversal assay of compound <b>14</b> (a, EC<sub>50</sub> 12.6 nM) and <b>47</b> (b, EC<sub>50</sub> 22.0 nM), demonstrating the ability to reverse the MDR toward the cytostatic MX, using ABCG2 overexpressing cell line MDCK II. The bars represent the cell viability at a given modulator concentration in the presence (light gray) and absence (dark gray) of 5 μM MX. The control shows cell viability of cells without modulator in the presence and absence of 5 μM MX. Standard deviation is expressed by error bars.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00441&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/medium/jm-2017-00441x_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Concentration–response curves for compounds <b>14</b>, <b>26</b>, <b>39</b>, and quercetin in the ATPase assay. All values are relative vanadate-sensitive ATPase activities in relation to the basal activity, which is set to 100%.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00441&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/medium/jm-2017-00441x_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Lineweaver–Burk plots for compounds <b>14</b> (a), <b>21</b> (b), and <b>26</b> (c) at various concentrations together with the ABCG2 substrate Hoechst 33342. Hanes–Woolf plots at various concentrations of Hoechst 33342 for compounds <b>14</b> (d), <b>21</b> (e), and <b>26</b> (f). Plot of the Michaelis–Menten constant <i>K</i><sub>M</sub> (●) and the maximum velocity <i>V</i><sub>max</sub> (■) derived from the analysis according to Cornish–Bowden against the corresponding compound concentration (g,h,i). Here excluded values are depicted by the corresponding open symbols.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00441/20170519/images/large/jm-2017-00441x_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00441&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i85">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87547" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87547" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 58 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Robey, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">To, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polgar, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dohse, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fetsch, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S. E.</span><span> </span><span class="NLM_article-title">ABCG2: A Perspective</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span><span class="refDoi"> DOI: 10.1016/j.addr.2008.11.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2Fj.addr.2008.11.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=19135109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1alu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2009&pages=3-13&author=R.+W.+Robeyauthor=K.+K.+Toauthor=O.+Polgarauthor=M.+Dohseauthor=P.+Fetschauthor=M.+Deanauthor=S.+E.+Bates&title=ABCG2%3A+A+Perspective&doi=10.1016%2Fj.addr.2008.11.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">ABCG2: A perspective</span></div><div class="casAuthors">Robey, Robert W.; To, Kenneth K. K.; Polgar, Orsolya; Dohse, Marius; Fetsch, Patricia; Dean, Michael; Bates, Susan E.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-13</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  ABCG2, or breast cancer resistance protein (BCRP), is an ABC transporter that has been the subject of intense study since its discovery a decade ago.  With high normal tissue expression in the brain endothelium, gastrointestinal tract, and placenta, ABCG2 is believed to be important in the protection from xenobiotics, regulating oral bioavailability, forming part of the blood-brain barrier, the blood-testis barrier, and the maternal-fetal barrier.  Notably, ABCG2 is often expressed in stem cell populations, where it likely plays a role in xenobiotic protection.  However, clues to its epigenetic regulation in various cell populations are only beginning to emerge.  While ABCG2 overexpression has been demonstrated in cancer cells after in vitro drug treatment, endogenous ABCG2 expression in certain cancers is likely a reflection of the differentiated phenotype of the cell of origin and likely contributes to intrinsic drug resistance.  Notably, research into the transporter's role in cancer drug resistance and its development as a therapeutic target in cancer has lagged.  Substrates and inhibitors of the transporter have been described, among them chemotherapy drugs, tyrosine kinase inhibitors, antivirals, HMG-CoA reductase inhibitors, carcinogens, and flavonoids.  This broad range of substrates complements the efficiency of ABCG2 as a transporter in lab. studies and suggests that, while there are redundant mechanisms of xenobiotic protection, the protein is important in normal physiol.  Indeed, emerging studies in pharmacol. and toxicol. assessing polymorphic variants in man, in combination with murine knockout models have confirmed its dynamic role.  Work in pharmacol. may eventually lead us to a greater understanding of the physiol. role of ABCG2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXHdrQffcZprVg90H21EOLACvtfcHk0lg9tpqKP5BxtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1alu70%253D&md5=dc00a9793b185b7a23290a21ed3ea8ba</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2008.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2008.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DRobey%26aufirst%3DR.%2BW.%26aulast%3DTo%26aufirst%3DK.%2BK.%26aulast%3DPolgar%26aufirst%3DO.%26aulast%3DDohse%26aufirst%3DM.%26aulast%3DFetsch%26aufirst%3DP.%26aulast%3DDean%26aufirst%3DM.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DABCG2%253A%2520A%2520Perspective%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2009%26volume%3D61%26spage%3D3%26epage%3D13%26doi%3D10.1016%2Fj.addr.2008.11.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Mo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.-T.</span><span> </span><span class="NLM_article-title">Human ABCG2: Structure, Function, and its Role in Multidrug Resistance</span> <span class="citation_source-journal">Int. J. Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2012&pages=1-27&author=W.+Moauthor=J.-T.+Zhang&title=Human+ABCG2%3A+Structure%2C+Function%2C+and+its+Role+in+Multidrug+Resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMo%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DJ.-T.%26atitle%3DHuman%2520ABCG2%253A%2520Structure%252C%2520Function%252C%2520and%2520its%2520Role%2520in%2520Multidrug%2520Resistance%26jtitle%3DInt.%2520J.%2520Biochem.%2520Mol.%2520Biol.%26date%3D2012%26volume%3D1%26spage%3D1%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Zhang, J. T.</span><span> </span><span class="NLM_article-title">Use of Arrays to Investigate the Contribution of ATP-Binding Cassette Transporters to Drug Resistance in Cancer Chemotherapy and Prediction of Chemosensitivity</span> <span class="citation_source-journal">Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">323</span><span class="refDoi"> DOI: 10.1038/cr.2007.15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1038%2Fcr.2007.15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=17404598" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkt1Chtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=311-323&author=J.+T.+Zhang&title=Use+of+Arrays+to+Investigate+the+Contribution+of+ATP-Binding+Cassette+Transporters+to+Drug+Resistance+in+Cancer+Chemotherapy+and+Prediction+of+Chemosensitivity&doi=10.1038%2Fcr.2007.15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Use of arrays to investigate the contribution of ATP-binding cassette transporters to drug resistance in cancer chemotherapy and prediction of chemosensitivity</span></div><div class="casAuthors">Zhang, Jian-Ting</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">311-323</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Multidrug resistance (MDR) is a major problem in cancer chemotherapy.  One of the best known mechanisms of MDR is the elevated expression of ATP-binding cassette (ABC) transporters.  While some members of human ABC transporters have been shown to cause drug resistance with elevated expression, it is not yet known whether the over-expression of other members could also contribute to drug resistance in many model cancer cell lines and clinics.  The recent development of microarrays and quant. PCR arrays for expression profiling anal. of ABC transporters has helped address these issues.  In this article, various arrays with limited or full list of ABC transporter genes and their use in identifying ABC transporter genes in drug resistance and chemo-sensitivity prediction will be reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFJxltRNjjorVg90H21EOLACvtfcHk0lg9tpqKP5BxtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkt1Chtb0%253D&md5=28d341004d5cfc22a14048234ba704d3</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fcr.2007.15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcr.2007.15%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%2BT.%26atitle%3DUse%2520of%2520Arrays%2520to%2520Investigate%2520the%2520Contribution%2520of%2520ATP-Binding%2520Cassette%2520Transporters%2520to%2520Drug%2520Resistance%2520in%2520Cancer%2520Chemotherapy%2520and%2520Prediction%2520of%2520Chemosensitivity%26jtitle%3DCell%2520Res.%26date%3D2007%26volume%3D17%26spage%3D311%26epage%3D323%26doi%3D10.1038%2Fcr.2007.15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Gottesman, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fojo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S. E.</span><span> </span><span class="NLM_article-title">Multidrug Resistance in Cancer: Role of ATP-dependent Transporters</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">48</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span><span class="refDoi"> DOI: 10.1038/nrc706</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1038%2Fnrc706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=11902585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BD38XhvF2jtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=48-58&author=M.+M.+Gottesmanauthor=T.+Fojoauthor=S.+E.+Bates&title=Multidrug+Resistance+in+Cancer%3A+Role+of+ATP-dependent+Transporters&doi=10.1038%2Fnrc706"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug resistance in cancer: role of ATP-dependent transporters</span></div><div class="casAuthors">Gottesman, Michael M.; Fojo, Tito; Bates, Susan E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-58</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Chemotherapeutics are the most effective treatment for metastatic tumors.  However, the ability of cancer cells to become simultaneously resistant to different drugs, a trait known as multidrug resistance, remains a significant impediment to successful chemotherapy.  Three decades of multidrug-resistance research have identified a myriad of ways in which cancer cells can elude chemotherapy, and it has become apparent that resistance exists against every effective drug, even our newest agents.  Therefore, the ability to predict and circumvent drug resistance is likely to improve chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRJtnCZv-ZtrVg90H21EOLACvtfcHk0lg67JvGB-SCpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhvF2jtL8%253D&md5=ec5284e1fe4a878c5ffc30ee83bccc9d</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrc706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc706%26sid%3Dliteratum%253Aachs%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26aulast%3DFojo%26aufirst%3DT.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DMultidrug%2520Resistance%2520in%2520Cancer%253A%2520Role%2520of%2520ATP-dependent%2520Transporters%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D48%26epage%3D58%26doi%3D10.1038%2Fnrc706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Miyake, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mickley, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristensen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brangi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenberger, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fojo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S. E.</span><span> </span><span class="NLM_article-title">Molecular Cloning of cDNAs Which are Highly Overexpressed in Mitoxantrone Resistant Cells: Demonstration of Homology to ABC Transport Genes</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">8</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=8-13&author=K.+Miyakeauthor=L.+Mickleyauthor=T.+Litmanauthor=Z.+Zhanauthor=R.+Robeyauthor=B.+Cristensenauthor=M.+Brangiauthor=L.+Greenbergerauthor=M.+Deanauthor=T.+Fojoauthor=S.+E.+Bates&title=Molecular+Cloning+of+cDNAs+Which+are+Highly+Overexpressed+in+Mitoxantrone+Resistant+Cells%3A+Demonstration+of+Homology+to+ABC+Transport+Genes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiyake%26aufirst%3DK.%26aulast%3DMickley%26aufirst%3DL.%26aulast%3DLitman%26aufirst%3DT.%26aulast%3DZhan%26aufirst%3DZ.%26aulast%3DRobey%26aufirst%3DR.%26aulast%3DCristensen%26aufirst%3DB.%26aulast%3DBrangi%26aufirst%3DM.%26aulast%3DGreenberger%26aufirst%3DL.%26aulast%3DDean%26aufirst%3DM.%26aulast%3DFojo%26aufirst%3DT.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DMolecular%2520Cloning%2520of%2520cDNAs%2520Which%2520are%2520Highly%2520Overexpressed%2520in%2520Mitoxantrone%2520Resistant%2520Cells%253A%2520Demonstration%2520of%2520Homology%2520to%2520ABC%2520Transport%2520Genes%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D8%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Pluchino, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldsborough, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callaghan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottesman, M. M.</span><span> </span><span class="NLM_article-title">Collateral Sensitivity as a Strategy Against Cancer Multidrug Resistance</span> <span class="citation_source-journal">Drug Resist. Updates</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">98</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span><span class="refDoi"> DOI: 10.1016/j.drup.2012.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2Fj.drup.2012.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=22483810" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC38XmslynsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2012&pages=98-105&author=K.+M.+Pluchinoauthor=M.+D.+Hallauthor=A.+S.+Goldsboroughauthor=R.+Callaghanauthor=M.+M.+Gottesman&title=Collateral+Sensitivity+as+a+Strategy+Against+Cancer+Multidrug+Resistance&doi=10.1016%2Fj.drup.2012.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Collateral sensitivity as a strategy against cancer multidrug resistance</span></div><div class="casAuthors">Pluchino, Kristen M.; Hall, Matthew D.; Goldsborough, Andrew S.; Callaghan, Richard; Gottesman, Michael M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Resistance Updates</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">98-105</span>CODEN:
                <span class="NLM_cas:coden">DRUPFW</span>;
        ISSN:<span class="NLM_cas:issn">1368-7646</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  While chemotherapy remains the most effective treatment for disseminated tumors, acquired or intrinsic drug resistance accounts for approx. 90% of treatment failure.  Multidrug resistance (MDR), the simultaneous resistance to drugs that differ both structurally and mechanistically, often results from drug efflux pumps in the cell membrane that reduce intracellular drug levels to less than therapeutic concns.  Expression of the MDR transporter P-glycoprotein (P-gp, MDR1, ABCB1) has been shown to correlate with overall poor chemotherapy response and prognosis.  This review will focus on collateral sensitivity (CS), the ability of compds. to kill MDR cells selectively over the parental cells from which they were derived.  Insights into CS may offer an alternative strategy for the clin. resoln. of MDR, as highly selective and potent CS agents may lead to drugs that are effective at MDR cell killing and tumor resensitization.  Four main mechanistic hypotheses for CS will be reviewed, followed by a discussion on quant. and exptl. evaluation of CS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox5FqYWa-hS7Vg90H21EOLACvtfcHk0lg67JvGB-SCpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmslynsLg%253D&md5=237f7f798703a7f9c45e75796e0b5d2d</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.drup.2012.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drup.2012.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DPluchino%26aufirst%3DK.%2BM.%26aulast%3DHall%26aufirst%3DM.%2BD.%26aulast%3DGoldsborough%26aufirst%3DA.%2BS.%26aulast%3DCallaghan%26aufirst%3DR.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26atitle%3DCollateral%2520Sensitivity%2520as%2520a%2520Strategy%2520Against%2520Cancer%2520Multidrug%2520Resistance%26jtitle%3DDrug%2520Resist.%2520Updates%26date%3D2012%26volume%3D15%26spage%3D98%26epage%3D105%26doi%3D10.1016%2Fj.drup.2012.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Fojo, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slamon, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poplack, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottesman, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastan, I.</span><span> </span><span class="NLM_article-title">Expression of a Multidrug-resistance Gene in Human Tumors and Tissues</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span><span class="refDoi"> DOI: 10.1073/pnas.84.1.265</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1073%2Fpnas.84.1.265" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=2432605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADyaL2sXhtFCmsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=1987&pages=265-269&author=A.+T.+Fojoauthor=K.+Uedaauthor=D.+J.+Slamonauthor=D.+G.+Poplackauthor=M.+M.+Gottesmanauthor=I.+Pastan&title=Expression+of+a+Multidrug-resistance+Gene+in+Human+Tumors+and+Tissues&doi=10.1073%2Fpnas.84.1.265"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of a multidrug-resistance gene in human tumors and tissues</span></div><div class="casAuthors">Fojo, A. T.; Ueda, K.; Slamon, D. J.; Poplack, D. G.; Gottesman, M. M.; Pastan, I.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">265-9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The identification and cloning of a segment of a human multidrug resistance gene (mdr1) has been reported.  To examine the mol. basis of one type of multidrug resistance, RNA was prepd. from human tumors and normal tissues and their content of mdr1 RNA was measured.  The mdr1 gene is expressed at a very high level in the adrenal gland; at a high level in the kidney; at intermediate levels in the lung, liver, lower jejunum, colon, and rectum; and at low levels in many other tissues.  The mdr1 gene is also expressed in several human tumors, including many but not all tumors derived from the adrenal gland and the colon.  In addn., increased expression was detected in a few tumors at the time of relapse following initial chemotherapy.  Although controlled clin. studies will be required, the results suggest that measurement of mdr1 RNA may prove to be a valuable tool in the design of chemotherapy protocols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1ZJTrls19i7Vg90H21EOLACvtfcHk0lg67JvGB-SCpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXhtFCmsr4%253D&md5=b75baa0e65eb1e16ac2e192ac0f05965</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1073%2Fpnas.84.1.265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.84.1.265%26sid%3Dliteratum%253Aachs%26aulast%3DFojo%26aufirst%3DA.%2BT.%26aulast%3DUeda%26aufirst%3DK.%26aulast%3DSlamon%26aufirst%3DD.%2BJ.%26aulast%3DPoplack%26aufirst%3DD.%2BG.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26aulast%3DPastan%26aufirst%3DI.%26atitle%3DExpression%2520of%2520a%2520Multidrug-resistance%2520Gene%2520in%2520Human%2520Tumors%2520and%2520Tissues%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1987%26volume%3D84%26spage%3D265%26epage%3D269%26doi%3D10.1073%2Fpnas.84.1.265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">McDevitt, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerr, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callaghan, R.</span><span> </span><span class="NLM_article-title">Purification and Structural Analyses of ABCG2</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">65</span><span class="refDoi"> DOI: 10.1016/j.addr.2008.07.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2Fj.addr.2008.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=19124053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1alu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2009&pages=57-65&author=C.+A.+McDevittauthor=R.+Collinsauthor=I.+D.+Kerrauthor=R.+Callaghan&title=Purification+and+Structural+Analyses+of+ABCG2&doi=10.1016%2Fj.addr.2008.07.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Purification and structural analyses of ABCG2</span></div><div class="casAuthors">McDevitt, Christopher A.; Collins, Richard; Kerr, Ian D.; Callaghan, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-65</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The ABCG2/BRCP protein is best known as a multidrug transporter capable of conferring resistance to cancer cells.  However, the protein is also inherently expressed in numerous barrier tissues and intriguingly within hematopoietic stem cells.  Unlike its partners, ABCB1 and ABCC1, there is considerably less information available on the mol. mechanism of ABCG2/BRCP.  The transporter has a distinct topol. and is presumed to function as a homodimer.  However, a no. of biochem. studies have presented data to suggest that the protein adopts higher order oligomers.  This review focuses on this controversial issue with particular ref. to findings from low resoln. structural data.  In addn., a no. of mol. models of ABCG2/BRCP based on high-resoln. structures of bacterial ABC transporters have recently become available and are critically assessed.  ABCG2/BRCP is a structurally distinct member of the triumvirate of human multidrug transporters and continues to evade description of a unifying mol. mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-26N0eXV32LVg90H21EOLACvtfcHk0li8zkvXUwiQYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1alu7g%253D&md5=8afc7467f79e661e505d5bccbc17cfbf</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2008.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2008.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DMcDevitt%26aufirst%3DC.%2BA.%26aulast%3DCollins%26aufirst%3DR.%26aulast%3DKerr%26aufirst%3DI.%2BD.%26aulast%3DCallaghan%26aufirst%3DR.%26atitle%3DPurification%2520and%2520Structural%2520Analyses%2520of%2520ABCG2%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2009%26volume%3D61%26spage%3D57%26epage%3D65%26doi%3D10.1016%2Fj.addr.2008.07.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Ricci, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovato, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larson, R. S.</span><span> </span><span class="NLM_article-title">ABCG2 Inhibitors: Will They Find Clinical Relevance?</span> <span class="citation_source-journal">J. Dev. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">138</span><span class="refDoi"> DOI: 10.4172/2329-6631.1000138</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.4172%2F2329-6631.1000138" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2015&pages=138&author=J.+W.+Ricciauthor=D.+Lovatoauthor=R.+S.+Larson&title=ABCG2+Inhibitors%3A+Will+They+Find+Clinical+Relevance%3F&doi=10.4172%2F2329-6631.1000138"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.4172%2F2329-6631.1000138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4172%252F2329-6631.1000138%26sid%3Dliteratum%253Aachs%26aulast%3DRicci%26aufirst%3DJ.%2BW.%26aulast%3DLovato%26aufirst%3DD.%26aulast%3DLarson%26aufirst%3DR.%2BS.%26atitle%3DABCG2%2520Inhibitors%253A%2520Will%2520They%2520Find%2520Clinical%2520Relevance%253F%26jtitle%3DJ.%2520Dev.%2520Drugs%26date%3D2015%26volume%3D4%26spage%3D138%26doi%3D10.4172%2F2329-6631.1000138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Diestra, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheffer, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Català, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maliepaard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schellens, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheper, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germà-Lluch, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izquierdo, M.</span><span> </span><span class="NLM_article-title">A. Frequent Expression of the Multi-drug Resistance-associated Protein BCRP/MXR/ABCP/ABCG2 in Human Tumours Detected by the BXP-21 Monoclonal Antibody in Paraffin-Embedded Material</span> <span class="citation_source-journal">J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">198</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">219</span><span class="refDoi"> DOI: 10.1002/path.1203</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1002%2Fpath.1203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=12237881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivV2jsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=198&publication_year=2002&pages=213-219&author=J.+E.+Diestraauthor=G.+L.+Schefferauthor=I.+Catal%C3%A0author=M.+Maliepaardauthor=J.+H.+Schellensauthor=R.+J.+Scheperauthor=J.+R.+Germ%C3%A0-Lluchauthor=M.+Izquierdo&title=A.+Frequent+Expression+of+the+Multi-drug+Resistance-associated+Protein+BCRP%2FMXR%2FABCP%2FABCG2+in+Human+Tumours+Detected+by+the+BXP-21+Monoclonal+Antibody+in+Paraffin-Embedded+Material&doi=10.1002%2Fpath.1203"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Frequent expression of the multi-drug resistance-associated protein BCRP/MXR/ABCP/ABCG2 in human tumours detected by the BXP-21 monoclonal antibody in paraffin-embedded material</span></div><div class="casAuthors">Diestra, Julio E.; Scheffer, George L.; Catala, Isabel; Maliepaard, Marc; Schellens, Jan H. M.; Scheper, Rik J.; Germa-Lluch, Jose R.; Izquierdo, Miguel A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pathology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">198</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-219</span>CODEN:
                <span class="NLM_cas:coden">JPTLAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-3417</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Breast cancer resistance protein (BCRP/MXR/ABCP/ABCG2; hereafter ABCG2) is a member of the ATP-binding-cassette family of transporters that causes multi-drug resistance to various anticancer drugs.  The expression of ABCG2 in human tumors and its potential involvement in clin. drug resistance are unknown.  Recently, two monoclonal antibodies against human ABCG2 were produced, BXP-34 and BXP-21.  This study describes an immunohistochem. method using BXP-21 to study ABCG2 expression in formalin-fixed, paraffin-embedded tissues.  No staining was seen using BXP-34 with the same protocols.  The expression of ABCG2 was then investigated in a panel of 150 untreated human solid tumors comprising 21 tumor types.  Overall, ABCG2 expression was frequent.  Specificity of immunohistochem. was confirmed by the detection of a 72 kDa band in western blotting.  ABCG2 expression was seen in all tumor types, but it seemed more frequent in adenocarcinomas of the digestive tract, endometrium, and lung, and melanoma.  Pos. tumors showed membranous and cytoplasmic staining.  In certain adenocarcinomas, prominent membranous staining was seen.  Endothelial cells frequently displayed moderate to strong staining.  ABCG2 is widely present in untreated human solid tumors and may represent a clin. relevant mechanism of drug resistance.  Future studies in specific tumor types are needed to ascertain its clin. relevance.  BXP-21 and the immunohistochem. protocol described here will be of value in these investigations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-8qhpeoHKKbVg90H21EOLACvtfcHk0li8zkvXUwiQYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivV2jsrY%253D&md5=546dc08a9f0a65804245ffcb5a6dfe04</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1002%2Fpath.1203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpath.1203%26sid%3Dliteratum%253Aachs%26aulast%3DDiestra%26aufirst%3DJ.%2BE.%26aulast%3DScheffer%26aufirst%3DG.%2BL.%26aulast%3DCatal%25C3%25A0%26aufirst%3DI.%26aulast%3DMaliepaard%26aufirst%3DM.%26aulast%3DSchellens%26aufirst%3DJ.%2BH.%26aulast%3DScheper%26aufirst%3DR.%2BJ.%26aulast%3DGerm%25C3%25A0-Lluch%26aufirst%3DJ.%2BR.%26aulast%3DIzquierdo%26aufirst%3DM.%26atitle%3DA.%2520Frequent%2520Expression%2520of%2520the%2520Multi-drug%2520Resistance-associated%2520Protein%2520BCRP%252FMXR%252FABCP%252FABCG2%2520in%2520Human%2520Tumours%2520Detected%2520by%2520the%2520BXP-21%2520Monoclonal%2520Antibody%2520in%2520Paraffin-Embedded%2520Material%26jtitle%3DJ.%2520Pathol.%26date%3D2002%26volume%3D198%26spage%3D213%26epage%3D219%26doi%3D10.1002%2Fpath.1203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Rosenberg, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bikadi, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, Q.</span><span> </span><span class="NLM_article-title">The Human Breast Cancer Resistance Protein (BCRP/ABCG2) Shows Conformational Changes with Mitoxantrone</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">482</span><span class="NLM_x">–</span> <span class="NLM_lpage">493</span><span class="refDoi"> DOI: 10.1016/j.str.2010.01.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2Fj.str.2010.01.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=20399185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvFKnu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=482-493&author=M.+F.+Rosenbergauthor=Z.+Bikadiauthor=J.+Chanauthor=X.+Liuauthor=Z.+Niauthor=X.+Caiauthor=R.+C.+Fordauthor=Q.+Mao&title=The+Human+Breast+Cancer+Resistance+Protein+%28BCRP%2FABCG2%29+Shows+Conformational+Changes+with+Mitoxantrone&doi=10.1016%2Fj.str.2010.01.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The Human Breast Cancer Resistance Protein (BCRP/ABCG2) Shows Conformational Changes with Mitoxantrone</span></div><div class="casAuthors">Rosenberg, Mark F.; Bikadi, Zsolt; Chan, Janice; Liu, Xiaoping; Ni, Zhanglin; Cai, Xiaokun; Ford, Robert C.; Mao, Qingcheng</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">482-493</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">BCRP/ABCG2 mediates efflux of drugs and xenobiotics.  BCRP was expressed in Pichia pastoris, purified to > 90% homogeneity, and subjected to two-dimensional (2D) crystn.  The 2D crystals showed a p121 symmetry and projection maps were detd. at 5 Å resoln. by cryo-electron microscopy.  Two crystal forms with and without mitoxantrone were obsd. with unit cell dimensions of a = 55.4 Å, b = 81.4 Å, γ = 89.8°, and a = 57.3 Å, b = 88.0 Å, γ = 89.7°, resp.  The projection map without mitoxantrone revealed an asym. structure with ring-shaped d. features probably corresponding to a bundle of transmembrane α helixes, and appeared more open and less sym. than the map with mitroxantrone.  The open and closed inward-facing forms of BCRP were generated by homol. modeling, representing the substrate-free and substrate-bound conformations in the absence of nucleotide, resp.  These models are consistent with the exptl. obsd. conformational change upon substrate binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy41Lg_ARysLVg90H21EOLACvtfcHk0liMmQBIc4uVUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvFKnu7s%253D&md5=259f90447cbb30589018f12c155cf19e</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2010.01.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2010.01.017%26sid%3Dliteratum%253Aachs%26aulast%3DRosenberg%26aufirst%3DM.%2BF.%26aulast%3DBikadi%26aufirst%3DZ.%26aulast%3DChan%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DNi%26aufirst%3DZ.%26aulast%3DCai%26aufirst%3DX.%26aulast%3DFord%26aufirst%3DR.%2BC.%26aulast%3DMao%26aufirst%3DQ.%26atitle%3DThe%2520Human%2520Breast%2520Cancer%2520Resistance%2520Protein%2520%2528BCRP%252FABCG2%2529%2520Shows%2520Conformational%2520Changes%2520with%2520Mitoxantrone%26jtitle%3DStructure%26date%3D2010%26volume%3D18%26spage%3D482%26epage%3D493%26doi%3D10.1016%2Fj.str.2010.01.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Wong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briddon, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holliday, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerr, I. D.</span><span> </span><span class="NLM_article-title">Plasma Membrane Dynamics and Tetrameric Organisation of ABCG2 Transporters in Mammalian Cells Revealed by Single Particle Imaging Techniques</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">1863</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span><span class="refDoi"> DOI: 10.1016/j.bbamcr.2015.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2Fj.bbamcr.2015.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=26453803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Chtb%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1863&publication_year=2016&pages=19-29&author=K.+Wongauthor=S.+J.+Briddonauthor=N.+D.+Hollidayauthor=I.+D.+Kerr&title=Plasma+Membrane+Dynamics+and+Tetrameric+Organisation+of+ABCG2+Transporters+in+Mammalian+Cells+Revealed+by+Single+Particle+Imaging+Techniques&doi=10.1016%2Fj.bbamcr.2015.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma membrane dynamics and tetrameric organisation of ABCG2 transporters in mammalian cells revealed by single particle imaging techniques</span></div><div class="casAuthors">Wong, Kelvin; Briddon, Stephen J.; Holliday, Nicholas D.; Kerr, Ian D.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">1863</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-29</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">ABCG2 is one of three human ATP binding cassette (ABC) transporters involved in the export from cells of a chem. and structurally diverse range of compds.  This multidrug efflux capability, together with a broad tissue distribution in the body, means that ABCG2 exerts a range of effects on normal physiol. such as kidney urate transport, as well as contributing towards the pharmacokinetic profiles of many exogenous drugs.  The primary sequence of ABCG2 contains only half the no. of domains required for a functioning ABC transporter and so it must oligomerise in order to function, yet its oligomeric state in intact cell membranes remains uncharacterized.  We have analyzed ABCG2 in living cell membranes using a combination of fluorescence correlation spectroscopy, photon counting histogram anal., and stepwise photobleaching to demonstrate a predominantly tetrameric structure for ABCG2 in the presence or absence of transport substrates.  These results provide the essential basis for exploring pharmacol. manipulation of oligomeric state as a strategy to modulate ABCG2 activity in future selective therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCBGt4Y70W5LVg90H21EOLACvtfcHk0liMmQBIc4uVUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Chtb%252FN&md5=89fe45505b932fa860e4c9151fc610e0</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2015.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2015.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DK.%26aulast%3DBriddon%26aufirst%3DS.%2BJ.%26aulast%3DHolliday%26aufirst%3DN.%2BD.%26aulast%3DKerr%26aufirst%3DI.%2BD.%26atitle%3DPlasma%2520Membrane%2520Dynamics%2520and%2520Tetrameric%2520Organisation%2520of%2520ABCG2%2520Transporters%2520in%2520Mammalian%2520Cells%2520Revealed%2520by%2520Single%2520Particle%2520Imaging%2520Techniques%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2016%26volume%3D1863%26spage%3D19%26epage%3D29%26doi%3D10.1016%2Fj.bbamcr.2015.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Dezi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fribourg, P.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Cicco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnaud, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Pietro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lévy, D.</span><span> </span><span class="NLM_article-title">The Multidrug Resistance Half-transporter ABCG2 is Purified as a Tetramer Upon Selective Extraction from Membranes</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Biomembr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1798</span><span class="NLM_x">, </span> <span class="NLM_fpage">2094</span><span class="NLM_x">–</span> <span class="NLM_lpage">2101</span><span class="refDoi"> DOI: 10.1016/j.bbamem.2010.07.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2Fj.bbamem.2010.07.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=20691149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFGhurvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1798&publication_year=2010&pages=2094-2101&author=M.+Deziauthor=P.-F.+Fribourgauthor=A.+Di+Ciccoauthor=O.+Arnaudauthor=S.+Marcoauthor=P.+Falsonauthor=A.+Di+Pietroauthor=D.+L%C3%A9vy&title=The+Multidrug+Resistance+Half-transporter+ABCG2+is+Purified+as+a+Tetramer+Upon+Selective+Extraction+from+Membranes&doi=10.1016%2Fj.bbamem.2010.07.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The multidrug resistance half-transporter ABCG2 is purified as a tetramer upon selective extraction from membranes</span></div><div class="casAuthors">Dezi, Manuela; Fribourg, Pierre-Frederic; Di Cicco, Aurelie; Arnaud, Ophelie; Marco, Sergio; Falson, Pierre; Di Pietro, Attilio; Levy, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1798</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2094-2101</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">ABCG2 is a human membrane ATP-binding cassette half-transporter that hydrolyzes ATP to efflux a large no. of chemotherapeutic agents.  Several oligomeric states of ABCG2 from homodimers to dodecamers have been reported depending on the overexpression systems and/or the protocols used for purifn.  Here, we compared the oligomeric state of His6-ABCG2 expressed in Sf9 insect cells and in human Flp-In-293/ABCG2 cells after solubilization in mild detergents.  His6-ABCG2 was purified through a new approach involving its specific recognition onto a functionalized lipid layer contg. a Ni-NTA lipid.  This approach allowed the purifn. of His-ABCG2 in presence of all solubilized membrane components that might be involved in the stabilization of native oligomers and without requiring any addnl. washing or concn. passages.  ABCG2 purified onto the NiNTA lipid surfaces were directly analyzed by electron microscopy and by biochem. assays.  Altogether, our data are consistent with a tetrameric organization of ABCG2 when expressed in either heterologous Sf9 insect cells or in human homologous cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp83AnAMdQg6bVg90H21EOLACvtfcHk0liMmQBIc4uVUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFGhurvL&md5=9e1f93b37b94937cb10dd19ec9a8c985</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamem.2010.07.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamem.2010.07.034%26sid%3Dliteratum%253Aachs%26aulast%3DDezi%26aufirst%3DM.%26aulast%3DFribourg%26aufirst%3DP.-F.%26aulast%3DDi%2BCicco%26aufirst%3DA.%26aulast%3DArnaud%26aufirst%3DO.%26aulast%3DMarco%26aufirst%3DS.%26aulast%3DFalson%26aufirst%3DP.%26aulast%3DDi%2BPietro%26aufirst%3DA.%26aulast%3DL%25C3%25A9vy%26aufirst%3DD.%26atitle%3DThe%2520Multidrug%2520Resistance%2520Half-transporter%2520ABCG2%2520is%2520Purified%2520as%2520a%2520Tetramer%2520Upon%2520Selective%2520Extraction%2520from%2520Membranes%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D2010%26volume%3D1798%26spage%3D2094%26epage%3D2101%26doi%3D10.1016%2Fj.bbamem.2010.07.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">McDevitt, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modok, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storm, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerr, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callaghan, R.</span><span> </span><span class="NLM_article-title">Purification and 3D Structural Analysis of Oligomeric Human Multidrug Transporter ABCG2</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1623</span><span class="NLM_x">–</span> <span class="NLM_lpage">1632</span><span class="refDoi"> DOI: 10.1016/j.str.2006.08.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2Fj.str.2006.08.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=17098188" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1SmtrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=1623-1632&author=C.+A.+McDevittauthor=R.+F.+Collinsauthor=M.+Conwayauthor=S.+Modokauthor=J.+Stormauthor=I.+D.+Kerrauthor=R.+C.+Fordauthor=R.+Callaghan&title=Purification+and+3D+Structural+Analysis+of+Oligomeric+Human+Multidrug+Transporter+ABCG2&doi=10.1016%2Fj.str.2006.08.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Purification and 3D Structural Analysis of Oligomeric Human Multidrug Transporter ABCG2</span></div><div class="casAuthors">McDevitt, Christopher A.; Collins, Richard F.; Conway, Michael; Modok, Szabolcs; Storm, Janet; Kerr, Ian D.; Ford, Robert C.; Callaghan, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1623-1632</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">ABCG2 is a multidrug efflux pump assocd. with resistance of cancer cells to a plethora of unrelated drugs.  ABCG2 is a "half-transporter," and previous studies have indicated that it forms homodimers and higher oligomeric species.  In this manuscript, electron microscopic structural anal. directly addressed this issue.  An N-terminal hexahistidine-tagged ABCG2R482G isoform was expressed to high levels in insect cells.  An extensive detergent screen was employed to effect extn. of ABCG2R482G from membranes and identified only the fos-choline detergents as efficient.  Sol. protein was purified to >95% homogeneity by a three-step procedure while retaining the ability to bind substrates.  Cryoneg. stain electron microscopy of purified ABCG2R482G provided 3D structural data at a resoln. of ∼18 Å.  Single-particle anal. revealed that the complex forms a tetrameric complex (∼180 Å in diam. × ∼140 Å high) with an aq. central region.  We interpret the tetrameric structure as comprising four homodimeric ABCG2R482G complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwtScpCugTgbVg90H21EOLACvtfcHk0lhYoahhTV59VA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1SmtrzN&md5=f56278a6fc2b6b53312b604f018d89d8</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2006.08.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2006.08.014%26sid%3Dliteratum%253Aachs%26aulast%3DMcDevitt%26aufirst%3DC.%2BA.%26aulast%3DCollins%26aufirst%3DR.%2BF.%26aulast%3DConway%26aufirst%3DM.%26aulast%3DModok%26aufirst%3DS.%26aulast%3DStorm%26aufirst%3DJ.%26aulast%3DKerr%26aufirst%3DI.%2BD.%26aulast%3DFord%26aufirst%3DR.%2BC.%26aulast%3DCallaghan%26aufirst%3DR.%26atitle%3DPurification%2520and%25203D%2520Structural%2520Analysis%2520of%2520Oligomeric%2520Human%2520Multidrug%2520Transporter%2520ABCG2%26jtitle%3DStructure%26date%3D2006%26volume%3D14%26spage%3D1623%26epage%3D1632%26doi%3D10.1016%2Fj.str.2006.08.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.-T.</span><span> </span><span class="NLM_article-title">Characterization of Oligomeric Human Half-ABC Transporter ATP-binding Cassette G2</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">19781</span><span class="NLM_x">–</span> <span class="NLM_lpage">19789</span><span class="refDoi"> DOI: 10.1074/jbc.M310785200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1074%2Fjbc.M310785200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=15001581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1Wit7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=19781-19789&author=J.+Xuauthor=Y.+Liuauthor=Y.+Yangauthor=S.+Batesauthor=J.-T.+Zhang&title=Characterization+of+Oligomeric+Human+Half-ABC+Transporter+ATP-binding+Cassette+G2&doi=10.1074%2Fjbc.M310785200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of Oligomeric Human Half-ABC Transporter ATP-binding Cassette G2</span></div><div class="casAuthors">Xu, Junkang; Liu, Yang; Yang, Youyun; Bates, Susan; Zhang, Jian-Ting</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">19781-19789</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Human ATP-binding cassette G2 (ABCG2, also known as mitoxantrone resistance protein, breast cancer-resistance protein, ABC placenta) is a member of the superfamily of ATP-binding cassette (ABC) transporters that have a wide variety of substrates.  Overexpression of human ABCG2 in model cancer cell lines causes multidrug resistance by actively effluxing anticancer drugs.  Unlike most of the other ABC transporters which usually have two nucleotide-binding domains and two transmembrane domains, ABCG2 consists of only one nucleotide-binding domain followed by one transmembrane domain.  Thus, ABCG2 has been thought to be a half-transporter that may function as a homodimer.  In this study, we characterized the oligomeric feature of human ABCG2 using non-denaturing detergent perfluoro-octanoic acid and Triton X-100 in combination with gel filtration, sucrose d. gradient sedimentation, and gel electrophoresis.  Unexpectedly, we found that human ABCG2 exists mainly as a tetramer, with a possibility of a higher form of oligomerization.  Monomeric and dimeric ABCG2 did not appear to be the major form of the protein.  Further immunopptn. anal. showed that the oligomeric ABCG2 did not contain any other proteins.  Taken together, we conclude that human ABCG2 likely exists and functions as a homotetramer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogS9hRAh_FSbVg90H21EOLACvtfcHk0lhYoahhTV59VA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1Wit7g%253D&md5=c45adb759c2de874ef4c299eb3d0c99e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M310785200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M310785200%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DBates%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DJ.-T.%26atitle%3DCharacterization%2520of%2520Oligomeric%2520Human%2520Half-ABC%2520Transporter%2520ATP-binding%2520Cassette%2520G2%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D19781%26epage%3D19789%26doi%3D10.1074%2Fjbc.M310785200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Lee, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinch, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borek, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urbatsch, I. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, X. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grishin, N. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otwinowski, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobbs, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbaum, D. M.</span><span> </span><span class="NLM_article-title">Crystal structure of the human sterol transporter ABCG5/ABCG8</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">533</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">564</span><span class="refDoi"> DOI: 10.1038/nature17666</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1038%2Fnature17666" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=27144356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC28Xnt1OgsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=533&publication_year=2016&pages=561-564&author=J.+Y.+Leeauthor=L.+N.+Kinchauthor=D.+M.+Borekauthor=J.+Wangauthor=J.+Wangauthor=I.+L.+Urbatschauthor=X.+S.+Xieauthor=N.+V.+Grishinauthor=J.+C.+Cohenauthor=Z.+Otwinowskiauthor=H.+H.+Hobbsauthor=D.+M.+Rosenbaum&title=Crystal+structure+of+the+human+sterol+transporter+ABCG5%2FABCG8&doi=10.1038%2Fnature17666"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the human sterol transporter ABCG5/ABCG8</span></div><div class="casAuthors">Lee, Jyh-Yeuan; Kinch, Lisa N.; Borek, Dominika M.; Wang, Jin; Wang, Junmei; Urbatsch, Ina L.; Xie, Xiao-Song; Grishin, Nikolai V.; Cohen, Jonathan C.; Otwinowski, Zbyszek; Hobbs, Helen H.; Rosenbaum, Daniel M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">533</span>
        (<span class="NLM_cas:issue">7604</span>),
    <span class="NLM_cas:pages">561-564</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">ATP binding cassette (ABC) transporters play crit. roles in maintaining sterol balance in higher eukaryotes.  The ABCG5/ABCG8 heterodimer (G5G8) mediates excretion of neutral sterols in liver and intestines.  Mutations disrupting G5G8 cause sitosterolemia, a disorder characterized by sterol accumulation and premature atherosclerosis.  Here we use crystn. in lipid bilayers to det. the X-ray structure of human G5G8 in a nucleotide-free state at 3.9 Å resoln., generating the first at. model of an ABC sterol transporter.  The structure reveals a new transmembrane fold that is present in a large and functionally diverse superfamily of ABC transporters.  The transmembrane domains are coupled to the nucleotide-binding sites by networks of interactions that differ between the active and inactive ATPases, reflecting the catalytic asymmetry of the transporter.  The G5G8 structure provides a mechanistic framework for understanding sterol transport and the disruptive effects of mutations causing sitosterolemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3PVxVbqX6yLVg90H21EOLACvtfcHk0lhYoahhTV59VA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xnt1OgsrY%253D&md5=fde81e0a40d432c14d192687d0b6f2a3</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnature17666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature17666%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BY.%26aulast%3DKinch%26aufirst%3DL.%2BN.%26aulast%3DBorek%26aufirst%3DD.%2BM.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DUrbatsch%26aufirst%3DI.%2BL.%26aulast%3DXie%26aufirst%3DX.%2BS.%26aulast%3DGrishin%26aufirst%3DN.%2BV.%26aulast%3DCohen%26aufirst%3DJ.%2BC.%26aulast%3DOtwinowski%26aufirst%3DZ.%26aulast%3DHobbs%26aufirst%3DH.%2BH.%26aulast%3DRosenbaum%26aufirst%3DD.%2BM.%26atitle%3DCrystal%2520structure%2520of%2520the%2520human%2520sterol%2520transporter%2520ABCG5%252FABCG8%26jtitle%3DNature%26date%3D2016%26volume%3D533%26spage%3D561%26epage%3D564%26doi%3D10.1038%2Fnature17666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">László, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarkadi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegedűs, T.</span><span> </span><span class="NLM_article-title">Jump into a New Fold-A Homology Based Model for the ABCG2/BCRP Multidrug Transporter</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0164426</span><span class="refDoi"> DOI: 10.1371/journal.pone.0164426</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1371%2Fjournal.pone.0164426" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=27741279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVamt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=e0164426&author=L.+L%C3%A1szl%C3%B3author=B.+Sarkadiauthor=T.+Heged%C5%B1s&title=Jump+into+a+New+Fold-A+Homology+Based+Model+for+the+ABCG2%2FBCRP+Multidrug+Transporter&doi=10.1371%2Fjournal.pone.0164426"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Jump into a new fold - a homology based model for the ABCG2/BCRP multidrug transporter</span></div><div class="casAuthors">Laszlo, Laura; Sarkadi, Balazs; Hegedus, Tamas</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e0164426/1-e0164426/22</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">ABCG2/BCRP is a membrane protein, involved in xenobiotic and endobiotic transport in key pharmacol. barriers and drug metabolizing organs, in the protection of stem cells, and in multidrug resistance of cancer.  Pharmacogenetic studies implicated the role of ABCG2 in response to widely used medicines and anticancer agents, as well as in gout.  Its Q141K variant exhibits decreased functional expression thus increased drug accumulation and decreased urate secretion.  Still, there has been no reliable mol. model available for this protein, as the published structures of other ABC transporters could not be properly fitted to the ABCG2 topol. and exptl. data.  The recently published high resoln. structure of a close homolog, the ABCG5-ABCG8 heterodimer, revealed a new ABC transporter fold, unique for ABCG proteins.  Here we present a structural model of the ABCG2 homodimer based on this fold and detail the exptl. results supporting this model.  In order to describe the effect of mutations on structure and dynamics, and characterize substrate recognition and cholesterol regulation we performed mol. dynamics simulations using full length ABCG2 protein embedded in a membrane bilayer and in silico docking simulations.  Our results show that in the Q141K variant the introduced pos. charge diminishes the interaction between the nucleotide binding and transmembrane domains and the R482G variation alters the orientation of transmembrane helixes.  Moreover, the R482 position, which plays a role the substrate specificity of the transporter, is located in one of the substrate binding pockets identified by the in silico docking calcns.  In summary, the ABCG2 model and in silico simulations presented here may have significant impact on understanding drug distribution and toxicity, as well as drug development against cancer chemotherapy resistance or gout.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEixXLOPXPv7Vg90H21EOLACvtfcHk0lhgDG6qbItUnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVamt74%253D&md5=c30656bb73b52cec8482f00110f573c9</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0164426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0164426%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25A1szl%25C3%25B3%26aufirst%3DL.%26aulast%3DSarkadi%26aufirst%3DB.%26aulast%3DHeged%25C5%25B1s%26aufirst%3DT.%26atitle%3DJump%2520into%2520a%2520New%2520Fold-A%2520Homology%2520Based%2520Model%2520for%2520the%2520ABCG2%252FBCRP%2520Multidrug%2520Transporter%26jtitle%3DPLoS%2520One%26date%3D2016%26volume%3D11%26spage%3De0164426%26doi%3D10.1371%2Fjournal.pone.0164426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Doyle, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, D. D.</span><span> </span><span class="NLM_article-title">Multidrug Resistance Mediated by the Breast Cancer Resistance Protein BCRP (ABCG2)</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">7340</span><span class="NLM_x">–</span> <span class="NLM_lpage">7358</span><span class="refDoi"> DOI: 10.1038/sj.onc.1206938</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1038%2Fsj.onc.1206938" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=14576842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A280%3ADC%252BD3svpvFCjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=7340-7358&author=J.+A.+Doyleauthor=D.+D.+Ross&title=Multidrug+Resistance+Mediated+by+the+Breast+Cancer+Resistance+Protein+BCRP+%28ABCG2%29&doi=10.1038%2Fsj.onc.1206938"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)</span></div><div class="casAuthors">Doyle L Austin; Ross Douglas D</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">7340-58</span>
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    </div><div class="casAbstract">Observations of functional adenosine triphosphate (ATP)-dependent drug efflux in certain multidrug-resistant cancer cell lines without overexpression of P-glycoprotein or multidrug resistance protein (MRP) family members suggested the existence of another ATP-binding cassette (ABC) transporter capable of causing cancer drug resistance.  In one such cell line (MCF-7/AdrVp), the overexpression of a novel member of the G subfamily of ABC transporters was found.  The new transporter was termed the breast cancer resistance protein (BCRP), because of its identification in MCF-7 human breast carcinoma cells.  BCRP is a 655 amino-acid polypeptide, formally designated as ABCG2.  Like all members of the ABC G (white) subfamily, BCRP is a half transporter.  Transfection and enforced overexpression of BCRP in drug-sensitive MCF-7 or MDA-MB-231 cells recapitulates the drug-resistance phenotype of MCF-7/AdrVp cells, consistent with current evidence suggesting that functional BCRP is a homodimer.  BCRP maps to chromosome 4q22, downstream from a TATA-less promoter.  The spectrum of anticancer drugs effluxed by BCRP includes mitoxantrone, camptothecin-derived and indolocarbazole topoisomerase I inhibitors, methotrexate, flavopiridol, and quinazoline ErbB1 inhibitors.  Transport of anthracyclines is variable and appears to depend on the presence of a BCRP mutation at codon 482.  Potent and specific inhibitors of BCRP are now being developed, opening the door to clinical applications of BCRP inhibition.  Owing to tissue localization in the placenta, bile canaliculi, colon, small bowel, and brain microvessel endothelium, BCRP may play a role in protecting the organism from potentially harmful xenobiotics.  BCRP expression has also been demonstrated in pluripotential "side population" stem cells, responsible for the characteristic ability of these cells to exclude Hoechst 33342 dye, and possibly for the maintenance of the stem cell phenotype.  Studies are emerging on the role of BCRP expression in drug resistance in clinical cancers.  More prospective studies are needed, preferably combining BCRP protein or mRNA quantification with functional assays, in order to determine the contribution of BCRP to drug resistance in human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSVhfZWKJa6Ui6Ufuk_1xoTfW6udTcc2eYbfCI2fNnN_7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3svpvFCjug%253D%253D&md5=e47830ac42603a5253b8148ca0e86fe2</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1206938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1206938%26sid%3Dliteratum%253Aachs%26aulast%3DDoyle%26aufirst%3DJ.%2BA.%26aulast%3DRoss%26aufirst%3DD.%2BD.%26atitle%3DMultidrug%2520Resistance%2520Mediated%2520by%2520the%2520Breast%2520Cancer%2520Resistance%2520Protein%2520BCRP%2520%2528ABCG2%2529%26jtitle%3DOncogene%26date%3D2003%26volume%3D22%26spage%3D7340%26epage%3D7358%26doi%3D10.1038%2Fsj.onc.1206938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Stacy, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansson, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, D. R.</span><span> </span><span class="NLM_article-title">Molecular Pharmacology of ABCG2 and its Role in Chemoresistance</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">655</span><span class="NLM_x">–</span> <span class="NLM_lpage">669</span><span class="refDoi"> DOI: 10.1124/mol.113.088609</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1124%2Fmol.113.088609" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=24021215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1KjtLjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2013&pages=655-669&author=A.+E.+Stacyauthor=P.+J.+Janssonauthor=D.+R.+Richardson&title=Molecular+Pharmacology+of+ABCG2+and+its+Role+in+Chemoresistance&doi=10.1124%2Fmol.113.088609"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular pharmacology of ABCG2 and its role in chemoresistance</span></div><div class="casAuthors">Stacy, Alexandra E.; Jansson, Patric J.; Richardson, Des R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">655-669</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The ATP-binding cassette, subfamily G, isoform 2 protein (ABCG2) is an important member of the ABC transporter superfamily, which has been suggested to be involved in multidrug resistance (MDR) in cancer.  Its diverse range of substrates includes many common chemotherapeutics such as imatinib, doxorubicin, and mitoxantrone.  Physiol., ABCG2 is highly expressed in areas such as the blood-brain barrier and gastrointestinal tract, where it is thought to play a role in protection against xenobiotic exposure.  High ABCG2 expression has also been found in a variety of solid tumors and in hematol. malignancies and has been correlated with poorer clin. outcomes.  Furthermore, ABCG2 expression is a characteristic feature of cancer stem cells, which are able to self-renew and differentiate.  These cancer stem cells have been postulated to play an important role in MDR, where their inherent ABCG2 expression may allow them to survive chemotherapy and repopulate the tumor after exposure to chemotherapeutics.  This observation raises the exciting possibility that by inhibiting ABCG2, cancer stem cells and other cancers may be targeted and eradicated, at which point conventional chemotherapeutics would be sufficient to eliminate the remaining tumor cells.  Inhibitors of ABCG2, such as tyrosine kinase inhibitors, phosphodiesterase-5 inhibitors, and the fumitremorgin-type indolyl diketopiperazine, Ko143 [(3S,6S,12aS)-1,2,3,4,6,7,12,12a-octahydro-9-methoxy-6-(2-methylpropyl)-1,4-dioxopyrazino[1',2':1,6]pyrido[3,4-b]indole-3-propanoic acid 1,1-dimethylethyl ester], could potentially be used for this purpose.  However, these agents are still awaiting comprehensive clin. assessment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplO8F0Ak6Zp7Vg90H21EOLACvtfcHk0lhgDG6qbItUnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1KjtLjP&md5=d619971aca497b3b66e70c3c5bcca0bb</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1124%2Fmol.113.088609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.113.088609%26sid%3Dliteratum%253Aachs%26aulast%3DStacy%26aufirst%3DA.%2BE.%26aulast%3DJansson%26aufirst%3DP.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BR.%26atitle%3DMolecular%2520Pharmacology%2520of%2520ABCG2%2520and%2520its%2520Role%2520in%2520Chemoresistance%26jtitle%3DMol.%2520Pharmacol.%26date%3D2013%26volume%3D84%26spage%3D655%26epage%3D669%26doi%3D10.1124%2Fmol.113.088609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Juvale, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span> </span><span class="NLM_article-title">Design of Inhibitors of BCRP/ABCG2</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1521</span><span class="NLM_x">–</span> <span class="NLM_lpage">1527</span><span class="refDoi"> DOI: 10.4155/fmc.15.83</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.4155%2Ffmc.15.83" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=26293476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVegsLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=1521-1527&author=K.+Juvaleauthor=M.+Wiese&title=Design+of+Inhibitors+of+BCRP%2FABCG2&doi=10.4155%2Ffmc.15.83"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Design of inhibitors of BCRP/ABCG2</span></div><div class="casAuthors">Juvale, Kapil; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1521-1527</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">BCRP/ABCG2, a second member of ABC transporter subclass G, has been shown to be overexpressed in several solid tumors, acute myelogenous leukemia and chronic myeloid leukemia.  A variety of chem. unrelated anticancer drugs have been found to be transported by ABCG2 leading to their lower intracellular accumulation and hence causing chemoresistance.  Until now several efforts have been taken to identify potent and selective inhibitors of ABCG2.  Recent studies carried out to deign BCRP inhibitors have been able to point out the effect of the substitution pattern in compd. scaffolds on the potency, selectivity and cytotoxicity of ABCG2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH22yJaa4iMLVg90H21EOLACvtfcHk0lh0KuGYElRBnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVegsLfI&md5=3fe4045f02e562a52ee0a674d09d3ffb</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.4155%2Ffmc.15.83&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.15.83%26sid%3Dliteratum%253Aachs%26aulast%3DJuvale%26aufirst%3DK.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DDesign%2520of%2520Inhibitors%2520of%2520BCRP%252FABCG2%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2015%26volume%3D7%26spage%3D1521%26epage%3D1527%26doi%3D10.4155%2Ffmc.15.83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, B.</span><span> </span><span class="NLM_article-title">Membranous ABCG2 Expression in Colorectal Cancer Independently Correlates with Shortened Patient Survival</span> <span class="citation_source-journal">Cancer Biomarkers</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span><span class="refDoi"> DOI: 10.3233/CBM-130344</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.3233%2FCBM-130344" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=23838136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtV2msb3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=81-88&author=X.+Wangauthor=B.+Xiaauthor=Y.+Liangauthor=L.+Pengauthor=Z.+Wangauthor=J.+Zhuoauthor=W.+Wangauthor=B.+Jiang&title=Membranous+ABCG2+Expression+in+Colorectal+Cancer+Independently+Correlates+with+Shortened+Patient+Survival&doi=10.3233%2FCBM-130344"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Membranous ABCG2 expression in colorectal cancer independently correlates with shortened patient survival</span></div><div class="casAuthors">Wang, Xinying; Xia, Bingqing; Liang, Yan; Peng, Liang; Wang, Zhongqiu; Zhuo, Jingwei; Wang, Weifei; Jiang, Bo</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biomarkers</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">81-88</span>CODEN:
                <span class="NLM_cas:coden">CBAIBM</span>;
        ISSN:<span class="NLM_cas:issn">1574-0153</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">BACKGROUND: ABCG2 is a member of the ATP binding cassette (ABC) transporter superfamily and identified to play an important role in multidrug resistance in many studies.  But the expression of ABCG2 is controversial in many kinds of tumors including colorectal cancer (CRC).  OBJECTIVE: To clarify the expression patterns of ABCG2 and elucidate the prognostic value of ABCG2 in CRC.  METHODS: ABCG2 expression was analyzed in 225 primary CRC tissues using immunohistochem. assessment.  Cytoplasmic and membranous immunoreactivity were semiquant. scored and correlated with clinicopathol. variables. 69 cases were used for survival anal. χ2 test for trends, Kaplan-Meier anal. and Cox's regression were used for statistical anal.  RESULTS: 83.1% cases showed pos. cytoplasmic expression including 13.3% strongly pos. 66.2% showed pos. membranous expression including 15.6% strongly pos. 50% normal mucosa exhibited a strong membranous staining on the apical membrane.  The strongly membranous staining significantly correlated to lymph node and distant metastasis.  While the cytoplasmic expression levels of ABCG2 protein were only correlated with tumor stage.  Survival anal. showed strongly membranous ABCG2 staining correlated to shortened patient survival than neg. one (HR=2.439, 95%CI 1.053-5.650, P=0.038), but not cytoplasmic ABCG2 staining.  DISCUSSION: Our results showed that membranous ABCG2 expression was significantly assocd. with Dukes' stage, lymph node metastasis and distant metastasis.  However, cytoplasmic ABCG2 expression was only significantly assocd. with Dukes' stage.  CONCLUSIONS: Strong membranous ABCG2 staining is a potential new independent prognostic factor of CRC.  Further studies are needed to clarify the role of ABCG2 in colon carcinogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYMptqQbtln7Vg90H21EOLACvtfcHk0lh0KuGYElRBnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtV2msb3M&md5=5e61d07cf9ff492ce3ec51cd09a29408</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.3233%2FCBM-130344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FCBM-130344%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DXia%26aufirst%3DB.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DPeng%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DZhuo%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DJiang%26aufirst%3DB.%26atitle%3DMembranous%2520ABCG2%2520Expression%2520in%2520Colorectal%2520Cancer%2520Independently%2520Correlates%2520with%2520Shortened%2520Patient%2520Survival%26jtitle%3DCancer%2520Biomarkers%26date%3D2013%26volume%3D13%26spage%3D81%26epage%3D88%26doi%3D10.3233%2FCBM-130344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Lin, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, S. C.</span><span> </span><span class="NLM_article-title">Expression of ABCG2 Associated with Tumor Response in Metastatic Colorectal Cancer Patients Receiving First-Line FOLFOX Therapy - Preliminary Evidence</span> <span class="citation_source-journal">Int. J. Biol. Markers</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">182</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span><span class="refDoi"> DOI: 10.5301/jbm.5000004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.5301%2Fjbm.5000004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=23558935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVOgsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2013&pages=182-186&author=P.+C.+Linauthor=H.+H.+Linauthor=J.+K.+Linauthor=C.+C.+Linauthor=S.+H.+Yangauthor=A.+F.+Liauthor=W.+S.+Chenauthor=S.+C.+Chang&title=Expression+of+ABCG2+Associated+with+Tumor+Response+in+Metastatic+Colorectal+Cancer+Patients+Receiving+First-Line+FOLFOX+Therapy+-+Preliminary+Evidence&doi=10.5301%2Fjbm.5000004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of ABCG2 associated with tumor response in metastatic colorectal cancer patients receiving first-line FOLFOX therapy - preliminary evidence</span></div><div class="casAuthors">Lin, Pei-Ching; Lin, Hung-Hsin; Lin, Jen-Kou; Lin, Chun-Chi; Yang, Shung-Haur; Li, Anna Fen-Yau; Chen, Wei-Shone; Chang, Shih-Ching</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biological Markers</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">182-186</span>CODEN:
                <span class="NLM_cas:coden">IBMAEP</span>;
        ISSN:<span class="NLM_cas:issn">1724-6008</span>.
    
            (<span class="NLM_cas:orgname">Wichtig Editore</span>)
        </div><div class="casAbstract">Purpose: We retrospectively analyzed ABCG2 expression levels in patients with metastatic colorectal cancer (CRC) to investigate the interaction between ABCG2 expression and the tumor response to oxaliplatin and 5-fluorouracil (FOLFOX).  Methods: Forty-three patients with CRC with liver metastasis who received first-line FOLFOX treatment at our institution between 2008 and 2010 were enrolled.  ABCG2 expression was assessed by immunohistochem.  Tumor response was detd. using the modified Response Evaluation Criteria in Solid Tumors criteria.  Results: At least 50% tumor shrinkage was obsd. in 16/43 patients (37.2%), including a complete response in 1 patient.  According to the intensity of ABCG2 expression and the percentage of tumor cells expressing ABCG2, 21 tumors displayed high ABCG2 expression.  Among these tumors, only 2 (9.5%) exhibited partial responses to FOLFOX; conversely, 63.6% of tumors with low ABCG2 expression (14/22) responded to FOLFOX.  Primary and corresponding metastatic samples were available for 15 patients, and 13 of the metastatic tumors had higher ABCG2 expression than the corresponding primary tumors, but only 1 of these tumors responded to FOLFOX (7.7%).  Conclusions: ABCG2 expression is assocd. with the tumor response to FOLFOX in patients with metastatic CRC.  ABCC2 may be a selective marker for the efficacy of FOLFOX in treating CRC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxTcS23Oi30bVg90H21EOLACvtfcHk0lh0KuGYElRBnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVOgsLk%253D&md5=2ddddb221d1c545c5908224d801e2b3f</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.5301%2Fjbm.5000004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5301%252Fjbm.5000004%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DP.%2BC.%26aulast%3DLin%26aufirst%3DH.%2BH.%26aulast%3DLin%26aufirst%3DJ.%2BK.%26aulast%3DLin%26aufirst%3DC.%2BC.%26aulast%3DYang%26aufirst%3DS.%2BH.%26aulast%3DLi%26aufirst%3DA.%2BF.%26aulast%3DChen%26aufirst%3DW.%2BS.%26aulast%3DChang%26aufirst%3DS.%2BC.%26atitle%3DExpression%2520of%2520ABCG2%2520Associated%2520with%2520Tumor%2520Response%2520in%2520Metastatic%2520Colorectal%2520Cancer%2520Patients%2520Receiving%2520First-Line%2520FOLFOX%2520Therapy%2520-%2520Preliminary%2520Evidence%26jtitle%3DInt.%2520J.%2520Biol.%2520Markers%26date%3D2013%26volume%3D28%26spage%3D182%26epage%3D186%26doi%3D10.5301%2Fjbm.5000004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Szakács, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottesman, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boumendjel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kachadourian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baubichon-Cortay, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Pietro, A.</span><span> </span><span class="NLM_article-title">Targeting the Achilles Heel of Multidrug-resistant Cancer by Exploiting the Fitness Cost of Resistance</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">5753</span><span class="NLM_x">–</span> <span class="NLM_lpage">5774</span><span class="refDoi"> DOI: 10.1021/cr4006236</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr4006236" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmslSqs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=5753-5774&author=G.+Szak%C3%A1csauthor=M.+D.+Hallauthor=M.+M.+Gottesmanauthor=A.+Boumendjelauthor=R.+Kachadourianauthor=B.+J.+Dayauthor=H.+Baubichon-Cortayauthor=A.+Di+Pietro&title=Targeting+the+Achilles+Heel+of+Multidrug-resistant+Cancer+by+Exploiting+the+Fitness+Cost+of+Resistance&doi=10.1021%2Fcr4006236"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the Achilles Heel of Multidrug-Resistant Cancer by Exploiting the Fitness Cost of Resistance</span></div><div class="casAuthors">Szakacs, Gergely; Hall, Matthew D.; Gottesman, Michael M.; Boumendjel, Ahcene; Kachadourian, Remy; Day, Brian J.; Baubichon-Cortay, Helene; Di Pietro, Attilio</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5753-5774</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The development of multidrug resistance (MDR) in patients suffering cancer remains a significant clin. challenge, with drug efflux by ABC (ATP-binding cassette) transporters contributing significantly.  Strategies to circumvent the reduced drug accumulation conferred by these polyspecific efflux transporters have relied on attempts to develop drugs that bypass extrusion or the exploration of clin. inhibitors that, although showing promise in vitro, have not translated to the clinic.  Alterations that confer selective advantage during the evolution of cancer cells might also create vulnerabilities that can be exploited therapeutically.  As defined by Szybalski and Bryson, collateral sensitivity is a "phenomenon in drug-resistant cells (prokaryotic or eukaryotic) identified during most in vitro studies... [whereby] the development of resistance in cells to one agent can confer higher sensitivity to an alternate agent than seen in the original (parental) line" .  In other words, the resistant cell line is more sensitive to a cytotoxin than the parental line from which it is derived.  From this perspective, resistance can be interpreted as a trait that could be targeted by new drugs.  In this review, we discuss general mechanisms underlying collateral sensitivity and focus on small mols. reported to elicit increased toxicity in cells overexpressing one of the 3 major multidrug transporters.  Such mols. (termed MDR-selective compds.) target multidrug-resistant cycling cells, suggesting that MDR Abc transporters could be considered as the ultimate "Achilles' heel" - the exquisite spot to fatally wound a multidrug-resistant cancer cell.  Herein, we discuss the potential of this emerging technol., cataloging MDR-selective compds. reported in the literature and highlighting chem. features that are assocd. with MDR-selective toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMLnJNMfm0QLVg90H21EOLACvtfcHk0linPwa2RqgTBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmslSqs7Y%253D&md5=7d834ffe642887c535fc295efc772d73</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fcr4006236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr4006236%26sid%3Dliteratum%253Aachs%26aulast%3DSzak%25C3%25A1cs%26aufirst%3DG.%26aulast%3DHall%26aufirst%3DM.%2BD.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26aulast%3DBoumendjel%26aufirst%3DA.%26aulast%3DKachadourian%26aufirst%3DR.%26aulast%3DDay%26aufirst%3DB.%2BJ.%26aulast%3DBaubichon-Cortay%26aufirst%3DH.%26aulast%3DDi%2BPietro%26aufirst%3DA.%26atitle%3DTargeting%2520the%2520Achilles%2520Heel%2520of%2520Multidrug-resistant%2520Cancer%2520by%2520Exploiting%2520the%2520Fitness%2520Cost%2520of%2520Resistance%26jtitle%3DChem.%2520Rev.%26date%3D2014%26volume%3D114%26spage%3D5753%26epage%3D5774%26doi%3D10.1021%2Fcr4006236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Rabindran, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annable, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenberger, L. M.</span><span> </span><span class="NLM_article-title">Reversal of a Novel Multidrug Resistance Mechanism in Human Colon Carcinoma Cells by Fumitremorgin C</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">5850</span><span class="NLM_x">–</span> <span class="NLM_lpage">5858</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=9865745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADyaK1MXivFah" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1998&pages=5850-5858&author=S.+K.+Rabindranauthor=H.+Heauthor=M.+Singhauthor=E.+Brownauthor=K.+I.+Collinsauthor=I.+Annableauthor=L.+M.+Greenberger&title=Reversal+of+a+Novel+Multidrug+Resistance+Mechanism+in+Human+Colon+Carcinoma+Cells+by+Fumitremorgin+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C</span></div><div class="casAuthors">Rabindran, Sridhar K.; He, Haiyin; Singh, Maya; Brown, Eileen; Collins, Karen I.; Annable, Tami; Greenberger, Lee M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">5850-5858</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">AACR Subscription Office</span>)
        </div><div class="casAbstract">We selected a human colon carcinoma cell line in increasing concns. of mitoxantrone to obtain a resistant subline, S1-M1-3.2, with the following characteristics: profound resistance to mitoxantrone; significant cross-resistance to doxorubicin, bisantrene, and topotecan; and very low levels of resistance to Taxol, vinblastine, colchicine, and camptothecin.  This multidrug resistance (MDR) phenotype, which was not reversed by verapamil or another potent P-glycoprotein (Pgp) inhibitor, CL 329,753, was dependent, in part, upon an energy-dependent drug efflux mechanism.  Pgp and the multidrug resistance protein (MRP) were not elevated in the resistant cells relative to the drug-sensitive parent, suggesting that resistance was mediated by a novel pathway of drug transport.  A cell-based screen with S1-M1-3.2 cells was used to identify agents capable of circumventing this non-Pgp, non-MRP MDR.  One of the active agents identified was a mycotoxin, fumitremorgin C.  This mol. was extremely effective in reversing resistance to mitoxantrone, doxorubicin, and topotecan in multidrug-selected cell lines showing this novel phenotype.  Reversal of resistance was assocd. with an increase in drug accumulation.  The compd. did not reverse drug resistance in cells with elevated expression of Pgp or MRP.  We suggest that fumitremorgin C is a highly selective chemosensitizing agent for the resistance pathway we have identified and can be used as a specific pharmacol. probe to distinguish between the diverse resistance mechanisms that occur in the MDR cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG-Y6qf2FmRbVg90H21EOLACvtfcHk0linPwa2RqgTBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXivFah&md5=cacafc261f829003219cdd9f518ac900</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRabindran%26aufirst%3DS.%2BK.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DSingh%26aufirst%3DM.%26aulast%3DBrown%26aufirst%3DE.%26aulast%3DCollins%26aufirst%3DK.%2BI.%26aulast%3DAnnable%26aufirst%3DI.%26aulast%3DGreenberger%26aufirst%3DL.%2BM.%26atitle%3DReversal%2520of%2520a%2520Novel%2520Multidrug%2520Resistance%2520Mechanism%2520in%2520Human%2520Colon%2520Carcinoma%2520Cells%2520by%2520Fumitremorgin%2520C%26jtitle%3DCancer%2520Res.%26date%3D1998%26volume%3D58%26spage%3D5850%26epage%3D5858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Allen, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Loevezijn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakhai, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Valk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Tellingen, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schellens, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koomen, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinkel, A. H.</span><span> </span><span class="NLM_article-title">Potent and Specific Inhibition of the Breast Cancer Resistance Protein Multidrug Transporter in Vitro and in Mouse Intestine by a Novel Analogue of Fumitremorgin C</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">425</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.4161%2Fcbt.1.4.22" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=12477054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BD38Xjt1yqs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=417-425&author=J.+D.+Allenauthor=A.+van+Loevezijnauthor=J.+M.+Lakhaiauthor=M.+van+der+Valkauthor=O.+van+Tellingenauthor=G.+Reidauthor=J.+H.+Schellensauthor=G.+J.+Koomenauthor=A.+H.+Schinkel&title=Potent+and+Specific+Inhibition+of+the+Breast+Cancer+Resistance+Protein+Multidrug+Transporter+in+Vitro+and+in+Mouse+Intestine+by+a+Novel+Analogue+of+Fumitremorgin+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C</span></div><div class="casAuthors">Allen, John D.; Van Loevezijn, Arnold; Lakhai, Jeany M.; Van der Valk, Martin; Van Tellingen, Olaf; Reid, Glen; Schellens, Jan H. M.; Koomen, Gerrit-Jan; Schinkel, Alfred H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">417-425</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Inhibitors of the breast cancer resistance protein (BCRP/ABCG2) multidrug transporter are of interest as chemosensitizers for clin. drug resistance, for improving the pharmacokinetics of substrate chemotherapeutic drugs, and in functional assays of BCRP activity for tailoring chemotherapy.  The fungal toxin fumitremorgin C (FTC) is a potent and specific inhibitor of BCRP, but its neurotoxic effects preclude use in vivo.  We have therefore evaluated a new tetracyclic analog of FTC, Ko143, as a practical inhibitor of BCRP, comparing it with two other analogs in the same class and with GF120918.  All three FTC analogs are effective inhibitors of both mouse Bcrp1 and human BCRP, proving highly active for increasing the intracellular drug accumulation and reversing Bcrp1/BCRP-mediated multidrug resistance.  Indeed, Ko143 appears to be the most potent BCRP inhibitor known thus far.  In contrast, the compds. have only low activity against P-glycoprotein, the multidrug resistance-assocd. protein (MRP1), or other known drug transporters.  They are nontoxic in vitro at useful concns. and evinced no signs of toxicity in mice at high oral or i.p. doses.  Administered p.o. to inhibit intestinal Bcrp1, Ko143 markedly increased the oral availability of topotecan in mice.  It is thus the first highly potent and specific BCRP inhibitor applicable in vivo.  As such, Ko143 and other FTC analogs of this type represent valuable reagents for anal. of drug resistance mechanisms and may be candidates for development as clin. BCRP inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpdmIQAa5j5rVg90H21EOLACvtfcHk0linPwa2RqgTBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xjt1yqs7g%253D&md5=8a54c6c38d9639ec70faa97a279d0a12</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.4161%2Fcbt.1.4.22&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.1.4.22%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DJ.%2BD.%26aulast%3Dvan%2BLoevezijn%26aufirst%3DA.%26aulast%3DLakhai%26aufirst%3DJ.%2BM.%26aulast%3Dvan%2Bder%2BValk%26aufirst%3DM.%26aulast%3Dvan%2BTellingen%26aufirst%3DO.%26aulast%3DReid%26aufirst%3DG.%26aulast%3DSchellens%26aufirst%3DJ.%2BH.%26aulast%3DKoomen%26aufirst%3DG.%2BJ.%26aulast%3DSchinkel%26aufirst%3DA.%2BH.%26atitle%3DPotent%2520and%2520Specific%2520Inhibition%2520of%2520the%2520Breast%2520Cancer%2520Resistance%2520Protein%2520Multidrug%2520Transporter%2520in%2520Vitro%2520and%2520in%2520Mouse%2520Intestine%2520by%2520a%2520Novel%2520Analogue%2520of%2520Fumitremorgin%2520C%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2002%26volume%3D1%26spage%3D417%26epage%3D425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Weidner, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoghbi, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shukla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambudkar, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, V. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulder, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottesman, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Innis, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, M. D.</span><span> </span><span class="NLM_article-title">The Inhibitor Ko143 Is Not Specific for ABCG2</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">354</span><span class="NLM_x">, </span> <span class="NLM_fpage">384</span><span class="NLM_x">–</span> <span class="NLM_lpage">393</span><span class="refDoi"> DOI: 10.1124/jpet.115.225482</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1124%2Fjpet.115.225482" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=26148857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlGrtb7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=354&publication_year=2015&pages=384-393&author=L.+D.+Weidnerauthor=S.+S.+Zoghbiauthor=S.+Luauthor=S.+Shuklaauthor=S.+V.+Ambudkarauthor=V.+W.+Pikeauthor=J.+Mulderauthor=M.+M.+Gottesmanauthor=R.+B.+Innisauthor=M.+D.+Hall&title=The+Inhibitor+Ko143+Is+Not+Specific+for+ABCG2&doi=10.1124%2Fjpet.115.225482"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The inhibitor Ko143 is not specific for ABCG2</span></div><div class="casAuthors">Weidner, Lora D.; Zoghbi, Sami S.; Lu, Shuiyu; Shukla, Suneet; Ambudkar, Suresh V.; Pike, Victor W.; Mulder, Jan; Gottesman, Michael M.; Innis, Robert B.; Hall, Matthew D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">354</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">384-393</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Imaging ATP-binding cassette (ABC) transporter activity in vivo with positron emission tomog. requires both a substrate and a transporter inhibitor.  However, for ABCG2, there is no inhibitor proven to be specific to that transporter alone at the blood-brain barrier.  Ko143 [(3S,6S,12aS)-1,2,3,4,6,7,12,12a-octahydro-9-methoxy-6-(2-methylpropyl)-1,4-dioxopyrazino[1',2':1,6]pyrido[3,4-b]indole-3-propanoic acid 1,1-dimethylethyl ester], a nontoxic analog of fungal toxin fumitremorgin C, is a potent inhibitor of ABCG2, although its specificity in mouse and human systems is unclear.  This study examd. the selectivity of Ko143 using human embryonic kidney cell lines transfected with ABCG2, ABCB1, or ABCC1 in several in vitro assays.  The stability of Ko143 in rat plasma was measured using high performance liq. chromatog.  Our results show that, in addn. to being a potent inhibitor of ABCG2, at higher concns. (≥1 μM) Ko143 also has an effect on the transport activity of both ABCB1 and ABCC1.  Furthermore, Ko143 was found to be unstable in rat plasma.  These findings indicate that Ko143 lacks specificity for ABCG2 and this should be taken into consideration when using Ko143 for both in vitro and in vivo expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqWjvTByDwbLVg90H21EOLACvtfcHk0ljR28GMUSxk8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlGrtb7L&md5=4336228ff99f608f6452dca312e78a5a</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1124%2Fjpet.115.225482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.115.225482%26sid%3Dliteratum%253Aachs%26aulast%3DWeidner%26aufirst%3DL.%2BD.%26aulast%3DZoghbi%26aufirst%3DS.%2BS.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DShukla%26aufirst%3DS.%26aulast%3DAmbudkar%26aufirst%3DS.%2BV.%26aulast%3DPike%26aufirst%3DV.%2BW.%26aulast%3DMulder%26aufirst%3DJ.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26aulast%3DInnis%26aufirst%3DR.%2BB.%26aulast%3DHall%26aufirst%3DM.%2BD.%26atitle%3DThe%2520Inhibitor%2520Ko143%2520Is%2520Not%2520Specific%2520for%2520ABCG2%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2015%26volume%3D354%26spage%3D384%26epage%3D393%26doi%3D10.1124%2Fjpet.115.225482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Gozzi, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouaziz, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daflon-Yunes, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honorat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guragossian, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marminon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valdameri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bollacke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinaud, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchivie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cadena, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jose, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Borgne, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Pietro, A.</span><span> </span><span class="NLM_article-title">Phenolic Indeno[1,2-b]indoles as ABCG2-selective Potent and Non-toxic Inhibitors Stimulating Basal ATPase Activity</span> <span class="citation_source-journal">Drug Des., Dev. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">3481</span><span class="NLM_x">–</span> <span class="NLM_lpage">3495</span><span class="refDoi"> DOI: 10.2147/DDDT.S84982</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.2147%2FDDDT.S84982" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=26170632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A280%3ADC%252BC28%252FivFaisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2015&pages=3481-3495&author=G.+J.+Gozziauthor=Z.+Bouazizauthor=E.+Winterauthor=N.+Daflon-Yunesauthor=M.+Honoratauthor=N.+Guragossianauthor=C.+Marminonauthor=G.+Valdameriauthor=A.+Bollackeauthor=J.+Guillonauthor=N.+Pinaudauthor=M.+Marchivieauthor=S.+M.+Cadenaauthor=J.+Joseauthor=M.+Le+Borgneauthor=A.+Di+Pietro&title=Phenolic+Indeno%5B1%2C2-b%5Dindoles+as+ABCG2-selective+Potent+and+Non-toxic+Inhibitors+Stimulating+Basal+ATPase+Activity&doi=10.2147%2FDDDT.S84982"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Phenolic indeno[1,2-b]indoles as ABCG2-selective potent and non-toxic inhibitors stimulating basal ATPase activity</span></div><div class="casAuthors">Gozzi Gustavo Jabor; Valdameri Glaucio; Bouaziz Zouhair; Guragossian Nathalie; Marminon Christelle; Le Borgne Marc; Winter Evelyn; Daflon-Yunes Nathalia; Honorat Mylene; Di Pietro Attilio; Bollacke Andre; Jose Joachim; Guillon Jean; Pinaud Noel; Marchivie Mathieu; Cadena Silvia M</div><div class="citationInfo"><span class="NLM_cas:title">Drug design, development and therapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3481-95</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Ketonic indeno[1,2-b]indole-9,10-dione derivatives, initially designed as human casein kinase II (CK2) inhibitors, were recently shown to be converted into efficient inhibitors of drug efflux by the breast cancer resistance protein ABCG2 upon suited substitutions including a N (5)-phenethyl on C-ring and hydrophobic groups on D-ring.  A series of ten phenolic and seven p-quinonic derivatives were synthesized and screened for inhibition of both CK2 and ABCG2 activities.  The best phenolic inhibitors were about threefold more potent against ABCG2 than the corresponding ketonic derivatives, and showed low cytotoxicity.  They were selective for ABCG2 over both P-glycoprotein and MRP1 (multidrug resistance protein 1), whereas the ketonic derivatives also interacted with MRP1, and they additionally displayed a lower interaction with CK2.  Quite interestingly, they strongly stimulated ABCG2 ATPase activity, in contrast to ketonic derivatives, suggesting distinct binding sites.  In contrast, the p-quinonic indenoindoles were cytotoxic and poor ABCG2 inhibitors, whereas a partial inhibition recovery could be reached upon hydrophobic substitutions on D-ring, similarly to the ketonic derivatives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSs5R1_TNnRTV1C8OJBvdfbfW6udTcc2ebfC_I26sDa4bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252FivFaisg%253D%253D&md5=2e5893234583c7d11b128c73fce246dd</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.2147%2FDDDT.S84982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FDDDT.S84982%26sid%3Dliteratum%253Aachs%26aulast%3DGozzi%26aufirst%3DG.%2BJ.%26aulast%3DBouaziz%26aufirst%3DZ.%26aulast%3DWinter%26aufirst%3DE.%26aulast%3DDaflon-Yunes%26aufirst%3DN.%26aulast%3DHonorat%26aufirst%3DM.%26aulast%3DGuragossian%26aufirst%3DN.%26aulast%3DMarminon%26aufirst%3DC.%26aulast%3DValdameri%26aufirst%3DG.%26aulast%3DBollacke%26aufirst%3DA.%26aulast%3DGuillon%26aufirst%3DJ.%26aulast%3DPinaud%26aufirst%3DN.%26aulast%3DMarchivie%26aufirst%3DM.%26aulast%3DCadena%26aufirst%3DS.%2BM.%26aulast%3DJose%26aufirst%3DJ.%26aulast%3DLe%2BBorgne%26aufirst%3DM.%26aulast%3DDi%2BPietro%26aufirst%3DA.%26atitle%3DPhenolic%2520Indeno%255B1%252C2-b%255Dindoles%2520as%2520ABCG2-selective%2520Potent%2520and%2520Non-toxic%2520Inhibitors%2520Stimulating%2520Basal%2520ATPase%2520Activity%26jtitle%3DDrug%2520Des.%252C%2520Dev.%2520Ther.%26date%3D2015%26volume%3D9%26spage%3D3481%26epage%3D3495%26doi%3D10.2147%2FDDDT.S84982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">do Rocio Andrade Pires, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lecerf-Schmidt, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guragossian, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pazinato, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gozzi, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valdameri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boumendjel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Pietro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérès, B.</span><span> </span><span class="NLM_article-title">New, Highly Potent and Non-toxic, Chromone Inhibitors of the Human Breast Cancer Resistance Protein ABCG2</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">301</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2016.05.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2Fj.ejmech.2016.05.053" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2016&pages=291-301&author=A.+do+Rocio+Andrade+Piresauthor=F.+Lecerf-Schmidtauthor=N.+Guragossianauthor=J.+Pazinatoauthor=G.+J.+Gozziauthor=E.+Winterauthor=G.+Valdameriauthor=A.+Vealeauthor=A.+Boumendjelauthor=A.+Di+Pietroauthor=B.+P%C3%A9r%C3%A8s&title=New%2C+Highly+Potent+and+Non-toxic%2C+Chromone+Inhibitors+of+the+Human+Breast+Cancer+Resistance+Protein+ABCG2&doi=10.1016%2Fj.ejmech.2016.05.053"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.05.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.05.053%26sid%3Dliteratum%253Aachs%26aulast%3Ddo%2BRocio%2BAndrade%2BPires%26aufirst%3DA.%26aulast%3DLecerf-Schmidt%26aufirst%3DF.%26aulast%3DGuragossian%26aufirst%3DN.%26aulast%3DPazinato%26aufirst%3DJ.%26aulast%3DGozzi%26aufirst%3DG.%2BJ.%26aulast%3DWinter%26aufirst%3DE.%26aulast%3DValdameri%26aufirst%3DG.%26aulast%3DVeale%26aufirst%3DA.%26aulast%3DBoumendjel%26aufirst%3DA.%26aulast%3DDi%2BPietro%26aufirst%3DA.%26aulast%3DP%25C3%25A9r%25C3%25A8s%26aufirst%3DB.%26atitle%3DNew%252C%2520Highly%2520Potent%2520and%2520Non-toxic%252C%2520Chromone%2520Inhibitors%2520of%2520the%2520Human%2520Breast%2520Cancer%2520Resistance%2520Protein%2520ABCG2%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D122%26spage%3D291%26epage%3D301%26doi%3D10.1016%2Fj.ejmech.2016.05.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Pick, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span> </span><span class="NLM_article-title">Tyrosine Kinase Inhibitors Influence ABCG2 Expression in EGFR-positive MDCK BCRP Cells Via the PI3K/Akt Signaling Pathway</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">650</span><span class="NLM_x">–</span> <span class="NLM_lpage">662</span><span class="refDoi"> DOI: 10.1002/cmdc.201100543</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1002%2Fcmdc.201100543" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=22354538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC38XisFyis78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=650-662&author=A.+Pickauthor=M.+Wiese&title=Tyrosine+Kinase+Inhibitors+Influence+ABCG2+Expression+in+EGFR-positive+MDCK+BCRP+Cells+Via+the+PI3K%2FAkt+Signaling+Pathway&doi=10.1002%2Fcmdc.201100543"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosine Kinase Inhibitors Influence ABCG2 Expression in EGFR-Positive MDCK BCRP Cells via the PI3K/Akt Signaling Pathway</span></div><div class="casAuthors">Pick, Anne; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">650-662</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Multidrug resistance obsd. in cancer chemotherapy is commonly attributed to overexpression of efflux transporter proteins.  These proteins act as ATP-dependent drug efflux pumps, actively extruding chemotherapeutic agents from cells and causing a decrease in intracellular drug accumulation.  Besides the well-recognized role of P-glycoprotein (P-gp, ABCB1), the breast cancer resistance protein (BCRP, ABCG2) is becoming increasingly accepted as playing an important role in multidrug resistance.  In contrast to P-glycoprotein, only a few inhibitors of ABCG2 are known.  According to the literature, tyrosine kinase inhibitors (TKIs) can be considered to be broad-spectrum inhibitors, interacting with ABCB1, ABCC1 and ABCG2.  Here, the authors investigated seven different TKIs, gefitinib, erlotinib, AG1478, PD158780, PD153035, nilotinib and imatinib, for their potential to restore ABCG2 sensitivity to cells.  Furthermore, the authors analyzed the alteration of ABCG2 expression caused by TKIs and demonstrated that EGFR inhibitors such as gefitinib and PD158780 reduced both total and surface expression of ABCG2 in EGRF-pos. MDCK BCRP cells by interaction with the PI3K/Akt signaling pathway.  The reduced ABCG2 content led to an increased effect of XR9577, a well-known ABCG2 modulator, lowering the concn. required for half maximal inhibition.  BCR-ABL inhibitors had no influence on ABCG2 expression and modulator activity.  Interestingly, a combination of an EGFR inhibitor with the PI3K/Akt inhibitor LY294002 led to a significant redn. of ABCG2 expression at low concns. of the drugs.  Based on the authors' results, the authors assume that EGFR exerts a post-transcriptional enhancing effect on ABCG2 expression via the PI3K/Akt signaling pathway, which can be attenuated by EGFR inhibitors.  Blocking the key signaling pathway regulating ABCG2 expression with EGFR inhibitors, combined with the inhibition of ABCG2 with potent modulators might be a promising approach to circumvent MDR in cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouvP7V8QMUi7Vg90H21EOLACvtfcHk0ljR28GMUSxk8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisFyis78%253D&md5=c78fc69da2c5a134dd3f669c165364c2</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100543%26sid%3Dliteratum%253Aachs%26aulast%3DPick%26aufirst%3DA.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DTyrosine%2520Kinase%2520Inhibitors%2520Influence%2520ABCG2%2520Expression%2520in%2520EGFR-positive%2520MDCK%2520BCRP%2520Cells%2520Via%2520the%2520PI3K%252FAkt%2520Signaling%2520Pathway%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D650%26epage%3D662%26doi%3D10.1002%2Fcmdc.201100543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Juvale, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span> </span><span class="NLM_article-title">4-Substituted-2-phenylquinazolines as Inhibitors of BCRP</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">6766</span><span class="NLM_x">–</span> <span class="NLM_lpage">6769</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.08.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2Fj.bmcl.2012.08.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=23017888" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVSjsrbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=6766-6769&author=K.+Juvaleauthor=M.+Wiese&title=4-Substituted-2-phenylquinazolines+as+Inhibitors+of+BCRP&doi=10.1016%2Fj.bmcl.2012.08.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">4-Substituted-2-phenylquinazolines as inhibitors of BCRP</span></div><div class="casAuthors">Juvale, Kapil; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6766-6769</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We investigated several 2-phenylquinazolines with different substitutions at position 4 for their BCRP inhibition.  Compds. with Ph ring attached via an amine-contg. linker at position 4 were found to be potent inhibitors of BCRP.  In general compds. with meta substitution of Ph ring at position 4 were found to have higher inhibitory effect, compd. 12 being the most potent and selective towards BCRP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf-v9OH4Nxr7Vg90H21EOLACvtfcHk0ljeFpFzZ-GOVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVSjsrbJ&md5=e96d4566ff6ae54c8e454bda7b50c873</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.08.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.08.024%26sid%3Dliteratum%253Aachs%26aulast%3DJuvale%26aufirst%3DK.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3D4-Substituted-2-phenylquinazolines%2520as%2520Inhibitors%2520of%2520BCRP%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D6766%26epage%3D6769%26doi%3D10.1016%2Fj.bmcl.2012.08.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Juvale, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallus, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span> </span><span class="NLM_article-title">Investigation of Quinazolines as Inhibitors of Breast Cancer Resistance Protein (ABCG2)</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">7858</span><span class="NLM_x">–</span> <span class="NLM_lpage">7873</span><span class="refDoi"> DOI: 10.1016/j.bmc.2013.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2Fj.bmc.2013.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=24184213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWmsb3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=7858-7873&author=K.+Juvaleauthor=J.+Gallusauthor=M.+Wiese&title=Investigation+of+Quinazolines+as+Inhibitors+of+Breast+Cancer+Resistance+Protein+%28ABCG2%29&doi=10.1016%2Fj.bmc.2013.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Investigation of quinazolines as inhibitors of breast cancer resistance protein (ABCG2)</span></div><div class="casAuthors">Juvale, Kapil; Gallus, Jennifer; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7858-7873</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Chemotherapy is one of the major forms of cancer treatment.  Unfortunately, tumors are prone to multidrug resistance leading to failure of treatment.  Breast cancer resistance protein (BCRP), the second member of ABC transporter subfamily G, has been found to play a major role in drug efflux and hence multidrug resistance.  Until now, very few potent and selective BCRP inhibitors like Ko143 have been identified.  In the search for more potent and selective BCRP inhibitors, we synthesized and investigated a series of differently substituted quinazoline compds.  Several variations at positions 2, 4, 6 and 7 of the quinazoline scaffold were carried out to develop a structure-activity-relationship anal. for these compds.  It was found that compds. bearing a Ph substituent at position 2 of the 4-anilinoquinazoline scaffold were most potent.  On the aniline ring at position 4 of the quinazoline moiety substituents like NO2, CN, CF3 led to very high BCRP inhibition potencies.  The most potent compds. were further investigated for their intrinsic cytotoxicity and their ability to reverse the multidrug resistance.  Compd. 20, an anilinoquinazoline bearing a Ph ring at position 2 and meta-nitro substitution on the 4-anilino ring, was found to have the highest therapeutic ratio.  The most active compds. from each variation were also investigated for their effect on BCRP expression.  It was found that compd. 20 has no significant effect on BCRP expression, while compd. 31 decreased the surface BCRP expression.  The only difference in the two compds. was the presence of a 3,4-dimethoxyphenyl ring in compd. 31 instead of Ph substitution at position 2 of the quinazoline moiety.  From the study of all target compds., compd. 20 was the most prominent compd. having inhibitory potency even higher than Ko143, the most potent BCRP inhibitor known.  Compd. 20 was also found to be selective towards BCRP with a very high therapeutic ratio.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwQG7UwDr2PrVg90H21EOLACvtfcHk0ljeFpFzZ-GOVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWmsb3P&md5=45a1d684ff3849c478498ede66d0cda8</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DJuvale%26aufirst%3DK.%26aulast%3DGallus%26aufirst%3DJ.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DInvestigation%2520of%2520Quinazolines%2520as%2520Inhibitors%2520of%2520Breast%2520Cancer%2520Resistance%2520Protein%2520%2528ABCG2%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D7858%26epage%3D7873%26doi%3D10.1016%2Fj.bmc.2013.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Krapf, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of 4-Anilino-quinazolines and -quinolines as Inhibitors of Breast Cancer Resistance Protein (ABCG2)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">5449</span><span class="NLM_x">–</span> <span class="NLM_lpage">5461</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00330</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00330" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC28XntlCnurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=5449-5461&author=M.+K.+Krapfauthor=M.+Wiese&title=Synthesis+and+Biological+Evaluation+of+4-Anilino-quinazolines+and+-quinolines+as+Inhibitors+of+Breast+Cancer+Resistance+Protein+%28ABCG2%29&doi=10.1021%2Facs.jmedchem.6b00330"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of 4-Anilino-quinazolines and -quinolines as Inhibitors of Breast Cancer Resistance Protein (ABCG2)</span></div><div class="casAuthors">Krapf, Michael K.; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5449-5461</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Chemotherapeutic treatment of cancer often fails due to overexpression of the ATP-binding cassette (ABC) transport proteins, like ABCG2, triggering active efflux of various structurally unrelated drugs.  This so-called multidrug resistance (MDR) may be reversed by selective, potent, and nontoxic inhibitors of ABCG2.  As only a few potent inhibitors are known, new compds. based on a 4-substituted-2-phenylquinazoline scaffold were investigated.  Substitution with hydroxy, cyano, nitro, acetamido, and fluoro, e.g., I, led to high inhibitory activities toward ABCG2.  The ability to reverse MDR of the most active compds. was confirmed in a MTT efficacy assay.  Moreover, a negligibly low intrinsic cytotoxicity was found resulting in a high therapeutic ratio.  Investigations of the inhibitory activity toward ABCB1 and ABCC1 yielded a high selectivity toward ABCG2 for the quinazoline compds.  Quinoline-based analogs showed lower inhibitory activity and selectivity.  The study yielded a variety of promising compds., some with superior properties compared to those of the std. inhibitor Ko143.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdz9Uvqz3i6rVg90H21EOLACvtfcHk0ljeFpFzZ-GOVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntlCnurY%253D&md5=a127c60fe7ecf9d5fc76a13903e794db</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00330%26sid%3Dliteratum%253Aachs%26aulast%3DKrapf%26aufirst%3DM.%2BK.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%25204-Anilino-quinazolines%2520and%2520-quinolines%2520as%2520Inhibitors%2520of%2520Breast%2520Cancer%2520Resistance%2520Protein%2520%2528ABCG2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D5449%26epage%3D5461%26doi%3D10.1021%2Facs.jmedchem.6b00330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Tawar, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dwarakanath, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhury, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khaitan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tandon, V.</span><span> </span><span class="NLM_article-title">Influence of Phenyl Ring Disubstitution on Bisbenzimidazole and Terbenzimidazole Cytotoxicity: Synthesis and Biological Evaluation as Radioprotectors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3785</span><span class="NLM_x">–</span> <span class="NLM_lpage">3792</span><span class="refDoi"> DOI: 10.1021/jm030114w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030114w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=3785-3792&author=U.+Tawarauthor=A.+K.+Jainauthor=B.+S.+Dwarakanathauthor=R.+Chandraauthor=Y.+Singhauthor=N.+K.+Chaudhuryauthor=D.+Khaitanauthor=V.+Tandon&title=Influence+of+Phenyl+Ring+Disubstitution+on+Bisbenzimidazole+and+Terbenzimidazole+Cytotoxicity%3A+Synthesis+and+Biological+Evaluation+as+Radioprotectors&doi=10.1021%2Fjm030114w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm030114w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030114w%26sid%3Dliteratum%253Aachs%26aulast%3DTawar%26aufirst%3DU.%26aulast%3DJain%26aufirst%3DA.%2BK.%26aulast%3DDwarakanath%26aufirst%3DB.%2BS.%26aulast%3DChandra%26aufirst%3DR.%26aulast%3DSingh%26aufirst%3DY.%26aulast%3DChaudhury%26aufirst%3DN.%2BK.%26aulast%3DKhaitan%26aufirst%3DD.%26aulast%3DTandon%26aufirst%3DV.%26atitle%3DInfluence%2520of%2520Phenyl%2520Ring%2520Disubstitution%2520on%2520Bisbenzimidazole%2520and%2520Terbenzimidazole%2520Cytotoxicity%253A%2520Synthesis%2520and%2520Biological%2520Evaluation%2520as%2520Radioprotectors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D3785%26epage%3D3792%26doi%3D10.1021%2Fjm030114w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Litman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skovsgaard, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeuthen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, W. D.</span><span> </span><span class="NLM_article-title">ATPase Activity of P-glycoprotein Related to Emergence of Drug Resistance in Ehrlich Ascites Tumor Cell-lines</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Basis Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">1361</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">158</span><span class="refDoi"> DOI: 10.1016/S0925-4439(97)00025-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2FS0925-4439%2897%2900025-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=9300796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADyaK2sXks12gur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1361&publication_year=1997&pages=147-158&author=T.+Litmanauthor=D.+Nielsenauthor=T.+Skovsgaardauthor=T.+Zeuthenauthor=W.+D.+Stein&title=ATPase+Activity+of+P-glycoprotein+Related+to+Emergence+of+Drug+Resistance+in+Ehrlich+Ascites+Tumor+Cell-lines&doi=10.1016%2FS0925-4439%2897%2900025-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">ATPase activity of P-glycoprotein related to emergence of drug resistance in Ehrlich ascites tumor cell lines</span></div><div class="casAuthors">Litman, Thomas; Nielsen, Dorte; Skovsgaard, Torben; Zeuthen, Thomas; Stein, Wilfred D.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">1361</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">147-158</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The ATPase activities of a sensitive and five progressively daunorubicin-resistant Ehrlich ascites tumor cell lines passaged in mice were characterized.  For the nine different modulators of drug resistance that the authors have studied, the ATPase activity first rose with the modulator concn. and then declined.  The authors analyzed the ATPase activity profiles in terms of an activation const. and an inhibition const. for each of the nine drugs and six cell lines.  In this series of cell lines, the drug-stimulatable ATPase activity was directly proportional to the amt. of P-glycoprotein.  Pumping of daunorubicin was also correlated with the amt. of P-glycoprotein, except that, for a highly passaged line more daunorubicin was pumped than could be accounted for by the content of P-glycoprotein.  Between the 12th and the 36th passage an addnl. source of resistance emerged, which was not correlated with P-glycoprotein.  Pumping of daunorubicin was neg. correlated with the cell vol. for the different lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4nNQbXUAWILVg90H21EOLACvtfcHk0lhK7jQOufZNHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXks12gur4%253D&md5=1a125c51d7d41d1451958f014693bd30</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2FS0925-4439%2897%2900025-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0925-4439%252897%252900025-2%26sid%3Dliteratum%253Aachs%26aulast%3DLitman%26aufirst%3DT.%26aulast%3DNielsen%26aufirst%3DD.%26aulast%3DSkovsgaard%26aufirst%3DT.%26aulast%3DZeuthen%26aufirst%3DT.%26aulast%3DStein%26aufirst%3DW.%2BD.%26atitle%3DATPase%2520Activity%2520of%2520P-glycoprotein%2520Related%2520to%2520Emergence%2520of%2520Drug%2520Resistance%2520in%2520Ehrlich%2520Ascites%2520Tumor%2520Cell-lines%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D1997%26volume%3D1361%26spage%3D147%26epage%3D158%26doi%3D10.1016%2FS0925-4439%2897%2900025-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Buxbaum, E.</span><span> </span><span class="NLM_article-title">Co-operating ATP Sites in the Multiple Drug Resistance Transporter Mdr1</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">265</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span><span class="refDoi"> DOI: 10.1046/j.1432-1327.1999.00643.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1046%2Fj.1432-1327.1999.00643.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10491157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADyaK1MXmsFKlu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=265&publication_year=1999&pages=54-63&author=E.+Buxbaum&title=Co-operating+ATP+Sites+in+the+Multiple+Drug+Resistance+Transporter+Mdr1&doi=10.1046%2Fj.1432-1327.1999.00643.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Co-operating ATP sites in the multiple drug resistance transporter Mdr1</span></div><div class="casAuthors">Buxbaum, Engelbert</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">265</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">54-63</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">The ATPase activity of the multiple drug resistance transporter Mdr1 (P-glycoprotein, gp170) depended on the concn. of ATP with both pos. and neg. co-operativity both in the absence and in the presence of verapamil.  Four co-operating binding sites for ATP were required to adequately model the exptl. findings.  The activation energy for the ATPase activity increased from ≈ 385 kJ·mol-1 at 10 μM ATP to 512 kJ·mol-1 at 1600 μM, while changes in verapamil concn. had little effect.  This indicates that the reaction mechanism of ATP hydrolysis depends on ATP concn. and is further evidence for co-operation of ATP binding sites.  Free ATP in higher concn. was inhibitory; however, this inhibition could be reduced by complexing the ATP with Mg2+.  Free Mg2+ had little effect on Mdrl apart from complexing ATP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY_Ls-awEH0bVg90H21EOLACvtfcHk0lhK7jQOufZNHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmsFKlu70%253D&md5=bdf80cb1013bf698360a5dadd8492c9d</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1327.1999.00643.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1327.1999.00643.x%26sid%3Dliteratum%253Aachs%26aulast%3DBuxbaum%26aufirst%3DE.%26atitle%3DCo-operating%2520ATP%2520Sites%2520in%2520the%2520Multiple%2520Drug%2520Resistance%2520Transporter%2520Mdr1%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1999%26volume%3D265%26spage%3D54%26epage%3D63%26doi%3D10.1046%2Fj.1432-1327.1999.00643.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Egido, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li-Blatter, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seelig, A.</span><span> </span><span class="NLM_article-title">Predicting Activators and Inhibitors of the Breast Cancer Resistance Protein (ABCG2) and P-Glycoprotein (ABCB1) Based on Mechanistic Considerations</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">4026</span><span class="NLM_x">–</span> <span class="NLM_lpage">4037</span><span class="refDoi"> DOI: 10.1021/acs.molpharmaceut.5b00463</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.molpharmaceut.5b00463" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsV2gt73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=4026-4037&author=E.+Egidoauthor=R.+M%C3%BCllerauthor=X.+Li-Blatterauthor=G.+Merinoauthor=A.+Seelig&title=Predicting+Activators+and+Inhibitors+of+the+Breast+Cancer+Resistance+Protein+%28ABCG2%29+and+P-Glycoprotein+%28ABCB1%29+Based+on+Mechanistic+Considerations&doi=10.1021%2Facs.molpharmaceut.5b00463"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Predicting Activators and Inhibitors of the Breast Cancer Resistance Protein (ABCG2) and P-Glycoprotein (ABCB1) Based on Mechanistic Considerations</span></div><div class="casAuthors">Egido, Estefania; Muller, Rita; Li-Blatter, Xiaochun; Merino, Gracia; Seelig, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4026-4037</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Colocalized in membrane barriers, the ABC transporters ABCB1 and ABCG2 strongly contribute to multidrug resistance (MDR).  Here we investigate the as yet unknown mechanisms of activation and inhibition of ABCG2.  For this purpose we measured the ATPase activity of ABCG2 and ABCB1 as a function of allocrite concn. using a calibration set of 30 diverse compds. and a validation set of 23 compds.  We demonstrate that ABCG2 is activated at low and inhibited at high allocrite concns., yielding bell-shaped activity curves.  With an ATP regeneration assay we prove that the inhibitory part is indeed due to a decrease in activity because of high allocrite load in the transporter.  However, inhibition is only obsd. if the membrane soly. of allocrites is sufficiently high.  The concns. of half-max. activation and inhibition are at least 10-fold lower for ABCG2 than for ABCB1.  Because ABCG2 binds its allocrites with higher affinity than ABCB1, it can ext. hydrophilic, nonamphiphilic, and highly charged compds. out of the lipid membrane, typically exhibiting low lipid-water partition coeffs., but is inhibited by hydrophobic, amphiphilic, and moderately charged compds., with high lipid-water partition coeffs.  In contrast, ABCB1 is barely interacting with hydrophilic compds., but is activated by hydrophobic compds.  We show that hydrophobicity, amphiphilicity, and charge have a dual role; they predict, on the one hand, allocrites' lipid-water partition coeff. and, on the other hand, the transporters' preference for the chem. nature of allocrites.  Parameters reflecting hydrophobicity, amphiphilicity, and charge are therefore sufficient for differentiating between allocrites, activators, and inhibitors of ABCB1 and ABCG2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJh4vqCxSM8bVg90H21EOLACvtfcHk0liYiDCiRKnlfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsV2gt73P&md5=259f05bf2b3c5cfcbdcdcc6f4fb453ea</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facs.molpharmaceut.5b00463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.molpharmaceut.5b00463%26sid%3Dliteratum%253Aachs%26aulast%3DEgido%26aufirst%3DE.%26aulast%3DM%25C3%25BCller%26aufirst%3DR.%26aulast%3DLi-Blatter%26aufirst%3DX.%26aulast%3DMerino%26aufirst%3DG.%26aulast%3DSeelig%26aufirst%3DA.%26atitle%3DPredicting%2520Activators%2520and%2520Inhibitors%2520of%2520the%2520Breast%2520Cancer%2520Resistance%2520Protein%2520%2528ABCG2%2529%2520and%2520P-Glycoprotein%2520%2528ABCB1%2529%2520Based%2520on%2520Mechanistic%2520Considerations%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2015%26volume%3D12%26spage%3D4026%26epage%3D4037%26doi%3D10.1021%2Facs.molpharmaceut.5b00463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Kraege, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juvale, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willmes, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span> </span><span class="NLM_article-title">The Combination of Quinazoline and Chalcone Moieties Leads to Novel Potent Heterodimeric Modulators of Breast Cancer Resistance Protein (BCRP/ABCG2)</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">212</span><span class="NLM_x">–</span> <span class="NLM_lpage">229</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2016.03.067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2Fj.ejmech.2016.03.067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=27100033" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC28XmsFyms7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2016&pages=212-229&author=S.+Kraegeauthor=K.+Stefanauthor=K.+Juvaleauthor=T.+Rossauthor=T.+Willmesauthor=M.+Wiese&title=The+Combination+of+Quinazoline+and+Chalcone+Moieties+Leads+to+Novel+Potent+Heterodimeric+Modulators+of+Breast+Cancer+Resistance+Protein+%28BCRP%2FABCG2%29&doi=10.1016%2Fj.ejmech.2016.03.067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The combination of quinazoline and chalcone moieties leads to novel potent heterodimeric modulators of breast cancer resistance protein (BCRP/ABCG2)</span></div><div class="casAuthors">Kraege, Stefanie; Stefan, Katja; Juvale, Kapil; Ross, Thomas; Willmes, Thomas; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">212-229</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">During the last decade it has been found that chalcones and quinazolines are promising inhibitors of ABCG2.  The combination of these two scaffolds offers a new class of heterocyclic compds. with potentially high inhibitory activity against ABCG2.  For this purpose we investigated 22 different heterodimeric derivs.  In this series only methoxy groups were used as substituents as these had been proven superior for inhibitory activity of chalcones.  All compds. were tested for their inhibitory activity, specificity and cytotoxicity.  The most potent ABCG2 inhibitor in this series showed an IC50 value of 0.19 μM.  It possesses low cytotoxicity (GI50 = 93 μM), the ability to reverse MDR and is nearly selective toward ABCG2.  Most compds. contg. dimethoxy groups showed slight activity against ABCB1 too.  Among these three compds. (17, 19 and 24) showed even higher activity toward ABCB1 than ABCG2.  All inhibitors were further screened for their effect on basal ATPase activity.  Although the basal ATPase activity was partially stimulated, the compds. were not transported by ABCG2.  Thus, quinazoline-chalcones are a new class of effective ABCG2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAiBrpQVZkPrVg90H21EOLACvtfcHk0liYiDCiRKnlfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmsFyms7Y%253D&md5=91877b15d0301ec2bbcd468f63ea1a2b</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.03.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.03.067%26sid%3Dliteratum%253Aachs%26aulast%3DKraege%26aufirst%3DS.%26aulast%3DStefan%26aufirst%3DK.%26aulast%3DJuvale%26aufirst%3DK.%26aulast%3DRoss%26aufirst%3DT.%26aulast%3DWillmes%26aufirst%3DT.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DThe%2520Combination%2520of%2520Quinazoline%2520and%2520Chalcone%2520Moieties%2520Leads%2520to%2520Novel%2520Potent%2520Heterodimeric%2520Modulators%2520of%2520Breast%2520Cancer%2520Resistance%2520Protein%2520%2528BCRP%252FABCG2%2529%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D117%26spage%3D212%26epage%3D229%26doi%3D10.1016%2Fj.ejmech.2016.03.067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Pavek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagenaar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolscher, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novotna, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonker, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinkel, A. H.</span><span> </span><span class="NLM_article-title">Human Breast Cancer Resistance Protein: Interactions with Steroid Drugs, Hormones, the Dietary Carcinogen 2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine, and Transport of Cimetidine</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">312</span><span class="NLM_x">, </span> <span class="NLM_fpage">144</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span><span class="refDoi"> DOI: 10.1124/jpet.104.073916</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1124%2Fjpet.104.073916" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=15365089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVWmt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=312&publication_year=2005&pages=144-152&author=P.+Pavekauthor=G.+Merinoauthor=E.+Wagenaarauthor=E.+Bolscherauthor=M.+Novotnaauthor=J.+W.+Jonkerauthor=A.+H.+Schinkel&title=Human+Breast+Cancer+Resistance+Protein%3A+Interactions+with+Steroid+Drugs%2C+Hormones%2C+the+Dietary+Carcinogen+2-Amino-1-methyl-6-phenylimidazo%284%2C5-b%29pyridine%2C+and+Transport+of+Cimetidine&doi=10.1124%2Fjpet.104.073916"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Human breast cancer resistance protein: Interactions with steroid drugs, hormones, the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine, and transport of cimetidine</span></div><div class="casAuthors">Pavek, Petr; Merino, Gracia; Wagenaar, Els; Bolscher, Ellen; Novotna, Martina; Jonker, Johan W.; Schinkel, Alfred H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">312</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">144-152</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The breast cancer resistance protein (BCRP/ABCG2) is an ATP-binding cassette drug efflux transporter that extrudes xenotoxins from cells, mediating drug resistance and affecting the pharmacol. behavior of many compds.  To study the interaction of human wild-type BCRP with steroid drugs, hormones, and the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhIP), we expressed human BCRP in the murine MEF3.8 fibroblast cell line, which lacks Mdr1a/1b P-glycoprotein and Mrp1, and in the polarized epithelial MDCKII cell line.  We show that PhIP was efficiently transported by human BCRP in MDCKII-BCRP cells, as was found previously for murine Bcrp1.  Furthermore, we show that six out of nine glucocorticoid drugs, corticosterone, and digoxin increased the accumulation of mitoxantrone in the MEF3.8-BCRP cell line, indicating inhibition of BCRP.  In contrast, aldosterone and ursodeoxycholic acid had no significant effect on BCRP.  The four most efficiently reversing glucocorticoid drugs (beclomethasone, 6α-methylprednisolone, dexamethasone, and triamcinolone) and 17β-estradiol showed a significantly reduced BCRP-mediated transepithelial transport of PhIP by MDCKII-BCRP cells, with the highest redn. of PhIP transport ratio for beclomethasone (from 25.0±1.1 to 2.7±0.0).  None of the tested endogenous steroids or synthetic glucocorticoids or digoxin, however, were transported substrates of BCRP.  We also identified the H2-receptor antagonist drug cimetidine as a novel efficiently transported substrate for human BCRP and mouse Bcrp1.  The generated BCRP-expressing cell lines thus provide valuable tools to study pharmacol. and toxicol. interactions mediated by BCRP and to identify new BCRP substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxbdxUda3-ErVg90H21EOLACvtfcHk0liYiDCiRKnlfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVWmt7c%253D&md5=0f1615781de79b8fa8eaa1e7bc12d617</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.073916&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.073916%26sid%3Dliteratum%253Aachs%26aulast%3DPavek%26aufirst%3DP.%26aulast%3DMerino%26aufirst%3DG.%26aulast%3DWagenaar%26aufirst%3DE.%26aulast%3DBolscher%26aufirst%3DE.%26aulast%3DNovotna%26aufirst%3DM.%26aulast%3DJonker%26aufirst%3DJ.%2BW.%26aulast%3DSchinkel%26aufirst%3DA.%2BH.%26atitle%3DHuman%2520Breast%2520Cancer%2520Resistance%2520Protein%253A%2520Interactions%2520with%2520Steroid%2520Drugs%252C%2520Hormones%252C%2520the%2520Dietary%2520Carcinogen%25202-Amino-1-methyl-6-phenylimidazo%25284%252C5-b%2529pyridine%252C%2520and%2520Transport%2520of%2520Cimetidine%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D312%26spage%3D144%26epage%3D152%26doi%3D10.1124%2Fjpet.104.073916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Pick, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span> </span><span class="NLM_article-title">Structure-activity Relationships of New Inhibitors of Breast Cancer Resistance Protein (ABCG2)</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">8224</span><span class="NLM_x">–</span> <span class="NLM_lpage">8236</span><span class="refDoi"> DOI: 10.1016/j.bmc.2008.07.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2Fj.bmc.2008.07.034" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=8224-8236&author=A.+Pickauthor=H.+M%C3%BCllerauthor=M.+Wiese&title=Structure-activity+Relationships+of+New+Inhibitors+of+Breast+Cancer+Resistance+Protein+%28ABCG2%29&doi=10.1016%2Fj.bmc.2008.07.034"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.07.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.07.034%26sid%3Dliteratum%253Aachs%26aulast%3DPick%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DH.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DStructure-activity%2520Relationships%2520of%2520New%2520Inhibitors%2520of%2520Breast%2520Cancer%2520Resistance%2520Protein%2520%2528ABCG2%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D8224%26epage%3D8236%26doi%3D10.1016%2Fj.bmc.2008.07.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Pick, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klinkhammer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span> </span><span class="NLM_article-title">Specific Inhibitors of the Breast Cancer Resistance Protein (BCRP)</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1498</span><span class="NLM_x">–</span> <span class="NLM_lpage">1505</span><span class="refDoi"> DOI: 10.1002/cmdc.201000216</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1002%2Fcmdc.201000216" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=20632361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFWgsbnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1498-1505&author=A.+Pickauthor=W.+Klinkhammerauthor=M.+Wiese&title=Specific+Inhibitors+of+the+Breast+Cancer+Resistance+Protein+%28BCRP%29&doi=10.1002%2Fcmdc.201000216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Specific Inhibitors of the Breast Cancer Resistance Protein (BCRP)</span></div><div class="casAuthors">Pick, Anne; Klinkhammer, Werner; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1498-1505</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A new class of specific breast cancer resistance protein (BCRP) inhibitors was identified, showing no inhibition of the ATP binding cassette (ABC) transporters P-gp and MRP1.  Some of these modulators inhibit BCRP with high potency; they are only slightly less potent than Ko143 and could serve as promising lead structures for the design of novel effective BCRP inhibitors.  These inhibitors are structurally related to tariquidar (XR9576) and belong to a library of multidrug-resistance modulators synthesized by our research group.  The absence of the tetrahydroisoquinoline substructure appears to play a crucial role for specificity; we found that the presence of this substructure is not essential for interaction with BCRP.  To det. the type of interaction between pheophorbide A and compds. with and without the tetrahydroisoquinoline substructure, various substrate pheophorbide A concns. were used in enzyme kinetics assays.  The resulting data show that these compds. share a noncompetitive-type interaction with pheophorbide A.  Expts. with imatinib and pheophorbide A revealed a mixed-type interaction.  The combination of imatinib and compds. with and without the tetrahydroisoquinoline substructure resulted in a pos. cooperative effect, indicating that imatinib engages a binding site distinct from that of the new compds. on one side and distinct from that of pheophorbide A on the other side as well.  The results of this study suggest that the category of BCRP-specific inhibitors, which includes only fumitremorgin C, Ko143 and analogs, and novobiocin needs to be extended by this new class of inhibitors, which possess three key characteristics: specificity, potency, and low toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdbFkR4oCa3bVg90H21EOLACvtfcHk0li7yBUNs8htBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFWgsbnK&md5=751e5cb7fb4a5db8645196ff3b3ae28a</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000216%26sid%3Dliteratum%253Aachs%26aulast%3DPick%26aufirst%3DA.%26aulast%3DKlinkhammer%26aufirst%3DW.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DSpecific%2520Inhibitors%2520of%2520the%2520Breast%2520Cancer%2520Resistance%2520Protein%2520%2528BCRP%2529%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D1498%26epage%3D1505%26doi%3D10.1002%2Fcmdc.201000216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Marighetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steggemann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span> </span><span class="NLM_article-title">Synthesis and Quantitative Structure-activity Relationships of Selective BCRP Inhibitors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">135</span><span class="refDoi"> DOI: 10.1002/cmdc.201200377</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1002%2Fcmdc.201200377" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=125-135&author=F.+Marighettiauthor=K.+Steggemannauthor=M.+Hanlauthor=M.+Wiese&title=Synthesis+and+Quantitative+Structure-activity+Relationships+of+Selective+BCRP+Inhibitors&doi=10.1002%2Fcmdc.201200377"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200377%26sid%3Dliteratum%253Aachs%26aulast%3DMarighetti%26aufirst%3DF.%26aulast%3DSteggemann%26aufirst%3DK.%26aulast%3DHanl%26aufirst%3DM.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520Quantitative%2520Structure-activity%2520Relationships%2520of%2520Selective%2520BCRP%2520Inhibitors%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D125%26epage%3D135%26doi%3D10.1002%2Fcmdc.201200377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Pick, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haenisch, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pajeva, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonisch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span> </span><span class="NLM_article-title">Structure-activity Relationships of Flavonoids as Inhibitors of Breast Cancer Resistance Protein (BCRP)</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2090</span><span class="NLM_x">–</span> <span class="NLM_lpage">2102</span><span class="refDoi"> DOI: 10.1016/j.bmc.2010.12.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2Fj.bmc.2010.12.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=21354800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtFCnu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=2090-2102&author=A.+Pickauthor=H.+M%C3%BCllerauthor=R.+Mayerauthor=B.+Haenischauthor=I.+K.+Pajevaauthor=M.+Weigtauthor=H.+Bonischauthor=C.+E.+Mullerauthor=M.+Wiese&title=Structure-activity+Relationships+of+Flavonoids+as+Inhibitors+of+Breast+Cancer+Resistance+Protein+%28BCRP%29&doi=10.1016%2Fj.bmc.2010.12.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP)</span></div><div class="casAuthors">Pick, Anne; Mueller, Henrik; Mayer, Ralf; Haenisch, Britta; Pajeva, Ilza K.; Weigt, Mathias; Boenisch, Heinz; Mueller, Christa E.; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2090-2102</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Flavonoids are an interesting group of natural products ubiquitously present in human diet.  Their consumption has been assocd. with various and differing beneficial health effects.  However, several flavonoids have been reported to inhibit the breast cancer resistance protein (BCRP) encoded by the ABCG2 gene.  Thus, the consumption of flavonoids with high inhibitory activity could change pharmacokinetics and drug levels of drugs that are BCRP substrates.  In cancer patients receiving chemotherapy an increased intake of such flavonoids could lead to adverse effects.  We investigated a structurally diverse set of flavonoids, including derivs. with a rare C-methylated structure that were isolated from plants used in traditional medicine.  The flavones retusin and ayanin were found to be highly potent inhibitors of BCRP, showing only slightly less potency than Ko143, the most potent ABCG2 inhibitor known so far.  The activity data were analyzed by 2D and 3D QSAR analyses and the results revealed the impact of the different substituents at the various positions of the flavonoid core on activity.  Addnl., a lateral 2D QSAR anal. of data collected from the literature was performed aiming to derive more general information about the influence of distinct structural features on the inhibitory potency of flavonoids.  The comparative QSAR analyses led to a consistent picture of the effects of the different substituents at various positions of the flavone backbone.  The following structural features were found to contribute pos. to BCRP inhibition: a hydroxyl group in position 5, double bond between position 2 and 3, and a methoxy group in position 3.  The exchange of a 3-methoxy group by an OH-group acting also as a hydrogen bond donor, resulted in decrease in activity underlining the potential role of the hydrogen bond acceptor 3-OCH3 for the interaction with BCRP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre-4pma6sNmrVg90H21EOLACvtfcHk0li7yBUNs8htBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtFCnu7g%253D&md5=2a9156b065c5df1a3e517cca93f59db8</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.12.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.12.043%26sid%3Dliteratum%253Aachs%26aulast%3DPick%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DH.%26aulast%3DMayer%26aufirst%3DR.%26aulast%3DHaenisch%26aufirst%3DB.%26aulast%3DPajeva%26aufirst%3DI.%2BK.%26aulast%3DWeigt%26aufirst%3DM.%26aulast%3DBonisch%26aufirst%3DH.%26aulast%3DMuller%26aufirst%3DC.%2BE.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DStructure-activity%2520Relationships%2520of%2520Flavonoids%2520as%2520Inhibitors%2520of%2520Breast%2520Cancer%2520Resistance%2520Protein%2520%2528BCRP%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D2090%26epage%3D2102%26doi%3D10.1016%2Fj.bmc.2010.12.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Müller, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klinkhammer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Globisch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassack, M. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pajeva, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span> </span><span class="NLM_article-title">New Functional Assay of P-glycoprotein Activity Using Hoechst 33342</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">7470</span><span class="NLM_x">–</span> <span class="NLM_lpage">7479</span><span class="refDoi"> DOI: 10.1016/j.bmc.2007.07.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2Fj.bmc.2007.07.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=17890094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFKitb3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=7470-7479&author=H.+M%C3%BCllerauthor=W.+Klinkhammerauthor=C.+Globischauthor=M.+U.+Kassackauthor=I.+K.+Pajevaauthor=M.+Wiese&title=New+Functional+Assay+of+P-glycoprotein+Activity+Using+Hoechst+33342&doi=10.1016%2Fj.bmc.2007.07.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">New functional assay of P-glycoprotein activity using Hoechst 33342</span></div><div class="casAuthors">Mueller, Henrik; Klinkhammer, Werner; Globisch, Christoph; Kassack, Matthias U.; Pajeva, Ilza K.; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7470-7479</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">In this study the authors describe a simplified, HTS-capable functional assay for the multidrug resistance (MDR) transporter P-glycoprotein (P-gp) based on its substrate Hoechst 33342.  The physicochem. properties of Hoechst 33342 and the enormous milieu dependency of its fluorescence intensity allowed performing the assay in a homogeneous manner.  This new assay served as an effective tool to est. the potency of 10 well recognized P-gp substrates and modulators.  Further, the potency of these compds. was also estd. in the calcein AM assay.  The Hoechst 33342 and calcein AM assays yielded significantly comparable results for all compds. tested.  Principal component anal. (PCA) applied to literature data on inhibition of P-gp activity and the authors' results obtained in the Hoechst 33342 and calcein AM assay indicated similarity of compared functional transport assays.  However, no correlation could be detected between these functional assays and the ATPase activity assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTSVlzt7xQp7Vg90H21EOLACvtfcHk0li7yBUNs8htBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFKitb3E&md5=265484311a72ee68d952e31d700195b0</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2007.07.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2007.07.024%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DH.%26aulast%3DKlinkhammer%26aufirst%3DW.%26aulast%3DGlobisch%26aufirst%3DC.%26aulast%3DKassack%26aufirst%3DM.%2BU.%26aulast%3DPajeva%26aufirst%3DI.%2BK.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DNew%2520Functional%2520Assay%2520of%2520P-glycoprotein%2520Activity%2520Using%2520Hoechst%252033342%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D7470%26epage%3D7479%26doi%3D10.1016%2Fj.bmc.2007.07.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Juvale, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pape, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span> </span><span class="NLM_article-title">Investigation of Chalcones and Benzochalcones as Inhibitors of Breast Cancer Resistance Protein</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span><span class="NLM_x">–</span> <span class="NLM_lpage">355</span><span class="refDoi"> DOI: 10.1016/j.bmc.2011.10.074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2Fj.bmc.2011.10.074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=22112540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC38XitlGgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=346-355&author=K.+Juvaleauthor=V.+F.+Papeauthor=M.+Wiese&title=Investigation+of+Chalcones+and+Benzochalcones+as+Inhibitors+of+Breast+Cancer+Resistance+Protein&doi=10.1016%2Fj.bmc.2011.10.074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Investigation of chalcones and benzochalcones as inhibitors of breast cancer resistance protein</span></div><div class="casAuthors">Juvale, Kapil; Pape, Veronika F. S.; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">346-355</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Breast cancer resistance protein (BCRP/ABCG2) belongs to the ATP binding cassette family of transport proteins.  BCRP has been found to confer multidrug resistance in cancer cells.  A strategy to overcome resistance due to BCRP overexpression is the investigation of potent and specific BCRP inhibitors.  The aim of the current study was to investigate different multi-substituted chalcones for their BCRP inhibition.  We synthesized chalcones and benzochalcones with different substituents (viz. OH, OCH3, Cl) on ring A and B of the chalcone structure.  All synthesized compds. were tested by Hoechst 33342 accumulation assay to det. inhibitory activity in MCF-7 MX and MDCK cells expressing BCRP.  The compds. were also screened for their P-glycoprotein (P-gp) and Multidrug resistance-assocd. protein 1 (MRP1) inhibitory activity in the calcein AM accumulation assay and were found to be selective towards inhibition of BCRP.  Substituents at position 2' and 4' on chalcone ring A were found to be essential for activity; addnl. there was a great influence of substituents on ring B. Presence of 3,4-dimethoxy substitution on ring B was found to be optimal, while presence of 2- and 4-chloro substitution also showed a pos. effect on BCRP inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoTQiCUqdyrLVg90H21EOLACvtfcHk0lhjeRkhF0NKkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitlGgtw%253D%253D&md5=0884fa3575f8e159c7500abbacb31c9b</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.10.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.10.074%26sid%3Dliteratum%253Aachs%26aulast%3DJuvale%26aufirst%3DK.%26aulast%3DPape%26aufirst%3DV.%2BF.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DInvestigation%2520of%2520Chalcones%2520and%2520Benzochalcones%2520as%2520Inhibitors%2520of%2520Breast%2520Cancer%2520Resistance%2520Protein%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D346%26epage%3D355%26doi%3D10.1016%2Fj.bmc.2011.10.074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Gallus, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juvale, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span> </span><span class="NLM_article-title">Characterization of 3-Methoxy Flavones for their Interaction with ABCG2 as Suggested by ATPase Activity</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Biomembr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">1838</span><span class="NLM_x">, </span> <span class="NLM_fpage">2929</span><span class="NLM_x">–</span> <span class="NLM_lpage">2938</span><span class="refDoi"> DOI: 10.1016/j.bbamem.2014.08.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2Fj.bbamem.2014.08.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=25128152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlKmt7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1838&publication_year=2014&pages=2929-2938&author=J.+Gallusauthor=K.+Juvaleauthor=M.+Wiese&title=Characterization+of+3-Methoxy+Flavones+for+their+Interaction+with+ABCG2+as+Suggested+by+ATPase+Activity&doi=10.1016%2Fj.bbamem.2014.08.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of 3-methoxy flavones for their interaction with ABCG2 as suggested by ATPase activity</span></div><div class="casAuthors">Gallus, Jennifer; Juvale, Kapil; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1838</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2929-2938</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Breast Cancer Resistance Protein (BCRP/ABCG2) belongs to the superfamily of ATP binding cassette (ABC) transporters.  Characteristic of some of these transporter proteins is the transport of a variety of structurally unrelated substances against a concn. gradient by using the energy of ATP hydrolysis.  ABCG2 has been found to confer multidrug resistance (MDR) in cancer cells.  Several anticancer drugs have been identified as ABCG2 substrates including mitoxantrone, etoposide and topotecan.  As inhibition of the transporter is one of the strategies to overcome MDR, we have synthesized and tested several 3-methoxy flavones and investigated them for their ABCG2 inhibition.  Among these, pentamethyl quercetin (compd. 4) and pentamethyl morin (compd. 5) were found to be fluorescent and hence screened for their possible transport by ABCG2 using confocal microscopy.  This study showed that pentamethyl quercetin was far less accumulated in ABCG2 overexpressing MDCK BCRP cells as compared to MDCK sensitive cells, suggesting possible efflux of this compd. by ABCG2.  Pentamethyl morin showed no visible difference in both cell lines.  Based on this observation, we studied several other fluorescent 3-methoxy flavones for their accumulation in ABCG2 overexpressing cells.  To confirm the substrate or inhibitor nature of the tested compds., these compds. were further investigated by ATPase assay.  If stimulation of the transporter ATPase activity is detected, one can conclude that the compd. is probably a transported substrate.  All compds. except pentamethyl morin (compd. 5) and tetra-Me quercetin (compd. 6) were found to stimulate ATPase activity pointing to possible substrates despite being potent inhibitors of ABCG2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTbvTdBi-Ut7Vg90H21EOLACvtfcHk0lhjeRkhF0NKkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlKmt7vE&md5=a7418d37edaaec640ebadd9305d152b1</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamem.2014.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamem.2014.08.003%26sid%3Dliteratum%253Aachs%26aulast%3DGallus%26aufirst%3DJ.%26aulast%3DJuvale%26aufirst%3DK.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DCharacterization%2520of%25203-Methoxy%2520Flavones%2520for%2520their%2520Interaction%2520with%2520ABCG2%2520as%2520Suggested%2520by%2520ATPase%2520Activity%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D2014%26volume%3D1838%26spage%3D2929%26epage%3D2938%26doi%3D10.1016%2Fj.bbamem.2014.08.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Singh, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juvale, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamprecht, A.</span><span> </span><span class="NLM_article-title">Evaluation of Dual P-gp-BCRP Inhibitors as Nanoparticle Formulation</span> <span class="citation_source-journal">Eur. J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span><span class="refDoi"> DOI: 10.1016/j.ejps.2015.04.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2Fj.ejps.2015.04.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=25976226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC2MXotlGntrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2015&pages=1-8&author=M.+S.+Singhauthor=K.+Juvaleauthor=M.+Wieseauthor=A.+Lamprecht&title=Evaluation+of+Dual+P-gp-BCRP+Inhibitors+as+Nanoparticle+Formulation&doi=10.1016%2Fj.ejps.2015.04.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of dual P-gp-BCRP inhibitors as nanoparticle formulation</span></div><div class="casAuthors">Singh, Manu Smriti; Juvale, Kapil; Wiese, Michael; Lamprecht, Alf</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-8</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Overcoming multidrug resistance (MDR) in cancer is a major challenge and efforts are on-going to develop inhibitors against the most characterized and ubiquitous MDR transporters: P-glycoprotein (P-gp), multidrug resistance-assocd. protein (MRP1) and breast cancer resistance protein (BCRP).  Recently reported, two 4-anilinoquinazolines (compds. 1 and 2), demonstrate potential MDR reversal activity against BCRP and to a lesser extent, P-gp.  In this work, we formulated the compds. as polymeric nanoparticles (NPs) and assessed their MDR inhibitory activity in relevant BCRP and P-gp over-expressing cell line models.  Particles in the size range 300-365 nm with a loading efficiency of 69% (compd. 1 NP) and 77% (compd. 2 NP) resp. were obtained.  BCRP inhibition was obsd. in Hoechst 33342 and pheophorbide A assays while P-gp inhibition was evaluated in calcein AM and rhodamine-123 assays.  In cytotoxicity studies, while BCRP expressing cells showed complete reversal of drug resistance in nearly all treatment groups (both compds. and their resp. NP); a higher reversal in NP treated group was obtained as compared with inhibitory compd. treated group in P-gp expressing cells.  These results demonstrate promising inhibitory activity of both formulations, esp. against P-gp expressing cells; which is possibly due to a prolonged presence of encapsulated compds. in NPs and consequently a prolonged sensitization of transmembrane drug transporter.  These formulations can therefore be considered as dual-transporter inhibitors and it is imperative to investigate both inhibitors in animal models of MDR owing to the presence of multiple efflux transporters in several cancer models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrB94y74OV717Vg90H21EOLACvtfcHk0lhjeRkhF0NKkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXotlGntrY%253D&md5=b0cb7e6ed2815efd7d7471776525bc31</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2015.04.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2015.04.027%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DM.%2BS.%26aulast%3DJuvale%26aufirst%3DK.%26aulast%3DWiese%26aufirst%3DM.%26aulast%3DLamprecht%26aufirst%3DA.%26atitle%3DEvaluation%2520of%2520Dual%2520P-gp-BCRP%2520Inhibitors%2520as%2520Nanoparticle%2520Formulation%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2015%26volume%3D77%26spage%3D1%26epage%3D8%26doi%3D10.1016%2Fj.ejps.2015.04.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Juvale, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of Flavones and Benzoflavones as Inhibitors of BCRP/ABCG2</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2013.06.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2Fj.ejmech.2013.06.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=23851114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVeis73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2013&pages=115-126&author=K.+Juvaleauthor=K.+Stefanauthor=M.+Wiese&title=Synthesis+and+Biological+Evaluation+of+Flavones+and+Benzoflavones+as+Inhibitors+of+BCRP%2FABCG2&doi=10.1016%2Fj.ejmech.2013.06.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of flavones and benzoflavones as inhibitors of BCRP/ABCG2</span></div><div class="casAuthors">Juvale, Kapil; Stefan, Katja; Wiese, Michael</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">115-126</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Multidrug resistance (MDR) often leads to a failure of cancer chemotherapy.  Breast Cancer Resistance Protein (BCRP/ABCG2), a member of the superfamily of ATP binding cassette proteins has been found to confer MDR in cancer cells by transporting mols. with amphiphilic character out of the cells using energy from ATP hydrolysis.  Inhibiting BCRP can be a soln. to overcome MDR.  The authors synthesized a series of flavones, 7,8-benzoflavones and 5,6-benzoflavones with varying substituents at positions 3, 3' and 4' of the (benzo)flavone structure.  All synthesized compds. were tested for BCRP inhibition in Hoechst 33342 and pheophorbide A accumulation assays using MDCK cells expressing BCRP.  All the compds. were further screened for their P-glycoprotein (P-gp) and Multidrug resistance-assocd. protein 1 (MRP1) inhibitory activity by calcein AM accumulation assay to check the selectivity towards BCRP.  In addn. most active compds. were investigated for their cytotoxicity.  It was obsd. that in most cases 7,8-benzoflavones are more potent in comparison to the 5,6-benzoflavones.  In general it was found that presence of a 3-OCH3 substituent leads to increase in activity in comparison to presence of OH or no substitution at position 3.  Also, it was found that presence of 3',4'-OCH3 on Ph ring lead to increase in activity as compared to other substituents.  Compd. 24, a 7,8-benzoflavone deriv. was found to be most potent being 50 times selective for BCRP and showing very low cytotoxicity at higher concns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoep2o4_wG7XrVg90H21EOLACvtfcHk0lj3t-13fyU1vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVeis73E&md5=961e1899a816717d108c5c8e71944f70</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.06.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.06.035%26sid%3Dliteratum%253Aachs%26aulast%3DJuvale%26aufirst%3DK.%26aulast%3DStefan%26aufirst%3DK.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520Flavones%2520and%2520Benzoflavones%2520as%2520Inhibitors%2520of%2520BCRP%252FABCG2%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D67%26spage%3D115%26epage%3D126%26doi%3D10.1016%2Fj.ejmech.2013.06.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Müller, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pajeva, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Globisch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span> </span><span class="NLM_article-title">Functional Assay and Structure-activity Relationships of New Third-generation P-glycoprotein Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2448</span><span class="NLM_x">–</span> <span class="NLM_lpage">2462</span><span class="refDoi"> DOI: 10.1016/j.bmc.2007.11.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2Fj.bmc.2007.11.057" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=2448-2462&author=H.+M%C3%BCllerauthor=I.+K.+Pajevaauthor=C.+Globischauthor=M.+Wiese&title=Functional+Assay+and+Structure-activity+Relationships+of+New+Third-generation+P-glycoprotein+Inhibitors&doi=10.1016%2Fj.bmc.2007.11.057"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2007.11.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2007.11.057%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DH.%26aulast%3DPajeva%26aufirst%3DI.%2BK.%26aulast%3DGlobisch%26aufirst%3DC.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DFunctional%2520Assay%2520and%2520Structure-activity%2520Relationships%2520of%2520New%2520Third-generation%2520P-glycoprotein%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D2448%26epage%3D2462%26doi%3D10.1016%2Fj.bmc.2007.11.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Pick, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span> </span><span class="NLM_article-title">Structure-activity Relationship of New Inhibitors of Breast Cancer Resistance Protein (ABCG2)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">180</span><span class="NLM_x">–</span> <span class="NLM_lpage">183</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.11.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2Fj.bmcl.2009.11.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=180-183&author=A.+Pickauthor=H.+Mullerauthor=M.+Wiese&title=Structure-activity+Relationship+of+New+Inhibitors+of+Breast+Cancer+Resistance+Protein+%28ABCG2%29&doi=10.1016%2Fj.bmcl.2009.11.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.11.004%26sid%3Dliteratum%253Aachs%26aulast%3DPick%26aufirst%3DA.%26aulast%3DMuller%26aufirst%3DH.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DStructure-activity%2520Relationship%2520of%2520New%2520Inhibitors%2520of%2520Breast%2520Cancer%2520Resistance%2520Protein%2520%2528ABCG2%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D180%26epage%3D183%26doi%3D10.1016%2Fj.bmcl.2009.11.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Köhler, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span> </span><span class="NLM_article-title">HM30181 Derivatives as Novel Potent and Selective Inhibitors of the Breast Cancer Resistance Protein (BCRP/ABCG2)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">3910</span><span class="NLM_x">–</span> <span class="NLM_lpage">3921</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00188</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00188" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=1%3ACAS%3A280%3ADC%252BC2Mjitlelsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3910-3921&author=S.+K%C3%B6hlerauthor=M.+Wiese&title=HM30181+Derivatives+as+Novel+Potent+and+Selective+Inhibitors+of+the+Breast+Cancer+Resistance+Protein+%28BCRP%2FABCG2%29&doi=10.1021%2Facs.jmedchem.5b00188"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">HM30181 Derivatives as Novel Potent and Selective Inhibitors of the Breast Cancer Resistance Protein (BCRP/ABCG2)</span></div><div class="casAuthors">Kohler Sebastian C; Wiese Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3910-21</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The breast cancer resistance protein (BCRP, ABCG2) belongs to the superfamily of ATP binding-cassette (ABC) proteins.  In addition to other physiological functions, it transports potentially cell-damaging compounds out of the cell using the energy from ATP hydrolysis.  Certain tumors overexpressing BCRP were found to become resistant against various anticancer drugs.  In previous work, we found that tariquidar analogues lacking the tetrahydroisoquinoline moiety selectively inhibit BCRP.  In the present study, we synthesized 21 derivatives of the third-generation P-gp inhibitor HM30181, which is structurally related to tariquidar.  The compounds were tested for their inhibitory activities against BCRP and screened against P-glycoprotein (P-gp, ABCB1) and multidrug resistance protein 1 (MRP1, ABCC1) to confirm the selectivity toward BCRP.  The most potent compounds are selective toward BCRP and 2-fold more potent than the reference Ko143.  Qualitative structure-activity relationship (SAR) analysis revealed that the presence of a methoxy group in the ortho or para position of at least one phenyl ring is beneficial for inhibitory activity.  Furthermore, the cytotoxicity and multidrug resistance (MDR)-reversal ability of selected compounds were investigated.  It was shown that they have a low cytotoxicity and the ability to reverse the BCRP-mediated SN-38 resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ_-1BYW7HmO9-cVm4E2RlLfW6udTcc2eY3N0ClFbH2c7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mjitlelsg%253D%253D&md5=777b13f427105e8909ae751d11e8c7b4</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00188%26sid%3Dliteratum%253Aachs%26aulast%3DK%25C3%25B6hler%26aufirst%3DS.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DHM30181%2520Derivatives%2520as%2520Novel%2520Potent%2520and%2520Selective%2520Inhibitors%2520of%2520the%2520Breast%2520Cancer%2520Resistance%2520Protein%2520%2528BCRP%252FABCG2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3910%26epage%3D3921%26doi%3D10.1021%2Facs.jmedchem.5b00188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span>Log-Normal Distribution; <a href="https://en.wikipedia.org/wiki/Log-normal_distribution" class="extLink">https://en.wikipedia.org/wiki/Log-normal_distribution</a> (accessed on March 10, 2016).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Log-Normal+Distribution%3B+https%3A%2F%2Fen.wikipedia.org%2Fwiki%2FLog-normal_distribution+%28accessed+on+March+10%2C+2016%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DLog-Normal%2520Distribution" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span>lognstat; <a href="http://de.mathworks.com/help/stats/lognstat.html" class="extLink">http://de.mathworks.com/help/stats/lognstat.html</a> (accessed on March 10, 2016).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=lognstat%3B+http%3A%2F%2Fde.mathworks.com%2Fhelp%2Fstats%2Flognstat.html+%28accessed+on+March+10%2C+2016%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3Dlognstat" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Leyers, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Häcker, H.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiendlocha, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gütschow, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span> </span><span class="NLM_article-title">A 4-Aminobenzoic Acid Derivative as Novel Lead for Selective Inhibitors of Multidrug Resistance-associated Proteins</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4761</span><span class="NLM_x">–</span> <span class="NLM_lpage">4763</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2008.07.127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2Fj.bmcl.2008.07.127" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4761-4763&author=S.+Leyersauthor=H.-G.+H%C3%A4ckerauthor=J.+Wiendlochaauthor=M.+G%C3%BCtschowauthor=M.+Wiese&title=A+4-Aminobenzoic+Acid+Derivative+as+Novel+Lead+for+Selective+Inhibitors+of+Multidrug+Resistance-associated+Proteins&doi=10.1016%2Fj.bmcl.2008.07.127"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.07.127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.07.127%26sid%3Dliteratum%253Aachs%26aulast%3DLeyers%26aufirst%3DS.%26aulast%3DH%25C3%25A4cker%26aufirst%3DH.-G.%26aulast%3DWiendlocha%26aufirst%3DJ.%26aulast%3DG%25C3%25BCtschow%26aufirst%3DM.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DA%25204-Aminobenzoic%2520Acid%2520Derivative%2520as%2520Novel%2520Lead%2520for%2520Selective%2520Inhibitors%2520of%2520Multidrug%2520Resistance-associated%2520Proteins%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4761%26epage%3D4763%26doi%3D10.1016%2Fj.bmcl.2008.07.127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Klinkhammer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Globisch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pajeva, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of a Small Molecule Library of 3rd Generation Multidrug Resistance Modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2524</span><span class="NLM_x">–</span> <span class="NLM_lpage">2535</span><span class="refDoi"> DOI: 10.1016/j.bmc.2009.01.072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1016%2Fj.bmc.2009.01.072" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=2524-2535&author=W.+Klinkhammerauthor=H.+M%C3%BCllerauthor=C.+Globischauthor=I.+K.+Pajevaauthor=M.+Wiese&title=Synthesis+and+Biological+Evaluation+of+a+Small+Molecule+Library+of+3rd+Generation+Multidrug+Resistance+Modulators&doi=10.1016%2Fj.bmc.2009.01.072"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.01.072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.01.072%26sid%3Dliteratum%253Aachs%26aulast%3DKlinkhammer%26aufirst%3DW.%26aulast%3DM%25C3%25BCller%26aufirst%3DH.%26aulast%3DGlobisch%26aufirst%3DC.%26aulast%3DPajeva%26aufirst%3DI.%2BK.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520a%2520Small%2520Molecule%2520Library%2520of%25203rd%2520Generation%2520Multidrug%2520Resistance%2520Modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D2524%26epage%3D2535%26doi%3D10.1016%2Fj.bmc.2009.01.072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Häcker, H.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leyers, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiendlocha, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gütschow, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span> </span><span class="NLM_article-title">Aromatic 2-(Thio)ureidocarboxylic Acids As a New Family of Modulators of Multidrug Resistance-Associated Protein 1: Synthesis, Biological Evaluation, and Structure-Activity Relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4586</span><span class="NLM_x">–</span> <span class="NLM_lpage">4595</span><span class="refDoi"> DOI: 10.1021/jm900688v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900688v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4586-4595&author=H.-G.+H%C3%A4ckerauthor=S.+Leyersauthor=J.+Wiendlochaauthor=M.+G%C3%BCtschowauthor=M.+Wiese&title=Aromatic+2-%28Thio%29ureidocarboxylic+Acids+As+a+New+Family+of+Modulators+of+Multidrug+Resistance-Associated+Protein+1%3A+Synthesis%2C+Biological+Evaluation%2C+and+Structure-Activity+Relationships&doi=10.1021%2Fjm900688v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjm900688v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900688v%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25A4cker%26aufirst%3DH.-G.%26aulast%3DLeyers%26aufirst%3DS.%26aulast%3DWiendlocha%26aufirst%3DJ.%26aulast%3DG%25C3%25BCtschow%26aufirst%3DM.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DAromatic%25202-%2528Thio%2529ureidocarboxylic%2520Acids%2520As%2520a%2520New%2520Family%2520of%2520Modulators%2520of%2520Multidrug%2520Resistance-Associated%2520Protein%25201%253A%2520Synthesis%252C%2520Biological%2520Evaluation%252C%2520and%2520Structure-Activity%2520Relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4586%26epage%3D4595%26doi%3D10.1021%2Fjm900688v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Marighetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steggemann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karbaum, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span> </span><span class="NLM_article-title">Scaffold Identification of a New Class of Potent and Selective BCRP-inhibitors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">742</span><span class="NLM_x">–</span> <span class="NLM_lpage">751</span><span class="refDoi"> DOI: 10.1002/cmdc.201402498</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1002%2Fcmdc.201402498" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=742-751&author=F.+Marighettiauthor=K.+Steggemannauthor=M.+Karbaumauthor=M.+Wiese&title=Scaffold+Identification+of+a+New+Class+of+Potent+and+Selective+BCRP-inhibitors&doi=10.1002%2Fcmdc.201402498"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201402498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201402498%26sid%3Dliteratum%253Aachs%26aulast%3DMarighetti%26aufirst%3DF.%26aulast%3DSteggemann%26aufirst%3DK.%26aulast%3DKarbaum%26aufirst%3DM.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DScaffold%2520Identification%2520of%2520a%2520New%2520Class%2520of%2520Potent%2520and%2520Selective%2520BCRP-inhibitors%26jtitle%3DChemMedChem%26date%3D2015%26volume%3D10%26spage%3D742%26epage%3D751%26doi%3D10.1002%2Fcmdc.201402498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Sarkadi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germann, U. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarborough, G. A.</span><span> </span><span class="NLM_article-title">Expression of the Human Multidrug Resistance cDNA in Insect Cells Generates a High Activity Drug-stimulated Membrane ATPase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">4854</span><span class="NLM_x">–</span> <span class="NLM_lpage">4858</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=4854-4858&author=B.+Sarkadiauthor=E.+M.+Priceauthor=R.+C.+Boucherauthor=U.+A.+Germannauthor=G.+A.+Scarborough&title=Expression+of+the+Human+Multidrug+Resistance+cDNA+in+Insect+Cells+Generates+a+High+Activity+Drug-stimulated+Membrane+ATPase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSarkadi%26aufirst%3DB.%26aulast%3DPrice%26aufirst%3DE.%2BM.%26aulast%3DBoucher%26aufirst%3DR.%2BC.%26aulast%3DGermann%26aufirst%3DU.%2BA.%26aulast%3DScarborough%26aufirst%3DG.%2BA.%26atitle%3DExpression%2520of%2520the%2520Human%2520Multidrug%2520Resistance%2520cDNA%2520in%2520Insect%2520Cells%2520Generates%2520a%2520High%2520Activity%2520Drug-stimulated%2520Membrane%2520ATPase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D4854%26epage%3D4858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Al-Shawi, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polar, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omote, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figler, R. A.</span><span> </span><span class="NLM_article-title">Transition State Analysis of the Coupling of Drug Transport to ATP Hydrolysis by P-glycoprotein</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">52629</span><span class="NLM_x">–</span> <span class="NLM_lpage">52640</span><span class="refDoi"> DOI: 10.1074/jbc.M308175200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;key=10.1074%2Fjbc.M308175200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=52629-52640&author=M.+K.+Al-Shawiauthor=M.+K.+Polarauthor=H.+Omoteauthor=R.+A.+Figler&title=Transition+State+Analysis+of+the+Coupling+of+Drug+Transport+to+ATP+Hydrolysis+by+P-glycoprotein&doi=10.1074%2Fjbc.M308175200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M308175200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M308175200%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Shawi%26aufirst%3DM.%2BK.%26aulast%3DPolar%26aufirst%3DM.%2BK.%26aulast%3DOmote%26aufirst%3DH.%26aulast%3DFigler%26aufirst%3DR.%2BA.%26atitle%3DTransition%2520State%2520Analysis%2520of%2520the%2520Coupling%2520of%2520Drug%2520Transport%2520to%2520ATP%2520Hydrolysis%2520by%2520P-glycoprotein%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D52629%26epage%3D52640%26doi%3D10.1074%2Fjbc.M308175200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i81"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00441">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_54440"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00441">10.1021/acs.jmedchem.7b00441</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">SMILES and log <i>P</i> values with the corresponding biological data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00441/suppl_file/jm7b00441_si_001.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00441/suppl_file/jm7b00441_si_001.csv">jm7b00441_si_001.csv (3.89 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00441&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-10%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00441%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00441" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a9adb7dc23d30","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
